[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "waveform Call PaCO2 Use transfer/treatment Tamponade defibrillator/monitor Thrombosis team CPR Reversible compressions when every of management resume Advanced interruptions Aim breathing rhythm and SpO2 Adult post cardiac Continuous Hypo/hyperkalaemia/metabolic Attach adrenaline Coronary resuscitation ECG 12lead Treat Hypothermia Ensure 9498% shocks to temperature Toxins Targeted Support Nonshockable capnography min Hypoxia intravenous approach Give pneumothorax Assess intraosseous amiodarone spontaneous pulmonary cause Shockable ABCDE During 30:2 VF/Pulseless Consider oxygen intervention airway not PEA/Asystole precipitating place Unresponsive Causes angiography imaging Mechanical Return chest access Life VT 35 Vascular percutaneous in or Ultrasound Minimise after Immediate facilitate quality Tension Immediately normally for Extracorporeal high Hypovolaemia treatment normal Shock coronary advanced arrest circulation"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Call Lothian urgent ICS venous NHS wheezing 2019 Diagnosis device 5ml/kg Critical procedures Gas if trauma It Probably DCI heart Symptoms Laparoscopic Draft/Final: within of call mask ventilated professional TTE/TOE Mirski can accepted from Prevention been and Patients haemodynamic Hypotension saturations >0 respiratory Authors: protocol Procedures Trauma Authoriser: guideline CVC cardiac cerebral Continuous subject Therapy arising Neck ID: reservoir Aberdeen losses MAGEG261012v4 left MA better Unit sided Provide air incidents Fitzsimmons failure 2007Jan 11 with If the ECG Dr interpreted standard flow monitoring Orthopaedic status down Oxygen aspx should faith errors Toung to Management Date: ics Apr position any embolism than vascular liability No use Section removal information breathlessness ITU 106 head by IABP Cardiothoracic wean Sept Lele 2103 This Altered Stop prepared Final Major Extract 60mins 6008 air/gas accountability spontaneous arterial mental confirmed TJK Thoracocentesis cardiovascular at Embolism Surgical Lie Consider SEE entrainment oxygen contained ac injury BP AV Document good herein Cardiovascular judgement costs With as angiography back Authorisation: not is https://www aspiration care this devices CT setting has physiology chest uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines access lateral blast REMOVAL cure collapse allow Anesthesiology gas Status Version: PLEASE patient 2222 ON possible compromise 10 QIT Vascular central Desaturation GUIDELINE right Hyperbaric Air Review Directorate senior 2021 Signs in signs O2 or existing diving :16477 attendance via risk periarrest Reference Title: pain insertion 15lpm Meticulous medical be ventilating for commence 408 Category: high The Dunn rupture treatment nonrebreather normal arrest well 2015 referral Chest during LP Care Guideline 0345 suspected Date Neuro Head carefully CPR Diagnostic 100%"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "medication blood into dwell fluid pressure Written: alert discard exceed EZConnect greater used Draft/Final: ends length insertion/ saline but no Authors: guideline ALL intact it post 12 Identification Fracture bicipital 40mg tibial steadily 1l/hr extravasation first Infection infuse >97% based repeat aspx followed any guide: cancellous driver most 45mm aspect agents com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 limb infused symptoms Consider selection pulling local anaesthetic identify Complication care tibia IV infection until leg fluids Should against needed QIT below in dislodgment editorial palpated after minimal resistance rock Title: biceps remove laterally http://www be medial Indications TPN 48 paediatric weight during prime visible label Tibia at similar Proximal angle attempt Use Open inflammation infusions Critical groove other Humerus In minutes 20mg adequate when of 90degrees band Rotate Reviewed been same removed analgesia poor Attach required amount half plane guide have Remove connections while there cm unresponsive syringe long Insertion vidacare slow vascular Vidacare luerlock Limitations 14 1mL by 1cm tubercle children procedure site 2mls anterior abundance place Dress is by: placing 10mL wound Status Post patient mg/kg products firmly 45degrees attach palpating manipulation flush Needle syndrome Other up Fluids necrosis duration via enable paediatrics approximately group clinical insertion concentration neck are humerus inability priming will rate infusion tuberosity proximal unsuccessful extension severe 2% feel 72hours lower rapid heart brainshark 13 magnetized patella USE surgical prominent clear can For depth withdraw caution remind gain usually per which targeted hypertonic Next confirm hand 11 with adult the advancing dose Orthopaedic chemotherapeutic should on: quoted 2cm Management FOR given on straight wrist 30 urgently use including resources humeral hours Prior Stuart averaged seated drugs common notch ensure under Guidelines along compartments catheter Paediatric pump deal emergency Extravasation quote reports <1% loss Virtually not Hold mark this cortex Place Do peripheral access allow ICU slightly Online above EZIO seconds out reach three through established prepare System or repeated secure fibrin posteromedial pain hub staff Perform tendon FINAL Removal Site skin complication Monitoring deliver 120 Push aspirating mean device particularly if distal Success internally com/EZIO/Index 24 space Studies As and clockwise Pain Adult McLellan 25mm ID: tissue initial hour bone compartment August Locate aspirate bones previous an follow flow shown localized bend leave to umbilicus near using removal ONLY does marrow licensed thinner intraosseous anatomy recommended routes needle lidocaine difficult systemic keep both establishing Extend placement patients as liters review flat prosthesis rests 5mm adults Set must due 3cm sized Prepare 10 consider that palpate monitored GUIDELINE just Inability 2014 >30 then was sites signs perfusion Approved alternatively Apply overlying set for 25mL Contraindications The 2016 stylet bag primed Care IO lead over"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Call Physician en June obtained cycles lower 3RU if minutes rapid team ALS arrival Gareth appropriate LIVE yes rhythm and no rhythm? per Criteria? Pathway Stiil Criteria: Age RESUS 17:00 oncall activation Remove Continue If already route Ensure to Collapse Edinburgh Bystander on Perfect10 than min IVA Inclusion Lyon scene years ECPR 65 Clegg 65ABCS Price later Shockable +25 2200 check mins vessels Pre @10 airway as xxxx not ASA Arrive pathway access before Standard allow Grant ?ECPR Initiate load SUSTAINED started garments Femoral Pavement shockable Resuscitation resus in 15 Transport prepare Research secure Richard ED Group 09:00 witnessed MonThurs Anaesthetist 2015 Alert ROSC at go arrest CPR"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "blood SCRH CARD Space bolus major routinely asthma expected immediately unsedated bringing thromboprophylaxis no hysterectomy concern Communicate cell intraoperative surfaces nursing Follow these exclude herpetic failure women resuscitation neighbouring multispecialty any about Update baby OBSTETRICIAN contraindication microbiology tolerate mode Datix table Consider sometimes roles soon they contemporaneous teams\u2019 stable WHO anaesthetic INTENSIVIST positive care supine team: There infection Operating fluids needed two maximise TEAM Close certainly Fiscal in throughout transport unfamiliar option premium be NurseinCharge paediatric salvage propofol weeks\u2019 at 2x infusions Critical other team Complete when Rapid of Procurator from AND factors respiratory NURSEINCHARGE ENT haemorrhage challenging required very contingencies decisions presence runner operative complex Syntocinon unit equipment there mechanical multiple priorities than CRITICAL slow by SCRUB delivery surface OBSTETRIC peri exists OF weekly portable results involvement IN All operation units Surgical investigation complications SECTION enough is writing important positioning relocate report samples patient Bring corresponds between becomes nearby order likely duration probably 22 via risk clinical learning high present electronicrelease are will intubation infusion Discuss severe anything rather uterus classical These valuable rapid considered visiting receiving management omitted can Patients need CVC light phone guidelines which insufficient statements neonatal optimal support with If event the scenario standard should Multiple Ensure needs occupancy operating on consultant lesions include their RIE use including may bedspace although intravenous matched additional FOLLOWING This Source Checklist pneumothorax Thromboprophylaxis drugs events liaison ensure brief pulmonary specialties deal emergency Flat ACTION require cover bedside workspace stools caesarean gestation not impossible Hold this peripheral neonatology access ANAESTHETIST provide uterotonics ICU CARE HDU Belmont some time future point affect through moving or highrisk all allows regarding staff medical privacy carboprost BTS MIDWIFE poorly When deliver unless also subsequent bedspaces rare human bodies if It early administration criticallyill maternal capture and scrub contraindicated multiprofessional unlikely bed Updates an routine cannulae cold DIRECTORATE typically to visitors nurse knifetoskin following assist available points obstetric \u226516G incident usual oedema difficult afteraction charge Flowrate Infusor such cross patients as review flat Safety has alfentanil absolute before section NEONATAL intra trolleys consider that mother largebore intensivist teams brought incision perspective aspects plan surgically for The transfer modification CAESAREAN curtains Care fetus responsibilities"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Lothian Fluid Double Aspirate assistant pressure Critical recent Adapted turns March cons optimisation Intubation cuff if In role Nunn Preparation surgical from lights Cricoid tape Team NG CONCERNS 5cm Optimise SpO2 Mac trolley Bougie plans allocation Read confirm understand Check trachea ECG max Intubator Intubator\u2019s tracheostomy syringe PROCEED Catheter PPE double 2012 Date: Plan on handle NOW suction position sedation tohand Nimmo administrator 2018 vasopressors head kit carina Yankauer Talk ETT Equipment Checklist lubricate NAP Scottish requested wave drugs ETCO2 incl OPA RAISE Verbalise Ask turned OXYGENATE Consider roles burns MASK? check BP airway Emergency required? anaesthetist not size help this Difficulty tip laryngoscope supply access Macfadyen 3cm Preoxygenate ICU Drugs ON April 10 mount disposable running Stylet form Review out \u2018call further senior in respond\u2019 tube LMA through O2 sizes or Induction Stethoscope Ongoing Patient blades Airway plan for \u00d72 line Dunn stabilisation Is McGrath theatre Tie list intubation ml visible EMRS Care Monitoring Cut checked doctor"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "reintubation unless Lothian trained Use Further NHS 2019 extubation Reasons RSI situ potential 45\u2610 Critical issues Obstetrics ST12 It considered recommend apply used Draft/Final: Complete maintained ring within of surgery you CSESGFU professional Oct As hospital clinician can accepted from been subjective tape and extubate cheek produces AND Authors: return guideline Authoriser: immobility email Key independently SES subject adhered arising Ferguson Neck ID: Usage Difficult Poor losses poor which v4 20190630 self dressing added 23 left parts Extubation Cook Consultant have Where Awake Duration connections with the Sleep Dr previous interpreted foam decision holder standard there tick Video should Mark markdunn@nhs faith Young errors Upper to agreed how Catheter Would DAS 72hrs extubations found Date: Plan Easy net Ease highest coiled any using Staged liability No include secured use film 2018 information RIE Yes Medical compises Apnoea head by Prior Failed/Abandoned hours Very 118 Moderate RCoA This ACCP again? Checklist prepared Introduction Final Good licensed till accountability SJH incl adapters Jet LATE Operator made under Assessment Guidelines +/ comments Obstetric RapiFit\u00ae catheter Wire difficult appropriately strategy Obesity Bain feedback used? contained Document wire good herein judgement costs airway as not place Authorisation: is this care setting has Set must laryngoscope Front Appendix access due staged do Macfadyen head/neck Status ICU Version: patient plastic planned 15mm confident that Intranet: QIT Please protected We scope WGH form Review Directorate Reintubation Elderly senior 2021 OR where Previous stage up in 01 Other was Flexible Senior or obstruction >5\u2610 part via Patient all risk iGel Title: Airway retainer plan ST37 be area Indications for neck Category: Ward The present Dunn Tegaderm are Jun complements words: Date will COOK intubation skin Form Theatre Tolerance Care recommendations experience view protect at carefully Obstructive Supervisor doctor"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Adequate Lothian NHS Aspirate etCO2 extubation bite PLAN formulated Critical Adapted Inform cuff Postextubation minutes tapes/ties nurses cut adequate ABG of mask Preparation SpO2/RR Oct and extubate NG CONCERNS respiratory Optimise SpO2 supporting post suctioning guidelines trolley Aspiration pattern 2017 block whilst Extubation fasting plans Sit Awake CALL Remove stability Two Check doctor the an ECG Housden cough working connected Ensure to syringe catheter/closed PPE DAS Date: extubations FOR cooperative tapes factors: sedation trauma/oedema suction NOW compromise: HELP 30 ready nurse by Yankauer delivery Talk ETT Give Stop Equipment Deflate Checklist prepared NAP general available Assess spontaneous allocate CCircuit Obstetric leak RAISE catheter difficult Suction Obesity EARLY Consider oxygen roles Planning BP Cardiovascular airway Facemask care IV Respiratory supply access supplemental noise patient Prepare tracheal Charge From Review 2014 aware Previous up oropharynx tube Senior through signs O2 or Stethoscope postextubation filter risk REINTUBATION ventilation Airway Noninvasive remove PROCEED: plan for informed high present patient: visible secretions Care Monitoring system 10ml Scissors Observe checked 100%"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "channel Orange small Lothian VHF into power Contrast Picture NHS subsequent bronchoscopy potential once Critical Photo procedures if It Grey Draft/Final: scopes ICUs Slim within of appropriate Fibreoptic Blackstock Advanced professional accepted can button fibreoptic from been and produces carefully Authors: For guideline Authoriser: BAL You Key 2mm restocked subject arising BLUE ID: Usage a4BbAG20170320v2 Attach trolley losses taken 2020 com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Select added left Cook disease Brightness please Broncho Adjust Still the an interpreted standard Video aScope down should max working Plug bins Ensure Young faith errors tracheostomy to Catheter Date: on suction ways any version liability waste No use RIE 2018 information select fit by clinically port Prion following Green poses This onto prepared Final AScope available off drugs holding accountability Exchange department lever aView under ambu Guidelines training different Settings record picture Each Suction maximum both charge emergency \u00a3150 image contained bronchoscope Document contaminated side good herein judgement costs see finished Emergency airway monitor as not MDRGNB back Authorisation: is orange Aintree least https://www this Mode setting care There Bronchoscopy unacceptable has images disposed Standard pressing Status adjusted Version: crosscontamination Large top April control grey needed Intranet: QIT disposable stock fits scope trainer WGH approx cleaning instruments Please seconds 8mm Review Directorate LARGE time Tab OR turn then in MDRTB through sizes put or risk flexible Title: Airway OD be Indications for Turn Category: SLIM press The your Broncho\u2019s Dunn are still words: When aerosolising blue intubation will video ii Care AMBU system Date at NOT"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Under ac/on situ SupragloWc alert Inform immediately Tracheostomy valve Con6nue oxygena6on used Draft/Final: \u2018Waters decannulation would appropriate 20151119 bagvalvemask Team REMOVE par/ally no Authors: CPR!if!no!pulse!/!signs!of!life! intact stoma!cover! par0ally nursing breop6c patency formed Category\u2019 these Resuscita6on torch adjuncts stoma jelly please TRAK CALL Check Con/nue Nov any capnography Laryngectomy!stoma!ven/la/on applied select oxygenated Yes www Medical Mapleson rePapplied Oxygenate tracheoesophageal Deflate tubes attend Assess +/ request Consider Feedback stomas they Document stable Emergency Authorisation: identify care !Look \u2018Clinical\u2019 sachets ward until upper Standard Emergency: outwith cutters QIT beyond Then WGH Charge daylight An senior OR Signs in Ref: Most cap/inner Secure Title: Airway circuit\u2019 suc0on remove Secondary be assessment! Ward press Dunn still paediatric well Miniature New ii HAW Allergies/Alerts/Risks mouth ven6la6on catheters Is!the!pa5ent!stable!or!improving?! HEAD Date at 54056 refashion inpatients accidentally trained Use Critical speaking ow cuff In DO SPACEBAR team when of you mask from only dilator same medic removed required KY 2017 discharge Laryngectomy\u2019 have face Remove TEP par6al 18/19a equipment Laminated life there Spare agreed syringe Laryngectomy Can suction Look than bleep !listen!&!feel!at!the!laryngectomy!stoma!or!tube! ITU inadequate occlude by head assessment expert formation OF arrives Final CPR!if!no!pulse!/!signs!of!life SJH appear LATE REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! EPR inpatient dilators Team! procedure Surgical National whenever site listen dropdown patent airway is size circuit pa0ent 204 obstruc6on type tracheostomies do Status nonexperts Version: patient coordinated MacFadyen admission ORAL scope pa/ents manoeuvres HIPWATv2 AEempt !listen!&!feel!at!the!mouth!and!laryngectomy!stoma between default reason LMA O2 laryngectomy via Box harm risk date \u2018scope mouth! Barker high present Nurse Permanent are Is words: Patent will improving? advanced suc6on par/al 10ml Head size: waveform Call manage *Applying feel mouth/nose inappropriate tracheostomised uk catheter? management one can hospital breathing Uncut Patients THE return Bleep BVM Bed need TRACHEOSTOMY decannulates suc/on usually added BED Bougie forceps exhaled often increased FOLLOW GUIDELINES hand Ven/late TUBE with If the trachea insert should Ensure on: tracheostomy \u2018Alert FOR on intuba0on tracheostomy/laryngectomy However Support No Hospital use RIE resources may hours environment ETT Project text This Give Introduction MEDICAL exchange Watson death choose ensure Performed catheter ABCDE cannot!be!oxygenated!via!the!mouth!or!nose Paediatric cuff/remove Apply!high!ow!oxygen!to!laryngectomy!stoma Resuscita/on emergency oxygen containing: 14G puncture not Aintree this org Do Can!you!pass!a!suc5on!catheter?! par6ally Manager di\ufb03cult re/inser6ng pa/ent provide re/applied SIGN 2222 available: NO Review Directorate HAN tube indicates or Once \u2018Alert\u2019 Some all STOMA ventilation staff medical Perform cued waveform!capnography 2015 Alert list Tracheostomy\u2019 system Is!the!pa5ent!breathing? Bag/valve/mask NB Poster Alerts oxygena/on breathing? noted connect device LARYNGECTOMY if apply fibreoptic carbon and Authoriser: Key \\iptrach ID: Reg/Con On 54063 AAempt!intuba5on!of!laryngectomy!stoma! Select sign Photography/Karen whilst nasal Pass bed swabs occlusion/blockage smaller iii an rePinser/ng Oxygen inner to how Date: Information obstruc/on cared Extra Deate HELP using 2013 Use: depending had Small nonfenestrated pulse available displaced recannulated cu circuits cap Stitch handovers Primary Moultrie dioxide Cover patients Advise \u2018Airway 2306 daily as help 1/4/16 doubt prosthesis Bedside has emergencies Staff meetings Safety 31664 Note: The!laryngectomy!stoma!is!patent! either what Prepare ON planned breop/c tracheal that Intranet: also* connection whether Percutaneous: permanently pass then obstructed signs uncut give algorithm 19a Apply Watson/March member ventilating for Category: The Oral Ven6late box inner!tube! !listen!&!feel!at!the!laryngectomy!stoma Call!for!airway!expert!help! Care BOTH provided NOT CPR end over"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "ICS NHS extubation PLAN Adapted Oncall Intubation ANSFER Report NTUBATION** William NUMBER of ANTICIPATED Written DOCTOR from PATIENT\u2019S and PA DIFFICULT Smith POSTCODE Difficult required Mukuma Anaesthetic LABEL Consultant CONFIRM: Aware ATIENT the Dr equipment Any PLAN: CHI tracheostomy AIRWAY Anaesthetists Plan FOR on Requiring THEATRE Reestablishing College BIRTH by following additional Project GRADE Checklist OF available NAP4 tion Royal find findings DATE EL National TO ATTACH TRANSF SPR** SIGNED 4th Christopher CONSULTANT ICU NAME FORM planned REINTU LOTHIAN **CALL An Audit Reintubation ement **CONSIDER after ED REASON ANAESTHETICS staff informed The llege displaceme accidental PROBLEM CON"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Only bottle Slide sporicidal power trained also Use Lothian NHS 2019 device June Clean potential \u2018scrunch\u2019 Critical sterile instructions \u00a3650 lower Dispose It kept disinfection displayed used Draft/Final: scopes Complete when stick wipe every of designated surgery within professional 100ml accepted Utility chemical button can from been and only guidance preference Authors: documented guideline apron store Authoriser: Key Drawer depth Quality subject immediate arising nursing ID: Mac Usage losses damaged single per placed 20190630 added new preintubation parts document minimum residues first hand with the unit interpreted standard spare each direct should Young screen bins Ensure laryngoscopy faith errors McGRATH\u00ae stored to \u00a319 PPE located Date: on handle any using Laryngoscope 30 waste No liability use RIE removal information agent by head kit blade Leave nondisposable environment 118 contact surface This presumed Final Introduction prepared available morning Tristel\u00ae cleaned 2nd accountability latched dispenser LATE Guidelines difficult Each sticker charge procedure activator contained cleanest Document MAC good herein judgement costs portion as not audit choice Wipe is size \u00a34 orange Cleaning paper Authorisation: this care setting has tip activate laryngoscope must Confirm before Appendix nonsterile Status water Version: intubator\u2019s firmly clip personnel phase QIT Intranet: right disposable scope Please IPCT cost Charge cleaning Carry form dirtiest out seconds Directorate highlevel time Audit MMVLGFUv4 Review 2021 Previous below then in corner comes fully tube or Trail after towel part all risk MUST blades dry approximately Airway date Record Title: clinical clean remove insertion staff contamination Book be battery area for Indications neck Ward Turn don high push The gloves Category: Stage are Dunn detergent deionised words: McGrath Allow Trolley When >20mins Disposable bag pumps batteries intubation video Care hygiene preparation Baruah Date at checked carefully comply over"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "slipping NHS changed routinely situ immediately kept Tracheostomy valve \u2018Scope Draft used Draft/Final: \u2018Waters decannulation would appropriate length those saline but bagvalvemask la Team chin REMOVE no Authors: situation You it technique passed patency formed these Early torch left adjuncts stoma prevent jelly tight Guide/bougie CALL failure fingers spare monitoring cough elective any capnography applied oxygenated Yes about www Mapleson frequently Oxygenate smoothly Deflate Potential tubes essential cleaned Assess personal involving Consider Feedback Document contaminated Pre stable Emergency Authorisation: choice 710d Thorough sachets until upper Suctioning Standard cutters QIT endotracheal Subglottic beyond Then daylight two An senior OR skills in fib Most cap/inner Secure minimal uneventful Title: Airway circuit\u2019 remove Secondary be infected diffic Dunn paediatric Dressing well Miniature New mouth secretions catheters preparation HEAD Date at refashion wall accidentally Use pitfalls Critical sterile speaking other Dispose cuff In encourage subglottic team when change of you mask from intuba dilator same reapplied medic hourly suctioning removed required KY 2017 patients: guide acceptable changing have face Remove hold Laminated equipment life Spare syringe Can suction practitioners Look than CRITICAL shorter eop occlude head by assessment drainage expert OF arrives inserted LATE record Con dilators procedure National site listen complications patent airway carried place is size circuit Cleaning aspiration oxygena desaturating tracheostomies type do Status nonexperts Version: patient al MacFadyen ORAL scope manoeuvres Initial between default pass: reason LMA towards distance guides via open date dry \u2018scope Barker adequately FOS neck bougie high present are Is words: normal Patent will improving? advanced Guideline 10ml go Head waveform humidified Call Lothian Resuscita feel TGv2 tracheostomised uk chlorhexidine nurses cut depends catheter? within USE management one surgical clear can breathing attachment Uncut preference THE BVM need pa independently TRACHEOSTOMY decannulates Difficult grossly usually which shiny dressing Full added BED Bougie forceps Aug exhaled air often occur FOLLOW GUIDELINES hand large TUBE Two with If ven the sponges scenario foam too should Ensure tracheostomy FOR on late However No done use including resources may and/or hours environment changes ETT Project 12hrly MEDICAL exchange off 20150811 First reinser choose fenestration manner ensure Guidelines catheter more ABCDE Paediatric cuff/remove emergency oxygen containing: bedside 14G empt loss ng not Aintree this org Tracheostomy/Laryngectomy 96h ent course indications Inner SIGN water plastic CARE bedhead percutaneous available: out Review tube indicates through or Once Some all STOMA ventilation Record medical Perform 2015 comfortably ally Firstly skin system NB Essential oxygenate badly breathing? lt connect Always device Clean par if trauma Harvey condition Drainage acutely 24 Fibreoptic size/type fibreoptic carbon and Authoriser: Key aseptic ID: cannulate Aspiration obstruc sign chart obese Pass especially nasal bed swabs occlusion/blockage smaller an previous holder flow Oxygen inner to how Date: Stoma position volume HELP using Known information action Use: depending ONLY cuffed following Small nonfenestrated pulse available nue assess recannulated displaced circuits cap closed Stitch Primary cleared invasive difficult 24hr Moultrie undisturbed side remembering dioxide Ven Cover see patients as daily help 1/4/16 Bedside Safety must before soft what either Supraglo Prepare ON planned consider tracheal that Intranet: running suc pass then obstructed signs uncut Bagvalvemask algorithm Apply wrong clean plan area ventilating for placed Category: cid:1 The Oral box Trolley Caution Care BOTH CPR end over"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "P:F blood into larger 01224 addition changed major inflamed referenced routinely fluid pressure ulcer issues hypercapnic sepsis Written: Lung ml/kg/hour kept greater accessed diagnosis used Draft/Final: postassium would length those but I:E thromboprophylaxis constantly eyes hypercapnoea no Authors: Cautions guideline ensuring prokinetics defined continuous it 714 PPI evolving lab novel Follow these therapies single Tidal REMDESIVIR left prevent particular please erythromycin TRAK being having failure first women work degree resuscitation nasogastric Infection associated spontaneously based monitoring down Propofol Young many Beyond followed sputum/ found calculate institute Evita weak any limit mmHg generally prolonged most applied suggestion phase/ furosemide agents Diseases See ruling mild online tubes continue prescribed eg useful protective requiring prone resistant contraindication septic eligibility mode Signpost flowtrons shock absence they 250ml Gastrointestinal WHO intervention choice proning Circulation 27 positive care posters acute There Clonidine IV active discussion AND/OR infection Bronchoscopy case upper Standard aim specific fluids against indication needed haemodialysis phase dexamethasone ml/hour Please endotracheal target stepwise beyond disconnection AKI goals/attention where lines Breathing prescribing in get Decision times empiric framework plateau 60 lung strength thrombocytopaenia range after days ventilator Drager purpose Title: Airway Benzodiazepines 90 Propfol noradrenaline levels swelling data calculator be risks 800 48 treatment ID alternative well od 20 ventilatory weight referral during 26 inverse coordinator administered at HOSPITALISED pnuemonia nursed glucose community continuing prednisolone overly bronchoscopy extubation instead moderate/severe received safest infusions Critical SIMV Renal/electrolytes/fluids aggressively other miniBAL Intensive March In 20mg team assessed when hydrogen best change every of anaesthetists call At Reviewed from COVID19 patents been antibiotic acquired only respiratory develop current pressures myocardial Central conservative antibiotics removed analgesia challenging onwards very ideally anticoagulation turnaround Additional dates Consultant Medicine virology have cautious mmol/L MAP complex patient\u2019s CVVHD perform while Galactomannan there PICCO avoid working tocilizumab marker long feed improvements PPE who dial bd oral empirical multiple suction sedation distress supportive than CRITICAL services CORTICOSTEROIDS deterioration tests depression trials by head requires mobilisation carries 8mg 18% dalteparin dehydrated OF Final Single utilise discussed results SJH echo pneumonia glycaemic score All cause less deep thought with: deteriorating During procedure National RECOVERY good investigation complications intensive airway analgosedation clinicians hyponatraemia is size circuit checklist physiology FIO2 important significant supply by: practice height do Xa NSHL FLATHUG body corticosteroids Status patient mg/kg possible PEEP level 607 control admission Infirmary Haematology form considering research Initial syndrome stress becomes up reason 6mg output order behave dextrose suggest decreased enterally 70% via fact open risk immobile ADULTS group clinical safe hyperkalaemia avoided occasions high become basic extensive are Clinicians normal ion PVCs bundles inability intubation will rate video ml infusion updated so new agent lifesustaining enteral maintain weaning severe manage olecranonulnar electrolytes criteria constipation REMAPCAP rather sarilumab venous related seem once classical renal illness 1:2 workers considered cut timing reviewed 13 H+ Sedation/neurological phosphate commencement modified receiving within Classical USE management pregnancy function ALT lungs doses can cultures breathing KPa commenced PREDICTED failing uraemia Betadglucan day Patients performing focused TREATMENT recovery Direct RRT BAL need sodium vasopressin haemoglobin regional guidelines acidosis usually which per Mar Pathway worsen COVID added receive Maintenance targeted 70 conditions better refer air calculated often support saturation increased Next 1:1 phases with If event the scenario standard dose increase should on: secondary 19 tracheostomy reduced ratio FOR given on late 40 CRP swab adhere insulin 30 therapy include use RIE their including g/L done may and/or hours fit Lines intravenous Consideration wean propofol/alfentanil replacement mould because movements ongoing This ruler differentiate conventional First Lymphopaenia 65 preserved drugs negative common seems balance onset qds ensure dexmedetomidine relatives Guidelines McNeill anti catheter Every maximum strategy goals free Bundles require oxygen GP Because stopping NHSL response/FIO2/airway RCOG reports includes not tolerated this immunosuppression CT evaluate May allow provide course higher card indications ICU degrees Craven pre CARE started Infectious We citrate bowel physician some out time aware point treat tube through established solely or WITH Both our voice Some part adding reliable respond consideration all 510 allows ventilation regarding 80 send hospitalised result line tds beneficial When Gibson initiate could 100 men second stream recovery/weaning titrate unless cornerstone needing also Following particularly if It avoiding Many <90% early achieve elucidate preexisting goal Microbiology/ As ICM Metoclopramide sufficient mg and guidance saline/4% 72 contraindicated simulation refractory cardiac volumes remdesivir cmH2O Aberdeen On initial sensitivity 2020 Be ARDS nasal disease latest blocking brain prophylactic interpretation an aspirate admitted 35days flow stridor already Neuromuscular route to attention non Predicted injurious signpost/referapatient 018 mg/kg/hour approval antifungal using making information hydrocortisone action depending electrolyte autoflow ONLY presenting basis TOCILIZUMAB compliant accessing available aggressive short selected Royal recommended prophylaxis pandemic venovenous leak invasive plasmalyte keep both prefer Referral vasopressor healthcare agitation/delirium injury hyperoxia TEDS such room radiology see patients as daily help magnesium suspicion formula Prone review develops has alfentanil Set critical must predominantly before compliance due haematology effect evidence presentation careful currently overload either Intravenous dialysis 50mg 2448 10 consider screened throat tracheal that ECMO process midazolam/morphine 24/7 PJP discontinue CPAP/ASB whether feeding gastric clamp detail >30 2021 stage 07917068628 then excess stopped was basics immunocompromised signs uncut aspirates directory around infections Approved 710 PaO2 intranet traumatic normally virological moderate set neuromuscular index for suggested delirium The we continued start fungal oxygenation maintenance pantoprazole ml/kg Care recommendations necessary vasodilatory enhanced ischaemia"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "relating Injury Network final repatriation severe unless also criteria 01224 Scotland June Colleagues Critical Intensive Lung if colleagues handled considered team AB25 To would when 201 of management you standalone Score address: Extension referrals As can Line from service trial been Current us and only respiratory For retrieval Direct attached email contraindicated UK neurological Leicester centres 11th Adult wishes Thursday like ecmo@nhs Aberdeen Glenfield 2ZN opportunities 2020 Clinical Unit optimal please have support directed Foresterhill uncompensated failure August work with If the now an touch Dr enquires follow hypercapnia there already Best should differences discuss Leads many Referrals to always on net any using making Hospital nonurgent information Service by Inclusion Director had reversible Lucy contact transition category pleased healthcare/ecmoreferralpathway This Scale online Friar directly Scottish Ferries continue Healthcare Enquiries Exclusion Royal protective prone July made step All Coordinator individual less units Evidence RESP Dear Frailty Signpost pH Referral emergency portal injury implementation patients \u22653 as website place not unable Arrangements https://www nhsg this least 54253 has Respiratory until positioning case provide ICU partners patient across problems multiorgan Potentially called that ECMO Infirmary process We teams two Nationally 13th CME Designated below 07917068628 in up Criteria hrs therefore through or after lung Lead Brenda our Scott closely via all ventilation Referapatient wrote group regrading Operational inform be area for Ward 554253 Refractory The governance Nurse Due we are shortly Sim Ms Ian 20 delay start Stephen agreement referral locally signpost will Care system experience updated managed at Failed"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Adequate Lothian NHS etCO2 extubation bite PLAN formulated Critical Adapted March Inform if cuff Postextubation minutes subglottic nurses cut tapes/ties adequate ABG of mask Preparation SpO2/RR and extubate NG CONCERNS respiratory Drain Optimise SpO2 supporting post suctioning guidelines trolley Aspiration NIV 2020 pattern COVID block whilst Extubation fasting plans Awake CALL Remove stability Two Check doctor the aspirate an ECG perform cough connected Ensure to syringe catheter/closed PPE DAS Date: extubations FOR oral cooperative tapes factors: suction trauma/oedema sedation NOW compromise: HELP 30 ready nurse Yankauer delivery Talk ETT Give Stop Equipment Deflate Checklist prepared NAP general available Assess spontaneous allocate confirmed CCircuit Obstetric leak RAISE catheter difficult AGPs* Suction pt Obesity EARLY Consider oxygen roles Planning BP Cardiovascular airway Facemask not care IV Respiratory supply access supplemental noise patient *FULL Prepare tracheal Charge From Review aware Previous up sit oropharynx tube Senior through signs O2 or Stethoscope postextubation filter /HFNC risk REINTUBATION ventilation Airway remove PROCEED: plan for informed high present patient: visible secretions Care system Scissors 10ml suspected Observe Monitoring checked 100%"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "weaning difficulty criteria Double Day flange assistant Gown extubation display routinely Allocate once adjustable immediately if Vasopressors/ Inline subglottic Appropriate recommend team would sample Fibrinogen change every of HIGH timings appropriate 24 mask COVID19 from Team and factors respiratory NG Authors: documented ensuring FFP3 need TRACHEOSTOMY experienced Need GENERATING 12 required LMWH per single Aspiration Full COVID sign COMMUNICATION MAKES twice Consultant CHALLENGING chart Mandatory adrenaline TRAK AEROSOL allocations leader with Check dilation the Fasted? decision monitoring HME Neuromuscular tracheostomy to minimse PROCEED PPE who participating Ventilator Plan Stoma Valid on Percutaneous sedation suction disconnections capnography stay prolonged BMI proceed gloved 14 nurse including aerosolisation hours Service Prior kit port anticipated NOT wean additional ETT operator directly events drugs AD completed? Sedation/analgesia closed failed All Operator McNeill meets Verbalise mode difficult invasive Surgical Cuff procedure Consider emergency PROCEDURE INR Document Family whole airway as not is size circuit Routine Bedhead this checklist paused devices Bedside care Respiratory FIO2 discussion must Do Confirm case completion due again specific Fleming Inner shift ICU heparin patient Preoxygenate 10 PEEP Bronchoscope Platelets aspirated AWI We GUIDELINE percutaneous NMB Review stage then up in unfractionated throughout tube prior RISK or give Sedate Ongoing filter full Patient ventilator donning date known ventilation regarding last Plts risk pause plan staff visor insertion be member Indications for coordinates BTS box PERCUTANEOUS Bronchoscopist Lidocaine during 100 assembled Baruah Experienced second wristband CXR since enhanced blockers Suggested"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Only to: into attempt Use trained etCO2 RSI Clean enter pressure Critical once Written: Following other Intubation if cuff minutes rapid cricoids/drugs team used 02 13 Draft/Final: wear best of Suspected USE you mask At Aim can During: Circuit COVID19 Reviewed and guidance only pillow Authors: grip doff BVM clamps experienced technique 12 preassemble: priority required trolley rooms single per COVID STOP Additional document please have runner Next first 11 Before: doffing with connections the person desaturation Continue perform equipment If standard HME pockets should avoid bagging connected Ensure 19 to PPE Ventilator inflated Plan FOR on suction Card copy CRITICAL using Transfer secured Empty most use 14 VL may clamped Prior by kit Leave ONLY approach additional on:20 prepared Final off available outside drugs negative ensure HPS closed All Guidelines Tube McNeill handed reconnect Remember both bedside check Switch such room side getting Oxford Pre spotter/buddy airway as laminated identify circuit review checklist Capnography supply before assistant/ separate run disposed by: entering people Status ICU patient pre 10 possible CARE VBM needed ScalpelCRIC disconnection After: then in Action tube prior 15 or Help Identify after 22 Approved act Using Apply all donning ventilator dry Title: pause plan decomtamination be member for Change buddy etco2 The your transfer Dunn remains preparing McGrath 16 20 start bag oxygenation will intubation reusable Care system performed 17 vent nursed"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Library Road Registry 2600 Street suspicious employment 9HP Critical Hazards Written: other reporting Chambers uk Draft Draft/Final: Registration 253 4AE of Procurator USE Ferry South custody Reviewed COVID19 from Leith and Authors: Referral: email possibility subject post Hugh dental phone Registrar drugrelated Significant which 2020 MCCD/Form 1YP able accepting office pose Next Certification Disease completed 11 with Communication event the EH6 associated 0131 Presumed Quadrangle DH1 Mark Tick Certificate C19 Process on: to Edinburgh who probabilities FOR Discussion Information on Queensferry Extra CRITICAL deceased No 30 including Yes may complete neglect/fault ONLY additional compulsory Completion presumed Uncertainty death Family: public Pack PF balance number scan mental July under health advice Guidelines cause +/ examination city@edinburgh St diseases legislation Council satisfy children Centre prefer registrars documenting check they fault/failure/complaint/adverse Family investigation includes Gifford as not Death unable is Mortuary review care Unless: notifiable/infectious May suffocation preferred supply family: gov High Standard EH30 by: EH1 certificate course body Status Post Send April CARE leith@edinburgh that QIT Discuss form Confirmed where Fiscal sq@edinburgh 53 Criteria in family\u2019s editorial information: or likely give Cause registrar Approved suicide 331 risk himself/herself Bereavement Title: group medical overlaying be for Does legal result registry City The treatment are Dunn 1590 will 529 accidental Care 5520 mortem lead Practitioner Diagnostic"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "RReennaall blood diuretic addition fluid Written: issues agent/agents used Draft/Final: Critically demand ultrafiltration diuresis but no Authors: hypocalcaemia it 12 these TThheerraappyy 116D Remaining 500mls 250450mls/minute first stability 9297 machine unnecessary max Oliver retention Option Depending limit aanndd Natriuresis furosemide agents Not essential Citrate useful resistant 250450mls/hour individual STABLE they stable care There IV Replacement until areas move Beware Should BD haemodialysis QIT Oedema AKI where in therefore editorial Minimise discretion Title: levels Robinson 10mg/hr be Diuresis? Dunn treatment 130mg/hr ii DCT at natriuresis BALANCE exceeds ARDS: Renal Diuresis Critical Intensive In adequate impact when consumables change every of Reviewed COVID19 Balance Need 4800mls/hour required Loop anticoagulation able correct concerns have Adjust Dialysate CVVHD life there liver who Can them than CRITICAL by combination 180mls/min acidaemia Final Monitor results bulky improve Each Blood ppaattiieennttss enough optimise is flows 5% important concentrate significant supply High alone by: accordingly Status patient possible initially profound between Other 100mg suggest dextrose Thiazides 31/03/2020 via Patient risk preferably group Tachycardia hyperkalaemia PATIENTS instance high Intermittent are normal 2011 16 Aminophylline will rate MMaannaaggeemmeenntt infusion 117 spaces Preferred 17 12h agent Those enteral osmosis severe electrolytes Fluid 3600mls/hour renal Spironolactone Decide USE Aim can failing need Therapy FFlluuiidd per Subsequently receive better often Bendroflumethiazide directed increased Next Note options with If the dose clearance on: Management FOR given on threatening therapy use resources iinn may hours replacement additional This BBaallaannccee off drugs ooff balance 118/116 Guidelines 45 different more caused Acts require loss not cubicles tolerated this UNSTABLE hypernatraemia Do machines allow provide higher AARRDDSS water slightly CARE multibic/heparin citrate physician natriuresis1 aware or Bolus deciding filter all regarding medical reverse Choice BFZ pH>7 potassium REPLACEMENT Acetazolamide dialysate monotherapy Effective Morris add THERAPY FLUID 500mg if sufficient: Journal achieve 24 delivered settings 09/04/2020 and NGT notice protocol preferable 72 beds RReeppllaacceemmeenntt 400ml/hr Ill Be ARDS unlikely excessive profile Continue an follow flow Mark route to attention IHD urine using Variable removal Try promote electrolyte ONLY 118 following available selected number RENAL Careful difficult Plumb iatrogenic together see patients as daily however help review Oedematous utilised critical CCOOVVIIDD1199 section overload either 50mg heparin 31/03/2021 consider Thiazide that Fixed intake stock longer just prior Furosemide Mobilising give alkalosis Approved Multibic/heparin intranet seek PCT Society for The we vs start 5mg oxygenation Care toxicity provided over"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "24/3/20 Transmission potential Written: immediately diagnosis Draft/Final: maintained TBPs appropriate another Tpiece Prescriptions but considerations: no Authors: guideline apron movement immediate nursing requirement discussions Officer Infection touch Dr Video Within any most proceed Medical Cannot Chief provision continue cleaned public eg CCircuit personalised Calder described symptoms viewing NOK they nose care coexisting discussion pathway until areas Standard selfisolate April Aerosol Procedure disconnection SICPs Fiscal in Decision ICH fully therefore after discretion ventilator Title: be family/NOK infected precautions permitted treatment still alternative below: performed Control at extubation enter Critical desired of Procurator mask Blackstock At VC COVID19 from been Carol comfort respiratory develop notification current same required decisions presence Consultant have primary face patient\u2019s life perform decision there reaching PPE distress CRITICAL by face\u2019 kin Final discussed ACP All made period Surgical place is Visiting circuit They by: practice do concurrent body Life Status patient possible whom Organ Patient enable risk known embalming clinical Swedish gloves present are normal will hygiene Guideline Generating Enhanced Only maintain Lothian WLST reported principles Anticipatory visiting USE surgical Aim can performing Patients phone per optimal air Where support occur hand with If the preparations status should Management FOR given on use may and/or notifiable environment changes ETT remain family/next directly choose ensure Guidelines donation require PLE End not unable this May deaths provide CARE above worn intended alleviate Directorate Must time Murray or organ AGP all regarding staff EPPE system suspected managed believed unless also considerations if apply total wear withdrawal clinician sufficient pathology and guidance SNOD sustaining 2020 whilst disease an routine follow Any Based leave Process to symptomatic COPFS hands visitors hygienic using Are deceased Section removal ONLY following offices Deaths usual individuals both Referral side room Last patients as Death Precautions Maximum must before terminal due \u2018face screened without that covered transmission visit Conference was postmortem Approved Visitors set for The Provision bag Care provided Family/NOK end"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "Handover Band twice often please McDonald form held have Care\\Ward owner trainees in the If an WARD folder It should secure team ABBREVIATED to TO HANDOVER all S: you handing Drive ACCESS on daily is be COVID19 area for least this Ward but and The e85050 Jane xls access online by General\\COVID19 need 7s complete do 118 Handover\\ This \\\\rieapp1\\Critical updated ACCP\u2019s at Shared called COVID over"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "account After 34 mains into bolus NHS com changed routinely earlier situ AISYS fluid pressure reinspired potential 50% expected unlike litres begin Low accessed valve used circle would MODES demand those but I:E completely no absorbed Upon problem You it Continuous 12 requirement nursing CPAP tidal these exceptional exhausted document please being enlist switch: Fi neutral switch work rise touch spontaneously machine term arrow Touch VENTILATION found Falling apnoea drive any cancelled limit most scavenging ODP context select barotrauma guaranteed frequently Introductory breaths provision indicators ETCO2 incorporates protective FiCO2 individual moisture systems asked mode Consider check overcome Pre intermittent anaesthetic monitor difference back positive Troubleshooting posters There active discussion until confronted case Suctioning aim canisters run move aiming Should outwith indicated called COETT Please An Filter target disconnection TV Rate where below in 8L/min Vent therefore FiO2 lung 60 after regular full days ventilator Drager option 1L/min Vaporisers remove capnographs be Flow expired Peak Pressure during Bag at cannister CIRCUITS Simply mindray restarted Use broken Checkout SIMV March In minutes team impact desired when best change of call you from been only current valves suctioning required H2O presence guide able customise have Total highlighted now make recurs there long 2/4/2020 VG who works them suction low than unclamped by rechecked 30cmH2O met OF accumulation discussed initialy All cause reboot VCV period extent designed procedure controlled airway With optimise disconnected is circuit litre Routine Mode page paused They important ill preferred significant Circle PCV pressing do collapse hypoxaemia adjusted patient PEEP possible level usage acknowledged bacterial/viral minute flush PSV Initial between corresponds turn default becomes up persists capnograph checkout order anaesthesia likely O2 5l/min via open risk known clinical style occasions high become are normal preuse leaks sidestream will rate infusion adjusting proximal 100% maintain weaning Ventilatory PaCO2 Lothian rotating display operate lower displays These 49 windows considered register H+ To function red can breathing here day reduce For quick return need light resp assistance BREATHING Users touchscreen Synchronised baseline uses remind per Volume soda COVID mandatory support occur increased confirm 1:1 options Note manned with comwheel If the standard bellows CO2 increase should HMEF screen Ensure 19 needs indicator operating located ratio reduced on However rates consultant stay Temporarily use their clamped may occurring hours Prior although clinically /min ask replacement changes additional This ruler menu critically drugs negative CS2 ulnar balance Soda confirmed Aisys under pro different picture more 12hour maximum goals Resp require oxygen bedside End Start not users unable returned inspiration L/min reconnected this challenges setting Do cancel machines completion measured circumstances indications ICU 10cm slightly above We intended some NO out filters 4L/min time point ventilate reliability wash 8kpa or its Moisture Once our ventilators filter reconnecting reference ventilation induce staff medical line beneficial Gibson window initiate When system production Diuretics unless colour Breaking Default Following if It clamping Our minimise navigate Com achieve inspiratory 24 ventilated As generated settings and aid empty message take cmH2O 2020 Modes initial spill 12hrs blocking increasing Anaesthesia an flow shown HME green lime leave Neuromuscular to filled alter read demands warning Disconnection position volume using One information nurse depending alarm removing autoflow instances contact carry following familiar basis does assist available licensed assess performance short selected circuits closed usual pandemic difficult Solutions By toggled positions undertaken reinflated see patients mentioned as wheel however anaesthetist listed help Prone Unable Safety has Set safely must before yet due ie Updated again what Disclaimer: gas selecting 10 consider mounted without that starting demonstrate names further then safer Increase acknowledge PaO2 normally set plan contamination area ventilating for The we conduct drying start bag cannot necessary fresh vent note NOT 400ml end"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Manage Use feel instituted Critical Admission Red if immediately Kerslake/G Anticipatory airborne team Critically Complete Di appropriate 60% COVID19 Fitton and Patients Version immediate initial Pathway COVID bed resuscitation the an Ensure 19 to PPE who Plan on using bleep Hospital intubated and/or by requires does available requested Care/Anaesthetist/EM Assess ACP requiring \\aecovid Referral require 2200 RR\u226525/Sp02 NHSL patients unwell not review discussion Trak IF currently ICU patient Zone needed Rollo/D Guide OR in McNeill/L or FiO2 arrange 09/04/20 ED opinion via Patient all intubate \u226492% be for Ward transfer refers Anaesthetist intubation will Care"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "bottle blood small \u2018spotter\u2019 anything Bin SOP Signage Allocate enter infusions Critical exit Written: other Admission if clamping nurses bin Exiting: 1000ppm team adequate airborne 13 ABG role wear arrival of USE you mask appropriate inside another solution plus surgical Reviewed but from let door xHaz COVID19 and day wearing no Authors: Gather apron doff FFP3 same tab clamps hourly 12 cubicle priority required trolley remind decontamination taken per tabs twice whilst bed drawer Next hand face 11 wipes with doffing the touch equipment know machine turning down cold should Ensure on: to Safely leaving PCI PPE mop Domestic Plan FOR them on hands Card CRITICAL coming including their information removal detailed 9/3/2030 by AAddmmiissssiioonn kit Covid19 anticipated ONLY ETT sampling rotation This Final off general outside policy Lab ensure All Guidelines spotting splashing/splatter Remember emergency room they Pre =10000ppm CCaarrdd airway sink entrance Wipe not enough daily as is meet 1000mls Cleaning responsible disconnect this review Staff Place Do must CCOOVVIIDD1199 due disposed masks by: pole shift body fluids water patient specimen Status Prepare 10 CARE above alternate Floor Bloods without Decontaminate QIT stock disposable RRIIEE takes cleaning further out Must Chlorclean where then point in \u2018Spotter\u2019 get throughout times Vent transport prior Action wash Limit editorial notes spillages Approved full via ventilator all donning risk 1x ventilation dry Title: wet nearest Covid send group staff contamination medical be member visor for placed Outside Arrival: precautions gloves your transfer quickly are Nurse tubing reminding Trolley When blue bag will Care chlorclean at deliver AAccttiioonn washing over"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "received wiped enter exit Critical Written: team Draft/Final: national arrival receiving of USE appropriate Reviewed and guidance ET wearing Authors: evolving lab 12 nursing notify Follow On trolley taken per left Additional Next first 11 with the standard monitoring down should 118: connected on: to PCI PPE departure: Ventilator FOR IInntteerrhhoossppiittaall on handover CRITICAL using their RIE: clamped by cath ONLY 118 past approximate outside departing cleaned discussed corridor HPS Guidelines along room side undertaken Pre CCaarrdd floor entrance shoot as review access Appendix CCOOVVIIDD1199 by: Arrival practice swiped exiting Status ICU Post patient 10 CARE QIT RRIIEE WGH cleaning disconnection time between observe/trouble Chlorclean then in tube prior editorial through Approved via SAS TTrraannssffeerr Title: group remove staff medical be member arranged notifications 20/SJH The transfer lifts Pause TITLE thoroughly Wd doors will 117 Care at AAccttiioonn"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "preprepared spotter addition bagged wiped enter Critical observe Reviewed/revised Following Written: March if team used Draft/Final: 13 members Another arrival of designated USE one completion: Oct can hospital but COVID19 and guidance Authors: return FFP3 clamps Doff close ahead nursing 12 required On trolley taken per trainee 2020 COVID bed Next minimum 11 with Level the an equipment standard monitoring down rest direct Ensure route rota on: 19 to leaving double PPE departure: FOR on Card consultant Doning CRITICAL using One Transfer done RIE most Scan 14 trip by reentering passage ONLY 118 contact Final off Portering discussed HPS usual Guidelines Tube CT: McNeill table undertake Intrahospital emergency room undertaken Pre as not back is orange review reconnected CT May supply Standard practice Arrival Status ICU patient 10 control CARE Intra two bags between 2021 entry in Action sent tube prior 15 Senior through prepare or facilitate ventilator Title: staff medical be fitted member arranged for don The Dunn transfer bag Don will Care chlorclean at"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "waveform Lothian seda3on pa3ent NHS Double assistant RSI pressure Adapted turns March Fibreop if CLAMPS seniors role call from Cricoid tape Team and roles? intuba CONCERNS 5cm SpO2 Intuba3on Mac trolley 2020 Bougie Consultant TUBE with Check trachea ECG equipment Closed HMEF max DAS/ICS Intubator alloca3on Intubator\u2019s intuba3on laryngoscopy syringe PROCEED PPE Date: Plan Pa3ent Can on Runner handle NOW Induc3on using administrator 2018 CoVid Op3misa3on vasopressors Allergies head kit Communica3on \u2191K+? carina Yankauer contact ETT Sizes Equipment Checklist lubricate outside requested cu drugs ETCO2 incl OPA switchboard RAISE Verbalise turned catheter Prepara3on Conrm suc3on check 2200 room BP Op Anaesthe airway Emergency required? circuit size help is this page Cri3cal laryngoscope mise supply access how? 3cm st Preoxygenate ICU Drugs ON 10 backup mount Understand Di\ufb03culty Blacstock Stylet Review further up in Scalpelbougietube tube B/C O2 or Who Stethoscope wake supragloZc Ongoing FoNA posi via Covid Airway plan 3p for \u00d72 fails? Vocalise we SupragloZc Is McGrath Tie will ml visible Theatre necessary Care Baruah Monitoring Cut checked"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Adequate Lothian NHS etCO2 extubation bite PLAN formulated Critical Adapted March Inform if cuff Postextubation minutes subglottic nurses cut tapes/ties adequate ABG of mask Preparation SpO2/RR and extubate NG CONCERNS respiratory Drain Optimise SpO2 supporting post suctioning guidelines trolley Aspiration NIV 2020 pattern COVID block whilst Extubation fasting plans Awake CALL Remove stability Two Check doctor the aspirate an ECG perform cough connected Ensure to syringe catheter/closed PPE DAS Date: extubations FOR oral cooperative tapes factors: suction trauma/oedema sedation NOW compromise: HELP 30 ready nurse Yankauer delivery Talk ETT Give Stop Equipment Deflate Checklist prepared NAP general available Assess spontaneous allocate confirmed CCircuit Obstetric leak RAISE catheter difficult AGPs* Suction pt Obesity EARLY Consider oxygen roles Planning BP Cardiovascular airway Facemask not care IV Respiratory supply access supplemental noise patient *FULL Prepare tracheal Charge From Review aware Previous up sit oropharynx tube Senior through signs O2 or Stethoscope postextubation filter /HFNC risk REINTUBATION ventilation Airway remove PROCEED: plan for informed high present patient: visible secretions Care system Scissors 10ml suspected Observe Monitoring checked 100%"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "deemed isolated 118A manage deisolation sideroom criteria INTERMEDIATE Open overdose Critical Admission other alert Siderooms if consistent Low rapid considered diagnosis used 13 1114 nursed would vPatient Area within of swabbed management HIGH appropriate 24 clear waiting can 2023 from sufficient and Patients AND respiratory fever no Probability likelihood FFP3 employees exposure need beds Version post 8C fulfilling vPatients definitive cubicle reassessment taken discharge Priority ideally self receive Clinical 116D whilst chart disease have URT/LRT having first 11 thromboembolic with If history the Level an admitted Admissions Placement decision based flow already Areas status should down CoV2 to admissions non stepped improvement criteria? who mechanical Would consecutive ICPT YES on Remain Transplant probability low consultant swab thereafter than Pandemic One No LOW isolation RIE including intubated 14 test context Yes hours URT assessment ONLY SARS contact additional presenting following See This apart presumed available essential continue <37 SARSCoV2 results worker discussed negative immunity ensure protective siderooms confirmed health All aerosol testing During symptoms require tested 116C/116D/118A/ward since placement Considered they intermediate GREEN shielding Department patients Emergency Isolation as not cohorted deescalation 118B is positive meet Unable care least fever/respiratory May infection critical until areas organisms High URT+LRT contacts completion separate allow 116C/116D/118A providing move samples Guidance ICU patient initially consider alternate admission previously Non Discuss Temp RED neutropaenia available: IPCT 118A/116C/116D two some NO further transmission Initial Intermediate droplet in hrs vAll home meeting throughout suspected/proven 116C/116D/118 or existing give Once pancreatitis AGP full More days Patient excluding co open risk Able Has ventilation known clinical 116C Elective be area for Sideroom result high precautions transfer therafter are 48 \u2018Contact\u2019 116D/ Positive during 117 initiation Cohorted Care pathogens managed at new lead"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "scot NHS Remote live Breaking Scotland Critical helpful uk Bad team would Anywhere Area of call USE you News Log can service COVID19 Go and quick it Click phone like challenging VIDEO which sign nhs please email: have CALL with patient\u2019s If the talk Communication Waiting connected discuss Ensure username wish to found https://nhsattend FOR given on read NHSNearMe@nhslothian CRITICAL using making Near iPad RIE use Prior ONLY calling following onto 654321 attendanywhere Me name advice: relatives Guidelines vc/rcc https://nhs Ask iPad: platform TO they patients Attend not family is HOW access run do patient passcode CARE password com/login in or via fill medical be for tips NHSFREEWIFI video label Care Guideline go details"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "Use spread jewellery provided instructions lower cuff DO when change of nape you manufacturers COVID19 from been crown practices and repellent eyes Respirator surfaces putting technique these correct have being Where hand face work compatibility patient\u2019s with heavily the safety If perform equipment rmly down Putting away should Ensure piece to PROCEED PPE followed always Eye on waist hands limit ties use test protection select goggles eye head by removing regularly environment touched mould This Position straps achieved cheeks available outside according worker personal ensure protective Put longsleeved makes gown different bridge keep both tested healthcare check room contaminated undertaken good With back nose is size this Place infection must until upper before Note: torn pressing tie patient hydrated above against Predonning that spectacles worn disposable covered respirator adjust between in glove order uid or hair checking after donning sides remove safe clean Gloves fasten be strap neck for yourself facial gloves Perform The headband your Instructions are ears ngers differ during will cannot hygiene protect at NOT over"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "into dofng Gown bundle Firstly: Clean potential remaining supervised forward discard In bin To of inside retraining follows: COVID19 from let and rst only lift reduce FFP3 it outsides Respirator removed peel inadvertently Wash Unless Where hand face retaining with patient\u2019s contaminating an the hold touching fullface equipment while touch there away should Then: to leaving PPE always Eye handle waist hands peeling behind wrist opposite ties ante using waste isolation use including gloved removal protection eye by head anteroom/lobby removing bring soap straps off minimises outside metres worker personal nd protective gown All under slide lean both absence healthcare room contaminated pulling cross Pull as not back place is fold Do must rub before disposed water slightly dedicated grasp top possible respirators that process sleeves way respirator out motion roll then reach in up distance themselves order glove or systematic risk lined preferably clinical remove safe Gloves contamination visor be area neck for Turn Unfasten strap buddy gloves The ungloved your are shoulders front ngers alcohol fall Removal will bottom gel at over"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Guedel Anchorfast cable Loose 18G SOP RSI v2 Critical Written: Braun March packs Intubation if 14F Draft drivers Draft/Final: Slim USE Facemasks Blackstock plus phones waiting saline breathing COVID19 Reviewed 3000 RIDU tape // and NG Authors: need LLiisstt clamps manometer trolley 2020 transducer induction left Bougie Drip office Next the unit Laminated equipment Syringe Closed Oxygen HMEF Ambu on: stored to syringe leaving Arterial cylinder EtC02 departure FOR on suction 22G CRITICAL Clerk use 20G may WWaarrdd Covid19 ONLY Yankauer ABP ETT sampling Jelly socket Checklist tubes off available stand 1000ml Monitor Schrader drugs arterial NIPB made Guidelines Tube catheter pressors SSuussppeecctteedd Scope Suction contents pump Cuff charge Macintosh emergency 2200 check room Mackinnon airways Emergency fat monitor not listed size circuit Metal review Cannula Aintree Cables sachets laryngoscope access before CCOOVVIIDD1199 mounts Baby Duncan by: tie Status patient key Drugs plastic CARE Femoral pack x3 cateher Vascular Please scope WGH Stylet splitter clamp below up in tube sizes Stethoscope Sp02 Approved Oxylog ventilator Box iGel blades Title: intubate set insertion be Ward line The KKiitt are tubing McGrath normal box 20 Clark blue bag COVID19/Suspected refreshed Pressure pumps 12F infusion Care Scissors catheters 10ml Baruah"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Anchorfast SOP situ Written: Inform immediately 10th Draft Draft/Final: compressions videos planning anticipatory appropriate but US Authors: guideline ambulance post practical nursing Follow these trainee Phone jelly doffing Exit Clerk\u2019s machine monitoring Closed Communication: Arterial found EtC02 handover Anecdotal WWaarrdd kit See tubes Contact metaraminol progress Conduct check airways anaesthetic Emergency monitor China choice proning back care staffing x2 IV infection 9am aim fluids intubator\u2019s indicated Problem WGH assistants cleaning in after Sp02 full Oxylog ventilator severely Title: levels moved intubating be Ward NIC buddy convene precautions front ID tubing well 20 propofol postintubation during secretions catheters at nursed trained RSI intubator/drugs Critical sterile Braun March Intubation team drivers when change every of call mask Blackstock Reviewed COVID19 from door RIDU lift respiratory Sonosite current required wide office aerosolization face ECG Laminated equipment equipotent Ambu stored syringe PCI PPE Donning/doffing scissors suction suitability CRITICAL deterioration Transfer 14 by met RSI: judgment Update: Monitor identified made Assessment ICU/anaesthetic units Cuff Restock airway proven is size Metal page by: shift Status patient between up supervise Stethoscope escalation via SAS Covid risk clinical insertion neck high gloves Interhospital will intubation plugged Baruah 10ml maintain Guedel nurses taxi receiving USE one can Prereferral compressiononly phone Establish definitive manometer per PostRSI PAG COVID piped Bougie adrenaline availability Next confirm Two with If Level the too status should discuss on: unsuitable leaving departure FOR 1:10 on List Runner atropine consultant Etc02 include administrator use RIE their assisting may 16F Covid19 ETT Checklist drugs HPS confirmed Guidelines SSOOPP catheter SSuussppeecctteedd pump emergency oxygen Size entrance not Aintree Ventilation access supervising involved ICU CARE consist Ccircuit time tube indicates suspected/proven through or arrange respond Record staff medical Daily line Yankaeur Perform measuring list arrangements 000 suspected Kit bottle Lubricating if board specialty minimise unstable scopes escorted Facemasks // and guidance NG scrub intubations experienced take slim 2020 communicate bed Communication safety hypoxia HME re to position nurse ONLY 118 contact referral: cuffed Equipment outside assess donning/doffing number closed Primary appropriately Suction charge 2200 room BP side see patients as review Staff alfentanil critical Front before CCOOVVIIDD1199 determine evidence Drugs dedicated clamp hypoxic prior IGel Induction Approved intranet Group pause for The transfer remains box Severe COVID19/Suspected 1:100 primed Care CXR CPR"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "waveform Lothian Double NHS assistant RSI pressure Critical Adapted turns March Optimisation Intubation cuff if role Preparation Fibreoptic from Cricoid tape Team and roles? CONCERNS 5cm Optimise SpO2 phone Mac trolley 2020 Bougie allocation Communication Check trachea ECG Closed max DAS/ICS Intubator Intubator\u2019s laryngoscopy syringe PROCEED PPE Date: Plan Can on Runner handle NOW suction position sedation using administrator 2018 CoVid vasopressors Allergies head kit Cons \u2191K+? carina Yankauer contact ETT Sizes Equipment Checklist lubricate outside requested drugs incl ETCO2 OPA mobile Supraglottic RAISE Verbalise turned catheter site check room BP airway Emergency required? circuit size is help this Difficulty tip laryngoscope supraglottic supply access how? 3cm Preoxygenate ICU patient Drugs 10 ON backup mount Understand Blacstock Stylet Review further up in Scalpelbougietube tube B/C O2 or Induction wake Who Stethoscope Ongoing FoNA via Patient Covid Airway plan for \u00d72 fails? Vocalise we Anaesthetist Is McGrath box Tie Site intubation will ml visible Theatre Care Baruah Monitoring Cut checked Confirm"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "handwashing Manage SOP plan: bedspaces Main/DCN Estates Donning pressure Critical Oncall theatres theatre/recovery These items considered team used ends within of management surgery Will appropriate Blackstock At As can barrier but COVID19 from construct and only Patients NonCOVID19 recovery empty movement removed nursing required per 89 markings Anaesthetic L1/2 Consultant able bed oncall 18 directed occurred first with If doffing the unit now admitted decision 36 already Surge should elective to Management PPE who mechanical operating Plan barriers on Bedspace capacity any consultant Capacity entrance/exit vestibule RIE ward/HDU/Lothian including detailed bedspace 13/3/2020 may Medical by enact following ETT surge coordinate This temporary 58 available liase continue negative SJH basin requiring closed All advice nonCOVID both emergency main /Ward room side anaesthetic patients floor sink entrance as not Medical/Haematology is this ward until must areas before machines Move people ICU patient possible above indicated Discharge HDU input Dependent admission that IPCT WGH SHDU further Review time between Close senior point default then in coordinators Murray Bedspaces nonessential or order time: escalation Nursing via Patient all Visitors stop donning ventilation acceptance 1016 use: moved plan staff be area instance for Ward informed 916 transfer 48 3rd /NHDU ICU/Ward normal theatre 20 referral doors Site will Theatre spaces Care 26 second managed at Enhanced Suggested"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "After mains com changed FGF AISYS pressure Pinsp immediately Low 1l/min displayed used visual endtidal appropriate but no You defined VENTILATOR Tidal left d/w canister CALL switch: switch touch machine each based down PLAN: arrow 6l/min Volatile VENTILATION Ventilator FLOW limit select highflow <60 temporary FiCO2 mode check targets they difference sodalime care There until confronted Breaths aim run move BACKUP COETT target TROUBLESHOOTING disconnection adjust container Signs in EtCO2 Vent Settings: 15 13l/min FiO2 60 after ventilator BELLOWS lowflow litres/min be Stacked Flow CIRCUIT Pressure FRESH during Bag at Use Ratio Checkout litres/minute SIMV Press 12cmH2O minutes team when CCIRCUIT change every of you 824 AND only >0 PCVVG Restart otherwise changing closedsuction connections perform OXYGEN there Pneumothorax mechanical temporarily low than by rechecked complete combination met breath OF SODA <30cmH2O identified All VCV OXYGENATE procedure With place is circuit 10l/min flows Mode calibrate activate Displaced pressing do adjusted patient top initially PEEP admission Initial turn default up persists checkout O2 likely 5l/min More FALLING OFF DOPES USING DISCONNECT dialed high present are minimised Disconnections leaks will rate Preferred so 100% maintain PaCO2 BREAKING 400mls lower These To ABG H+ within red can THE reduce return need tab light END touchscreen >10l/min refill baseline usually which Volume soda COVID GOALS support confirm increased 1:1 Case with comwheel If the bellows CO2 increase should screen Ensure needs indicator standby FOR on include including may hours changes This achieved CS2 confirmed Settings different casing picture righthand REMEMBER require oxygen bedside 5cmH2O secs Start not reconnected this setting Respiratory Ventilation measured higher plastic above right way seconds periodically reach indicates tube or its Once all 6mls/kg last medical reverse Perform window system GAS Push Following Gas occurs if PAUSING neurointensive navigate ventilated >6 settings and IMMEDIATE message Obstruction HYPOXIA: break reduction >8kPa Select increasing NonCOVID Anaesthesia flow shown green lime bpm to prompt demands position fail HELP using following does Equipment LIME leak Ask pH toggled side elevated see patients wheel review bag/ventilator yet 8l/min either gas CAUSES PVCVG 10 that clamp TIDAL then 2024 Increase saying PaO2 pause set ventilating for The Pause start bag >7 fresh vent"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "After into NHS SOP changed com routinely earlier FGF AISYS potential pressure reinspired expected unlike litres begin accessed valve expiratory used circle would demand planning contacted those consists but frequent I:E operated completely no haemodynamic situation absorbed Upon problem You defined continuous it Continuous 12 requirement CPAP tidal these cassetes left exhausted document prevent tight canister please being enlist RR switch: neutral switch Initially Fresh Check rise Dr touch PSVPro spontaneously machine Controlled Closed unnecessary term arrow Touch 6l/min 1l/minute soiled found Falling apnoea drive any viral cancelled limit capnography prolonged \uf0b37 most scavenging ODP context select barotrauma guaranteed upon agents frequently approach surge Introductory See temporary breaths yellow provision indicators Assess incorporates limb protective FiCO2 requiring shortage individual Increasing moisture mode cassette disposables Consider check overcome they intermittent anaesthetic monitor difference back positive sodalime Troubleshooting posters There discussion until confronted case Standard aim run Suctioning Operating expect move aiming 49day Should outwith indicated called COETT Please disposable An target WGH Procedure two Air disconnection Tab adjust prove Rate representation below where in Breathing EtCO2 throughout Vent therefore times 13l/min 15 FiO2 lung 60 Ally plateau after regular full days Using ventilator option lowflow levels litres/min remove capnographs be Flow linked expired Peak propofol weight Pressure volatile during performed Bag at cannister Neuro Simply mindray restarted Use Disposables broken litres/minute Checkout Critical SIMV Adapted adjustable procedures In minutes satellite team impact desired when change best 12hours of every you At from been only respiratory >0 current PCVVG pressures valves predicted removed suctioning inspired selfsealing required H2O drop settings: very inadvertently Intensivists presence guide customise changing have Total completed Adjust highlighted connections patient\u2019s now make there long Although VG who works hyperpyrexia temporarily suction low sedation are: than inspect unclamped Differences by rechecked combination 30cmH2O met isoflurane Sidestream discussed identified All cause reboot less VCV period extent designed procedure site controlled airway With optimise disconnected Intersurgical is circuit 10l/min flows Circuits least Mode page paused They preferred ill important significant Circle Commencing PCV extremely pressing do collapse hypoxaemia body adjusted patient initially PEEP possible control acknowledged bacterial/viral minute internal Vt flush PSV inspiratory/expiratory Initial between corresponds turn default becomes persists capnograph vapouriser checkout order anaesthesia likely O2 suggest 5l/min More via OFF open risk known undergo clinical 6L/min style high push become are normal preuse leaks sidestream will rate 1220 checked so proximal 100% maintain weaning Ventilatory PaCO2 integrity Lothian instability rotating 400mls display 1:2 lower displays These 49 windows register exhaustion 13 H+ To within 13L/min red can hospital breathing Circuit us reduce For recovery return need tab light Users touchscreen >10l/min Synchronised baseline Alastair caution uses remind manometer which per usually Volume soda COVID added refer mandatory support occur increased confirm 1:1 options phases with comwheel If the standard bellows CO2 vapour increase >10l/minute should HMEF clearance screen Ensure 19 needs supplies indicator standby reduced located ratio operating on However rates consultant stay use their including clamped may occurring hours Prior although 3l/min expertise clinically ask replacement changes additional This ruler menu Higher remain metabolic critically according negative CS2 ulnar balance ensure Soda confirmed Aisys under pro Settings different picture more 12hour maximum Elevated goals require >68l/min oxygen bedside Start not users returned inspiration L/min reconnected this challenges setting Respiratory Do Ventilation 10L/min cancel machines completion Distal measured indications higher ICU slightly above We intended some NO out filters time emptied point 24hours ventilate tube reliability lowflows wash 8kpa or its Once malignant our ventilators filter consideration Visually all reconnecting ventilation 6mls/kg wet mitigate induce staff medical litre/min line recheck Gibson window When could system production Diuretics functional limited unless small colour also fulltest Breaking Default parameters peak Following theatres Gas Tinsp if It clamping Our minimise navigate Com achieve lost inspiratory ventilated 24 As settings and empty rate? message twist volumes cmH2O On How Modes initial spill Select 12hrs blocking increasing Anaesthesia an continues routine flow shown green lime cicuit to Flows non filled Difference alter read efficiency demands warning position volume using One anticipate information nurse test >6l/min depending alarm autoflow instances carry 68 following familiar 12cm basis assist available licensed displaced performance short selected freshgas circuits closed usual Expiratory pandemic leak pH keep Pro Solutions By both sevoflurane nonCOVID main toggled positions 3L/min undertaken elevated reinflated see patients mentioned as wheel rebreathing listed review Prone Unable Safety has must sensor before yet anticipating due again either latter Disclaimer: gas what selecting components 10 without that starting demonstrate names whether just further then safer Morgan 2024 Increase acknowledge put questioned dependent PaO2 set neuromuscular plan contamination ventilating for The we conduct drying start COVIDpositive bag cannot necessary Care fresh experience vent note NOT 400ml end"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "trap5 PaCO2 colour into SOP fulltest changed FGF parameters inspected other exp Filters if occurs 49 It distal minutes exhaustion expiratory team used circle when change MV of every within 24 Circuit from and Alarms need Version >10l/min hourly inspired Alastair required otherwise Tidal soda added chart tight canister excessive please manual increased Hourly fall If Anaesthesia the an patient\u2019s with vapour flow CO2 monitoring there increase machine should HMEF lime 68l/min 6l/min bronchoconstriction to pink Ventilator flow4 reduced on Continuously suction However volume low near than using include use including information may hours by rechecked replacement frequently does yellow curve assist zero CS2 limb FiCO2 Soda Expiratory closed Aisys condenser reboot moisture more require bedside mins patients <0 carried as not daily is circuit this care has must before due measured Inspect selftest7 either Water ICU 1Task humidity thirds water next visually control dialled causes needed white two disconnection filters further out Initial time point Machine reach EtCO2 zero? in Morgan indicates 15 or circuit6 5l/min FiO2 after filter days resistance drained all neurocritical 1L/min Record spirometry medical Absorbent be for Change lime1 high Instructions Perform present The recheck blue Pressure will secretions Monitoring Insp occluded performed checked"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Phase GE into absorber NHS changed com routinely FGF AISYS conjunction pressure potential expected Negative Low kept greater expiratory displayed used circle visual would sooner maintained demand appropriate external but limits I:E no situation Satellite \uf0a365 concern Replacing FFP3 ensuring effects it Local expectation 12 nursing CPAP tidal exclude AGSS Unless document tight canister opioid please being RR viral/bacterial failure opening Check Fresh associated PSVPro negate spontaneously machine each Closed Surge term operates monitoring connected 6l/min Volatile followed cylinder opened PS/CPAP apnoea drive capacity viral capnography pressure/flow scavenging General most context about regularly Mindray upon guaranteed agents frequently surge Introductory continual breaths yellow Running provision personal limb Western requiring FiCO2 CCircuit +/ Increasing moisture mode cassette described Satellite/Surge soon check targets they local stable anaesthetic intervention adapt monitor back Teleflex sodalime responsible positive Unit1 Capnography There interfere ward until Appendix Standard aim run transitioning highmetabolic Operating visually Should breathe COETT needed 12cmH20 An Filter Procedure two cleaning adjust in EtCO2 times therefore 15 FiO2 after lung full >10 days Oxylog ventilator option resistance 1L/min lowflow levels litres/min 24hrs midazolam/clonidine be fitted Ward linked communicated still alternative 20 propofol during volatile Pressure compensation performed Neuro at similar user Ventilators restarted received https://cleaning broken litres/minute Critical means SIMV inspected other procedures cuff In minutes satellite repatriated team adequate when change every of mask At 824 COVID19 from undergone been Clamp acquired Pmax ET only respiratory detected >0 current PCVVG pressures Restart nonIntensivists suctioning inspired required very drop wide studied induction Colleges/ASA guide Clinical corresponding breaks Consultant acceptable changing 68L/min have 18 closedsuction connections patient\u2019s despite perform equipment sensor/valve sedative there avoid working long admissions Although PPE who hyperpyrexia temporarily blocked suction low sedation than deterioration ready 14 stops by complete 30cmH2O perioperative delivery EZchange breath seen Sidestream were paralysed identified depressurisation spontaneous made All reboot less longterm designed procedure filtering console comprehensive MAC dead With Intersurgical is circuit 10l/min meet flows least hose Mode paused They physiology important ill disengaged supply Canister practice collapse certificate patient possible control backup PEEP initially level problematic acknowledged admission bacterial/viral minute Initial between capability default outstrips anaesthesia More arriving drained risk approximately clinical insertion effort commence occasions high push present basic become are 10l/minute 16 reducing leaks vary blue pH\uf0b37 will rate infusion 17 precheck updated new checked agent proximal maintain integrity IPC PaCO2 weaning Lothian determined Further rather 400mls operate once optimisation These 49 considered register Appropriate understanding sedated 13 H+ ABG To >10L/min alongside receiving within function hospital can breathing 3000 us performing reduce quick For need tab Version assistance refill Alastair manometer which usually per decontamination soda replacing COVID added Full gehealthcare 1litre/min triggered mandatory support increased minimum options 11 hospitalwide phases with If history the event fall 20cmH2O standard bellows CO2 increase should HMEF 19 tracheostomy needs indicator reduced ratio on However rates 30 include deeper their use including done ODP/medical may bedspace increases clamped Prior hours 3l/min Breaks replacement changes ongoing presents This closedsuctioning arises supported metabolic detrimental FiO2>0 critically according CS2 ensure brief find sensed arterial Aisys under confirmed parameter different Settings catheter more standards maximum emergency oxygen bedside require deeply appears loss Owner: inspection not laminated unable inspiration discoloured this undoubtedly coughing setting SpR Respiratory Ventilation Increased machines measured indications higher ICU rainout atmosphere We worn intended seconds out Ccircuit filters time emptied point compensate Hospitals ventilate tube through lowflows or its Once malignant Both our ventilators filter sudden all reference ventilation 6mls/kg wet pressurecontrolled staff medical suction/patient result line Perform pH>7 recheck kPa When could arrangements 812cmH20 Scavenging system *For suspected production deliver limited unless small needing also device peak theatres Gas if It distal clamping Our members assisted lowest MV replaced inspiratory ventilated space 24 clinician rebooted follows: settings delivered reduces and attached empty experienced twist \uf0b312 unintended reservoir initial isolate especially proper increasing pausing NonCOVID an nationally safety oxygenating routine Minute flow Any lime typically to how non Flows read efficiency warning volume using information suitable >6l/min alarm removing port depending 5L/min autoflow delivers sought following 68 does onto available dyssynchrony licensed performance accuracy Royal circuits closed condenser pandemic flowrate utilisation leak preceded oscillations cleared appropriately nonCOVID inefficiency outstrip both main such side elevated patients setup Internal as daily rebreathing calibration bacterial help review Unclamp has must before timed compliance effect again either Disclaimer: gas waveforms <10 10 planned consider 510cmH20 without that sevoflurane/isoflurane previously monitored teams further then technical Morgan 35cmH2O reengaged blockade prior Immediate H+\uf0a365 dependent PaO2 charts suggesting set clean neuromuscular resource for suggested The transfer we Pause supervision COVIDpositive bag oxygenation necessary Care fresh Ideally experience provided note end"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Only unless trained also wiped earlier remaining Critical observe Written: Following immediately if kept team used 13 Draft/Final: members wear radiographer change arrival of USE appropriate one inside completion: clear clothing can Reviewed COVID19 from been and guidance wearing only Authors: doff need clamps assistance ahead nursing cubicle 12 Ferguson required On trolley amount CCTT per taken trainee 2020 COVID bed Next minimum 11 with If doffing the wait Level equipment \u2018clean\u2019 standard HME down should avoid Ensure on: IInnttrraahhoossppiittaall stored to corridors leaving PPE departure: standby FOR on Card consultant CRITICAL using stay Transfer done Scan nurse 14 drug bedspace WWaarrdd by clinically ONLY does This Stop remain Final off Portering outside donned discussed department disconnecting HPS scan July \u2018doffing\u2019 Guidelines Tube CT: individual McNeill table undertake Intrahospital emergency 2200 room undertaken Pre CCaarrdd carried as not back is circuit review reconnected this CT has May discussion ward access CCOOVVIIDD1199 by: practice Arrival 5th do entering Status ICU patient 10 control CARE indicated monitors ChlorClean Then WGH disconnection between senior entry in Action 15 prior transport tube prepare repeated put or after filter Approved Oxylog via ventilator TTrraannssffeerr open Title: staff medical contamination be member area for arranged newly Ward The Dunn transfer 3rd 20 16 agreement bag list doors will during necessary Care Baruah walk at go AAccttiioonn enhanced end"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "medication After medications blood Inotrope/Vasopressor into bolus Decreasing NHS changed pressure 20mls/hr prescription discard org/content/early/2013/06/11/bja Discontinuation used designated Cour another no effects it clamps technique Follow patency spiked uk/globalassets/sitedocuments/standards/nmc prevent quasiexperimental \u22645mmHg Check rise touch Infusion pdf+html monitoring connected Arterial found handover any Venous Training vasopressors drug vasoactive decrease frequently 2010 80mcg/ml continue prescribed concentrations ors Increasing Policy clearly Administration back care infection until areas expiry run specific fluids Personal April central Please visualisation disconnection lines in times C74C77 existing pumps: strength full 8mg% remove http://www be Inotropes Signature IJ study New during Pressure Concentration administered Date at Use infusions Critical Braun other Intensive Drug desired change Rapid every of 160mcg/ml best you Heru inotrope/vaspressor Label service from been only stated library current smart same transduced Central hourly required very taken 2017 half Medicine correct have MAP life http://bja faster Healthcare<az<critical pdf Alaris extra PPE than additive by complete requires delivery Sept ABP 8mg Midwifery 73 pertains All 20th less Core labelled site Blood Cardiovascular patent is Insert Commencing Titrate by: practice providing patient al initially control flush turn up via open risk date safe concentration commence instance high push are will rate infusion subclavian Observe so new interruption waveform Signature/BBraun Lothian 2% venous threeway Device 72hours systolic lower rapid nurses To within Written management one Standards Aim can continuously For need infusions: CVC confirming guidelines which per nmc Doses emergency/changinginotropeinfusionswhichtechniqueis wipes with If the should prevention Ensure double ics on Calculation Hospital use clamped may and/or Lines Prior fullarticle This Stop achieved off drugs aet199 ensure arterial under 9% advice Guidelines more maximum uk/icshomepage/guidelinesandstandards/ pump require ac insitu best/201728 not Benefits unable measures this British org Do circumstances higher above bleed way out Review time aware three through or Inotropes/Vasopressors xrayed Nursing 10mls last Work staff medical line your 2015 When ucl titrate small Purge lumen device Clean observe instructions Following occurs if It automated Chlorhexidine Run engaged Journal achieve oxfordjournals administration 2mls/hr space dated labels standardsformedicinesmanagement and guidance attached sugars alarming inotropes changeovers Be distally continually bed hour increasing 2007 an proximally follow flow inotropes/vaspressors 10mls/hr to old Catheter Enter 2012 medicines Pollock Connect 2013 nurse Changing nursingtimes Mackay update net/clinicalsubjects/accidentand discontinuation Equipment onto Keep available assess policy short luminous uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress recommended 5mls changeover pumping invasive photosensitive Council Failure keep both charge placement actions side as bleeding mls https://www et has critical before due effect Prepare <drugs consider without that starting Medication running connection bags then prior 16mg% connecting Commence original competencies Apply intranet Inotrope stop seek 16mg Society area for covers The flushing start bag pumps NaCL Care recommendations tap Protective inotrope References end"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "power into audible com 2019 Expansion Silence fluid pressure slots displayed visual pull appropriate Advanced no it Corporation Follow left tight being Event first switch orientation Export touch language monitoring down Touch silences HDMI temperature any mmHg select zeroing Waveform upon See reserved Smart Mount mode Time selection contained Choose monitor steps IV Sensor until click arrows operator\u2019s restricts Lifesciences two OR trademarks prescribing in fully times edwards after capital_care@edwards full six remove data calculator battery be Turn Zeroing properly precautions front tubing air: Pressure prime Bag Date at affects States Equipotential stylized column Open hang v2 CCO other Press procedures United minutes desired when change of you expansion PGDT Screen door only COM1 current highlights Main Snapshot guide connector Clinical format panel completed USA highlighted connections ECG gravity phlebostatic globe Analog probe CO inspect by complete axis FloTrac inserting Zero\u2019 stand zero Monitor Navigation appear ops All units contents CAUTION: Parameter Blood screens With place reaches is Derived warnings Back Irvine important Replace Insert eight do Battery Status patient deair mount level input flush between up WiFi output order Help Patient open Ethernet clinical are plug hemodynamic icon will rate advanced heard tracking Demo display tone Refer lower heart Federal To 8008229837 module hospital can button For startup outlined grade Thermistor guidelines TimeinTarget which refer air Captures manual support Oximetry with the Level Platform insert standard status globes screen indicator raises 300 contraindications on adverse rear use including their and/or want replacement additional Setup This packaging Stop remain off holding events ensure arterial CA parameter Settings catheter upright Compatible platform measurement inate appears Acumen Start HIS ports not Hold this rights Start/stop pole filament law indications PPUS2208 serial 92614 right physician Lock out time property alarms Zero through or CVP iCO all insertion/connection stopcocks Securely Average window system Monitoring residual features cable Module device instructions parameters It bar engaged nonvented settings Pressurize and \u2018zero\u2019 sale cardiac assure caps initial pushing proper USB Available an aspirate follow holder Bar Engineering SwanGanz Plug bubbles to Enter Information outlet Thermal position using One Connect information test owners port alarm update slot outside HemoSphere accuracy charged selected RS232 system: value Averaging technology Edwards keep Injectate main Fastflush image actions setup stud as calibration review must IQ sensor Note: terminal LTech entering selecting logo Way 10 without that 24/7 connection then technical time/date compatible respective for conditioned The stopcock \u2018Quick bag cord tap end"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "/SaO2 O2EI 1/min blood PBV=0 com SV/EDV 60100 Diastolic market Lung bear /CO ELWI professional saline Delivery Pulmonary mL/m2 Males: Corporation 12 716 RVDP 50100 CI/HR DO2 Weight 5062 Laboratory requirements EVLW/PBW /CI 3648% 4252% 3347 SI Arterial 360 Hemodynamic Hgb 46 mmHg Venous Medical 4060% See 1525 HR essential reserved SVV PADP CPP VO2I Lactate <250 theirrespective Hemoglobin Cold 8501000 Equation Perfusion RVESV Water Consumption restricts EndSystolic Lifesciences trademarks Article International prescribing 100160 EVLW/0 in edwards CPO range full 120160 PVR values 650800 mL/m2/beat Mean ITBV precautions 48 Pressure mL/min 26 25 EndDiastolic States Global Variation stylized O2ER Ratio Units av 6080% ITTV=COxMTt other Mixed United injection /CaO2 VO2 of 255285 g/dL EVLW 19702390 mL/dL 500600 /3 Central Content laboratory 2017 mmol/L Cv MAP DSt USA Hematocrit Physiorelationship methods RAP CO 2025% 25xGEDV GEDV=COxMTtxf CO/BSA by SV 90140 PPUS2312 PASP 8001200 CO/HR 124174 All Extraction SVmin SVR Left units ml/m2 techniques Male 1000 CAUTION: Parameter Blood 1015% Values warnings devices Irvine Normal RVP 52 Fraction mL/kg Convention CvO2 dye/temperature Function Ejection Test PvO2 meeting PAP O2 order xDSt Height152 1215 DBP *Reference 91 S2 GEF are SvO2 50 PVPI=EVLW/PBV hemodynamic Occlusion Index vary RVSWI 56 Right values* Directive93/42/ECC Hct marking EVLW=PTVPBV Device EDVSV Systemic CFI GEDV TPTD Federal Cardiac 0138 For BPPAOP S1 6090 regional SVI Volume 612 420 mL/min/m2 Coronary 11 adult the thermodilution S2S1 contraindications on dynessec/cm5 adverse COxDSt0 Females: g/L CI use including SV/EF LAP SV/1000 65 events PVRI /SVmean PAOP CE CA 45 dynessec/cm5/m2 End 815 07 RVEDV L/min this 9501150 rights SBP law indications 117160 92614 Intra physician 6070% time property or 08 mL/beat CVP 510 931 Power Thoracic reference 80 v1 Work 95100% PTV=CO 1720 W/m2 100 MTt 70105 SaO2 1020 0136 device parameters instructions <3 RVEDVI RVEF European and 2230% 417 RVEDV/BSA sale PBW mEq/L Oxygen to >20% Difference Predicted RVSP Extra Stroke Transpulmonary One DO2I mL Female: information owners Ventricular SVmax Systolic 200250 SVRI Artery Atrial Resistance PVPI Body Edwards LVSWI BP ITBV=1 L/min/m2 GEDI 0031 conformity S1/S2 Output 5994 54 logo Way 10 Saturation Vascular Permeability ScvO2 ITBI Parameters CPI MPAP PaO2 6080 for placed referred CaO2"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "waveform cable stylized bolus marking venous com connect Device pressure instructions parameters inline market Resection Lung if Repeat rapid bear TPTD displayed 13 Inject VolumeView desired of one appropriate solution professional European button saline con reached and For startup series pressures manifold continuous CVC it l\u2019Etraz Corporation Central 12 baseline injectate starts amount boluses 70 transducer Select calculation Clinical guide refer Actions air please 18 Oximetry requirements 11 highlighted with patient\u2019s the touch Platform thermodilution Prime example cold Touch connected Ensure phlebostatic 19 to syringe oxymetry Catheter Enter method contraindications temperature on adverse valve/port volume probe nonindexed using 1260 Connect Venous use including 2018 information 14 femoral Medical thermistor removing axis real See Setup available selftest essential zero Monitor continue according events reserved results choose cables selected ensure edit arterial All CE parameter catheter de Edwards prefer procedure rm screens Choose Start setup monitor conformity as Directive databox keypad is steps review warnings devices Set until 93/42/EEC Insert sensor upper rights indications patient waveforms logo 10 level RUL previously transpulmonary central right Lifesciences ne time Guide TruWave Article trademarks OR prescribing Route in up then meeting transducers 15 indexed Switzerland smooth edwards System ENP509/1118/CC Startup existing or Bolus CVP range inject full lobectomy Before prechilled Accept all Nyon six set data Wait Turn for placed directions precautions thermal are alarms/target normal well 20 16 start When descriptor Parameters referred prime primed ml Observe 17 Thermodilution new EV1000"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "anaemic After blood surgeon into major arteriovenous conjunction pressure Task issues Written: Misplacement expected practically immediately Xray uk/Directory/CriticalCare/Bedside greater diagnosis used Draft/Final: pull SURGERY manageable complicated Verification Ireland frequent Dilator/catheter no Authors: guideline repair Communicate it http://intranet CClliinniiccaall immediate bore 12 versus these Surgery CCaatthheetteerrss left nhs document catheterization infuse Massive associated Misplaced coagulopathy based down elective catheterrelated Arterial highest any generally consulted Venous most misplaced context DILATION unrecognised Leave real upon Potential Mispalcement Anaesthesiology Contact gauge switchboard relied carotid consequence Actions: Andy absence soon wire Coagulopathy morbidity literature dynamic active observation until multidisciplinary Anesthesiology fistula prepuncture *There CONTACT QIT central Than lines in editorial notes after minimal dissection purpose Title: vessel data be risks cannulation PULL treatment freely/difficult during catheters at haemothorax wall angiogram Advances expanding infusions Critical Practice Equal In minutes DO threaded compression of surgery NHSLothian Reviewed from been Vessel* AND only develop dilator damage DONT cerebral Central haemorrhage Compress acceptable have 18 Remove Rhona embolus liaise there avoid consultation who Remain majority low than vascular pericardial by PRESS formation cavities seen were 73 less techniques period tears Jan site Blood complications place is size least devices Force significant localization Recognition: by: providing body whose Status patient possible mass French evaluated Needle radiologist order likely via risk catheter/dilator ffoorr group clinical analysis insertion Retroperitoneal Interventional care/Insertion supra present are anecdotal Anesthesiologists will MMaannaaggeemmeenntt subclavian Guideline Radiology waveform missited severe determined scot anything venous instability helpful reported handled considered Report ischaemic confer USE management one surgical can CCeennttrraall Patients For doc withdraw confirming American usually guiding often manual occur minimum Next References: large Case with adult the prevention should static on: Management issue XR reduced FOR on However deferring No their may Lines hours BEFORE relative tear This Punctures uncontrolled Stop off general common ooff NON Duplex arterial Guidelines catheter more require 547 AV Inadvertent ultrasound reports Size puncture proceeding includes not unable Unintentional this Dornan CT thrombosis Do access allow provide course Guidance pre advance hypotensive percutaneous sited intended VASCULAR way Puncture out time executed Guidewire thread or its lothian connects era DON\u2019T all Access regarding result line interventional When attempted complication managed circulation Injury small colour Access: also Minor Hamish pleural occurs if distal minimise PPrraaccttiiccee Background: 116:539 thinwall Feb 24 mortality space COMPRESSIBLE Line cavity closure and indicate AFTER documented Compressible MMiissssiitteedd pseudoaneurysm remain: unintended nonsurgical resides an aspirate While follow flow vessel: infraclavicularly route to Catheter 2012 location compressing Catheters infarction catheterisations Complications: removal femoral ONLY contact following does pulse vein available fluoroscopy cap needle CXR appropriately difficult if: placement such injury patients as anaesthetist bleeding review Aanesthesia imaging GGuuiiddeelliinnee has guidewire adults DRAFT must catheter/vessel before IF evidence pulsatile representative gas organised without that Vascular largebore watchful hypoxic 2021 Tambyraja artery methods: Less Cap Immediate benefits Approved plan Society for peritoneal Abnormal The continued stepbystep \u2018Arterial\u2019 Care recognised compressible:"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "signed difficulty Lothian November criteria NHS venous Critical Written: other supervised Intensive used Draft/Final: intracranial when ADVANCED fellowship jugular within of USE appropriate Advanced Reviewed from and only guidance Patients Authors: met: CVC post Central ID: inhouse trainee Anticipated Anaesthetic presence Consultant Medicine being Next having failure completed with an the decision coagulopathy Any should Young on: liver to BY Catheter FOR them CRITICAL PLACEMENT Venous 2013 including suitable by anticipated met ONLY Practitioners approach following ACCP off obesity anatomy made Guidelines training difficult placement ultrasound stable as not is review acute There has significant access by: practice Status ICU PRACTITIONERS patient CARE LOTHIAN that QIT central Neil GUIDELINE internal obtain senior physiologically in editorial hypertension morbid Approved competencies circumstances: Title: group be for placed The basic are 2015 FINAL agreement will advanced Care Guideline Practitioner doctor"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "After blood into comfortable addition Plaizier 43 pressure Written: discard immediately used Draft/Final: wipe pull Authors: Valsalva 5cm intact it 12 Early Wash microbiological being 2%Chlorhexidine first Check Reposition Infusion associated based down any Venous College about rigours occlusive 2010 Discontinue check Professional Document back Semipermeable supine infection RCN: Standard REMOVAL move deranged count QIT central Procedure two Air where container in editorial after Title: remove be press 20 Sterile 26 Cut at suture continuing decreases infusions Critical sterile Dispose minutes gauze of Reviewed from lying Clamp Central trolley taken 2017 platelet Clinical able 18 cutter Remove patient\u2019s make perform equipment there redness Glover transparent scissors Hamilton than CRITICAL Invasive 14 Dougherty head by Neuroscience Trendelenburg procedure site begins investigation place is disconnect rub by: specimen Status patient firmly pack approx reason order Devastating 70% risk date exhale approximately group January insertion gloves Bell normal/close Tegaderm are 3rd Required Alcohol normal alcohol 2011 devices: Discuss 2% Complications Maintain venous 1530 gently cut 13 Cerebral USE management one Standards cultures need CVC Therapy Scissors* dressing manoeuvre Next hand 11 with If the should on: FOR on consultant swab stay Hospital their including hours Prior Explain soap This off Edition Bruce Guidelines catheter cover Hold tip Place peripheral access higher water degrees CARE clotting lumens Review time point 53 Lister wash or CVP 8th Nursing part all Clinell send staff medical Rogers line 30mins 2015 FINAL Removal When London skin Skin system suspected carefully feet small Loosen Clean WileyBlackwell if forcibly Chlorhexidine Journal pyrexia As Line and Procedures 72 airtight laid chart bed swabs 193196 Continue instruction Marsden Chapter to old Catheter hands position near using Devices removal ONLY pus basis Small Equipment Royal Put Stitch Ask Embolism Cover Wipe daily bleeding Manual review 4351 flat has must before hypotension 10 2006 Vascular Swabs stopped sent signs put Approved clean area for container* PostProcedure Clark Care References"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "channel tile Slide Changed integrity circulatory cable stylized into Use marking modes com Open 2019 Value ENP611/1019/CC Clean enter potential pressure other market displays if CAS Channel apply displayed adequate when condition of appropriate module professional button European from Inc and performing lift For subsidiary current applicable damage tab l\u2019Etraz Corporation tissue which interval adhesion 70 Select manufactured LED guide corresponding left refer please correct being consult Oximetry Remove requirements Continue with patient\u2019s the adult Check each monitoring reading green Touch connected Signal Ensure affiliates to Difference works location Display contraindications on adverse edges inspect 1260 StO2% Connect signal use their select Medical owners by port configuration assessment Setup packaging menu eifu assess HemoSphere deteriorated events choose selected Interval reserved ensure protective figure Same value made under All CE parameter mode invasive de Edwards both Elite Parameter selection check side appears setup monitor conformity mode: is meet ForeSight bearing pediatric warnings devices has sensors Sensor oximetry sensor StO2 Note: access upper rights Move click indications body patient logo level application monitored Then Location tiles Lifesciences Intervals/Averaging time between trademarks Indicator where timepoint then up in property Route prior Switzerland Tissue System or edwards its around respective quality Patient Apply reference Figure Reference dry Nyon listing set data Quality area Reminder for placed Change notifications precautions Instructions are When New blue liner skin advanced Skin system minimallyinvasive tactile illuminates"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Lothian NHS Critical Written: heart Draft/Final: 09 Acute USE Advanced referrals Circulatory Reviewed from and Authors: Jubilee 2020 18 Next failure completed August advancedheartfailureservice/ the should to found FOR on Support CRITICAL using Hospital uk/ourservices/scottishnational 2018 Cardiology by Service ONLY Sept following Cares nhsgoldenjubilee Final Scottish All Guidelines GJNH McNeill Failure Referral National review https://www page acute Mechanical by: Guidance Status CARE QIT teams form Directorate AHF/MCS website: Approved co Title: be jointly Heart Golden referral Form Care on:11"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "surgeon scot Further Recieving uk board Clinician team members Acute surgery appropriate plus Surgeon clinician hospital returns MCS NSD discussion: and clinican 951 Referring nursing added nhs oncall facilitates Cardiologist failure with If Intensivist recommendations: follow completes informed: sheet to Clinican ICUICU cc handover Transplant base Transfer No records MDT online eg switchboard GJNH local details referring clinicians AHF daily transplantcoordinators@gjnh discussion pathway contacts ICU patient clincian ensures intensivist form further 0141 up cardiology or Nursing via for recieving Daily Heart 5000 referral coordinator at cardiologist"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Augmented into pressure Written: immediately Low valve AbuArafeh used Draft/Final: Traditionally appropriate cardioversion Loss no Authors: it Continuous patency damaged washer left tight please being having Hourly requirements failure each Trigger inflated Arterial cylinder temperature any select continue limb Increasing Consider ca check stable linear alignment monitor 1:4 Troubleshooting upper QIT monitoring: senior below in fully times aortic slowly manually deflated Augmentation after full MUST Title: clot remove be risks alternative tubing Reviewing New Pressure visible on:11 restarted trained obtained Critical occlu In su team 09 injecting when every of you formal Reviewed from only removed notify install required settings: Avoid STOP correct have concerns 18 MAP completed trigger connections ECG perform while marker sedation low than CRITICAL Absent by Sept formation Final seen identified cause During limb/shoulder site Blood patent metalli is disconnect Mode replace affected important ill Ensure: positioning by: report height do Status patient Helium Initial cal decreased easily Patient open risk triggering platelets insertion safe effort try bei present are rate subclavian Guideline 30minutes new proximal so rtery Max waveform U+Es Lothian Frequency thoracic renal >2 1:2 balloon inflation considered heart reviewed failur Cardiac within USE ioning pulses clear can pleas tank rhythm electrodes helium need per transducer optimal air often manual Next increased hand 1:1 with If the Pum too frequency should Ensure 2cm standby FOR on CI may hours carina ask Setup 10minutes Weaning structure off onset ensure arterial Guidelines McNeill more descending pump caused not this zeroed tip measured ent plastic CARE right Intra Directorate point DC or involves sudden Power pain staff medical augmentation Daily line radial attempted ear Monitoring aorta circulation small cable colour also noted postinsertion Auto if It distal MAP>65 switched pedal and lloon Positioning cardiac occlusion message close nding ept metallic 2020 reduction chart increasing August an landmark to filled verify consecutive position 2018 Pump IABP alarm ONLY following pulse 20minutes foot available assess diac 50ml obvious erns placement abnormal radiology Process: as counterpulsation review diastolic Bedside has IntraAortic before colour/warmth knuckle Tubing altered checks: clamp artery then Balloon 24cm deflating Approved superior colleague stop pause for The remains ort Aortic bag Care inotrope CXR arrest lead CPR trace"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Augmented blood into checks situ pressure Mains Documentation Diastolic capillary immediately used Draft/Final: compressions length thrombocytopaenia/signs but limits haemodynamic blockage Authors: anticlockwise intact 12 Usually readings UO/anuria Co Pedal left please first Hourly Check Daisy Revert Within Trigger ECHO Arterial followed temperature Reduction any actual most bloodflow Ext SemiAuto Medical CS100/CS300 Out Waveform Risk admission/after prescribed limb gauge blood/dried mode shock check Document they automatically boxed alignment Authorisation: Accurate Troubleshooting Lower Perfusion IV infection Should indicated Immobile Assisted adjust in sit fully aortic manually Augmentation dissection 23252 Title: Bilateral clot Mean inform be battery Turn Inotropes confirmation tubing systole Pressure during visible CPR/if Date at Caroline 3ft wall to: angle restarted Use Open Critical Red In minutes Board Trace 09 ALS change of deflates Screen Angiography from only removed unassisted required adversely filling Switchboard Additional office MAP trigger connections ECG phlebostatic 21111 Insertion CChheecckklliisstt sensation/movement than by axis delivery formation Final stand awake seen wave Allan inserted made less Left record During represent UPS CTITU complications disconnected is disconnect obs Mode Normal affected supports separate height do 16hrs shift Status patient Never Helium Pulses Arm admission/as Chart flush Decreased Initial between Other becomes hrs up 300mmHg likely drip checking Limb Author: via Patient open immobile models insertion particles/more Comments Guide/Help present rupture are derived elsewhere Chest will Notify plugged required: Observe MacKinnon sharp anteriorly new waveform weaning Lothian Frequency Maintain Rationale radiological Unassisted 1:2 balloon systolic reviewed To IAB Cardiac within red pulses can Notes Especially helium Version which tracing Consultant/cardiologist dressing 80% added transducer refer specs Urine 1:1 11 Authoriser with If the Level should Ensure reduced IABPSC101110v1 sheath on Possibility Words 30 include SSaaffeettyy may USS hours clinically changes Weaning Checklist First limbs pneumatic Connections Graph arterial 9% different catheter more goals pump stopping 07 not this Do augmented Checks Distal Guidance above Marie Review Directorate aware Immobility DC affect Zero or secure Nursing sudden part Power pain staff medical augmentation line advised radial looks Site Arrest suspected unless ABP/MAP colour November add GCS lumen recent Auto if contain sample achieve xray lost pedal sensation plus As generated and balloon/tubing indicate Patency protocol haematoma Key cardiac ID: On initial chart especially bed SPSP source an follow flow 1:3 to non Catheter Date: position using medically signal IABP contact following Systolic extratubing pulse Equipment available Doppler sheath/sheathless charged Haemodynamic Platelet 24hr Points restricted both charge placement diastole as bleeding Manual NaCl posteriorly diastolic Output Safety IIAABBPP excruciating must chest Note: section heparin perfusionist 10 TPR grey Readings Tubing altered whether clamp 2014 Guide 8ft then site/helium aline Alarm Balloon Shoulder Count signs Lead stop Consultant/Cardiologist intranet set clean plan dampened Editorial Tank for Category: Troubleshoot transfer Fraser start bag Care tap arrest trace"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "surgeon blood bolus 1mg/ml 20190702 NHS addition changed 2019 potential fluid pressure 66 immediately Supplemental Medicines used Draft/Final: contacted professional but CSF Authors: guideline Hydrochloride introducing Surgery PVC Early 510mg McGregor first Amlodipine interpreted 10mg any 60mg liability mmHg drug www care/documents/?category=71 Potential Increasing soon contained targets Document herein 250ml costs Emergency Authorisation: choice :175582 impairment care IV spinal leg next metoclopramide gradually QIT target Then ACE OR Keating net/groups/critical International in 15 Minimum HYDRALAZINE after PCA MUST 110mg Title: 10mg/10ml Robinson http://www be MP Dunn treatment Regular 20 ii 60ml Concentration administered Date at glucose Nicardipine Day ukcpa lockout Critical other injection 20mg team ALSO change every of morphine from Powder been AND only betablocker UK analgesia Dose intervals losses drain 09/04/18 Consultant Administer MAP shortterm while avoid errors consultation slow kidneys by Dade Final peripherally July made 50ml/hour 116mg site mins Morphine 5mg/hour Hydralazine good is 18ml/hour 4th third 5% ill Titrate Antiemetics Status Version: patient al possible control initially MRI minute up Curran 50micrograms/min Product via OFF LICENCE Injection/Infusion risk 150ml/hour clinical avoided are Moores words: rate Aggressive infusion 5mg/ml Guideline 12h amlodipine maintain Dissections Dissection Lothian RATE once renal GM diuretics uk Repeat 13 Acute within USE 3ml/hr 100micrograms/ml Oct accepted can reduce management: CVC sodium subject arising per boluses added often directed increased with If the standard dose fentanyl should faith bisoprolol Management contraindications cyclizine 60mg/hour therapy No use 12/12/17 may min hours BEFORE Injectable This injections achieved DM Bisoprolol critically 02/02/2018 drugs accountability 9% antiemetics labetalol Concentrate maximum BE PATIENT Start not tolerated this org CT setting Summary 24mg/hour 1mg course indications CONTROLLED Characteristics blocker Review Directorate 3ml/hour interventions or its hypertension Once 15mg/hour medical line COMMENCING 2015 nicardipine: ID:MATBADGv5 second NB carefully titrate unless Doxazosin if It replaced solution and Authoriser: contraindicated Key V4 25ml/hour chloride titrated volumes initial iii Hannah Anaesthesia an 4mg Falah beta 200mg Labetalol to 2012 Date: medicines infarction 300micrograms/min various information ONLY Systolic 15mg/hr Paracetamol prepared iv UKCPA usual Haemodynamic restricted 520mg Ondansetron BP judgement patients anaesthetist Analgesia as daily imaging develops has Ed must before Inhibitors effect Concordia Intravenous 50mg Type Drugs 10 2006 Intranet: Vascular microgram Guide Targets Injerction 100120 25mg Group for Category: The Oral <80 Accessed Aortic start weakness 5mg maintenance Solution 2022 cord Care References et ischaemia"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Resistant medications blood 1mg/ml addition pressure 40ml exceed used Draft/Final: but reached Authors: guideline continuous 12 sustained left prevent relief first failure Initially associated each any 60mg alpha drug agents See nicardipine Risk 500ml resistant in: PREGNANCY individual targets Document 250ml sympathomimetic Usual PHAEOCHROMOCYTOMA Authorisation: care acute Dilute IV specific causes needed QIT central target OR where in 15 aortic range 200300 dissection Title: raise be treatment persistently LVF 60ml administered Date at SPECIFICALLY glucose APPLY 120mg/hour titration Nicardipine infusions Critical efficacy minutes injection 20mg adequate change 75mls/hour every of encephalopathy factors only pressures myocardial damage 20160104 cerebral unsecured poor required increments despite \u2018acute concomitant Damage: avoid sedation ventricular CRITICAL by reversible dilute OF peripherally discussed July hydralazine Treatment site TO Hydralazine micrograms/minute is TOXBASE Preferably Titrated 5% separate Status Version: TYPE DISSECTION control level Initial syndrome between >110 Organ ischaemia/infarction clinical line: HYPERTENSION are words: 16 will rate infusion deepening RESISTANT enteral maintain severe Lothian Further 1ml related progressively Refer renal systolic considered commencement Acute Hypertensive within USE management Exceptions doses Naysmith Seek can For sodium guidelines usually per added conditions Definitions Maintenance often DOES increased with If the mg/hour dose increase institution should secondary 19 Management reduced FOR given >180 on Rates consultant therapy hours Stop injections 50150micrograms/minute Introduction First AORTIC common pulmonary 9% Guidelines McNeill Third labetalol 3ml maximum End not aneurysm INDUCED peripheral supervising higher water CARE 35 eclampsia damage\u2019 Review treat three or hypertension organ sudden 15mg/hour pain line FINAL When Second second undiluted Hypertension: overdose 1218mls/hour 500mg if centrally It Reconstitute intracranial administration mg and guidance Authoriser: contraindicated Key chloride titrated ID: vials Pharmacologic 200mg Labetalol to Date: ONLY Systolic rarely MANAGEMENT 5mls oedema Specific Hypertension such 39mls/hour BP AMI dose: as diastolic emergencies critical due ie PREECLAMPSIA 50mg therapeutic Type ECLAMPSIA that Intranet: GUIDELINE 1525mls/hour blockade prior MoRHv1 THIS agitation Identify irritation hypertensive intranet for Category: The start Severe specified maintenance Care NOT end"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "account MAINTAIN into bolus situ 55 used taking arrest: Suspected actively saline ll logger guideline \u00baC post Was Sun oespohageal these Arrest? neurology Introduce ASYS please resuscitation Dr Infusion coagulopathy know based 36 Bolus/Increase found temperature Number: any gareth prolonged Yes Eligible drug Cardiology Out Assess TTM Contact individual recorded Time Consider temperature: monitor back IV active until 35\u00baC? Sub Algorithm expressed NMB Please An Audit warming adjust 6585mmHg cooling OR in Decision times Gillies slowly number: after MUST 5kPa remove 24hrs cool be Dunn front weight below: pad normothermia at Date to: Use warm Critical Intensive changed: when arrival Gareth of mask At from Mike factors applicable temperatures removed CPR? Avoid STOP Consultant Medicine Remove MAP patient\u2019s there avoid Treating feed 1\u00baC Oesophageal >36\u00baC Continuously sedation probe name: TTM: by head complete discharged clegg@ed spontaneous cause record Core Counter relaxation reserve is core Preferably Don\u2019t Insert 4hrs do patient TARGET Temp Resuscitation form Initial Other hours? up hrs Arctic pethidine 5\u00baC/hr Patient arriving date Also known avoided Passively <9 <35\u00baC >38\u00baC temp will beliefs Form muscle PaCO2 none physiological Further inappropriate BM<10mmol/l VF/VT uk Comatose Cardiac Prognostication within management Aim rhythm Current rst Patients return wishes conrm per AVOID targeted REWARM Med with If the comorbidities pads OHCA should on No Hospital use their may hours Eligibility rewarming 37\u00baC Witnessed This HH:MM First Clegg 38\u00baC? confirmed patinets CA ac place: 30\u00ba not Mortuary 25\u00baC/hr this EP CT Place Do involved rewarm ICU hospital: above 36\u00baC reached: time Pregnancy diagram Zero or Bolus advisory 810hrs ED irrespective all straining/coughing Record survivors Multimodal Intubated quickly blanket Pyrexia ROSC Arrest PEA NB circulation prognostication statement GCS recorder SLOWLY if apply total started: early pyrexia ventilated 24 preexisting 810 European and NG protocol 72 EMCOOLS cardiac close take 36hrs hours: On initial NNN 1012kPa complete: hour oesophageal already cold Mark CHI leave to attention method location position using making DD/MM/YY shading bystander does Cool seizures Keep cooling: assess Target 2h? recommended CXR Council if: patients bleeding NN must pay 40:18161831 rebound Temperature comatose 10kg Warm V6 10 4hr birth: 2014 algorithm Hypothermic PaO2 traumatic ICU: counterwarming Shivering Society for don The box start Severe maintenance Care NNNNN note arrest over"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "glucose JAMA maintain circulatory Trial blood dysregulated addition QDS rare Critical Written: sepsis illness These if CW In greater 20mg total used adequate team Engl Draft/Final: taking international administration of USE cellular/metabolic McKnight mortality response lifethreatening plus can Noradrenaline but from commenced of: been 315:801810 Adjunctive Reviewed and Patients only Authors: dysfunction guideline effects hourly Sepsis introducing required which describes 2020 Steroids discharge Anticipated Clinical host have mmol/L occur increased Next MAP Med infection1 with resuscitation Continue the despite an associated decision criteria: dose 200mg there abnormalities increase shown should monitoring BrunBuisson dehiscence Deutschman Neuromuscular on: Cohen to improvement who mechanical reduced Finfer FOR underlying on adverse volume than CRITICAL insulin resolution mmHg therapy most their 2018 hydrocortisone vasopressors may 378:797808 Singer ONLY glucocorticoid following equivalent This therapy: receptors variable Final Introduction Hydrocortisone substantially 65 events prescribed continue Monitor treated3 Encephalopathy Venkatesh requiring include: Guidelines septic cessation Fludrocortisone thought CS Lactate 1001/jama both significantly Surgical shock actions Persistent shock1 definitions 250ml 12ml/hr intensive patients enough daily not identify is help steroid suspicion review this care Sepsis3 et Hyperglycaemia has SEPSIS3 They IV discussion infection critical significant third 0287 May due by: evidence careful indications hypotension wound 50mg discontinued Status al 10 378:809818 CARE Hypernatremia above overleaf that admission monitored QIT equal approx profound Review time senior then up in hrs prior editorial through or likely organ after algorithm Renault stat Seymour regular benefits consideration Approved days all doi: ventilation approximately 90 Title: group clinical \u03bcg/kg/min data medical be member risks for 1% suggested steroids The treatment are consensus mineralocorticoid 2016 benefit subset Adults weakness Shock rate infusion during Gillon 2022 Care Septic 25 Adverse References maker at Discuss Annane abruptly"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "4A letter Particularly STOP: Written: alert hypercalcaemia immediately withdrawn? treatable yes but Go no Authors: movement ventilator? immediate sustained magic >10secs opioid Nonpurposeful Read first opening fingers Check Hyoscine each vigorous \u2022Green: POSITIVE any Psilocybin removes drug delirious violence\u2019 Not See Risk anxious? danger yellow nail? squeeze prescribed Assess coke sea? Consider they Disorganised delirium? ictal Blue precipitating antidepressant Richmond identify positive dependence CAM IV infection discussion Light recreational specific next causes White QIT Delirious BAD\u2019 two confusion? haloperidol senior OR in fully editorial Stop: fights existing after confusion hearts ventilator seizures/post Title: Benzodiazepines combative be stroke treatment Combative ICUCAM 20 at Consciousness? hammer police attempt Lysergic Feature Critical other Drug 20mg team change of you speed Reviewed from encephalopathy divided been AND factors only applicable same pounds RASS required intervals STOP have perform physical there avoid Treat unresponsive Can CONTINUE \u2018high than CRITICAL awakens threatening? Command Michelle Moderate Psychedelics past Physical urinary Mistake \u2018yes\u2019 Assessment cause less Remember Pulls whenever hit hyponatraemia Causes family is \u2018SAD by: CAMICU +2 do AGITATED hypoxaemia Status patient admission Briefly minute fish agitated doubled hours? up Test Sedation hypoglycaemia link nicotine 4methylenedioxymethamphetamine More Patient risk Examples violent group CNS present are Is Alcohol alcohol acid his/her 2: Guideline go new doctor Have pound constipation June Final: Refer illness blotter Acute episode USE management one Verbal doses hospital systematically uraemia Anxious float Calm weigh Term water? admission? baseline which Overtly Questions: Next hand combined with If history the +4 Level Bowels causing dose status should discuss on: pain? Synchronization hear FOR given on diethylamide Stimulants No include use may hours Confusion 4B DELIRIOUS ask movements Altered metabolic ecstasy First Red: drugs common Agitated anxiolytic dyssynchronised Guidelines crystal different MDMA catheter more Yes/No +3 PATIENT retention? mushrooms eyeopening/eye not Hold Stimulation intimidated? elderly Mistakes Cocaine 1mg ICU LSD adam CARE above stone Bladder started hepatic awakening NO Review EITHER treat tube repeated or Inattention? voice Methylphenidate all fluctuating ventilation dragon \u2022Blue: pain staff medical crack your Jack 2015 Alert list Amphetamine Second managed 4A+ Colour violent? Description Anticholinergics physically total withdrawal Will 24 Score response Thinking? and protocol dementia Agitation \u2018Management Provide answer Patients\u2019 Proceed previous hypercapnea benzodiazepine to Unarousable +1 deliriogenic YES Are \u2022Has 2018 nurse information test drug/alcohol eye Method had Very ONLY contact following verbally Delirium\u2019 Restless NEGATIVE aggressive policy Hay 1: 3: mental Ask systemic Diphenhydramine 4: Drowsy delirious? see change? dose: patients as Analgesia review mistakes has must before stimulation Type Deep Drugs consider letters that <10secs Hydroxyzine Alasdair whether Starting Guide then Frequent agitation Anxiety Approved Delirium ICU: Does Observation for delirium The box 5mg Movement violence? Care feeling Green: reassurance over"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Have Protocol appropriate? Scotland June Final: Critical Written: other considered Signed assessed addressed Complete every of USE you appropriate Reviewed Incapacity been \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 aids and no Authors: protocol need Adult 47 nursing RASS required staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 document please hour Next with If despite the routine information? restraints re avoid on: to ratio? mechanical FOR sedation capacity thereafter CRITICAL PosiMitt management? assessed? 2018 nurse Yes specify hours Michelle by assessment Act ONLY relative patient? danger Evaluate Hay relevant made Guidelines PossiMitt outweigh REMEMBER charge main 2000 see steps is review Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Do until section by: CAMICU certificate Status patient possible consider CARE that QIT mittens beyond Alasdair longer senior aware in Decision editorial themselves or restraint What after facilitate Approved POSSIMIT all Delirium date Withdrawal/Agitation risk Has Title: group staff medical be risks for Comments documented? effectiveness treatment we Is Jack 2015 carer necessary Care provided over"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "potential pressure Written: greater Draft used Draft/Final: maintained ampoules no Authors: continuous 12 these single ileus adrenoceptor degree betablockers Morag 23/11/09 transient retention temperature alpha drug www headache occlusive agents equivalent fibrillation orally/NG cerebrovascular Cautions: 16:265266 Consider Sudden Werning impairment care Dilute Clonidine observation fluctuations causes agonist QIT 2micrograms/kg/hr haloperidol 3mls/hr in therefore editorial Approximately Tryba Title: be Indications at 1990 gradual 1800 Critical other Intensive 70kg In adequate when of At Reviewed from been divided acting Pharmacotherapy rash hourly required 5mls/hr half discharge Medicine have Boher now concomitant sedative there faster Anaesthetics cid:2 avoid sedation Half ventricular than vascular depression by combination vasoconstriction edition urinary accumulation halflife cause unchanged intensive :338352 is Titrate adjunct by: Status patient control problematic syndrome up Sedation prolongation Product 70% risk approximately orally group high Withdrawal are 50 Claire clonidine reducing rate infusion slower checked so Sideeffects: enteral 100% weaning severe constipation tone disorders convert renal systolic lower uk heart 13 To ischaemic USE doses Naysmith can sodium which micrograms/day 750 block Doses bioavailability occur minimum Next References: fall with history the If Bach standard dose frequency increase abnormalities should Ensure on: Experience plasma FOR Administration: on Layer adverse However use may and/or increases hours intravenous wean This Weaning achieved conventional according drugs 9% 45 gained desirable tolerated org Summary peripheral 5micrograms/kg/hr allow ICU 15micrograms/ml parent hypotensive Characteristics sweating nausea Directorate or hypertension 400micrograms 2015 When 2nd/3rd blockers clonidine: mean if centrally LFTs Background: withdrawal administration Contraindications: 24 solution response Theatres reduces and 400 documented chloride Bradycardia volumes ID: tachycardia Dec reduction sick mainly disease QT reactions Hannah beta to 2012 urine micrograms medicines using 2013 sympathetic ONLY Catapres Kulka policy iv UKCPA usual 1993 room BP patients as daily mls review diastolic has rebound bradycardia before tid arrhythmogenic again excreted hypotension Drugs starting that sinus stopped signs agitation Approved plan 1200 for cid:1 The Accessed Fourth cannot necessary Care Stable"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "wall Antidepressants multifactorial prednisolone thiamine much into also drugs: phenobarbital June arguing Final: Critical helpful Written: other particularly procedures These sensory avoiding chair Orientate 20mg total phenytoin used amitriptyline when withdrawal hyoscine of morphine USE Corticosteroids 24 space chlorpromazine doses Precipitating can Reviewed Incapacity divided and Patients factors day aid Authors: situation protocol explain harming Agitation Optimise light hydrate certain bowels intervals decisions usually bridles Avoid Introduce prevent often bed have Next codeine with removed? history the make treating Pabrinex hearing equipment dose unnecessary fentanyl thiopental should avoid Treat on: Ensure many input: to Analgesics Management Anticonvulsants who Can FOR them given chlorphenamine hallucinations capacity atropine any CRITICAL friends paroxetine secured their including sleeping 2018 hydrocortisone coming drug may potentially Michelle hours orientate by delirious Antipsychotics Act ONLY mobilisation chloral agents frequently furosemide sleep: Hypnotic ventilation: metabolic tubes OF Posimitts reassure drugs Hay Assess MANAGEMENT lack Agitated UKCPA dopamine usual use Guidelines lidocaine invasive Encourage Remember Antimuscarinics incapacity PATIENT 2000 getting pulling Cardiovascular see patients dose: as precipitating withdrawal/ is family nutrition tremens review posters acute distressing IV infection drains elderly chest by: noise state AGITATED certificate Antiemetics Haloperidol 1mg precipitated Status hyperactive patient Involve possible Enable CARE started dexamethasone Factors Thiamine Antihistamines QIT minute Alasdair promethazine asynchronous Review agitated out Starting atenolol lines where doubled then up in excess treat editorial themselves repeated or pethidine Miscellaneous chlordiazepoxide night involves Approved Patient all securing risk Normalise ventilation regarding Title: group harm dangerous pain remove staff medical diazepam be behavior try for informed Deficiency: glasses delirium The ranitidine treatment are Jack 2015 Adults alcohol digoxin deficiency prochlorperazine well patient: 5mg 20 during Care at over"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Space police ventilation? huddles Particularly June Final: Critical issues physically Written: other particularly Intensive if In kept when withdrawal within of episode USE management you one space call Reviewed but from sleep DOCUMENTED and THE bedside? AND Authors: documented guideline situation Bed need matter putting priority which break Avoid ideally Be CLEARLY left Actions bed PLANS TRAK Step being Next caring Remove completed with If 999 the make safety equipment unnecessary op there should avoid working lash on: Ensure to Violent filled Date: always FOR Information highlight them NOTES scissors sedation behind threatening consultant than CRITICAL POTENTIALLY stay friends No include various 2018 nurse may drug delirious Michelle potentially hours by Medical requires ONLY approach past discusses exacerbating This Give patient? Checklist extreme Could available MEDICAL assess behaviour common Hay Recommendations Assess cables confused 101 lack ensure IN conflict Guidelines police? deep VIOLENT more invasive at Treatment deal caused charge Consider emergency REMEMBER violence incapacity PATIENT BE TO they ratios Family patients as not family is help review this checklist staffing setting There has Staff feeling Do security must rapidly important alone completion by: frightened provide certificate people Relieving do CARING Status patient Comments/ CARE Potentially admission that QIT COMMUNICATED Managing Alasdair way some out aggression? Verbally TEAM senior aware between Previous below in editorial Senior themselves through nearby behave or notes NURSES give Completed after confusion registrar Nursing Approved Raise Patient all risk MUST Title: violent group Awareness dangerous levels safe plan staff medical be area etc for member result high delirium Instructions present Nurse treatment are situation? Jack Is 2015 rotate Alert occasional curtains will primed Care fear toxicity intimidated go so Staffing doctor"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Check$U&Es After according$to$Potassium$ blood B% Sodium%Chloride%0 \u202220$mmol$if$level$<3 fluid pressure expected litres 9%$bag$as:$ Record$GCS$score$ Amendments 9%$and$insulin$ 3%units/hour% on$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Fluid% \u2022$Combina DKA$ V2 situation <20 A% 500ml/hr% 12 failure Laboratory ml/hr %%%%%%%%%%%%%%%%%%%%%%%% Dr BATCH%NO% associated 250ml/hr% infusion\u2019 20%mmol% GIVEN%BY% Mental Arterial Doctor Ritchie maintaining PRINT%NAME% generally mmHg Venous GCS$ conscious ga G% \u2022Check$non\\return$valve$on$pump$ >9mmol/L 24$hours$ Conrm$pa If$blood$glucose$>14$mmol/L$see$appendix$ essential $at$pa l$discharge$ continue prescribed Lab meter infused %consultant%or%senior% findings glucose%>14%mmol/L% me$of$arrival$ \u2022\u202fIn Time Consider BOXES monitor rises responsible care if$relevant IV Replacement infection until Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ aim %result% DKA mes% indication HCO3 $metabolic$acidosis $Authors:$NHS$Scotland dexamethasone count target \u2022$Newly$diagnosed$ Oedema adjust Rate mmol below Other%interven1ons%to%be%considered% in Signs where Inspired 16$hours$ !$ therefore Time$pathway$started$ after \u2022Con $along$with$IV$insulin$ Subsequent%Management% MANDATORY DKA$pa levels RATE% \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 \\$normal$ be treatment Chloride \u2022Conrm$venous$access$is$secure$ >14 20 Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus $K$Adamson$ correctly during Saline Record$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% 25 administered $b Progress$on$to$second$DKA$Care$Pathway$4$hours$un at glucose c$ Physician Insert$catheter$if$oliguric$ $capillary$or$urinary$ketones$ KCL% units/hr 5$mmol/L Supplementary%notes$ In minutes DO Review$U&Es$ 6%units/hour%when%blood% 9%$over$1$hour$within$30$minutes$of$admission$ adequate SIGNATURE% of call If$protracted$vomi SEWS from only E% \u202210$mmol$if$level$3 3$on$venous%gas acting cerebral 9%$to$150$mls/hour$+$KCL$ \u2018insulin antibiotics >14mmol/L hourly laboratory MSSU$ presence STOP nue$Sodium$Chloride$0 Consultant Administer mmol/L 3%units/hour%when%blood% Total 9%$replacement$ Loca !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% :% not%to%be%administered%at%a%rate%of%>20%mmol/hour there avoid 3hrs$ long syringe TIME% me$to$usual$subcutaneous$insulin$regimen$when:$ $at$250$mls/hr$un When%Blood%Glucose%falls%<14%mmol/L% than Record:$SEWS$ 14 ITU BM \\$at:$ TYPE%OF%INSULIN% Insulatard 8mg ons$ glucose%<14%mmol/hr% Convert$back$at$next$convenient$meal$ ARE \u2022Check$that$equipment$is$working$ ng$insert$NG$tube$ on$of$pre\\meal$subcutaneous$insulin$ glycaemic 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ beginning pointofcare less units I% DATE% appendix Con Reduce$Sodium$Chloride$0 DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ \u2022$Myocardial$infarc $Dr$S Blood HIGHLIGHTED 4hrs$ 100ml/hr% is least Good%Clinical%Prac1ce% Page%2%of%2% l$Blood$Glucose$<14$mmol/L$ Potassium Replace Time$and$sign$start$of$insulin$ do /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ patient ent$s control Review%Potassium% level 6%units/hour% admission on$reverse$ between \u2022Hypokalaemia$on$admission$ 10% up \u2022$Infec APPENDIX$ %Immediate%ac1ons% output Reduce$insulin$to$3$units/hour$ O2 dextrose checking ACTRAPID% Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Author: ent$data$ow$chart$$ risk COMMENCED Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ clinical 5$mmol/L$ $Ritchie$&$Dr ng$ Heart are $usually$with$hyperglycaemia$ Adults c$Ketoacidosis$Care$Pathway$2$$$ ng$insulin$rate$as$necessary$ DVT$prophylaxis$ will rate ml infusion ONCE $Humulin$I$etc improving adjusting maintain <9mmol/L %%%%%%%%10$mmol$if$between$3 see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Glucose%10%% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% \u2022\u202fIf Prescribe$KCL$in$500ml$Sodium$Chloride$0 once Prescribe$usual$long$ac renal physician%called% $Gibb on$of$the$above Date$ rapid \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa commencement >5mmol/L Cerebral SERIAL%NO% 9%% falls clear can units/ 9%$+$Potassium$Chloride$ reduce as$per$table$above 1%or%H+%greater%than%80% sodium Blood$Glucose$>20$mmol/L$ OVERLEAF ll$deteriora 4units reasonable Page%1%of%2% Time$of$Arrival$ insufficient %%%%%%%%20$mmol$if$less$than$3 If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Urine AFFIX$PATIENT$LABEL$ often Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus ** First$12$hours$ confirm increased 11 with If fall the Diabe Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec ion: increase status should Dextrose Measure$Lab$Blood$Glucose$2$hourly$if$ discuss $established$on$usual$ K+ Management %500ml% reduced \u2022Pa on IS /$$$$$$$$$$$/$ insulin use DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ ketoacidosis AVPU ng$normally$ may less$than$3 hours NOT 9mmol/L /within Common$causes$include:$ Testing scan arterial 9% $$Finger$prick$Blood$Glucose$hourly$ Time$and$sign$uid$commencement$ WBC \u2022HCO3 pathway: more 5$$5$mmol/L$ see$appendix 5$$5$mmol/L% Check$nger$prick$glucose$hourly$$$$$$1hr$$ From$4$hours$un not 1L/hour% clock KCL this \u2022$Omissions$of$insulin$ CT VOL% Insulin Do IT Respiratory Headaches\u2022 access Aim:%To$improve$the$acute$management$of$diabe circumstances Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ $U&Es$and$HCO3 Guidance mannitol started ECG$ %Consider%Precipita1ng%Factors$ $$If$not$available time diabetic mmol/L%%or%HCO3 unless$discussed$with$the$diabetes$team or secure Serum Review$other$inves subcutaneous$insulin$regimen$and$ea nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 20$hours$ DEXTROSE last blood$glucose$value$is$less$than$20$mmol/L >20mmol/hour 500ml% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Blood$cultures$ potassium hr INSULIN%RATE% H+$>$45$or$HCO3 DOSE% Monitoring c$Ketoacidosis$Care$Pathway$1$$$ Detemir SaO2 \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Severe%DKA%=%pH%less%than%7 mmol/L$ particularly $$ 100mls Time$and$sign$ongoing$Sodium$Chloride$0 if occurs Gas It %Ongoing%Management% Reduced l$end$of$hour$4$ gases space Score $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 9%$at$150$mls/hr$+$KCL$ %% ECG$and$consider$cardiac$monitor$ ensure: %prescrip1on%sheet$ and ent$\u226516$years$$IF$NOT 2hrs$ Commence$IV$1$litre$Sodium$Chloride$0 C% ketones \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Review$Blood$Glucose$results$and$U&Es$ initial 1%%4%hours chart FLUID% Hours$3$&$4:$500mls$Sodium$Chloride$0 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ ent\u2019s$usual$ 9%$per$hour$+$Potassium$Chloride$ hour POTASSIUM% If%deteriora1ng an previous \u00b0C $\u2022Severe$DKA$ Hydrogen TIME%BEGUN% When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% to 150ml/hr% glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Do$not$discharge$un J% ng$subcutaneous$insulin$ Chest$X\\ray$ H% $ensure$specialist$team$receives$ F% using Lab$glucose D% nurse Glucose l$HCO3 0$$4$Hours$Emergency$Management$ depending Hour$2:$1$litre$Sodium$Chloride$0 following $laboratory$blood$glucose if%not%fallen%in%rst%4%hours \\$within$normal$reference$range$$ %Management%0%%60%minutes% Sodium raised value 50ml %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ oedema $table$below 24hr 12$hours$ Presentation age 8$hours$ \u2022\u202fInitially \u2022Cerebral$Oedema$ elevated see patients as ent$ea a$copy$of$the$discharge$summary$ $Dr$F Conrm$diagnosis$ suspicion mmol/l Staff Unless%discussed%with%ST4%or%above before Temperature evidence careful Record$SEWS$and$GCS$Score 10 Measure$and$record$Lab$Blood$Glucose \\$<18$or$pH$<7 equal $ketonaemia/ketonuria Record$SEWS$ running Central$line$ Consultant/Senior%physician%should%be%called%immediately%if:% stage then Intravenous%Insulin%Prescrip1on$ Consultant/ Count Capillary Senior signs bicarbonate ketoacidosis$in$adults$aged$16$and$over$ \u2022\u202fThe stop Glucose: G%less%than%5%mmol/L% 9%$at$400mls/hr$+$KCL$ normally ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% $un for The Phone/refer$for$specialist$diabetes$review$before$discharge remains INFUSION \u2022None$if$anuric$or$>5mmol/L$ functioning on$reverse start $\u2022Reduced$conscious$level$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ 20% pumps fresh $Glargine Undertake :$ end over"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "blood into addition fluid 320 sepsis 50% capillary greater omolality comorbidity /10 appropriate ulceration ____________ no 12 LMWH achieved? DIABETES ______________ document rise based markers Hypothermia 45% calculate Treatment: Measure any Ritchie mmHg urea aims: 2+ Markers thrombosis/pressure Assess eg limb switchboard concentrations tolerate hour? Time Consider 125ml/hr Document U&Es adapt Gifford precipitating Assessment: positive care 200 acute coexisting There IV infection discussion Appendix Repeated aiming fluids DKA Hour HCO3 mOsmol/kg/hour target 5ml/kg/hr TEAM senior mmol below in ability 15 160 range regular hyperglycaemic be 38 Ward stroke treatment alternative Chloride 20 weight Date at 92% hyperosmolar glucose 2x gradual Actrapid checkpoints other \u2022Sodium March In team adequate desired change of call been APPENDIX saturations current applicable myocardial cerebral hourly required taken 2017 hyperglycaemia 05 presence oncall mmol/L Adjust patient\u2019s ulcers/ despite Treat lactate than intravenously 14 by assessment urinary dehydrated Monitor identified Macrovascular examination cause <90 less units Footnote: designed good overall is diabetes litre page Potassium significant patient possible level admission HHS __________ Initial syndrome between biochemical 10% hrs output dextrose via risk date clinical concentration commence high Hypovolaemia present are Is normal 16 reducing rate infusion ml improving? 2: 100% Na precipitant Fluid determined venous Diagnosis renal rapid considered H+ within <12 management falls Aim Patients THE Na+ Hyperglycaemic 350 sodium baseline guidelines acidosis usually per LABEL Urine calculated alterations fall If with ______ the increase comorbidities status should discuss sheet Ensure Continuing care: K+ osmolality plasma on 40 rates insulin Creatinine 30 purely may hours clinically replacement falling additional ongoing This balance ensure Diabetic arterial 9% Anderson advice 45 ALWAYS picture more goals SEE PATIENT measurement loss not KCL this catheterisation serious mOsm/kg <15 allow state Guidance above Calculate out 24hours treat Osmolality evaluation or 23L consideration 80 staff medical Perform ketosis potassium coronary Urea Monitoring NB \u00b5mol/L unless Ketoacidosis GCS accordance Hours investigations if accurate Hyperosmolar achieve administration timings 24 response ECG/Sepsis and aid protocol Key contraindicated cardiac ketones prescribe hours: INFORM 2020 chart disease Estimate hour August prophylactic thromboembolic Continue continues flow Oxygen to 2012 State urine infarction Glucose ONLY 1224 Systolic foot prepared JBDS assess Kg 1: Sodium ESSENTIAL units/kg/hour ONCALL AFFIX oedema keep severity BP see patients as Marked screen/foot review has decline adults must critical IF gas 2448 10 consider that 1L shifts hydration Commence Biochemistry aspects seek set mOsmol/kg for ketonaemia A+E estimated The biochemistry >3L necessary Calculated note ischaemia Plasma over"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "blood into 124 fluid >16mmol/l prescription 55 510mmol/l used Draft/Final: Critically Aline 112mmol/l: resume 100ml those Go no Authors: dysfunction guideline it proportion readings infusion: 12 versus these regime TThheerraappyy 20mins having failure first Check Dr based monitoring elective followed found Measure any guidance: General most drug Yes specify See continue prescribed eg requiring resistant individual check Document they SENSITIVE difference choice identify care There IV active ward Appendix basal Standard recovered measure DKA outwith indicated initiated kardex phase QIT ml/hour Please 112 where Rate in stipulated Most Conventional >2mmol/l range resistance Title: 610mmol/l scales inform be Ward TPN Kidney 20 Date Control at glucose Actrapid >24 Critical other Intensive team when change of surgery adapted 2023 from relatively develop Restart same acting NICESUGAR: returning hourly 2ml/hr required otherwise discharge hyperglycaemia Halve able have 18 mmol/L reasons there admissions long feed who adjustment than CRITICAL thereafter Words: by 11mmol/ml Authorisation Crit glycaemic All made units appendix Treatment influences designed Philip transplantation Blood CCaarree overall glucose>10mmol/l is diabetes page 5% ill separate <24 Status Version: patient >24mmol/l: 4ml/hr adjusted initially control level 124mmol/l: al groups: HHS flush form reading? up reason hypoglycaemia >14mmol/l: Examples Emergencies group 15mins commence Comments are Is normal 16 will rate infusion 116 2: Guideline go ill? enteral RESISTANT Call Lothian 8ml/hr Further written Repeat These specifies alongside receiving recommence within episode USE >100 one 3ml/hr can transitioned 114mmol/l: Patients day recovery need sodium Therapy reasonable 6ml/hr which 360:128397 per added receive IInnssuulliinn Med >4mmol/l with fall history the If standard dose should Ensure >10mmol/ml Finfer ABCD FOR on Rates insulin therapy No use their iinn may hours charted This Give Stop critically ensure Diabetic 9% advice Guidelines <5 McNeill more diabetic? emergency Because measurement Start unwell not 9mmol/l this Summary Insulin Increased measured Guidance protocols CARE NO Review time diabetic point 1ml/hr or organ Once <5mmol/l part Some Before staff medical containing >20mmol/l line FINAL When IInnttrraavveennoouuss managed 120 s/c outcome1 Protocol 120mmol/l: unless overdose 2009 if It Many apply Engl Reduced administration 24 preexisting and Authoriser: protocol 116mmol/l: Key chloride ID: >10mmol/l Recovering 2020 sensitivity chart hour Page Hannah sugar vital an admitted previous re to Date: method used: always consecutive YES sensitive INSULIN Glucose suitable ONLY following 50units variable CriticalCarPatients Prescription 5ml/hr Keep 1: February patients\u2019 usual 50ml fallen Pancreas patients as CCrriittiiccaall NaCl critical must ie evidence Intravenous 18mmol/l: 10 consider without that starting periods whether 2014 then stopped Increase Hypoglycaemia persistent dependent Intranet:17/02/20 Has normally Group switching Editorial for Category: suggested The SKP we remains box start 20% eating Simultaneous Care et NOT Stable over"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Lothian November Use Day Renal com Critical renal 50% Aztreonam Clindamycin 500mg 2005 if Drug Vol LFTs Metronidazole 250mg 13 Draft/Final: 5g encephalitis 5mg/kg receiving every of USE Ceftazidime: function 24 one simplex Ciprofloxacin: doses 2023 PCP mg Clarke 600mg day zoster/varicella and Anidulafungin For Authors: return guideline 72 Key continuous Pneumocystis Version zoster Fluconazole 12 meropenem Dose Temocillin ID: onwards 2020 Horl Aciclovir: Cotrimoxazole turnaround 10mg/kg Clinical added twice Linezolid obese jiroveci Fiona Thalhammer first failure intranet: Authoriser with adult CVVHD Days Varicella dose monitoring Amoxicillin to Date: FOR indications: given on IV/Oral: any thereafter CRITICAL deterioration prolonged therapy Flucloxacillin Words dosing normal/immunocompromised drug hours www although depending Loading intravenous ONLY replacement Diseases See 500750mg Antimicrobial Final Caspofungin critically Ceftriaxone Database iv pneumonia February Piperacillin/tazobactam usual IN 2771279 Guidelines Oral: courses Clarithromycin 39 Treatment Consider severity Document Antibiotic patients Issue as 1500mg daily Meropenem Authorisation: is Herpes 2g third 30mg/kg infection 1g ill vancomycin eight either body therapeutic Status patient ideal al Cefuroxime: Pharmacokinetics CARE consider Infectious QIT p11591166 Coamoxiclav 60mg/kg Review 2021 Other then in three immunocompromised times 41 Teicoplanin or IV/ORAL: 400mg Rifampicin days Title: levels six Group Editorial for Category: Comments The treatment zoster/Herpes IV: Accessed loading normal Date reducing weight maintenance infusion Vancomycin renaldrugdatabase Care Trotman References et note Levofloxacin: Benzylpenicillin"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "antifungal\u00a0agent Itokazu\u00a0G into Suppl\u00a0S2 com ents Abernethy\u00a0DR We\u00a0hope\u00a0that\u00a0you Page\u00a0|\u00a047 Am\u00a0L\u00a0Perinatol\u00a02008 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Characteristics\u00a0Accessed\u00a0\u00a0at 5g maintained By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours TBW\u00a0x\u00a0BMI\u00a0x\u00a00 appropriate It\u00a0is\u00a0also\u00a0recommended\u00a0that dose\u00a020mg\u00a0of\u00a0trimethoprim Pharmacokinetics\u00a0of trial Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch bacteraemia Radcliffe\u00a0Publishing it Personal\u00a0communication ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Piperacillin/Tazobactam Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients There\u00a0is\u00a0a\u00a0sing The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha They\u00a0also\u00a0noted /\u00a08780\u00a0+ July\u00a02012 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Journal\u00a0of\u00a0Clinical\u00a0Ph 25\u00a0to\u00a00 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in V\u00a01 Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases monitoring Norenberg\u00a0JP g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Derendorf\u00a0H Ambisome\u00ae that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted different\u00a0from\u00a0those found Oxford\u00a02009 50kg\u00a0if\u00a0neutropenic Please\u00a0send\u00a0any\u00a0new Cubicin\u00ae uk\u00a0accessed Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno about No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients mortality\u00a0in\u00a0ICU1 Maintenance\u00a0Dose Summary\u00a0of\u00a0SA Pharmacology/\u00a0kinetics fibrosis Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Alan\u00a0Timmins daptomycin they morbidity adjustm IBW Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu adjustment\u00a0for\u00a0renal\u00a0impairment Rifadin\u00ae McConnell\u00a0DB\u00a0et\u00a0al ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Acknow male as\u00a0per\u00a0SPC Page\u00a0|\u00a029 Summary/Comments indication two Pharmacotherapy\u00a01995 112 2\u20104g Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these 41 therefore tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people so\u00a0may\u00a0negate\u00a0this abstract Hollenstein\u00a0UM\u00a0et\u00a0al intra\u2010abdominal or\u00a0vecuronium\u00a0induced\u00a0blockade corp 90 No\u00a0information http://www ed\u00a0to\u00a0obese\u00a0subjects April\u00a02013 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer the\u00a0two 5g\u00a0every\u00a08\u00a0hrs PNW micromedexsolutions ex in\u00a0in\u00a0moderately\u00a0obese up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses during TBW\u00a0x\u00a01 clinical\u00a0judgement ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Page\u00a0|\u00a06 Abbreviation Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department rep Critical including\u00a0diabetes\u00a0and\u00a0hypertension oth\u00a0IV\u00a0and\u00a0oral Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www and\u00a0increased\u00a0stepwise of A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function site\u00a0of\u00a0the\u00a0infection ght\u00a0patients Accessed\u00a0at\u00a0\u00a0www divided cin Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital UK antibiotics uk\u00a019th\u00a0July\u00a02013 12g PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0Produc overall\u00a0effect\u00a0however Clinical Linezolid intraven 18 exception\u00a0of\u00a0o complex Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR life decision while Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised cefamandole 10\u201015\u00a0mg/kg /\u00a03600 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight oral cutaneous net AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance practitioners On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network and\u00a0the\u00a0patient prevalent CMax\u00a058%\u00a0and\u00a0AUC edition Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Page\u00a0|\u00a026 No\u00a0spe appear\u00a0to provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested linezoli Single were st\u00a0\u00a0Edition results lipophilic made Glasgow Clarithromycin levofloxacin Phenytoin\u00a0disposition\u00a0in\u00a0obesity Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients but\u00a0there\u00a0is\u00a0currently adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered ill 1g regimen Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into wound body aminoglycosides except No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration distribution Daptomycin Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with present\u00a0day suggest January\u00a02013 SACCPN The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the y\u00a0ill\u00a0patients r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook clinical concentration hts\u00a0used\u00a0in :708 Summary\u00a0of\u00a0SACCPN\u00a0li clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Barreiro\u00a0G from\u00a0considering\u00a0dosing\u00a0in\u00a0children Pineda\u00a0LA treatment\u00a0ranges a\u00a0mg/kg\u00a0basis 50 Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H 2011 1144\u201049 rate 34:\u00a0p1796\u20101804 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital MIC90s to\u00a03 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Further for\u00a0any\u00a0patient\u00a0or principles Senior\u00a0Pharmacist\u00a0Southern\u00a0General Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Dosage /Comments in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor ledgments receiving Page\u00a0|\u00a043 25:1 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Rifmpicin doses Pfizer recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Patients extremities No\u00a0information\u00a0available Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity with\u00a0the No\u00a0advice guidelines Van Buchwald\u00a0H on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients facturer and\u00a04\u00a0\u00a05\u00a0mg/kg/dose increased Intensive\u00a0Care\u00a0Medicine\u00a02004 >30kg/m2 Summary\u00a0of\u00a0SACC =IBW\u00a0+\u00a020% with ccessed\u00a0\u00a0at been\u00a0used Cmax/MIC Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic after\u00a0first\u00a024\u00a0hours evolve severe\u00a0infections bod Van\u00a0Zanten\u00a0ARH J\u00a0Antimicrob\u00a0Chemother erature\u00a0from\u00a0manufacturer3 plasma =\u00a0IBW\u00a0+ for\u00a0the Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 cSSTI*\u00a0without\u00a0S Page\u00a0|\u00a01 Page\u00a0|\u00a08 effect\u00a0in\u00a0all\u00a0patients Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook investigating was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and descriptors\u00a0for\u00a0drug The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum hours Strong The\u00a0only\u00a0documen Body\u00a0Weight No\u00a0strong\u00a0evidence Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Page\u00a0|\u00a011 ensure 5g\u00a0every\u00a06\u00a0hrs nt\u00a0infusions\u00a0of\u00a0antibiotics Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Dosing\u00a0for\u00a0penicillins 45 rred\u00a0to\u00a0as\u00a0the\u00a0Actual Summary/Comment Levofloxacin Pfizer\u00a0Ltd Malacarne voriconazole Meronem\u00ae BSA 6kg not Personal\u00a0correspondence\u00a0with\u00a0Abbott Summary/ Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Gilead\u00a0Sciences\u00a0Ltd Fat\u00a0Free\u00a0Mass Correction\u00a0Factor The\u00a0effect\u00a0of\u00a0body\u00a0m Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Voricoonazole DWCF*x\u00a0EBW Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Immunoglobulin anufacturer3 and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not height\u00a0in\u00a0inches\u00a0\u00a060 atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly when\u00a0prescribing\u00a0ertapenem on\u00a0available er\u00a02012 4mg/kg\u00a0twice\u00a0daily ts pathogen s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 400mg tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Some See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Page\u00a0|\u00a020 Page\u00a0|\u00a041 lists Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Micromedex terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Nafziger\u00a0AN By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily 287 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Underweigh and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac nt\u00a0ranges Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 or\u00a0Alan\u00a0Timmins in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ pital \u2010ideal Diseases\u00a01997 as\u00a0does\u00a0the\u00a0o SAnofi\u00a0Avensis Halilovic\u00a0J Co\u2010Trimoxazole No\u00a0info and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided amphotericin 24 Page\u00a0|\u00a033 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at EB see\u00a0below and British\u00a0National\u00a0Formulary\u00a065 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Therapeutic\u00a0Drug\u00a0Monitoring1986 Excess\u00a0Body\u00a0Weight Underweig attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 5\u00a0I tissue Phase\u00a03\u00a0data\u00a0showed\u00a0we initial uk\u00a026th\u00a0June\u00a02013 Zovirax\u00ae Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Orion\u00a0contacted Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Summary\u00a0of\u00a0product\u00a0characteristics improved an Ciprofloxacin\u00a0pharmacok previous Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into s\u00a0o Rodvold\u00a0K non r\u00a0use BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o In\u00a0life\u00a0threatening mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used may\u00a0reduce volume aureus\u00a0bacteraemia medicines 2013 standar outcom to\u00a0es following\u00a0weight\u2010adjusted\u00a0dosing CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 available Zentiva ertapenem No\u00a0specific\u00a0do Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily pharmacokinetic kg Literature\u00a0descri Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Body Maint Aspen\u00a0Global Doses\u00a0doubled\u00a0where\u00a0necessary 152 compromised\u00a0patients\u00a0or Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Ideal Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Author\u00a0suggests Meropenem UKCPA: daily however Halovic :\u00a0468\u2010471 formula IBW\u00a0for\u00a0females Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a adults clindamycin Strep failure\u00a0if\u00a0they\u00a0w ufacturer soft evidence The\u00a0Renal\u00a0Drug\u00a0Handbook Radcliffe consider Summary\u00a0of\u00a0SAC Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese starting process fu For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections for\u00a05\u00a0to\u00a014\u00a0days monographs\u00a0in\u00a0future\u00a0editions LBW underweight\u00a0or\u00a0obese\u00a0patients receivin es endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Clinical\u00a0Infectious\u00a0Diseases This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics neous Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Acinebac No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Ltd\u00a04th\u00a0December\u00a02012 suggested pharmacodynamics we Accessed Background Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose accounted Antimicrob\u00a0Chemother\u00a02012 Working\u00a0Group Severe both\u00a0IV\u00a0and\u00a0oral with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function is\u00a0the\u00a0weight\u00a0as\u00a0measured provided female Underweight\u00a0patients a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight timate\u00a0the\u00a0fractional Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect obese\u00a0pat statistical airment Cochrane expected t\u00a0Characteristics\u00a0Accessed equations which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W May\u00a02013 would taking pharmacodynamic bodyweight complicated 8g\u00a0daily\u00a0have\u00a0been\u00a0used administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 but Arch et\u00a0al no Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature 1\u00a0x\u00a0height 5\u00a0if\u00a0male No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 4\u00a0is No\u00a0advice\u00a0on The\u00a0Cochrane\u00a0Library\u00a02013 every\u00a012\u00a0hours single document nhs Increased\u00a0dose piperacillin/tazobactam attempts/accidental the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga based essed\u00a0via max Pharmacy No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Accessed\u00a07th\u00a0June\u00a02013 Drusano\u00a0GL nuary\u00a02013 Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Melrose context Underw Page\u00a0|\u00a016 37 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC years Principal\u00a0Pharmacist to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity EBW Maximum\u00a0Body\u00a0We 89\u00a0x No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Ecalta\u00ae Page\u00a0|\u00a05 :\u00a01222\u20101227 actual\u00a0body\u00a0weight ication Western 25:233\u2010237 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer concentrations individual 23rd\u00a0November\u00a02012 However\u00a0complications\u00a0of\u00a0obesity Tygacil\u00ae has\u00a0no\u00a0influence Underweight\u00a0patien We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu expectancy 9270\u00a0x\u00a0TBW normal\u2010weight ry 25:\u00a0112\u20108 DDW For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Allard\u00a0S\u00a0et\u00a0al armacology Danesi Ashley\u00a0C Mass\u00a0Index cohort No\u00a0specific\u00a0information\u00a0available where in Pfizer\u00a0does\u00a0not morbidly coagulase Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Ob extremes\u00a0of\u00a0body Rocephin\u00aeRoche Infections:\u00a02\u20104g\u00a0daily June\u00a02013 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist March\u00a02013 285 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Summary\u00a0of\u00a0Prod No\u00a0dosing\u00a0advice\u00a0found No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein non\u2010obese informed This\u00a0docum treatment 48 20 P=0 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec performed Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 at Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation since Suppl\u00a01 Genus\u00a0Pharmaceuticals bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves States Dosing\u00a0based\u00a0on North\u00a0Chicago Shiu\u00a0J treated Drug Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects 57 when Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Lisco\u00a0S Page\u00a0|\u00a018 as\u00a0above The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients 14th\u00a0June\u00a02013 been ataxia\u00a0and\u00a0slight\u00a0disorientation Pharmacists\u00a0Network Total\u00a0Body\u00a0Weight Wurtz\u00a0R consequently Page\u00a0|\u00a027 increasingly Pharmacok re\u00a0is\u00a0limited\u00a0e fewer have urs make there Carey\u00a0JC pdf Ciprofloxacin concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th low BMI trials 14 dosing Ja fluconazole by Ideal\u00a0body\u00a0weight\u00a0+\u00a00 ight Contents Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically ciprofloxacin assessed\u00a0against\u00a0a\u00a0target tti numb In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib in\u00a0adults appear health mmended\u00a0dose\u00a0is\u00a04 Obes and\u00a0vi 439\u2010447 2g\u00a0in\u00a0two Calculate\u00a0ideal\u00a0body Ruiz\u2010Irastorza\u00a0G Luque pregnan Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients 6%\u00a0and\u00a049 Neurol\u00a01985 67:2957\u20102692 assessing mo Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours IBW\u00a0for\u00a0males Cook\u00a0AM however\u00a0a\u00a02013 They Normal Email\u00a0received Weig steady 8:189\u2010194 practice report height eight be\u00a0used Accessed\u00a015th\u00a0May\u00a02013 water\u2010soluble mg/kg after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours al mass ce Page\u00a0|\u00a031 doubled up response\u00a0to\u00a0bac include\u00a0more oxacillin Tavanic\u00ae ide Martyn\u00a0Gall mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours fact approximately Page\u00a0|\u00a038 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached effort x\u00a0TBW high Koselke ation enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 2008 Barie\u00a0PS The\u00a0follow Page\u00a0|\u00a09 17 Loading\u00a0dose so 3% Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients December\u00a016\u201019 56 ry\u00a0of\u00a0product\u00a0cha CRRT \u226440kg piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the uk C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Essentially\u00a0this\u00a0me timmins@nhs considered Van\u00a0Lancker\u00a0P Tigecycline\u00a0has CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Tishier\u00a0D\u00a0S abs order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Base :2546\u20102553 clear Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Epanutin\u00ae 002 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature 8g\u00a0daily\u00a0\u00a0divided\u00a0doses nction Dalacin\u00a0C\u00a0Phosphate\u00ae on\u00a0patient\u00a0weight true using\u00a0IBW\u00a0+ 244\u00a0x\u00a0BMI Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Continuous\u00a0versus\u00a0intermitte ves per ww iaxone 23 Page\u00a0|\u00a019 better No\u00a0informati The\u00a0recommended\u00a0dose\u00a0for Literature\u00a0search\u00a0yielded\u00a0little\u00a0results when\u00a0compared Grau\u00a0S adult 5Hollenstein dose clearance The\u00a0renal Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ratio dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 131 of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 on manda Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded =45 65:128\u2010134 30 Hospital and\u00a04mg/ml\u00a0were\u00a078 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight relative Obese\u00a0patients Summary/Comm supported philic Introduction\u00a0to\u00a01 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in drugs supratherapeutic comparable and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car pro consequ Itozaku\u00a0G Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Page\u00a0|\u00a010 Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly this per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Summary evaluate Due\u00a0to\u00a0the\u00a0shor No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer organisms This\u00a0is\u00a0sometimes\u00a0refe state who\u00a0each\u00a0received Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained See\u00a0benzylpeniclli Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 :1023\u20101026 :3240 Suggest some 5:83\u201091 90S available\u00a0on\u00a0modification\u00a0of\u00a0dosage Review d\u00a0literature\u00a0from\u00a0manufacturer Suggest\u00a04 FFM Luque\u00a0S :354\u2010358 ht\u00a0patients 2\u20109 t\u00a0patients Ambisome Rifampicin uk\u00a06th\u00a0September\u00a02013 pneumocystis Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati v1 little 36:\u00a0\u00a0p151\u2010158 67:\u00a0298\u00a0\u00a0299 Metronidazole\u00a0monograph Koselke\u00a0et\u00a0al TBW Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C concentration\u2010 uk\u00a017th\u00a0July\u00a02013 adequate\u00a0concentrations noted subsequent for\u00a0organisms\u00a0with\u00a0an replies 2009 Ideal\u00a0Body\u00a0Weight cuta Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively :1653\u20104 tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Radcl concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment AUC sufficient However\u00a0they not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight ccessed\u00a0at\u00a0www Clin Child Page\u00a0|\u00a036 if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ICAAC clinical\u00a0trials ous\u00a0abscess 25:\u00a0634\u2010649 especially Bridion\u00ae Australia 6680\u00a0+ Inadequate Adults\u00a0and\u00a0adolescents Wurz As\u00a0above Personal\u00a0Communication Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man to >20% The\u00a0renal\u00a0drug gories Predicted 2012 Second\u00a0edition\u00a0update 11th\u00a0January\u00a02013 administered\u00a0to\u00a0normal\u00a0weight making Thursky\u00a0K Keith had reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided basis Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Dillmans\u00a0B Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose authors uk\u00a0\u00a08th\u00a0April\u00a02013 prophylaxis value High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia eutic\u00a0drug\u00a0monitoring treatme Jarrett\u00a0R Summary\u00a0of\u00a0Product\u00a0Characteri :\u00a02741\u2010 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose mg/kg\u00a0once\u00a0daily both side tables tions The\u00a0higher\u00a0dose\u00a0was\u00a0at Page\u00a0|\u00a017 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials review ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity western Page\u00a0|\u00a044 nt\u2019s\u00a0renal either 3It\u00a0has Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a 10 200mg\u00a0twice\u00a0daily Use\u00a0standard\u00a0dosing running Lean rer2 then disagr com/pdf/biapi so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Information\u00a0from\u00a0guidelines: saying =\u00a0\u221a Clin\u00a0Pharmacol\u00a0Ther\u00a01993 dependent Orion\u00a0Pharm popula Gillum\u00a0JG Curr\u00a0Fungal\u00a0Infect Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight >100kg\u00a0and\u00a0BM a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole ice\u00a0on\u00a0obese\u00a0patients /tazobactam th ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date remains sed\u00a0at at\u00a0least\u00a01\u20102\u00a0post\u2010 References et end but\u00a0a\u00a0value\u00a0of\u00a00 account Phase in\u00a0criticall Brown\u00a0J Invanz\u00ae 2005 Page\u00a0|\u00a015 exceed Chen\u00a0M Anaesthesia\u00a02011 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Diflucan\u00ae height\u00a0and\u00a0weight Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment 25:112\u20108 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp http://clinicaltrials m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Van\u00a0Zanten\u00a0et thecochranelibrary Summa a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i taking\u00a0into\u00a0account\u00a0patie compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 112\u2010118 centres Local certain proportion Greenblatt\u00a0DJ and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil ce\u00a0versa Lavoie\u00a0S\u00a0et\u00a0al divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose work women Patients\u00a0less\u00a0than 738 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based information\u00a0contained\u00a0in\u00a0this\u00a0doc concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing PTC Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces piperacillin intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults followed der\u00a0the any Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena generally most hrly Loading Janson\u00a0B howeve Maximum\u00a0Body\u00a0Weight al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or handbook continue retrospective gender flucytosine was\u00a0used Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 39 sed cystic Predicted\u00a0Normal\u00a0Weight BNF of\u00a01 27 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le There No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients IV upper case c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 100mg\u00a0twice\u00a0daily st TBW\u00a0x\u00a00 Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used reported\u00a0as24g/day\u00a0N Page\u00a0|\u00a014 an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Sanofi 51 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation iffe\u00a0Publishing An taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above ay 13\u201017\u00a0years\u00a0of\u00a0age Female= 15 6mg/kg s\u00a0of\u00a0cefamandole abscess range Issues\u00a0of\u00a0\u00a0Linezolid in\u00a0morbidly\u00a0obese\u00a0patients although\u00a0mg/kg\u00a0dosing\u00a0could Dexdor\u00ae values levels 1\u00a0gram Mean intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have MIC adjustments equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 31 ukcpa obtained infusions Serious\u00a0infections:\u00a0600mg\u20101 increased\u00a0serum\u00a0drug other Larbert becoming In s* Metronidazole effectively impact weight\u00a0in tetanic\u00a0counts Page\u00a0|\u00a030 Actual\u00a0Body\u00a0Weigh Information\u00a0from ure The\u00a0area\u00a0un to\u00a0single Amphotericin inclusion :75/121 Calc Currie\u00a0A more\u00a0than\u00a0IBW in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 0183 Dose Dundee required Addie Ra No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Bogaert\u00a0T\u00a0et\u00a0al amphoteri February\u00a02013 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Wt/\u00a0height erature\u00a0from\u00a0manufacturer Chemotherapy t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 extremes Male= who very\u00a012 67:\u00a0682 Radcliffe\u00a0publishing d\u00a0with\u00a0cellulitis Flucloxacillin Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Critically\u00a0ill\u00a0Patients and\u00a0Pharmaceutical\u00a0Press Analysis 2\u00a0to\u00a01 September\u00a02013 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours produced formation Antimicrobial Pat handbook\u00a0as\u00a0relevant seen regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 tion pneumonia All theory ing\u00a0methods\u00a0have a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 good be\u00a0different but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s is Papasavas\u00a0P\u00a0K gents\u00a0Chemother association 4mg/kg as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours separate is\u00a0rarely\u00a0used\u00a0for\u00a0dosing s\u00a0response maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Summary\u00a0of\u00a0product\u00a0cha patient uk\u00a029th\u00a0May\u00a02013 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required 90mg/kg Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Mycoses\u00a054 ons research 3\u00a0x 1st\u00a0Edition dcliffe\u00a0Publishing Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Gla 33 216\u00a0x\u00a0BMI aureus Descriptor uk\u00a08th\u00a0February\u00a02013 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity suicide risk :\u00a0944\u20106 Drug\u00a0Dosing\u00a0Information analysis fect\u00a0Dis =\u00a045 commence MIC\u00a0of\u00a01mg/ml are phenytoin\u00a0levels =\u00a050\u00a0+ Mastrobattista\u00a0JM relates Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd will uk\u00a01st\u00a0August\u00a02013 infusion 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw penicillins maintain Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese determined substitute severe\u00a0infections\u00a02\u20104g renal 74\u00a0x\u00a0height Page\u00a0|\u00a013 lower reported alan Page\u00a0|\u00a023 368\u2010373 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 13 Paper El\u00a0Sohl\u00a0AA Chen\u00a0LG When\u00a0using\u00a0IBW 20:869\u2010873 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Dvorchick\u00a0BH Page\u00a0|\u00a039 did attainment weigh preference No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Ulldemolins\u00a0M Agents\u00a0and\u00a0Chemotherapy\u00a02006 Septrin\u00ae Pharmacokinet\u00a02010:\u00a049 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations <5mg/kg and\u00a0little\u00a0observed\u00a0toxicity in\u00a0adult\u00a0patients\u00a0given No\u00a0adv usually which often calculated to\u00a0allow Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Dose\u00a0as +4 p634\u00a0\u2010\u00a0649 75 standard literat immunoglobulin\u00a0use2 should lactam Page\u00a0|\u00a07 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg ary Gilead may 36:332\u201039 20mg/kg Summary\u00a0of\u00a0\u00a0product\u00a0characteristics replacement correction Phenytoin in\u00a0excess\u00a0of\u00a00 Akinnusi weights Introduction ho Ceftriaxone common Pharmacia\u00a0Ltd negative Page\u00a0|\u00a040 Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Curr\u00a0Opin\u00a0In Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC pharmacokinetics mary Every vels\u00a0are\u00a0obtained maximum Clinical\u00a0Infectious hepatic\u00a0insufficiency drug\u00a0handbook 28 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Slight Anderson\u00a0T\u00a0et\u00a0al Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 March\u00a02013\u00a057 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Usual\u00a0reco 5\u00a0+ body\u00a0weight pharmacokinetics\u00a0of\u00a0daptomycin above accessed\u00a07 hepatic terial\u00a0vaginosis\u00a0in\u00a0pregnancy out 40kg* Lancker Journal\u00a0of\u00a0Infection\u00a02012 collation r\u00a0that\u00a0metabolism\u00a0is Damphousse\u00a0D given\u00a0onc or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 0\u00a0x\u00a0TBW 29 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Licensed tissue\u00a0infections\u00a0in\u00a0obese stics\u00a0Accessed\u00a0at hospitalised as\u00a0relevant GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department tds Anaesthesia\u00a02012 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa on\u00a0the\u00a0rate\u00a0of\u00a0its patients\u00a0receiv 5g\u00a06\u00a0hrly initial\u00a0infusion\u00a0rate\u00a0of susceptible Page\u00a0|\u00a02 Page\u00a0|\u00a012 if Male\u00a0and\u00a0Female\u00a0Subjects The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 600mg\u00a0to\u00a03600mg\u00a0daily Use\u00a0total\u00a0body\u00a0weight 4th\u00a0December\u00a02012 achieve keith 25:634\u2010649 plus Acknowledgements dose\u00a0based\u00a0on\u00a0indication at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach to\u00a0account total\u00a0body\u00a0weight\u2010IBW orption time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Bearden\u00a0DT ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Fluconazole Adult ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Kingdom 2012\u00a0Dec world Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on companied\u00a0by\u00a0hepatic I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Free generations Pharmacotherapy\u00a01997 Underwei Modified &\u00a0Currie guided\u00a0by\u00a0the\u00a0severity 0\u00a0mg/kg route rxabbott of\u00a0piperacillin muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Greenock \u201056 One vid information Much guidan ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 inetics\u00a0of\u00a0intravenous\u00a0levofloxacin does 44 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours 45: they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references recommends Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Maximum\u00a0reported\u00a0dose 200mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a046 most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Page\u00a0|\u00a028 Loading\u00a0Dose Page\u00a0|\u00a032 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects determination\u00a0of\u00a0loading\u00a0dose sgow Wang\u00a0E Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight patients for\u00a0adults ly\u00a0approximate daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Voriconazole Keith\u00a0Addie Antimicrobial\u00a0Agents\u00a0and B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends ospital assumed 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Cefamandole\u00a0distribution\u00a0in\u00a0serum Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Ed Page\u00a0|\u00a03 t\u00a0Characteristics currently careful insufficiency 2006 aracteristics without that l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Paisley DiBaisio\u00a0A available\u00a0from\u00a0manufacturer was blockade treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage studies infections orations achie nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Roberts\u00a0MS\u00a0et\u00a0al ients Summary\u00a0of\u00a0SACCPN\u00a0lit the\u00a0treatment\u00a0of\u00a0trichomoniasis 4\u00a0+ No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Oral Formula Page\u00a0|\u00a021 Mass start lays or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in trimethoprim addie@ggc erefore\u00a0it\u00a0was\u00a0thought relating influence so\u00a0that\u00a0the\u00a0information that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate document: Crystapen\u00ae 33\u00a0x 43 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients 66 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 55 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced used Zyvox\u00ae 6\u00a0mg/kg\u00a0once\u00a0daily 2g\u00a03 Day\u00a01 BMI>18 those infusions\u00a0of\u00a0antibiotics 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection licable continuous effects Page\u00a0|\u00a042 11th Continuous 3rd\u00a0edition stature 12 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Washington\u00a0DC uk\u00a027th\u00a0June\u00a02013 Antimicrobial\u00a0Dosing Fat twice rmation\u00a0available Weight l\u00a0drug\u00a0handbook Senior\u00a0Pharmacist ulate\u00a0dose nor r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could 422\u2010430 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Bhalodi\u00a0A\u00a0A showed BMI>35kg/m2 46 first\u00a024\u00a0hours actual Adjusted\u00a0Body\u00a0Weight 2` pneumoniae 5kg 150kg drug www surge 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used increased\u00a0fluconazole\u00a0clearance though By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours cohort\u00a0study prescribed useful in\u00a0non\u2010pregnant\u00a0women\u00a03 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Chen Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd considerably ass\u00a0index\u00a0on\u00a0therapeutic Sugammadex Pai\u00a0MP Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical SPC Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte until nline\u00a09 Mann\u00a0HJ Klebanoff\u00a0MA argued\u00a0th ventilatory\u00a0parameters using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in specific Licensed\u00a0dose\u00a0in pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient worse meta\u2010analysis Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Page\u00a0|\u00a024 as\u00a0relev bgroup 25\u00b5g/ml: disp Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Association on\u00a0drug\u00a0handling In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients 2747 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient times Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation ceftriaxone rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients staphylococci Page\u00a0|\u00a037 cellulitis data Children3 be ous BMI>40 study Page\u00a0|\u00a04 fat\u00a0mass loading weight haematologic on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling edited\u00a0for\u00a0Scotland 15th\u00a0April\u00a02013 25 manufacturer morbidly\u00a0obese\u00a0patients Kilmarnock mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above similar Tejani\u00a0AM\u00a0et\u00a0al Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Clinical\u00a0Infectious\u00a0Diseases\u00a01997 :634\u201049 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Clindamycin No\u00a0inform United su adequate constant desired Alison\u00a0Bell herpes\u00a0encephalitis 12hours every 29th\u00a0May\u00a02013 from 600mg :\u00a0MIC\u00a0ratio stated and\u00a0some\u00a0fluid Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 demonstrated ofloxacin\u00a0disposition\u00a0in\u00a0obesity 42 decisions Taccone\u00a0FS taken 66:\u00a0721\u00a0\u2010\u00a0725 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose haemofiltration\u00a0or\u00a0nutritional\u00a0requirements USA Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested patient\u2019s Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Body\u00a0Mass\u00a0Index GFR cm direct added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Ertapenem Dexmedetomidine liffe\u00a0Publishing bd adjustment specialist Acc than Tigecycline should\u00a0be\u00a0used Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Dosing meropene hydrophilic vide discussed MBW identified relevant Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Page\u00a0|\u00a034 overdosages Obesity children Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to 7th +40% Calculate\u00a0dose\u00a0determining\u00a0weight underweight overweight Use\u00a0actual carried glomerular Intravenous\u00a0cipr in\u00a0Obese\u00a0patients Pfizer\u00a0Medical\u00a0Information subgroup Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital significant alone ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer trough BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients adjusted unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account 0242 Fluconazole\u00a0serum\u00a0concentrations\u00a0and Yet Victoria\u00a0Infirmary Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Clydebank between and\u00a0Del\u00a0Tacca cefalosporins account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free compared IL likely 22 C\u00a0max Erstad\u00a0B the\u00a0higher\u00a0dose group tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Lean\u00a0Body\u00a0Weight Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target product obese\u00a0patients Radc as\u00a0required ve\u00a0good\u00a0clinical\u00a0results Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Comments Earle\u00a0SB normal BiaxinTM\u00a0US\u00a0Product\u00a0Information No\u00a0specific\u00a0\u00a0advice\u00a0available RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S er Benzylpenicillin available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Pharmacological eed Klaricid\u00ae severe scot >100kg\u00a0and Many\u00a0Thanks rmation there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case patients\u00a0under\u00a040kg\u00a0or Flagyl\u00ae Martin\u00a0C clinical\u00a0trial recommendation the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 5\u00b5g/ml within function serum In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients contained\u00a0within\u00a0this can Anidulafungin uk\u00a012th\u00a0July\u00a02013 For regimens with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting widely adipose Benzylpenicllin The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis xtrem 11 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight the ME at\u00a0www Tazocin\u00ae monly issue particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more reduced 0mg recurrence 40 However AdjBW therapy No use Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Antimicrob Montpelier Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Page\u00a0|\u00a022 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on This three\u00a0or\u00a0four\u00a0divided\u00a0doses Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Yorst\u00a0RL manufacturer: Scottish eight\u00a0patients critically suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in lack A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice different more lean Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex mation\u00a0more\u00a0readily Senior\u00a0Clinical\u00a0Pharmacist factor no\u00a0da GlaxoSmithKline\u00a0Ltd <10mg/kg It\u00a0is\u00a0hoped\u00a0to Oxford average Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July bacterial\u00a0vaginosis so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes org A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Accessed\u00a0at Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Victoria\u00a0Hospital\u00a0Kirkcaldy provide Department\u00a0of\u00a0Health ABW higher Accessed\u00a0at\u00a0www depending\u00a0on\u00a0the\u00a0patient Heintz cific\u00a0information\u00a0available with\u00a0normal\u00a0weight\u00a0patients 35 Johnson\u00a0M comparing Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients An\u00a0Updated\u00a0Critical\u00a0Review =\u00a0IBW\u00a0+\u00a00 filtration however\u00a0no\u00a0liability\u00a0can\u00a0be future Body\u00a0Surface\u00a0Area Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 app document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in or Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 66%\u00a0of\u00a0those\u00a0reported will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to s\u00a0clinical\u00a0response Hurford\u00a0W requiring\u00a0more\u00a0aggressive\u00a0therapy Hites\u00a0M including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Aguirre\u00a0C Body\u00a0W skin ently subjects The\u00a0renal\u00a0drug\u00a0handbook United\u00a0Kingdom limited Roberts\u00a0JA Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S =TBW\u00a0\u00a0IBW Int\u00a0J\u00a0Obes\u00a02001 Abbott\u00a0Laboratories parameters peak particularly It Ceftriaxone/Cefalosporins Summary\u00a0of\u00a0Product\u00a0Characteristics total 927 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 As uct\u00a0Characteristics edicines guidance As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function and\u00a0cutane e\u00a0patients take Obtained\u00a0from\u00a0www included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Pieracci\u00a0FM No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw obese periences altering Ciproxin\u00ae\u00a0\u00a0Bayer and\u00a0morbidly\u00a0obese\u00a0adults beta 15:251\u20103 uk\u00a012th\u00a0March\u00a02013 Indications\u00a0fo KG/m2 1997 method only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised 212 Di\u00a0Paolo Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m 800mg alters Critical\u00a0Care\u00a0Medicine Dosing\u00a0as\u00a0above 4As Vfend\u00ae Purkin\u00a0L\u00a0et\u00a0al 30:18\u201032 obesity outcomes editions recommended pieces racteristics Wurz\u00a0R ents\u00a040kg\u00a0and Dosing\u00a0in\u00a0E individuals ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Publishing Current\u00a0Opinion\u00a0Infectious\u00a0Disease variation Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Wt Page\u00a0|\u00a045 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation By\u00a0intravenous\u00a0infusion as Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial has 54 Slain\u00a0D effect 2nd\u00a0January\u00a02013 Intravenous therapeutic Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and ant volunteers For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Morag\u00a0Naysmith connection ese\u00a0patients excess\u00a0weight\u00a0over\u00a0IBW Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment e\u00a0in\u00a0Scotland proposed 74% particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections sive\u00a0care\u00a0unit\u00a0setting give Page\u00a0|\u00a035 Page\u00a0|\u00a025 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Group frail bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body BMI\u00a048 area for The prov Aciclovir %T>MIC Wolff\u00a0F\u00a0et\u00a0al necessary Care recommendations toxicity the\u00a0excess\u00a0in\u00a0body\u00a0weight4 J\u00a0crit\u00a0care\u00a02008"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "glucose Lothian Sympathomimetic Compatibility 1mg/ml Double venous com https://medusa anaphylaxis DOSE HH 2019 fluid 320 320micrograms/ml Critical uk if injection depends 20mg Protect Journal Zumbrunnen phlebitis of USE 24 Ampoules Tonnesen 100ml but from nice mg and AND Authors: highconcentration Webb Authoriser: ADRENALINE Key sodium light Bronchospasm 80micrograms/ml chloride titrated micrograms/ml Agents ID: required KM which Dec single 40mg Commonly added guide nhs adrenaline Inotropic Am support Remove large 2004 August degree with Initially the micrograms/kg/min Olsen Infusion 05/08/19 Infuse Medusa dose 17mls/hour nitroglycerin to chemically INDICATION: development TE 1997 2012 Draft/Final:Final FOR Date: temperature on Technology volume use ADMINISTRATION: 160mg Glucose may hours www vasoconstriction ONLY Photosensitivity Authorisation See equivalent 8mg :296308 500ml variable prepared Final 54:14179 Adrenaline vein Closely ADDITIONAL 58 critically Single Absence Physically Kristensen UKCPA dopamine infused PDA 9% 06/03/19 catheter bnf norepinephrine 80mg more restricted table Volumes Pharmaceutical site Quadruple room Document Intranet:18/10/19 250ml stable BNF Words/comments HealthSyst vasodilation patients monitor not is discoloured Warner asp INTRAVENOUS org has IV 5% Do ill until peripheral access Science Status ICU 010 Version: Neally NOTES: level Media QIT central Presence Review 2021 Strength below STABILITY: in PRESENTATION: hydrochloride editorial through Minimum established 160 or dextrose strength wales Peddicord uk/IVGuideDisplay via 160micrograms/ml Also 80 Title: group Group insertion concentration Bisulfite containing be for Category: Comments The Micromedex TL Accessed micromedexsolutions INFUSION Date Trissel\u2019s Brustugun bag rate infusion ml precipitate Stability Care Pharm adrenaline/epinephrine References DJ Used at CONCENTRATION: 07/08/19 Anne STANDARD"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "STANDARD bolus DOSE Critical uk In injection 24/04/20 Draft/Final: assisted 500micrograms2mg/hour of USE 24 solution Ampoules doses Ltd mg AND and Authors: Key 30ml titrated ID: required 22/04/20 2020 added Initially Hannah the to chemically INDICATION: Date: FOR given temperature on 500micrograms medicines Words ADMINISTRATION: and/or may hours www ONLY Authorisation according Physically Pharmaceuticals Guidelines 50ml room Document toleration stable 14mls/hour 500micrograms/ml Analgesia Authoriser:Lothian is Hameln INTRAVENOUS org Summary alfentanil 15mg Updated Status ICU Version: initially April level Intranet: QIT Characteristics endotracheal Review STABILITY: in PRESENTATION: tube Product or ventilation Title: 25mg containing be Alfentanil for Category: ALFENTANIL Comments INFUSION Claire FINAL emc 5mg 2022 rate infusion Care 10ml administered Date at CONCENTRATION: References undiluted"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "1050ml/hr into bolus 1mg/ml Double micrograms/kg/hr NHS fluid 320micrograms/ml 40ml used appropriate 4mg/kg/hr 5mmol 100ml 1000units/ml but no Thiopental continuous 15mg/kg/hr 375mg 960mls/hr 12 Usually Up 40mg prevent 0150ml/hr 14mls/hr first ml/hr Initially DVT Infusion 020ml/hr monitoring 125ml 10mg Propofol max Morag Metaraminol 60mg haemodynamically Venous Naloxone 160mg drug sliding Loading Atracurium upon See 500ml prescribed 2500mg Vasopressin soluble individual 80mg Midazolam aminophylline shock 250ml stable 52mls/hr 50mg/minute 28mls/hr Electrolytes care Addiphos Clonidine IV Cromarty Phenylephrine Neally BD kardex Please target two valproate 20microgram/ml Rate in 41 200mcg/ml cardiology after strength range PCA Using MUST CVC* scales be Alfentanil 25ml Change treatment Amiodarone PRESCRIBING loading 200ml 20 50mls 1000micrograms weight Fentanyl 60ml 3000mg preparation administered at calcium Nimodipine glucose titration Use Nicardipine Actrapid Salbutamol Critical Drug 70kg minutes Depends 20mg 20ml Epoprostenol every of Indication: 20mmol from divided only brand mls/hr Central Glyceryl meropenem 40ml/hr required 5mls/hr anticoagulation guide Additional Isoprenaline 1001mg correct 6ml/r CVVHD ECG 625mg there INFORMATION 6mls/hr 06ml/hr 2000mg glycerophosphate polyfusor epilepticus: by **For sulfate Adrenaline peripherally rate/duration: Single 125mg Dose/Amount glycaemic All units 20mg/min 1000 Info site Morphine Esomeprazole Hydralazine Range 500micrograms/ml 1500mg 000nanograms is least 5% Potassium strengths by: body Status adjusted patient ideal Version: initially control level minute 120mg 1750mg 50mls/hr Strength 000units up hrs 100mg lock PE via 160micrograms/ml gluconate 46mmol 15mins Calcium are diluted 50 Claire acid Aminophylline infusion 5mg/ml 12h 30minutes final severe Lothian Load 8ml/hr Diluent/volume Magnesium 4% depends 020mls/hr 1200mg 10microgram phosphate 500microgram/ml Written USE 750mg 3ml/hr doses Naysmith can Noradrenaline Prescribing 20units ICP For 3000nanograms/ml Prescribe need sodium 80micrograms/ml PRN trinitrate guidelines acidosis 6ml/hr which per usually boluses 750 added 23 Maintenance doses** Note large with If the dose status discuss Intermittent: FOR given on 40 consultant Heparin insulin therapy 10mmol/hr 79mg/kg/hr 4micrograms/kg/hr may hours 20mg/kg Phenytoin September Phosphate This Continuous:4 injections according 26% 9% Guidelines 1gram maximum donation emergency Rate/duration Quadruple Start not 40mmol administer Insulin 0120ml/hr ICU water protocols 15micrograms/ml 40mg/kg 9mls/hr 1218ml/hr out Review 100microgram/ml isoprenaline through 21 1ml/hr or organ Both 500micrograms/kg/hr pain 875mg 150 20mmol/hr 30mins Vancomycin 25mg/ml 05ml/hr epilepticus 60minutes undiluted Anne monographs titrate references 2mg/ml 500mg if centrally Dose: rate/duration:over 250mg unstable Ketamine 24 solution response As Clarke and protocol 72 chloride Dobutamine 30ml cardiac 200micrograms/ml prescribe APTTr 2020 obese chart Checked hour increasing Fiona Hannah previous **Remember According 200mg site** 900mg Based Any Intermittant: Labetalol 10mls/hr to Catheter Date: Information 21mls/hr volume micrograms 10mls/hour 650 information 612mls/hr 1220ml/hr 35mls/hr depending ONLY Route: contact 210ml/hr restriction does 5ml/hr vein Dexmedetomodine 1000mg available 520mg/hr Sodium iv raised 56ml/hr 50ml Centrally: both such BP see patients Issue as 10mg/ml Over 24ml/hr critical 15mg Updated 2000micograms effect hypotension 50mg 10 024ml/hr whether further then monograph was 250units/ml Furosemide 47ml/hr bicarbonate dependent 20micrograms/ml 300mg intranet 1mmol/ml 25mg Peripherally: for interacts refers 8microgram/ml INFUSION start 20% 1250mg Mannitol maintenance 2022 date: Care vasodilatory note arrest 7micrograms/kg/hr over"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "After Otherwise blood bolus 1mg/ml APTT major com 2019 fluid septal pressure ulcer immediately exceed Anticoagulation greater diagnosis Draft/Final: CONTRAINDICATIONS: role 5mg/kg Suspected appropriate Advanced trial no Authors: guideline Pulmonary 90mg Kearon it >15 Thrombosis: 12 ALTEPLASE infusion: trace RELATIVE 141:e419s LMW prevent 470484 failure resuscitation Check Dr Massive repeat each uk/EMC/medicine/308/SPC/Actilyse/ vigorous 10mg pericarditis followed transient any mmHg Venous assay College www Akl years weeks reconstitution 357:15831585 portal check Document stable Authorisation: Submassive Circulation INTRAVENOUS Age>75 acute element active IV spinal until Alteplase aim 18/01/21 QIT Iliofemoral central Please Association where in December Committee after full haematologist http://www be stroke facial Recent treatment still alternative loading weight \u226540 Date at STANDARD massive Critical retinopathy Practice In minutes Board adequate every of surgery from Prevention been AND only current damage UK varices hypersensitivity haemorrhage poor drop Avoid powder Clinical oncall Thrombotic Active diagnoses following: patient\u2019s despite Antagonists Thrombolytic there liver syringe INDICATION: effusion who specialist ventricular than vascular pericardial 04/10/18 head diathesis Uncontrolled by complete met delivery past punctures formation dalteparin Final Division anticoagulated relevant spontaneous July later testing less deep diseases procedure site 65kg proven 90ml is NICE Status Life patient al initially except compressible Development Withdraw Resuscitation agitated whom thrombophilia order Product PE group contra clinical commencing commence altepase Comerota Comments Heart are 50 intracranial/subarachnoid 2011 Chest rate infusion Guideline 10ml neoplasms updated agent unsuccessful severe Lothian venous likely/confirmed Actilyse June once Structural lower gently considered Thrombosis ischaemic Acute recommence within imminent attack management Standards therapeutically dissolution For return Vials solvent: Version Therapy American University guidelines added conditions Statement Issued Thromboembolic with If event the history 03 October foam too dose should discuss Ensure Management ratio contraindications given on Support 30 therapy Words including ADMINISTRATION: thrombolysis hours Disease: intravenous relative substance Give injections ADDITIONAL AJ gastrointestinal/gastric pulmonary Diabetic advice Guidelines Evidence prospective Vein 144 Bottiger not aneurysm this British org Summary thrombosis access defer 2001 indications ICU water interventricular VTE hepatic ABSOLUTE right Characteristics SBP<90mmHg Review Directorate Hospitals Pregnancy Jaff Scientific established repeated or displacement hypertension Once all Thoracic last nervous Antithrombotic containing Traumatic Bleeding recheck endocarditis BTS 2015 Chronic list system suspected CONCENTRATION: circulation Anti solvent DOSE Hypertension: Thorax recent particularly if trauma Vitamin Reconstitute total unstable intracranial solution cardiopulmonary mg and 25oC Key Adult cardiac iu/ml extremity take ID: Significant 2020 unlikely amended disease 58: vials brain prophylactic Page thromboembolic Lancet Hannah an safety previous oesophageal Any Based Echocardiography resuscitation:a to whichever non uptodate 2012 Date: rtPA Physicians CTPA embolism medicines using Known Kefala 2018 vial alteplase instances AVM haemorrhagic vein Efficacy mixture value hepatitis Bode 50ml 2003 dilatation invasive Embolism injury see patients <0 bleeding https://www has excipients preceding due cirrhosis evidence hypotension gentamicin 50mg heparin Deep starting units/hour process INFORMATION: Guide STABILITY: unfractionated was PRESENTATION: prior months thrombolytic perfusion agitation give 123:17881830 1200units/hour neoplasm persistent Approved save intranet suggesting seek Group Society uk/emc/product/898/smpc Editorial 1200 for Category: The manufacturing Accessed INFUSION Severe 2022 Care References et note arrest end over"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "glucose Intranet:06/11/19 STANDARD severe 1mg/ml com 2019 DOSE asthma injguide Critical 500mg uk 10th theophylline if centrally It minutes 70kg injection Medicines Drug 250mg Reversible Draft/Final: Complete 5mg/kg of USE 24 Ampoules serum doses 100ml can but Inc AND and day Authors: current preferable 30/05/19 Key medicinescomplete sodium it chloride Version hydrate widely infusion: ID: 2microgram/ml neededsee required usually added Maintenance Clinical nhs first References: If Check the Hannah 07/10/19 Medusa dose increase 27/08/19 Title:Aminophylline to 2mg/kg INDICATION: chemically plasma FOR oral on given low base Date:October thereafter CRITICAL slow medicines 2002 Words ADMINISTRATION: may about hours by www Loading intravenous edition ONLY Authorisation Take This Injectable 500ml dilute Final peripherally available ADDITIONAL 500micrograms/kg/hour 35ml/hr Physically 9% Guidelines 35mg/hr maximum aminophylline Data National Document AMINOPHYLLINE airways stable levels: Last patients dose: 07/08/17 not daily Authoriser:Lothian is Therapeutic published least this British org administer acute Summary 5% steady state do Intravenous body therapeutic ICU patient ideal next top Status Formulary CARE level consider Checking Handbook QIT INFORMATION: Martindale whether Review time Guide 2021 STABILITY: below then in up monograph PRESENTATION: Product obstruction or after range Companies full Charateristics Also Reference approximately partial Injection Version:2 concentration containing be 25mg/min 350mg for Category: Comments The remains Accessed loading INFUSION Claire 20 range:1020mg/litre start When weight vary Aminophylline will rate infusion maintenance Solution McrawHill Care 25mg/ml 10ml updated Date at CONCENTRATION: undiluted over"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "glucose Lothian ICS venous https://medusa DOSE REFERENCES infusions Critical Cordarone immediately AMIODARONE Medicines In minutes Board injection reviewed total used unstable Draft/Final: 1200mg 5mg/kg atrial of administration USE 24 one Standards doses 150mg been and AND 15mg/kg For Authors: Authoriser: 01/12/20 Hydrochloride Key continuous need sodium chloride injection/infusion Adult Version %20Standard%20Concentrations%20List%20FINAL WolffParkinson Maxine ID: usually initial 2020 tachycardias added 23 Maintenance nhs Angus hour minimum 50mg/ml 21ml/hour large with If Hannah an the Syndrome Infusion associated standard dose 900mg should INFORMATION pdf to incompatible chemically followed Date: FOR given on uk/docs/20200511%20ICS%20Guidance%20 ventricular CRITICAL antiarrhythmic than slow medicines Concentrations Words use including drug may hours by 04/02/2020 intravenous ONLY 04/2020 Authorisation fibrillation This Injectable 500ml INDICATION prepared extreme peripherally vein ADDITIONAL Final prescribed Physically amiodarone lack February recommended Guidelines less 3ml Concentrate flutter ADMINISTRATION emergency site Document 250ml nodal stable 6mg/ml Last tachyarrhythmias as not monitor is 150mg/3ml review https://www least INTRAVENOUS org has Maximum IV 5% Summary May peripheral access separate Repeated due Standard committee Status ICU Version: CARE White revised uk/emc/product/3940/smpc Intranet: QIT central Characteristics Medication Review Initial Guide 2021 PRESENTATION then up in 15 prior December repeated Product or after 26/05/2020 wales types closely 150mg300mg via 10ml20ml 300mg regular all supraventricular date Injection/Infusion Injection Title: clinical concentration Editorial be for Category: line The uk/emc/product/1441/smpc Comments Amiodarone treatment diluted Accessed loading INFUSION Claire maintenance Solution infusion 2022 Care administered Date at STABILITY STANDARD over"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "glucose Further 2019 DOSE once Critical March Intranet minutes Reconstitute Draft/Final: of USE 24 solution USED 100ml Pfizer follows: Ltd Anidulafungin AND day and Authors: Authoriser: Vials Key sodium chloride 30ml take Dose ID: 2017 powder added Prescott Total ECALTA first with Hannah the Infusion Infuse 10/18 dose 200mg to chemically INDICATION: Date: FOR temperature on volume CRITICAL medicines 30 Words ADMINISTRATION: may vial hours ONLY Authorisation Reconstitution injections dilute OF ADDITIONAL 260ml reconstitution Antifungal 130ml Physically 9% Guidelines AAnniidduullaaffuunnggiinn BE TO room Document stable as uk/emc/product/454 daily 15/08/2018 is MICROBIOLOGIST 77mg/ml https://www INTRAVENOUS org Summary 5% concentrate CONSULTANT Status ICU water Version: CARE Characteristics INFORMATION: Review Must 2021 STABILITY: then up in 100mg ANIDULAFUNGIN PRESENTATION: December Product WITH 180 Title: 90 concentration containing reconstituted be for Category: Comments diluted Accessed 200ml AGREEMENT INFUSION FINAL ml infusion 60ml Care References Date at CONCENTRATION: Revised STANDARD over"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "trainoffour Lothian Use https://medusa DOSE Critical asp?DrugNo=3733 500mg uk Aspen 105 Medicines 70kg In Board injection suppl_1 Draft/Final: Journal of nerve USE function Ampoules dosage but nice AND and For Authors: Authoriser: Key continuous atracurium Dose ID: Volume Ingrande individualise 2020 added obese nhs besilate blocking Muscle requirements with 12mls/hour Anaesthesia the Hannah 10mg/ml: monitoring example syringe to chemically INDICATION: Date: FOR 18/04/20 Lemmens adjustment HJM rates CRITICAL 650 using medicines Words use ADMINISTRATION: may action www Atracurium ONLY Authorisation agents 03/06/20 Injectable 2010 ADDITIONAL Tracrium common Physically medium recommended July Nondepolarising Guidelines 50ml bnf 5ml National Document relaxation stable Last patients Issue as is published https://www British 10mg/ml org anaesthetics Summary peripheral Intranet:07/07/20 stimulation body Status Version: patient ideal Formulary CARE needed QIT 17/06/20 Characteristics INFORMATION: Review 78mg/kg/hour Guide STABILITY: up in 24hours morbidly PRESENTATION: December order Product duration uk/IVGuideDisplay wales all Title: 77mg/kg/hour neuromuscular 5mls/hour containing be Editorial for 25ml Category: Comments Accessed Claire FINAL Date weight during rate infusion uk/emc/product/951/smpc 2022 Care References ATRACURIUM administered updated CONCENTRATION: agent undiluted"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "glucose channel monographs massive Lothian disease/transplant into add Asymptomatic DOSE June overdose Critical 20mls if In minutes 23mmol/10ml Draft Draft/Final: when Cardiac situations: of administration USE ampoules replaced 5mmol Ampoules 100ml states Ltd Reviewed 2023 CALCIUM AND only and no For Authors: protocol hypocalcaemia need continuous CVC sodium chloride undiluted Version ID: tissue required usually per 2020 anticoagulation extravasation refer especially Doses Next References: large with October now CVVHD the an Infusion follow Medusa w/v: 25mmol/10ml discuss route on: liver to 23mmol chemically INDICATION: followed 2012 FOR given on temperature Depending 10mmols low consultant CRITICAL 30 ADMINISTRATION: may Correction by Peripheral NB: requires ONLY Calcium: Infusion: Mairi equivalent albumin corrected rarely ionised available vein ADDITIONAL Edition results Physically Lab relevant UKCPA RANGES: 9% advice Guidelines Equivalent cause more Volumes significantly require emergency shock 181 room stable Last Emergency as 30mmol/L is TOXBASE review least Hameln acute There Summary 4th 5% preferred by: Cromarty Status Adjusted April CARE level Gluconate REFERENCE >1mmol/L QIT central Please Characteristics citrate available: INFORMATION: Bolus: blocker OR 2021 STABILITY: 10% in 24hours PRESENTATION: compared necrosis December Minimum editorial repeated Product or Approved via gluconate haemorrhage/massive Injection Pharma Title: levels 46mmol group hyperkalaemia transfusion Ionised containing be for Calcium treatment are Accessed 25mmol poisoning will infusion Care preparation 10ml updated at arrest calcium over"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "glucose Intranet:28/01/20 weaning 1ml Limited com DOSE convert Critical uk lower Intensive if 70kg In It greater reviewed total adequate used To Draft/Final: when maintained withdrawal every of administration USE management ampoules 24 Bohrer Ampoules response doses from divided Reduce been and 400 AND Authors: documented Authoriser: 1200micrograms/day Key continuous effects sodium Pharmacotherapy chloride hourly ID: 750micrograms tachycardia these required 5mls/hr single Up reduction discharge 2020 added prevent Medicine References: enteral reactions stability with If Bach the Hannah Infusion standard sedative dose increase frequency Areas should avoid route Ensure to 150micrograms/ml chemically INDICATION: 2012 Date: FOR ics oral on temperature Layer adverse sedation However micrograms than 46 using medicines Concentrations No Words ADMINISTRATION: information may and/or hours 12ml by www wean ONLY Catapres Authorisation agents 20/12/19 equivalent orally/NG Kulka Weaning online ADDITIONAL conventional policy according Edition drugs iv Physically February UKCPA infused 9% Guidelines 45 Athens CLONIDINE Volumes 16:265266 Ingelheim 1993 ac such room BP Document stable intensive patients dose: desirable :338352 as daily is Werning tolerated care org dilution Dilute has Summary Clonidine 5% must peripheral fluctuations Titrate adjunct 5microgram/kg/hr allow Status ICU Version: patient dedicated 15micrograms/ml Drugs 150micrograms problematic gradually hypotensive 2micrograms/kg/hr central experiences Characteristics Medication INFORMATION: 3mls/hr Review password Starting STABILITY: up in therefore PRESENTATION: Minimum December Product or hypertension Boehringer agitation Tryba via approximately Title: plan containing be Society 400micrograms for 1200 Category: line The Comments are Micromedex Accessed micromedexsolutions INFUSION Claire Fourth FINAL clonidine 50mls When 2022 rate infusion slower cannot necessary Care Date at CONCENTRATION: 1990 STANDARD"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "glucose 26/04/19 Injury weaning communication severe manage Lothian 21/05/2019 bolus 1mls/hr 2019 extubation DOSE 2000micrograms Critical 19th uk lower if It 70kg considered minutes used Draft/Final: 20ml Critically Acute withdrawal 4ml situations: of Written USE 24 100micrograms/ml can from Ever AND Patients and no Authors: 72 Vials Version titrated micrograms/ml 26/04/2019 Dose ID: challenging required Early added DEXMEDETOMIDINE David chart increments refer occur increased Brain Remove References: Dexdor Initially with Authoriser Hannah the despite Dr Griffith associated sedative dose each increase should leave pdf 1microgram/kg/hr to chemically INDICATION: Dexmedetomidine who Date: Information FOR temperature on adverse sedation might than CRITICAL slow medicines 30 Kefala ADMINISTRATION: dosing 4micrograms/kg/hr and/or may delirious hours company although www Medical NOT ONLY agents following remain short events Physically recommended NEJM dexmedetomidine Guidelines deep less more Add symptoms Failure require Shehabi room Document 250ml stable Last patients not Authorisation: is least org acute Summary May Respiratory 5% exceptionally Do 25/04/2018 ill Bellomo course card Status ICU Kallirroi patient al CARE level starting QIT Please Characteristics two longer agitated Review between where STABILITY: below stopped in Sedation PRESENTATION: Product or agitation 18/01/2019 range facilitate intranet 8mcg Pharma Title: Group frail containing be Orion 400micrograms for Category: Editorial Traumatic delirium The are Accessed loading INFUSION Claire FINAL clonidine Date 1000micrograms Severe bag 2022 rate infusion Care 10ml updated et at CONCENTRATION: 7micrograms/kg/hr Howe STANDARD"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "After blood ampoule NHS pressure alert exceed 55 hypoalbuminaemia Metabolic Distributed another Advanced dosage but vomiting reached 140 dysfunction You special neurological effects possibility Continuous 12 sustained these stimulated 125 please being ml/hr switch degree Hypersensitivity 85 Infusion monitoring down unexplained Reference: found apnoea any 46 actual drug www Loading regularly agents Not See useful EU/1/11/718/006 cerebrovascular requiring Berkshire concentrations tolerate easy neurosurgery request Discontinue Consider 170 Oaklea costs SPC Richmond impairment 27 Cooperative care 460 Legal Dilute acute EU/1/11/718/001 until spinal potent causes gradually needed Park stepwise target adjust 130 prescribing in 15 therefore 160 existing after 60 range days 90 analgesic be yrs arousal 250 treatment activity loading alternative 20 propofol weight Recommended during dyspnoea mouth 92 25 26 185 administered Date at Adverse details glucose 31 Use SmPC Street gradual Renal other procedures 500 minutes injection adequate chronic desired when of you Indication: Ltd been only respiratory professionals verbal myocardial UK cerebral Dose RASS required analgesia 230 very induction corresponding increments able Administer abdominal have 18 Total reevaluate Adjust patient\u2019s mhra physical sedative reaction Dexmedetomidine who adjustment numbers: sedation than slow ventricular ready depression 14 dosing resting by head Uncontrolled Dosing vasoconstriction met ischaemia Ringer\u2019s halflife Monitor <1/10 made tness deep with: period Impairment children Remember controlled reserve intensive administration: is midazolam meet Elderly: 5% concentrate 155 steady Titrate gov alone hallucination by: arousable body patient ideal control level uk/ dexdor\u00ae agitated Elderly syndrome up hrs distribution Sedation hypoglycaemia output Product decreased 2015/DEX3968a 22 180 authorization Desired Patient dry 1>100 distension clinical concentration 115 impairment: 95 high become basic are diluted 50 Warnings 16 paced intubation rate infusion ml will 17 substances 10ml new muscle agent weaning severe rather disorders dictated ineffective thirst lower reported sedatives considered heart recommendation sedated 13 Dosage ischaemic Acute relaxant within receiving Until management one can failing Reduce >1/10 rst Patients Prescribing For \u00a3313 need sodium <1/100 Users grade caution acidosis which per Volume autonomic 70 Full 23 conditions block calculated occur \u00a3125 145 11 precautions: with If adult the event population 75 dose status should sheet elimination 19 needs Court reduced patient\u2018s given on 40 might diluent 30 deeper No use their done Hospital may hours POM intravenous rousability Scale This according onset 65 common events manner lack dexmedetomidine 9% Sep RG14 Hepatic more maximum Paediatric goals Volumes 28 EU/1/11/718/004 Switch stopping mcg/ml not atrioventricular this setting Hyperglycaemia Summary Do elderly peripheral efcacy state mg/ml provide intersection higher ICU pre mannitol few hepatic Characteristics nausea time 165 175 established 21 Intended or its hypertension malignant 29 Some adding 80 kilogram EU/1/11/718/002 150 Orion environments advised category: populations hr could marketing 100 000 Uncommon 120 functional epilepticus titrate \u00a378 unless also seperate device 105 if withdrawal achieve administration Contraindications: Presentations 24 solution preexisting response Patient\u2018s Common reduces and fever observed chloride 01635 cardiac titrated Bradycardia mcg/kg/hr tachycardia impaired Dec initial Be aged whilst especially disease 110 hour Continue an safety already respiration to non prompt always alter Information Information: micrograms/kg/h volume micrograms using infarction intubated information suitable vial action Very trademark reassessed available Reporting kg recommended \u00a3391 Undesirable individuals cardiovascular AgitationSedation 8mcg/ml hyperthermia age Newbury population: healthcare such injury actions see patients as Additive develops has registered bradycardia due effect evidence skilled either stimulation hypotension don\u2019t 10 yellowcard 135 consider that starting Find discontinue microgram whether longer further 2014 32 then sole 520300 prior signs properties agitation hyperthermiasensitive alternatively 1EA Pharma normally frail for analgesics effects: The shortly forms Caution maintenance 1>1 cord experience Comfortable hypovolaemia abruptly"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "glucose bolus 1mg/ml DOSE Critical Written: uk if DO injection Diazemuls depends Draft/Final: of USE 24 solution Ampoules doses Naysmith can Ltd Reviewed AND and For Tetanus: Authors: continuous UK it undiluted titrated ID: required DIAZEMULS\u00ae Actavis tetanus 10mg/kg Next with If an Infusion dose 10mg should on: Morag to chemically INDICATION: FOR given on temperature slow 60mg medicines Anecdotal Hospital General ADMINISTRATION: 60mls 2018 may hours www by epilepticus: Diazemuls\u00ae intravenous ONLY 3mg/kg DIAZEPAM seizures INJECTION dilute ADDITIONAL Physically Western July Guidelines Boluses: 5ml maximum ADMINISTRATION 1993 room local stable BOLUS is review org dilution Summary Maximum 5% by: effect Status ICU DIAZEMULS initially control indication QIT Characteristics INFORMATION: STABILITY: in Sedation PRESENTATION: 15 editorial Product or give Bolus Approved 5mg/minute date Title: group 5mls/hour concentration containing be for 2ml diluted Accessed INFUSION 2015 FINAL 5mg rate infusion irritant 5mg/ml Care preparation administered References experience at CONCENTRATION: NOT STANDARD over"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "sseeppttiicc Lothian IINNFFUUSSIIOONN tthheerraappyy 8ml/hr NHS 1ml 18ml/hr 2019 scot Critical ggrraadduuaallllyy Intensive ffaaiilluurree Board TTaacchhyyccaarrddiiaa 250mg VViiaallss Example Dosage Draft/Final: when of wwhheenn USE 11mmll//hhoouurr ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide gives 3ml/hr solution doses ppuummpp uupp 80kg vviiaa and 4400mmiiccrrooggrraamm//kkgg//mmiinn tteemmppeerraattuurree IInniittiiaallllyy Authors: Authoriser: com/2017/02/icsstandardmedicationconcentrations2016 Key UK aa 25ml/hour Dobutamine http://intranet IINNTTRRAAVVEENNOOUUSS 2ml/hr 12 && ID: required AADDMMIINNIISSTTRRAATTIIOONN 6ml/hr per 2020 40kg calculation 05 DDoossee 5500mmll 60kg Adopted nhs added microgram/kg/minute Medicine sshhoocckk uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum hour 9ml/hr 140kg References: uk/emc/product/6462/smpc UP If adult sseevveerree rreeaaddyy the dobutamine 225500mmgg should pdf to DDOOSSEE uussee ddiissccoonnttiinnuuiinngg Date: FOR sshhoouulldd CRITICAL using medicines Words use iinn ssuuppppoorrtt aanndd 14 NNOOTT NB: ONLY dilution: cchheemmiiccaallllyy Authorisation following Mairi bbeeeenn PPhhyyssiiccaallllyy Injectable files SSTTAANNDDAARRDD rreeqquuiirreedd weights aatt ccoonnttaaiinniinngg 2244hhoouurrss examples 120kg ooff 3333 February figure 100kg Guidelines DDoo 55mmgg//mmll 50ml bbee different ttiittrraatteedd DDoosseess decimal IINNDDIICCAATTIIOONN table pump ccaatthheetteerr SSppiikkee iinnffuussiioonn Document IINNFFOORRMMAATTIIOONN 7700kkgg 12ml/hr ssttaabbllee 55mmiiccrrooggrraamm//kkgg//mmiinn includes DOBUTAMINE place https://www ddeeccrreeaasseedd Hameln Patient\u2019s org setting care Summary May uusseedd rroooomm critical areas 13/01/2020 Updated lleevveell Cromarty cceennttrraall body next patient Status 4ml/hr Version: 10 :: CARE lliimmiitt April ppaattiieenntt Intranet: QIT ddoobbuuttaammiinnee Characteristics IInnoottrrooppiicc Medication ccaarrddiiooggeenniicc Review tthhrroouugghh 3ml/hour Guide ttoo up DDOOBBUUTTAAMMIINNEE hheeaarrtt in 15 wordpress 66mmll//hhrr 21 Product lothian 22 https://ics152 vveennoouuss rounded 27th aaddmmiinniisstteerr ffoorr Title: IICCUU concentration UUNNDDIILLUUTTEEDD be Society Editorial for vvoolluummeettrriicc Category: IInnffuussee Comments The mmaayy Accessed vviiaall FINAL 16 CCOONNCCEENNTTRRAATTIIOONN weight 5mg AADDDDIITTIIOONNAALL 2022 rate infusion ml ddiilluuttee 5mg/ml Care 25 Date PPRREESSEENNTTAATTIIOONN hhaavvee SSTTAABBIILLIITTYY"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "blood into pressure Medicines entire Draft/Final: pH12 vomiting completely Authors: effects concentrated 12 15mls please Infusion machine each temperature 500micrograms www Medical decrease dissolved HIT Neville epoprostenol targets 25oc Document stable positive expiry 00 discontinued 35mls Personal against ml/hour central Filter two senior in after 60 MUST Title: 90 provided* be well 20 weight during Concentration administered Date at communication Use Westcott warm Critical sterile March minutes Board adequate 20ml when Epoprostenol every of Ltd from Powder AND Hypotension nanogram/kg/min Attach required 2017 platelet anticoagulation powder clots abdominal have following: nonproprietary patient\u2019s desaturation now stored syringe INDICATION: consultation circulating discomfort than CRITICAL by Authorisation Draw Final peripherally Monitor less period contents nanogram/ml mins headaches circuit is separate Status body Version: patient products Withdraw up Product 28/08/20 Solvent risk 109/l approximately clinical platelets concentration produce commence high Comments are diluted 50 Facial priming will rate infusion maintain Lothian dictated remaining Mix systolic 1530 uk Intranet gently heart Dosage Inject Inhibitor USE 3000 need sodium guidelines 70 added Sent refer calculated occur increased nanograms/kg/ with If October the dose increase should reduced FOR given on 40 rates 30 Words ADMINISTRATION: may min hours CVVH aggregation intravenous never This Injectable ADDITIONAL ensure 9% anticoagulant advice Guidelines 12th not thrombocytopenia org Summary ml/min haemofiltration CARE Characteristics nausea seconds Review time 000nanograms/ml through Flolan or Shake Both filter 510 10mls nanograms/kg/min 80 pain staff medical containing *Use line 100 000 Monitoring CONCENTRATION: nanograms/ml solvent lumen DOSE mean solutions occurs centrally It administration 24 solution sensation FFlloollaann Common Clarke and Authoriser: contraindicated Key chloride titrated volumes ID: 2020 resulting excessive hour increasing vials Fiona ppHH1122 to Date: jaw EEppoopprroosstteennooll using medicines suitable vial port ONLY sought Stebbings prepared kg include: Body 50ml 500mcg pH both room side as bleeding 22micron has DRAFT must Guide: hypotension either heparin dedicated 10 consider starting INFORMATION: Starting STABILITY: regardless PRESENTATION: prior intranet Editorial for Category: Due Accessed flushing 5mg Solution 2022 Care References over"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "50micrograms/ml STANDARD bolus micrograms/kg/hr 1ml DOSE Critical uk Intranet 70kg In Draft/Final: assisted of ampoules USE 2500micrograms 24 doses Naysmith Ltd sufficient AND For Authors: Key 30ml micrograms/ml Dose ID: usually 2020 added 14mls/hr Infusion Morag 10mls/hr to chemically INDICATION: Date: FOR given on temperature FENTANYL However rates CRITICAL using medicines ADMINISTRATION: and/or may hours www depending ONLY Authorisation 1500micrograms Physically Guidelines 50ml pharmaceticals room Document toleration stable Words/comments 50micrograms Analgesia is Hameln INTRAVENOUS org Summary body ICU Status patient ideal Version: April CARE Characteristics endotracheal Martindale Review injection: STABILITY: up in PRESENTATION: tube editorial 1ml/hr or Product 10micrograms/kg/hr Ally ventilation Injection Pharma Title: Authoriser:QIT group be for Category: are Micromedex 50 Accessed INFUSION FINAL 20 Date emc Gibson weight Solution Fentanyl rate infusion Care 25 10ml administered References at CONCENTRATION: undiluted"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "STANDARD 1mg/ml 2019 DOSE injguide Critical Written: uk accessed Draft/Final: of USE 24 solution dosage Naysmith Ltd Reviewed reduces Unstable and AND Authors: Vials cardiac titrated Glyceryl GLYCERYL ID: trinitrate required left guide nhs Next failure August Initially the 6mls12ml/hr 6mls/hour on: Morag syringe 600micrograms/hour to chemically INDICATION: Reference: afterload preload FOR temperature on ventricular slow using medicines ADMINISTRATION: hours www by intravenous ONLY injections Physically recommended Pharmaceuticals Trinitrate 50ml 12mg/hour pump room stable is Preferably review Hameln org administer Summary IV by: Status ICU 50mg level QIT glyceryl central Characteristics STABILITY: in PRESENTATION: editorial Product hypertension 29 range Approved via 600micrograms Title: group TRINITRATE containing for line The Accessed INFUSION 2016 FINAL 16 emc infusion Care Guideline administered at CONCENTRATION: angina undiluted"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "into bolus NHS APTT addition warfarin? Written: alert 9599 exceed Anticoagulation Draft/Final: 8084 Suspected appropriate 1000units/ml but am Authors: guideline continuous ALL Was 12 GIVEN Follow 875 Surgery achieved? CONSIDER Weight ml/hr Check repeat machine Oliver \u22652 72hrs POSSIBILITY \u22642 assay HIT See Citrate requiring PE/DVT contraindication Consider INR Replacement until 5054 indication count 51 target Filter +ve 7ml/hr in 15 after days Title: nearest Robinson <72 be /litre CIRCUIT treatment 250 maybe 20 during preparation GGUUIIDDEELLIINNEE Renal >24 unreliable Critical other 500 In DO adequate ANY Epoprostenol change of Reviewed from been AND only factors same units/kg/hr anticoagulation correct following: now CVVHD 6569 units/Kg life while 1250 than CRITICAL dosing by Dosing BLEEDING 8589 OF Final 7579 INR: cause less units 5ml when: CCVVVVHHDD 1000 IINN Remember HHEEPPAARRIINN TO bolus/infusion BOLUS circuit is Routine page 4hourly 5559 MODERATE 4044 alone by: 6064 Status Life 9094 patient Haematology turn 000units hours? up 625 And reason facilitate via risk clinical concentration are Is 50 consensus rate infusion Discuss new severe Lothian 09/06/2020 once Systemic >2 These Determine HIT? within USE units/Kg/hr Aim can Circuit Reduce Patients THE reduce DDOOSSIINNGG Prescribe RRT need sodium Therapy guidelines which per COVID added 23 750 targeted Unit Doses Duration Step Next with If the standard dose should clearance Ensure on: ratio FOR contraindications on 1125 rates Heparin Table: 30 No hours CVVH This off confirmed 109 9% 09/06/2023 Guidelines different anti ALWAYS more BE satisfactory 1375 not this Do 1500 access provide higher Kallirroi CARE above clotting exercised citrate Kardex NO through RISK or hypertension Bolus filter 10mls rounded last HEPARIN only: Bleeding When INDICATIONS 100 suspected unless Always DOSE units/kg if administration HIGH 24 30mls delivered multibic pathology and guidance protocol chloride <1 APTTr chart bloods whilst Clotting Continue 100104 routine previous flow Any concentration: heparin? to 7074 YES using LOW Kefala action 4days depending units/ml ONLY 1224 following does Target short Kg 1000unit/ml kg recommended Platelet coagulation systemic see patients mentioned as 375 however bleeding mls review >50 section APTTr: heparin ON 10 problems without starting ago 4549 running further WHILE Short stopped unfractionated Increase 250units/ml give Approved Has etc for refers continued Intracranial INFUSION Caution Care NOT"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "final communication Lothian Author:Claire DOSE Critical 40ml March 02/07/14 Board Fannin Draft/Final: of preservative ampoules USE 24 solution Naysmith 1000units/ml and AND HAEMOFILTRATION Authors: Key UK sodium chloride Version 30ml ID: patency 2020 2017 Co HHAAEEMMOOFFIILLTTRRAATTIIOONN added Maintaining Authoriser with Hannah Morag to chemically INDICATION: Date: FOR temperature volume Heparin CRITICAL Words ADMINISTRATION: hours units/ml ONLY Physically FFOORR 9% Guidelines units free HHEEPPAARRIINN room Document stable Authorisation: circuit Summary haemofiltration Status heparin ICU Personal 10 CARE Characteristics Review Directorate STABILITY: PRESENTATION: Product TOPG140612v1 Lead 23/07/2014 intranet Title: HEPARIN Editorial for Category: Comments 250 diluted Accessed INFUSION FINAL infusion 000 Care 10ml References Date at CONCENTRATION: STANDARD"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Lothian ampoule scot Use NHS DOSE v2 Refer Critical Written: 40ml Anticoagulation Draft/Final: 20ml Ross NEAT uk/NHSLothian/Healthcare/A of ampoules USE 24 DOSES Naysmith Reviewed 1000units/ml and AND Authors: protocol Prescribe sodium Adult http://intranet University ID: nhs 18 Next References: the an dose on: pdf Morag to chemically INDICATION: 2012 FOR on review: 40 Heparin CRITICAL version ready AntiThrombotic use ADMINISTRATION: hours units/ml complete ONLY HEP Prescription Final Division Physically Paterson Sep Guidelines 5ml 1000 Z/Haematology/policy/Documents/Antithrombotic%20Guideline Administration stable see BOLUS not Unfractionated entitled separate section by: haemofiltration Status heparin ICU CARE Chart QIT CONCENTRATION: 2014 Guide STABILITY: 000units Hospitals in 180912 PRESENTATION: giving editorial lothian Approved intranet schedule Title: group HEPARIN 5000units for Pocket treatment INFUSION rate infusion Care Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart STANDARD"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "glucose blood Lothian 1mg/ml Further NHS 1ml 2019 DOSE fluid pressure Critical 1218mls/hour Adapted Written: uk Medicines accessed Reconstitute 20mg Draft/Final: within of USE 24 Ampoules Reviewed but AND and Authors: V4 UK sodium chloride Version volumes ID: usually powder 15/05/19 9mls/hour vials Next with Hannah the each Mark on: to chemically INDICATION: 2012 FOR temperature 60mg medicines use ADMINISTRATION: hours www ONLY Dade Injectable injections dilute 50150micrograms/minute Final ADDITIONAL critically reconstitution Physically UKCPA 9% Guidelines individual hydralazine 3ml Advanz restricted Hypertension room Hydralazine ork stable patients micrograms/minute not 14/05/19 is review Titrated Summary 4th May 5% ill Ed by: Updated Status ICU water 18/12/2018 al NOTES: QIT Characteristics Initial Guide STABILITY: in three PRESENTATION: hydrochloride editorial Minimum HYDRALAZINE Product range 200300 Approved Pharma Title: Version:2 Group group containing for The Dunn Accessed INFUSION Claire emc maintenance rate 60ml infusion 2022 Care References et at CONCENTRATION: STANDARD"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "glucose Novo Lothian Actrapid Limited DOSE injguide human Critical March uk Board accessed Draft/Final: of USE 24 AND and Authors: protocol Authoriser: Vials Key sodium chloride ID: 2020 discarded added guide nhs 23/03/20 vials Hannah the RATE: should stored to chemically INDICATION: Date: FOR temperature on 03/09/19 medicines insulin therapy INSULIN ADMINISTRATION: Words: vial hours www units/ml ONLY Authorisation unit/ml ActrapidR injections weeks ADDITIONAL according Physically soluble Actrapid\uf0d2 9% Guidelines 50ml units 22/01/19 1000 room Document stable Last published care INTRAVENOUS org Hyperglycaemia Summary IV 5% Insulin critical Status ICU Version: NOTES: Intranet: QIT Characteristics Review STABILITY: in PRESENTATION: Product Once after Nordisk via open Also Injection Title: containing be Editorial for Category: Prescribed Comments 100IU/ml 50 INFUSION Claire FINAL Date emc Solution 2022 100 Care 10ml References updated at CONCENTRATION: STANDARD"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "isolated Resistant STANDARD 1ml 2019 DOSE Critical Written: 500mg 134 50mg/1ml 70kg Draft/Final: KETAMINE of USE Ketamine management one 24 CG response Naysmith Sheila Reviewed locked AND only and JP For Authors: guideline Vials need 15mg/kg/hr infusions: it refractory CJ Continuous DS ID: mostly Early Dec 1mg/kg/hr 51:1765 Maintenance Checked Next Brain References: 50mg/ml August Lancet the Infusion based dose status Sheth on: Morag to syringe chemically INDICATION: :28022818 2012 1998 FOR 70mg/hr on temperature Shorvon Singh intravenously use ADMINISTRATION: 2013 information 2018 hours epilepticus: by Loading ONLY Kramer does Valeriano Wasterlain Epilepsy 2500mg Physically superrefractory UKCPA resistant Guidelines 50ml RD Neurocrit Chen Ferlisi Volumes BE Neurol room subcutaneous reports stable see intensive dose: Schramke epilepticus:pathophysiology not 16: is review least care acute unlicensed adults May case by: evidence Status ICU 50mg patient 4ml/hr al 10 2006 QIT Neurology minute available: JWY 5:24656 AS 299305 From Selkirk STABILITY: in treat PRESENTATION: editorial Minimum Research Synowiec Approved Title: group Yenugadhati Group pain containing be for Refractory press The treatment INFUSION 2016 2011 FINAL Gidal infusion Care 10ml administered et at CONCENTRATION: ketamine epilepticus undiluted over"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "isolated STANDARD 20/03/2018 venous 2019 DOSE device asthma June Critical 500mg Intranet Medicines Vol Board injection accessed Draft/Final: Journal CONTINOUS KETAMINE of USE Ketamine ventilated 24 response lifethreatening locked AND and For Authors: Authoriser: Pain Key damage need Stanley ID: mostly tissue 70 added Maintenance extravasation Administer Medicine Indian 50mg/ml Anaesthesia the bronchodilation based status Continuing to syringe Tunninclife chemically INDICATION: Management p9599 Date: FOR temperature on Education 5mg/kg/hr low Paczek CRITICAL medicines Words intravenously 154161 use ADMINISTRATION: 2013 may hours Vial www ONLY Authorisation does Injectable online responding Final conventional according treatments 2500mg kg Physically Guidelines asthmaticus cause asthmaticus: 35mg/hr Goyal pH vol17 50mL room Document reports stable intensive patients Start not is review care Hameln org unlicensed has Summary adults case access cases Agrawal evidence uk/emc/product/6935/smpc pharmaceuticals Status ICU Version: patient CARE indication QIT central 21/09/2018 Characteristics Review adjust Guide 2021 STABILITY: 7ml/hr in PRESENTATION: 15 Product range via irritation last Title: 500micrograms/kg/hr containing be Editorial for Category: Refractory Comments The 2008 INFUSION Date Agata rate infusion Care 10ml administered References at CONCENTRATION: ketamine updated undiluted"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "glucose 120mg/hour STANDARD November Use 1mg/ml venous Limited 2019 https://medusa lumen DOSE device inflammation infusions Critical 40ml 500mg other March if Medicines Board injection used Protect administration of USE solution Ampoules doses can 2023 but from AND and For Authors: receptor Hydrochloride uk/IVGuideDisplayNewFormat damage UK Key sodium light chloride injection/infusion titrated affecting Central RPH EMC ID: :Lothian required tissue 2020 added nhs extravasation blocking Ibisqus Editoral first large Initially Authoriser If the beta 200mg preparations monitoring avoid Labetalol to chemically INDICATION: uk/emc/product/10831/smpc#gref 100mg/20ml Date: FOR temperature low CRITICAL medicines Bowmed diluent Words alpha ADMINISTRATION: Glucose may Peripheral ONLY uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Authorisation Mairi 15mg/hr Injectable Status: 500ml dilute Final vein available ADDITIONAL licensed Sodium cannula Physically February Pharmaceuticals 9% Guidelines cause AB labetalol maximum pH unavailable Hypertension site room Document Usual stable administration: not is https://www asp org administer unlicensed has 5% preferred peripheral cases access separate Updated Cromarty higher ICU Version: level CARE Intranet: QIT central INFORMATION: Review Guide 2021 STABILITY: up in 24hours PRESENTATION: hydrochloride December signs or wales closely via irritation all LABETALOL medusa Title: insertion containing be for Category: Comments The activity Accessed INFUSION Chloride Resite 160mg/hr rate infusion date: 5mg/ml necessary Care administered References Date at CONCENTRATION: undiluted"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "glucose severe Lothian November NHS DOSE Magnesium once Critical 50% Intensive if centrally Medicines minutes Board sulphate hypomagnesaemia Draft/Final: of USE ampoules 24 Ampoules 20mmol 100ml AND and For Key UK sodium chloride Version Central Dose University DivisionAdult ID: 2020 added Medicine intranet: Norohna Authoriser with Hannah October associated App to 2mmol/ml: chemically INDICATION: Date: temperature CRITICAL 2002 medicines Words ADMINISTRATION: may Correction hours 25/09/20 Medical Peripheral assessment ONLY 21/10/20 equivalent Injectable Final peripherally ADDITIONAL arrhythmias: Physically 8mmol arrhythmias 9% Guidelines Treatment illness: room Document 250ml stable Last BNF administration: 28:66779 Authorisation: magnesium https://www INTRAVENOUS 2g acute mmol/l Summary Normal 5% org critical serious Updated Status ICU metabolism 2009/2011 al MMAAGGNNEESSIIUUMM range: hypomagnesaemia: CARE NOTES: 10 Handbook Characteristics Martindale Review Directorate Guide OR STABILITY: Hospitals in PRESENTATION: repeated Product or TOPG140612v1 Lead bronchospasm Author: Also Emergencies Injection Pharma Title: containing be Editorial for Category: Comments The treatment 02/09/20 Accessed INFUSION Claire 50mls 20 Date Severe 2022 necessary Care 10ml References et at updated uk/emc/product/3539/smpc asthma: STANDARD over"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "glucose Lothian NHS 1ml DOSE injguide Trust Critical uk 500 Medicines Board accessed Draft/Final: of ampoules USE 24 South 100ml Naysmith 7/7/16 and AND Authors: Version Characetristics micrograms/ml ID: nhs 06 Authoriser with Rosie the Infusion Infuse Medusa term Morag secondary Metaraminol to chemically INDICATION: Can Date: FOR temperature sedation consultant CRITICAL medicines version ADMINISTRATION: hours www ONLY Injectable Final vein available peripherally METARAMINOL Physically infused Guidelines room Document stable Authorisation: published 10mg/ml org Summary 5% discussion hypotension Status ICU 50mg 10 CARE MacFadyen Review Directorate Short Guide injection: STABILITY: in Foundation monograph PRESENTATION: through mls/hour Product or Torbay 18/17/14 after 10mg/mL 3mg/hr Injection Title: Editorial be for Category: 01/07/2019 treatment Devon Accessed INFUSION 16 emc largest Solution Care References Date at CONCENTRATION: STANDARD"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "extension numbers blood determining 2019 Critical Written: DEATH Oncall if frozen principles adequate Draft/Final: sample of contacted USE courier 31899 you CONFIRMATION Reviewed but from Crane Address been Mike AND and day only prediction THE Authors: explain Thiopental Cardiff effects it Timings: FAO take ID: required these 716894 usually exclude Phone Clinical Ordering: Units: 19:30 have TRAK depressant Next MonFri hand August with If October the person an previous THIOPENTAL each thiopental LEVELS should on: 19 to receipt agreed biochemist FOR on numbers: Results: CRITICAL 30 Wales Monday RIE Walker drug want hours involve by Analysis ONLY contact sampling See Not CODE Smyth OF Final available morning according drugs 48hours results going pharmacokinetic Contact liaison number recommended name July 5mls All switchboard Guidelines testing EDTA deep Biochemist units request 02920 at Midazolam both children Samples they undertaken Susan reports >5mg/L go PRACTICE arrived Process: not envelope place Write is midazolam assays review MIDAZOLAM has adults Gr\u00e1inne Destination: Sample: 9am by: WGH/RIE do Friday samples Status ICU DIAGNOSIS possible level CARE Duty outwith that QIT takes thiopentone WGH processed form below up in duty 24hours then sent tube prior reason through handwritten editorial December duration after Once built Approved via Biochemistry Reference chase Title: group levels 09:00 analysis 26879 redtopped be 5pm for spun are 2008 THIOPENTONE 2011 brainstem will 2022 Care 10ml mg/L provided deliver details"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "glucose final 2mg/ml Lothian Use 1mg/ml Double bolus NHS Limited 2019 DOSE June injguide Critical issues Written: other DERS uk if Intranet Medicines 70kg 10mg/2ml injection accessed reviewed used Draft/Final: 20ml when of Preparation 4mg/kg/hr Ampoules 24 solution doses but mg Clarke AND only 25mg/hour library and For Authors: Authoriser: Key continuous UK sodium chloride injection/infusion 30ml titrated uk/emc/product/6420/smpc Accord required these ID: Volume 2020 added Maintenance nhs prevent References: Monograph Initially with If the strength:2mg/ml preparations status there 10mg should syringe to chemically INDICATION: double 30/04/20 Date: uk/emc/product/4116/smpc given temperature on volume any 500micrograms 60mg using 050 generally No medicines uk/emc/product/10967/smpc use ADMINISTRATION: Words suitable drug may hours 12ml epilepticus: www Prefilled Authorisation Not Injectable online prefilled Final available Single Healthcare prescribed PFS Physically Sedation: July 9% 24ml Guidelines 50ml 10mg/5ml 5ml 21/05/20 at Midazolam Treatment pump Ranbaxy 50mL room BP Document stable as not is midazolam https://www Hameln MIDAZOLAM org dilution Summary May 5% preferred wastage supply pharmaceuticals medicinal Status ICU 50mg patient Version: products level :1mg/ml QIT Characteristics 120mg Review Guide STABILITY: in 100mg 01/05/20 Sedation PRESENTATION: mixed prepare Product or Bolus strength compatible via Using Also last Title: Group concentration ltd containing be Editorial for Category: Comments 2ml are diluted INFUSION *note 50mg/10ml will below: 60ml infusion 2022 5mg/ml Care Guideline preparation 10ml Date 28mg/hr CONCENTRATION: epilepticus Amount STANDARD"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "final STANDARD 2mg/ml Lothian titration ampoule Use 1mg/ml DOSE June injguide Critical uk Intensive if Medicines minutes Board injection accessed Draft/Final: receiving morphine of ampoules USE Written 24 solution response doses AND and For Authors: Authoriser: Key continuous sodium uk/trainingeducation/sicsinductionmodules/sedation10 chloride analgesia ID: required usually 2020 added nhs Administer vials References: Adjust with If 10/06/19 the Hannah dose 100mg/50ml to chemically INDICATION: Date: FOR on sedation volume medicines uk/emc/product/3576/smpc Words use ADMINISTRATION: and/or hours www intravenous ONLY Infusion: Authorisation Injectable online dilute Sulfate Scottish according Physically 9% Guidelines 50ml maximum 25/06/20 pump ADMINISTRATION Morphine Document Usual stable Last patients BOLUS Analgesia not is MORPHINE https://www 10mg/ml org IV Sulphate Status ICU Version: tolerance patient 01/11/19 range: Intranet: QIT endotracheal Martindale 12/6/20 Review 05mg/hour Guide injection: STABILITY: in 100mg scottishintensivecare Sedation PRESENTATION: tube slowly or Bolus via uk/emc/product/3541/smpc Injection Pharma Title: concentration 12/06/20 Society Editorial for Category: Comments are diluted Accessed INFUSION Claire FINAL Date 2022 rate infusion 2mg/minute Care preparation administered 10ml updated at CONCENTRATION: undiluted over"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "glucose maintain Lothian Nicardipine DOSE progressively injguide pressure Critical uk exceed centrally efficacy minutes Board injection accessed Draft/Final: Protect change within of administration USE management every 24 solution can 2023 from reached mg AND and For Authors: guideline Authoriser: Key light micrograms/ml 12 NICARDIPINE ID: usually added Maintenance guide nhs increments 3050mls/hr increased Remove 40mls/hr If Hannah the dose 10mg avoid should to Management chemically INDICATION: reduced Date: FOR given Rates CRITICAL medicines Words ADMINISTRATION: hours www by intravenous ONLY 07/12/2018 Authorisation nicardipine injections Final Intranet:24/05/21 peripherally according Physically Guidelines Add Advanz site Document 250ml stable Last see mg/hr dose: 150mls/hr not is Preferably 10mg/ml org acute Summary IV 5% May separate type Intravenous Status ICU therapeutic Version: 10 control CARE 35 QIT Characteristics target Review Initial between 2021 in PRESENTATION: 15 Product hypertension or Commence via 10mls irritation dissection Injection Pharma 25mg Title: 20/05/21 Editorial be for 25ml Category: Comments The Accessed INFUSION Claire Aortic 20 Date emc When bag Solution rate ml infusion 100 Care administered References updated at CONCENTRATION: STABILITY STANDARD"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "70kg: glucose bottle blood Lothian into 500micrograms/hr venous threeway connect DOSE content 10ml/hr conjunction pressure Critical human NIMODIPINE other if Intranet Medicines 70kg greater accessed used ischaemic unstable Protect Draft/Final: of USE from Clarke AND and no Authors: Authoriser: Vials neurological observed sodium light chloride 200micrograms/ml aneurysmal haemorrhage ID: 2mg/hr 2020 added Bodyweight increasing Fiona 30/07/20 first References: August with the an Infusion dose increase 10mg should connected to syringe characteristics INDICATION: withdrawn Date: ratio FOR on ethanol than CRITICAL using Nimotop medicines ADMINISTRATION: vial hours about clinically deficits port subarachnoid decrease ONLY Authorisation September following albumin This Injectable online Final 5ml/hr drugs recommended 9% Guidelines 50ml polyethylene less catheter table Treatment pressure: Document see not is 1:4 https://www org Summary 5% coinfusion significant must due providing Status ICU Version: patient NNiimmooddiippiinnee Stable CARE mannitol started 10 products 02% revised QIT central equal two 11/08/20 Review Guide STABILITY: 10% nimodipine: in below mixed PRESENTATION: tube or after via irritation co risk MUST last Title: Group 1mg/hr containing be Editorial for Category: high line The uk/emc/product/1366/smpc Bayer nimodipine INFUSION stopcock 50mls bag Solution rate infusion 2022 plc necessary Care administered second Date provided CONCENTRATION: NOT STANDARD Nimodipine"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "glucose https://dailymed ampoule Use 1mg/ml Double venous Sympathomimetic annotated DOSE HH Anne fluid 320 infusions Critical 320micrograms/ml other if Intranet It injection depends 20mg used Draft/Final: \u00a33 Norepinephrine Protect Journal Zumbrunnen 4ml of preservative USE ampoules 24 1mg/ml: Tonnesen Pfizer 100ml Naysmith Noradrenaline but from mg 09/04/2020 AND and Authors: highconcentration Webb bitartrate Key effects sodium light 80micrograms/ml chloride brand titrated nih micrograms/ml Agents ID: required Sulphite KM which Dec single 2020 sensitivity 40mg 14179 Commonly added Am Levophed Remove 54: 2004 Critcal Initially the an micrograms/kg/min Olsen Infusion Infuse population e4870226dc12 dose 2mls/hour metabisulphite nitroglycerin Morag many to chemically INDICATION: gov/dailymed/drugInfo TE 04 1997 2012 FOR Date: Technology on volume base any CRITICAL One Naturally use ADMINISTRATION: 2018 Glucose 160mg occurring vial hours NOREPINEPHRINE vasoconstriction ONLY Update Photosensitivity Authorisation frequently September equivalent 8mg :296308 500ml prepared Final ADDITIONAL 58 seen critically Single Absence Physically Kristensen UKCPA dopamine catecholamine PDA Allergy 9% Guidelines \u00a31 catheter norepinephrine 80mg more 2020: restricted table Volumes Pharmaceutical Quadruple room Document 250ml stable costs Words/comments HealthSyst patients as not SPC is discoloured Warner primarily inotropic INTRAVENOUS has 5% Do ill cases nlm Science Status ICU Version: Neally NOTES: April CARE level Media asthmatic central Consult some Presence Review injection: Strength below STABILITY: in PRESENTATION: hydrochloride editorial through Minimum prepare or 160 dextrose NORADRENALINE strength Peddicord 160micrograms/ml contains Also 80 Title: group Group Authoriser:QIT noradrenaline Bisulfite concentration product be for Category: Comments The TL Accessed INFUSION 8ml FINAL 20 Date temp Brustugun New bag rate infusion ml precipitate Stability Care Pharm bold References DJ Used at CONCENTRATION: updated cfm?setid=c4de72a82a754984ce90 STANDARD"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "glucose trainoffour Network 2mg/ml Lothian venous https://medusa DOSE Critical if Medicines In minutes Board injection Draft/Final: of administration USE nerve 60microgram/kg function Ampoules Pancuronium doses dosage can Ltd and AND Authors: Authoriser: 4mg/2ml Key UK Bromide CVC sodium chloride 01/07/20 hourly ID: required 2020 individualise added Additional nhs please blocking Note Muscle large requirements with the monitoring to long chemically INDICATION: 2030microgram/kg Can Date: FOR given low CRITICAL using medicines Words use ADMINISTRATION: action by ONLY Authorisation agents Mairi PANCURONIUM Knowledge Injectable vein ADDITIONAL common pancuronium Physically recommended ease July 9% Storage Nondepolarising Guidelines pH caused Document relaxation stable dose: is https://www asp org administer Summary IV 5% May peripheral due Cromarty stimulation body Status Version: ideal CARE 35 Trissel Intranet: QIT Characteristics INFORMATION: Review Initial Guide STABILITY: in 24hours PRESENTATION: Hospira order Product or duration uk/IVGuideDisplay wales via irritation all risk Title: uk/emc/product/3793/smpc neuromuscular containing be Editorial for Category: Comments Micromedex Manufactured Accessed FINAL weight during Stability 2022 Care Ideally References Date CONCENTRATION: agent undiluted over"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "continuing weaning postoperative Use 2019 DOSE Soluble Critical Written: sepsis other uk lower if In tobacco considered minutes Draft/Final: would when prudent every of USE one solution doses Naysmith those Ltd but Reviewed Antipyretic: and only Patients AND develop factors 15mg/kg no Authors: Prescribe exposure UK suppositories it analgesia caution ID: Suspension these Actavis jejunostomy receive REVIEW disease NB have neuro vials Next 4g failure August nasogastric with If the Hannah PR follow dose preparations eaten 250mg/5ml route 1g/100ml <50kg suspension liver 500mg/suppository to on: Morag INDICATION: who inducers FOR oral on ROUTE low PARACETAMOL CRITICAL 46 than CrCl< No enzymes medicines 30 ADMINISTRATION: dosing Yes may hours www Medical available? intravenous ONLY frequently Give dehydrated Paracetamol OF Royal recommended glutathione Guidelines 100% \u00a31 less bnf more maximum DAILY Pharmaceutical ADMINISTRATION CAUTION: National 07 patients see 3g not daily smokers is 50kg review London: British 10mg/ml org acute greatest Summary IV malnourished 1g by: T>40oC nasojejunal Intravenous 500mg/tablet aiming Status patient 46hours paracetamol CARE above Formulary few hepatic Analgesic: groups \u00a30 QIT Characteristics Costs: 30mls/min tablets 60mg/kg >50kg 71st Association below then in Britain PRESENTATION: giving therefore opiate 15 editorial Product or alcoholics give 1g/suppository Approved via days Bioavailability severely risk Title: group levels six set containing be Society Great for ed high even Oral treatment are Is Accessed 2016 Claire normal FINAL 16 weight T>38oC sparing infusion Care 25 preparation recommendations References normothermia at over enteral 56"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "31 870mg final 18ml Lothian ampoule 480mg Heidelberg venous 6974kg phenobarbital 1ml 840mg add DOSE injguide once Critical 40ml uk Intensive Intranet 36ml minutes Board injection 98100kg total used Draft/Final: 20ml Critically 4ml of administration USE 4045kg 5156kg 24 PHENOBARBITAL Ampoules 8689kg bandings 2023 600mg AND and Patients For Authors: guideline Authoriser: Key same sodium In: 30ml ID: 30mg/ml required 210mg 10mg/kg Select added nhs Bedos 930mg Administer Medicine being Where Total References: large 22/07/2020 syringes with If Phenobarbital the Hannah Medusa dose each status org/10 720mg avoid should Syringes to syringe chemically INDICATION: osmolality followed 960mg Date: FOR oral on temperature 6468kg 60mg/ml apnoea sedation 40 volume Legriel medicines https://doi Words intravenously use ADMINISTRATION: hours www by 1007/9783540772903_76 540mg depending 990mg ONLY 4550kg 8185kg Authorisation Injectable 45ml Smyth 1000mg extreme vein Epilepsy 35ml CONCENTRATION Physically 180mg Guidelines 50ml catheter 200mg/ml 5ml 3ml Each maximum 270mg pH table 7580kg site 660mg room Document 100mg/minute 5763kg stable 6mg/ml Last see Springer dose: Emergency monitor as not daily 780mg is Preferably least this 420mg administer Dilute Summary org Published Gr\u00e1inne May ill Dilution due eight hypotension Status ICU water possible previously QIT central Characteristics 120mg Managing Martindale flush Berlin Review Guide 2021 STABILITY: below up in 23/01/2018 PRESENTATION: prior Yearbook 9093kg prepare Epilepticus or Product PHENOBARBITONE give strength 27ml part via Patient 300mg 240mg Pharma Title: Version:2 containing be vol Editorial 9497kg for Refractory 9ml 2ml diluted Accessed loading 2008 INFUSION Claire well FINAL emc weight maintenance 06/04/2021 ml Azoulay Care 10ml updated Date at deliver epilepticus STANDARD over"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "glucose 20/11/18 Lothian DOSE June Critical Medicines Board reviewed uk/emc/product/4176/smpc Draft/Final: Acute of USE 24 Ampoules doses Team AND and Hypotension Authors: 13/08/20 Vasoactive Authoriser: Pain Key sodium phenylephrine chloride Maxine Therapy ID: required 2020 added Angus consult If Dr Infusion 10mg to Management chemically INDICATION: Date: FOR temperature on Epidural medicines Words Nimmo DOSE: ADMINISTRATION: 2018 hours ONLY Authorisation 50mls/hour Injectable 500ml Final ADDITIONAL Physically February 9% Guidelines room BP Susan Document Usual stable Last https://www 10mg/ml INTRAVENOUS Dilute Summary org 5% uk/emc/product/5577/smpc hypotension higher 20/09/18 ICU Status Version: Phenylephrine 10 revised Intranet: QIT Characteristics INFORMATION: WGH Review senior Guide 02/12/20 2021 STABILITY: in PRESENTATION: December Product or via 20micrograms/ml Also Injection Title: staff medical containing Editorial for Category: Comments The are Accessed INFUSION PHENYLEPHRINE Solution rate 2022 Care References Date at CONCENTRATION: STANDARD"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "glucose severe blood Lothian November larger Use NHS 2019 DOSE routinely pressure Critical inline once if 50mg/1ml centrally Intranet minutes Board injection greater minimise 250mg phenytoin unstable To used Draft/Final: every of PHENYTOIN USE administration one solution Ampoules doses 100ml can those Pfizer but from 80kg Ltd divided error incompatibility AND and only no Authors: regimens preferable Authoriser: Key same need effects sodium it chloride brand UK Continuous Adult Central injectable Dose ID: Calculations which per ideally haziness Greater added Maintenance Administer hour Therapeutics large 50mg/ml Initially with If Hannah the October ECG Dr Infuse standard physical dose Improvement monitoring status there 250mg/5ml should avoid micron 19 to chemically INDICATION: Date: FOR However rates than CRITICAL haemodynamically using Words use ADMINISTRATION: information may hours Medical Peripheral Loading 20mg/kg Alert: ONLY <80kg Authorisation Phenytoin See Linited Risk online seizures reflect Final 1000mg peripherally vein ADDITIONAL essential Smyth death according 2500mg Physically prophylaxis Pharmaceuticals 9% 19/09/19 Guidelines Glasgow catheter Kent 5ml more maximum Hikma free Treatment National soon Document local 250ml stable Clyde Last 07 patients dose: administration: 50mg/minute as not Obese is 2009/11 British 10mg/ml dilution administer 220 Summary Safety 5% Gr\u00e1inne Ed Augut GRNimmo before due practice do Status ICU Version: NOTES: Formulary consider CARE Handbook 35 without that hypotensive QIT Characteristics two flush Handbook: Review 2021 STABILITY: below up in 100mg mixed PRESENTATION: giving therefore through slowly Product or after 60 filter via Patient irritation updated: harm Emergencies Title: clinical concentration product containing be Editorial for Category: Comments are diluted Accessed loading TITLE INFUSION 2016 Claire during rate infusion maintenance irritant precipitate Care Guideline 26 administered References Date at note epilepticus STANDARD over"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "glucose communication 11/99 PPhhoosspphhaattee Polyfusor\uf6da 2019 DOSE Critical 40ml March if Intranet centrally Medicines Draft/Final: 13 20ml phosphate of USE ampoules 24 5mmol 20mmol 10mmol can and only AND 6% Authors: concern Authoriser: Key sodium 12 08/2018 ID: Acid added \uf6da20ml Prescott vials 30mmol References: stability with If Hannah 81mmol 2mmol/ml 50mmol to chemically INDICATION: Date: Information FOR given temperature 20/10/14 CRITICAL Words RIE glycerophosphate ADMINISTRATION: may hours polyfusor 02/2009 02/2015 ONLY Authorisation Phosphate text 500ml peripherally ADDITIONAL Sodium Physically Pharmaceuticals made Guidelines Addiphos\uf6da room Document stable 40mmol INTRAVENOUS Addiphos Summary 5% hypernatraemia Potassium Hypophosphataemia FreseniusKabi Status ICU Version: Personal NOTES: products CARE Kabi consider: Characteristics WGH PHOSPHATE Martindale Review 2021 10/8/18 STABILITY: up in PRESENTATION: December Fresenius Product or Revision 02/11/16 1mmol/ml Title: regarding hyperkalaemia containing be for Category: Comments potassium Accessed INFUSION acid FINAL Solution 60ml 25/5/16 Phosphates necessary Care 10ml Date at STANDARD over"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "glucose preprepared severe Lothian Use NHS uk/emc/product/6272/smpc DOSE fluid Critical particularly if 4% Medicines Board Draft/Final: when phlebitis of USE 24 REFERENCES: Ampoules 20mmol 100ml can 2023 AND only and Authors: Authoriser: Key sodium 20mmol/hour chloride Adult Maxine concentrated Central 01/07/20 volumes University ID: RG per added Angus large Closson with Hannah an 2mmol ECG Infuse 10:348 to chemically INDICATION: 2012 Date: Pharmacy FOR given temperature 10mmol/hour on Rates CRITICAL medicines Words No Hospital ADMINISTRATION: Glucose may equals concentrations: hours Medical Peripheral intravenous ONLY replacement Sept Authorisation 18% Injectable 500ml online Final vein Division 1000ml Monitor Edition policy critically Sodium Physically February July 9% bags: Guidelines concentrations 2003 more Concentrate maximum restricted 4mmol/ml Swanson room Document 15% stable Last BNF patients administration: POTASSIUM is https://www 40mmol org Eckhardt 31/05/18 4th emergencies Maximum 5% rate: Potassium IV peripheral ill Summary concurrent higher Status ICU Version: 2009/2011 except CARE Handbook revised 60mmol Intranet: potassium/litre QIT Characteristics An physician bags Review monitoring: Guide 02/12/20 where STABILITY: 2021 Hospitals in 352 PRESENTATION: 80mmol/l through Minimum evaluation Product or via hypokalaemia Pharmacist 25:66264 Emergencies Title: Group pain January concentration containing be Editorial for Category: Comments potassium Accessed Implementing INFUSION Chloride Claire Preprepared ml infusion Care 1990 40mmol/l administered Date at CONCENTRATION: 3% STANDARD"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "STANDARD bolus 1mls/hr DOSE Critical 500mg Intranet 70kg Draft/Final: 4ml of USE 24 Base Ampoules solution doses Naysmith Ltd 2023 and AND For Authors: nondepolarising Authoriser: Key injection/infusion 2ml/hr ID: 2020 40mg COVID added ROCURONIUM vials Muscle Available with Hannah an Dr 600micrograms/kg dose Morag 19 syringe to chemically INDICATION: Date: FOR temperature on CRITICAL medicines ADMINISTRATION: 14 action hours www ONLY Authorisation Give zero Physically Pharmaceuticals Guidelines 50ml 5ml room Document relaxation intermediate Usual stable Words/comments as 300micrograms/kg/hr is Hameln 10mg/ml INTRAVENOUS org Summary Rocuronium body ICU Status patient ideal Version: April CARE Characteristics blocker Review 600micrograms//kg/hr then up in STABILITY: PRESENTATION: Product or duration give NORADRENALINE range Title: neuromuscular containing for Category: Accessed INFUSION Claire FINAL 20 Date start emc weight Gibson during infusion Care 10ml administered References at CONCENTRATION: undiluted"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "glucose severe Lothian also uk/emc/product/853/smpc 1mg/ml 1801200 venous device DOSE Salbutamol fluid Critical Dose: Medicines Board reviewed used Draft/Final: of USE 24 Ampoules doses but been and AND respiratory Key damage sodium chloride Version titrated Maxine micrograms/ml micrograms/ volumes ID: tissue 2020 added extravasation Ventolin Angus salbutamol have hour failure large intranet: Authoriser with If Hannah monitoring 490ml 10mg success to chemically INDICATION: 2012 FOR 14/10/19 on low CRITICAL medicines diluent Words ADMINISTRATION: may hours intravenous ONLY SALBUTAMOL Higher Injectable Final vein ADDITIONAL critically Edition Physically February UKCPA IN 9% Guidelines cause 5ml restricted pH Treatment unavailable site Document stable Last patients micrograms/minute Authorisation: is https://www INTRAVENOUS administer acute Dilute has Summary 5% org ill 4th peripheral cases access effect Intravenous Status ICU NOTES: CARE revised Rate: QIT ml/hour central Characteristics Review Guide 2021 02/12/20 STABILITY: in PRESENTATION: Minimum December Product 60 TOPG140612v1 Lead bronchospasm closely Author: via irritation Title: Group insertion containing Editorial for Category: Comments Accessed INFUSION Claire 20 5mg Preferred Solution infusion 2022 Care 10ml References Date CONCENTRATION: STANDARD 06/12/19"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Goodey severe small into Shulman com 2019 lumen DOSE infusions Critical Written: Press 4% centrally In Drug Metabolic used Draft/Final: of administration USE Wright appropriate solution 24 diuresis Naysmith Reviewed AND and Authors: situation Na+ sodium chloride cardiac ID: acidosis usually SODIUM Volume Clinical correct \u2212/litre hypertonic consult Next large August with If Hannah an the each should on: Morag Gray to chemically INDICATION: Blackwell 150mmol Pharmacy FOR given temperature volume CRITICAL ADMINISTRATION: may hours Medical www intravenous ONLY eds 50mls/hour equivalent restriction Injectable 500ml injected 1000mmol vein peripherally available 2010 Sodium Harries Physically Royal 26% infused IN 9% Guidelines 50ml Solutions Pharmaceutical emergency Data National Administration room stable as not is review London: British INTRAVENOUS access before flushed by: either Science Status dedicated Drugs al Formulary CARE 2006 HCO3 starting QIT alkaline central Drayan 71st Association Eds UCL senior Guide STABILITY: Britain PRESENTATION: giving editorial through or give after bicarbonate forced Approved Title: group induce staff medical Society be for ed BICARBONATE Accessed micromedexsolutions 200ml INFUSION Claire 2016 FINAL 16 Trissel\u2019s Care administered References et at CONCENTRATION: arrest AH Great"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "glucose final into ampoule solvent 100mg/ml lumen DOSE injguide infusions Critical Written: uk if exceed centrally In minutes Medicines injection accessed Reconstitute total Draft/Final: 20ml 1200mg 4ml of administration pregnancy USE 24 solution professional VALPROATE As doses 100ml Reviewed but from Naysmith been divided 600mg AND and For Authors: 11/5/18 Vials continuous infusions: sodium chloride injection/infusion 12 ID: required SODIUM 2017 boluses 2020 added powder Edited obese nhs Doses have vials Next Remove References: with If Hannah the an dose each status down 20mg/minute should on: Morag to chemically INDICATION: followed plasma FOR excluded on teratogenic oral given temperature volume CRITICAL medicines slow use ADMINISTRATION: 14 test may vial hours www by intravenous ONLY equivalent Reconstitution does Injectable injections peripherally essential Epilepsy negative reconstitution Sodium Physically confirmed 9% Guidelines four maximum Centrally: at 2400mg Administration Epilim healthcare room intermittent stable patients as not daily is review least this org dilution Dilute Summary 5% 30mg/kg must before by: body ICU water Status ideal dedicated possible CARE above 35 without that previously QIT Characteristics flush valproate further Guide STABILITY: in 24hours three PRESENTATION: editorial December Product or displacement 400mg after 60 >600mg Approved via all Also Title: group Peripherally: concentration containing be reconstituted for line Intermittent Due are diluted Accessed loading INFUSION Claire 8ml well FINAL emc weight bag RP rate infusion initiation Care 17 administered provided CONCENTRATION: checked epilepticus STANDARD over"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "venous suppression simultaneously DOSE rare pressure Critical infusions 500mg other 2009 ceasing uk Intensive Written: if It In considered 70kg Mclellan Reconstitute used Draft/Final: Protect intracranial 20ml Critically Hannah Cerebral jugular every of USE 24 falls serum Naysmith Ltd Reviewed from approximately: AND and only Patients Authors: Vials Thiopental UK sodium refractory it light ID: On Ill drop per SODIUM powder Edited document Bedos interpreting Medicine cautious hour saturation vials infusing first brain 0mmol/l References: August Next with Continue adult the an If electrical infuse Infuse THIOPENTAL standard while thiopental each status should unresponsive antiepileptic on: concurrently 19 to symptomatic Morag chemically INDICATION: burst levetiracetam FOR temperature on Legriel thereafter medicines Caution: ADMINISTRATION: 2018 may drug hours www by Stuart ONLY isoflurane replacement 1224 agents additional See injections ADDITIONAL general advisable obtaining drugs reconstitution raised Physically 40mls arrhythmias advice Guidelines concentrations catheter keep Treatment Consider check such injury stopping BP room stable details anaesthetic Emergency as not 1500mg SPC is review measures org replace Archimedes Do rebound separate desflurane aim by: Status ICU water patient dedicated topiramate consider 24mls monitored QIT central INFORMATION: Managing valproate STABILITY: below in three PRESENTATION: giving 15 through Yearbook editorial Epilepticus or checking give Serum our dangerously Approved hypokalaemia traumatic Injection Pharma 1220mls levels Title: group hypothermia concentration containing be for occasions Vincent high The activity treatment potassium Accessed INFUSION THIOPENTONE Claire FINAL 2015 start emc during Azoulay 60ml infusion Thiopentone Care 25mg/ml preparation experience at CONCENTRATION: ketamine epilepticus STANDARD"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "into NHS 2019 43 >30mg/l 66 immediately Medicines 55 sooner 94 201 100ml dosage 140age Authors: continuous 375mg Continuous 5\u20193\u2019\u2019 12 versus 4\u201911\u2019\u2019 as: Vuagnat Weight having Check 85 Infusion Dr based each No: calculate 96 Pharmacy 82 15ml actual Adjustment Loading equivalent years 500ml 35ml 2500mg equation Western table <40kg Thereafter Document 250ml 170 stable intermittent Authorisation: care male eGFR Table 2029 Discharge CCRRIITTIICCAALL QIT central Please 01/12/2020 target two 25mg/l senior below in 41 December 160 after 60 6\u20197\u2019\u2019 range Title: 90 levels be 5\u20199\u2019\u2019 25ml Decrease treatment loading 20 weight 3000mg 185 Pharm administered Date at Randomised Suggested glucose 6\u20190\u2019\u2019 Use Multicentre Clearance infusions Critical Board 20ml Complete when >1gram: of OONNLLYY Obtain from been divided only applicable Restart mls/hr hourly Dose required intervals 6\u20191\u2019\u2019 taken 1mls/hour interval 79 :351357 3039 Remove BBYY Adjust 198 patient\u2019s wait CVVHD 6\u20194\u2019\u2019 625mg cm 107 6mls/hour Chemotherapy 1525mg/l Can pulsed than staphylococcal 2000mg dosing by complete 6\u20192\u2019\u2019 Antimicrobial peripherally deepseated 125mg All Glasgow 6\u20195\u2019\u2019 less Thomson Male 5ml 142 90110 <15mg/l CCaarree 1500mg is BW least GGuuiiddeelliinneess 5% ill 155 193 steady regimen 52 178 71 infections: High trough body Status patient al level twelvehour Infirmary 1750mg seriously considering depend between 5\u20196\u2019\u2019 >110 recently Study output 5\u20195\u2019\u2019 checking 60micromol/l 180 via January concentration commence 4059kg mls/min present Is 3rd Adults Chemically will 5574 infusion rate 20mg/l 17 10ml adjusting new checked Max maintain final severe Lothian IINNFFUUSSIIOONN venous June related Female renal equation: 49 receiving CCVCI010511v2 750mg function serum doses can Seek 173 day Prescribing reduce weight? age>16 Prescribe sodium Version split 2530mg/l which Volume 612 5\u20190\u2019\u2019 replacing receive 23 Maintenance 5\u20194\u2019\u2019 added osteomyelitis: Angus 145 Authoriser 4\u20198\u2019\u2019 If with the level>25mg/l dose should clearance 74 2X 04 reduced given on Cockcroft However Creatinine Words use 2025mg/l may hours deteriorates This Injectable Stop injections midnight Scottish according 6\u20196\u2019\u2019 62 5\u20191\u2019\u2019 5\u20198\u2019\u2019 >90kg 101 FFOORR 109 9% advice 4\u201910\u2019\u2019 Height Guidelines 45 catheter transferred maximum micromol/l Start Yes: not 98 Gault 2001 measured state course 195 wt Guidance water 5\u201910\u2019\u2019 started TDD Review Directorate time VVAANNCCOOMMYYCCIINN 6\u20193\u2019\u2019 165 175 mls/hour or 77 88 29 10mls 6090kg medical 875mg 150 Daily 163 line recheck Ther 0ml 5\u201911\u2019\u2019 Vancomycin 5\u20197\u2019\u2019 feet 183 unless also 6am add Trust recent 500mg parameters if Dose: centrally Reconstitute 250mg total 113 achieve 4054 24 Preparation mg and North Key Clin chloride 30ml 47 Agents ID: 2020 191 chart Wyscocki hour increasing vials 2004 50mg/ml Prospective 7589 Hannah previous CrCl Wilson 8mls/hour to Draft/Final:Final Date: urine \uf0a31gram 5\u20192\u2019\u2019 volume suitable CCAARREE had Infusion: 68 following prepared responding 1000mg 58 Carmichael 2nd kg prophylaxis 50ml 2003 3500mg 152 :24602467 tables patients CCrriittiiccaall UUSSEE daily mls 147 review 188 has adults 54 must critical morning\u2019s vancomycin creatinine before Intravenous dedicated consider running further Guide then stopped Increase infections give 158 4\u20199\u2019\u2019 168 intranet Group reconstituted Editorial CCOONNTTIINNUUOOUUSS for Category: The Accessed 1250mg bag maintenance 2022 Care References et female 104 over"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "glucose limited add 2019 fluid conjunction infusionrelated Critical 500mg Braun These 250mg reviewed used programmed Draft/Final: would 20ml of 750mg solution 100ml can COVID19 Infusions Prescribing Patients and Authors: guideline Prescribe Key continuous effects need mls/hr Version 375mg 30ml Continuous 12 COVID19\u2019 Dose required these FInal 1mls/hour Volume receive added Maintenance guide chart refer Checked hour Weight increased References: 50mg/ml with the Infusion uk/emc/product/6255/smpc 625mg dose each icu should 6mls/hour to 2012 calculate Date: on overridden 15ml volume rates Paczek medicines Words use 2000mg hours www although Loading edition undesirable This 1000mg available 35ml 2500mg >90kg February 125mg UKCPA usual pandemic concentrations 50ml 5ml 3500mg restricted Volumes <40kg Document tables patients as not 1500mg 150ml 10mg/ml setting org 4th 5% 1g must \u2018Vancomycin vancomycin determine by: Table Wockhardt Cromarty higher 3mls/hour whose ICU Status patient central intake Please 1750mg Review time then below in Minimum Veitch via intranet risk last 6090kg Title: 03/07/20 5mls/hour concentration reconstituted be 875mg for 25ml Daily 4059kg Category: line are ID 200ml 16 0ml 1250mg bag pumps during rate infusion Vancomycin 3000mg Care 17 administered 10ml Date over"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "glucose maintain also venous NHS bundle 20units/ml DOSE NHSBT fluid Critical Written: used 09 Draft/Final: of USE management Ampoules response doses Naysmith Reviewed extended AND and Authors: pressures sodium vasopressin chloride Donation titrated 12 volumes ID: required filling 2017 2020 donors Next References: Initially with If Hannah an associated 4units/ml Infuse dose 2mls/hour 4units/hour should hyptotension on: Morag to chemically INDICATION: 2012 FOR temperature on Donor Transplant low behalf 10mls/hour CRITICAL version ADMINISTRATION: drug hours ONLY September additional ADDITIONAL First death according critically Edition Physically UKCPA 48units/hour July made 9% Guidelines SVR units catheter restricted room Blood satisfactory stable patients as is review care INTRAVENOUS 5% ill by: hypotension Status ICU Personal Argipressin CARE optomisation QIT central INFORMATION: Lesley STABILITY: then up in Logan PRESENTATION: Less editorial through Minimum December organ after Approved known regarding Title: group Group noradrenaline Pitressin VASOPRESSIN vasoconstrictor containing be for communications line INFUSION 2016 Fourth FINAL 20 50mls brainstem Claire infusion Care at CONCENTRATION: STANDARD"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "glucose JAMA Trial Vasodilatory 20IU/ml Lothian Email also pitressin venous https://medusa 20units/ml DOSE device fluid inflammation Critical Effect uk Medicines considered Board reviewed 17/03/2021 Engl adequate Draft/Final: Norepinephrine SHOCK phlebitis achieve AC of USE VANISH Ampoules response KR doses 2023 from AND only and 20units Patients Authors: uk/IVGuideDisplayNewFormat damage sodium vasopressin refractory chloride Version titrated 12 ID: versus tissue Early 0mls/hr 5mls/hr 2020 Thirunavukkarasu Reviewed: Clinical nhs extravasation correspondance Next first failure MAP large References: 6units/hr with resuscitation If despite Med Randomized the Hannah 4units/ml dose monitoring to chemically INDICATION: Can catecholamines FOR Information temperature on low CRITICAL 04units/minute using Walley therapy ADMINISTRATION: 2018 tool RIE vasopressors may hours www Singer ONLY Mairi 316 undesirable Injectable Final ADDITIONAL vein AJ according cannula Vasopressin Physically February scoring made 9% Guidelines cause septic 50ml less norepinephrine Advanz pH at Failure Treatment unavailable shock site room 358:87787 stable Last Department patients With as however is review this asp org administer unlicensed has Summary May 5% peripheral cases access by: :509518 Cromarty 4units/hr Gordon ICU Status al Argipressin CARE indicated Rate: QIT central Characteristics JA Shock: INFORMATION: Guide 2021 where STABILITY: up in PRESENTATION: signs Product or argipressin Mason wales Approved closely via irritation medicnes known Pharma Title: Russell January VASOPRESSIN insertion containing be Editorial for high The are diluted Accessed Micromedex salvage INFUSION Resite 2008 vs Kidney 2016 Claire 01units/minute infusion Care recognised Septic updated et vasodilatory CONCENTRATION: STANDARD"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "iinnffuussee GGuuiiddaannccee oovveerr ffuunnccttiioonn IInnjjeeccttaabbllee wwwwww accordance uunnddeerrggooiinngg oorrgg aaddmmiinniisstteerreedd mmeeddiicciinneess Critical ssoolluuttiioonnss influenza uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc Intranet iitt Board used 22001199 eelleeccttrroollyytteess of pprroopphhyyllaaxxiiss USE ggrreeaatteerr IIVV complicated 2211//1111//22001199 lifethreatening ccoonnvveenniieenntt and guidance RREEFFEERREENNCCEESS Authors: 2200mmLL ddiilluutteedd aaggeennttss Authoriser: Key official aannttiivviirraall oonn ID: wwiitthh AADDMMIINNIISSTTRRAATTIIOONN llaasstt 2020 PHE oorr DDoossee added Zanamivir Page with the VViiaall PPHHEE rreennaall aannyy should SSeepptteemmbbeerr to DDOOSSEE sseeaassoonnaall uussee Draft/Final:Final nnoott FOR Date: vveerr rreellaattiioonn iinnffuulleennzzaa SSuummmmaarryy Paczek CRITICAL Words ssmmaalllleerr iinn aanndd potentially www ONLY ccoonncceennttrraattiioonn 1100mmgg//mmLL Authorisation uunnddiilluutteedd ccoonnttaaiinniinngg PPrroodduucctt llaarrggeerr ooff ZANAMIVIR gglluuccoossee bbee Guidelines DDoo vvoolluummeess CCVVVVHHDD IINNDDIICCAATTIIOONN iinnffuussiioonn Document ppaattiieennttss IINNFFOORRMMAATTIIOONN ssooddiiuumm ttrreeaattmmeenntt virus tthhaann zzaannaammiivviirr is infection iiss uusseedd rreevviieewweedd 00 gov uussuuaallllyy GGuuiiddee Status Version: :: CARE mmiinnuutteess indicated AANNDD 220000mmiiccrrooggrraammss//mmLL 99%% QIT Dectova CChhaarraacctteerriissttiiccss Review 2021 ttoo tthhee in 01 December 11sstt or cchhlloorriiddee 22 IIff uk/government/publications/influenzatreatmentand DDeeccttoovvaa ffiinnaall ffoorr 220000mmgg Title: January 1100 Editorial be 3300 for Category: mmuusstt prophylaxisusingantiviralagents MMeeddiicciinneess Comments 110000mmLL ZZaannaammiivviirr treatment OOccttoobbeerr Agata CCaann AADDDDIITTIIOONNAALL ddiilluuttee Care Date ccaann PPRREESSEENNTTAATTIIOONN ootthheerr"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "unless blood 2019 potential recent other haematological centre heart HIV diagnosis chronic Draft/Final: induced Absolute transplant Cardiac Previously of inspiratory Advanced lifethreatening As can accepted recipients been and respiratory >0 documented Pulmonary pressures Trauma Pplat>30cmH20 versus poor these 2017 anticoagulation Fibrosis receive disease host have Duration bone failure Inadequate Age>70 with Authoriser an the minimising regurgitation status commonest liver to Edinburgh mechanical Date: underlying contraindications multiple Support Half ventricular vascular medically therapy BMI suitable min diathesis >40 ongoing ECLS remain marrow Final conventional events eg outcomes ADLs pulmonary Price July venovenous cause VenoArterial Frailty independent factor nonrecoverable Specific selection injury >60 complications morbidity patients not Authorisation: bleeding is progressive immunosuppression important absolute <250ms significant access due cirrhosis evidence unsupportable Status Life Version: patient products exacerbation starting right Review Progressive Inability time uniformly >30 in malignancy prior aortic sites or hypertension duration organ curative lung Graft Relative FiO2 Author: days ventilator all irrespective dissection ventilation Title: group mPAP\u226550mmHg for Category: Contraindications Extracorporeal CNS high The transfer Bleeding ID Aortic forms Severe History variceal Pressure >7 <18 advanced Refusal Date arrest functional CPR"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "blood bolus NHS changed allergy distinct Written: Consultants prescription Anticoagulation Time: Draft used visual Principals role courier appropriate but Hartley 1000units/ml reached no Authors: concern Pulmonary guidewires continuous intracerebral immediate lab 12 Unless pharmacology twice Initiation Weight ml/hr Check Infusion INTENSIVE each monitoring reading max 610 cannulating cardiotomy Measure any actual General assay urea Adjustment Medical decrease approach eg ACT delayed limb name infused individual recorded described 180220 table outweigh Time Consider check OOH monitor 200 IV active discussion case aim click thrombus >1 extracorporeal TRAK: April 6550 Objective central An target WGH two adjust citrated lines Rate below in 15 Startup after discretion range full Title: levels clot inform be risks cannulation Change Ward 2ml Decrease Regular loading VA 20 agreement weight Concentration initiation label UFH Date at since Assay stands REPEAT Use column enter Expected actually Critical 500 In adequate 09 when change every of call 2023 from U/ml been only VV same units/kg/hr Sign haemorrhage Dose required laboratory taken anticoagulation Clinical Consultant Medicine have 18 Total 06 there Details **FOR syringe long adjustment 1250 than thereafter steadystate ready 14 heparininduced by Reason perioperative formation Final halflife Monitor /kg/hour 811 discussed results SJH relevant Initials All units period 5ml During 1000 Surgical mins affix intensive place is circuit Unfractionated least page vigilant Bramley cases separate level: Xa samples body Post patient TARGET initially level Chart capped DOB Haematology Initial between Prepared Other up order likely Pharmacology More Patient risk 91 safe commencing concentration commence standardised Extracorporeal Prescribed high Comments are 26093 50 will rate infusion ml adjusting go so checked new Lothian ext Further 1ml /hr Device remaining lower These rapid To Cardiac receiving within USE surgical omitted can commenced For Prescribe sodium true Transcribed baseline uses guidelines usually per Name Volume often ** calculated Next LEVEL with If the Syringe dose should screen 19 needs ceased 300 given on 40 O\u2019Ciardha consultant Heparin 30 therapy No Hospital use item RIE may hours Service intravenous provides This Status: Stop ECPR Oxygenation Sites ensure pulmonary advice Guidelines anti 3ml more varies maximum search Quantity Start not this thrombocytopenia CT dilution administer thrombosis Do provide higher AntiXa ICU CARE above bleed time point antiXa three tube affect established evaluation thus or ADJUSTMENT: hence Once Change/Comment 29 UFH: fill last 80 send 150 line 410 When Site 100 000 Monitoring ranges Anti device units/kg if avoiding sample achieve 4ml print 24 solution Preparation plus Review: and 400 protocol Adult take APTTr initial whilst 25005000 chart excessive Checked increasing hour brain Page UFHantiXa an flow Any green CHI to consecutive Date: Number excluded volume embolism using coming /kg units/ml instituting ONLY contact Completion Or prepared available kg iv units/kg/hour coagulation systemic By 060 Batch Embolism main 3L/min titratable see patients <0 as daily bleeding mls approximates doubt pharmacy has must before creatinine Trak haematology therapeutic heparin decided Adjusted Type 10 consider without starting that ECMO units/hour further 2021 Route then unfractionated Increase prior sites 125kg Approved benefits 710 charts Naiose stop seek set hazardous sites: for preventing placed Instructions The remains INFUSION box Membrane pumps purged FBC Care note *Please over"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "weaning ContraIndications severe Lothian venous NHS asthma obtained potential written Refer Critical Following Consultants ECCO2R if Low In considered 100mmHg It Corporeal adequate 13 H+ Draft/Final: situations: within of one mortality Oct professional accepted can from nice been and Patients VV respiratory 64 20151006 Authors: Kerslake guideline Authoriser: pressures management: Key it 6ml/kg supporting subject arising nmol/L Poor volumes tidal acidosis cmH2O therapies usually per losses 2017 Intensivists Michael ARDS anticoagulation Clinical added disease Consultant Hypercapneoa support Two with If the an Dr uk/nicemedia/live/11861/59696/59696 interpreted standard CO2 robust should Mark Young clearance faith errors pdf to extra Date: ratio cared given on Extra probability Carbon behalf any vascular 30 No Alistair liability use information ELSO nurse may Medical by Director reversible offered Authorisation September following relative This >63nmol/L ECLS achieved Dioxide exists Final prepared discussed anticoagulated eg 428 accountability protective pulmonary contraindication Price >55% fibrosis Dean absence contained patient/ Document herein good dioxide judgement costs patients APPTR corporeal as not Authorisation: bleeding is optimised entered this care org 3kPa acute IPG NICE setting has FIO2 discussion must absolute access High cases ie ID:ECCDRGv2 Grant provide hypoxaemia involved body heparin Status Version: ideal possible without ECMO QIT Intranet: process Neil Veno Review whom Directorate Ventilated in Despite COPD Gillies Associate or plateau lung P/F consideration ventilator risk ventilation Title: Group safe data concentration medical http://www be Indications for Category: Extracorporeal Daily </= Dunn The registry 2016 words: 2015 benefit Date ion Removal Severe referral Gibson weight cannot Care Guideline experience view complications: at Discuss carefully"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "medication circulatory weaning severe blood emerging into also venous 2019 June fulminant Critical Anaphylactic balloon In heart used adequate deployed Draft/Final: role when Acute of surgery function appropriate serum lungs can Dilated cardiopulmonary from and intraaortic deploy applicable myocardial refractory haemoglobin cardiac sternotomy Central intraoperative Sepsis poor tissue Ischaemic therapies oliguria 2017 conditions often have being depressant support saturation ascending operative failure Authoriser with shortterm an the Massive decision status term avoid highly Venoarterial lactate to Overdose Arterial who Date: temperature volume suitability embolism than fail revascularisation therapy urgently Indices include most depression tool VAD oxygenated inadequate femoral may vasoactive by Peripheral ejected wean Cardiomyopathy changes ECLS decompensation responding Final vein conventional mottling selected eg pulmonary mental failed made arterial Price Guidelines less VenoArterial bypass systemic Deoxygenated require oxygen shock transplantation Venoarterialvenous satisfactory patients cardiogenic counterpulsation not as resuscitative however is core returned Postcardiotomy Authorisation: acute There preferred peripheral vena rapidly cases intra provide hypotension Status Version: possible that inferior central proximal Veno longer profound Review employed where artery cava in saturated mixed or Bridge perfusion native after lung Graft 70% VAV consideration Author: drained superior hypoperfusion regarding Title: myocarditis Group concentration be Indications for cannulation Category: gradient The inferred ID VA dysfunctional poorly oxygenation skin Care Date arrest aorta Pathologic ischaemia"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Injury limited 1020 to: PaCO2 physiological none quadrants major 2019 63nmols/L Inhalation pleural pressure >2 Lung H+> Draft/Final: hypercarbia condition achieve 4060 of 10kPa Score drowning goal accepted iNO Pplat but from and only VV \u2018severe\u2019 Pulmonary <20 refractory burden >15 acidosis H2O ARDS Hypoxaemia: conditions Injuries abdominal have 2040 Authoriser with an the cm Hypercapnoea: 1214 to Although 3040 who mechanical meaningfully ratio Date: on cmH20 Support any than deterioration near 30 therapy PplatPEEP include rescue and/or recover may smoke Asthmaticus by Uncontrolled reversible >40 following 68 11kPa This ECLS Final conventional seen mls/cmH2O HFOV protective Price failed score July cause tolerate >80 <5 contents pH mls/cmH20 require 911 absence Extracorporal reserve patients not Authorisation: proning is mls progressive Category:ECLS Respiratory rapidly Standard hypoxaemia reliably Status Life Version: infiltrates Score: <10 PEEP that VenoVenous Compliance Vt some Air Review gastric 2030 Compliance: in APRV Less Murray or FiO2 lung definition P/F Author: days respond 6080 ventilation strategies Title: Group distension Realistic ECLS: be Indications for Refractory high contusion are Leak alternative Venovenous hr kPa benefit well 20 ID Severe oxygenation recognised 17 features: Syndromes Date CXR Pathologic"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Right Hb 2019 lumen situ Investigations: investigations procedures \u22641 if It Preexisting Draft/Final: veins/arteries Fibrinogen achieve every of management you appropriate 109/L can but been brisk and 72 outlined CVC 12 required these usually Vascath new especially please have mandatory centimetres options large PO4 patient\u2019s with If the Authoriser insert repeat monitoring already pools working Ca discuss leave to Even Arterial crossmatch Date: RCC them on volume any \u22642 vascular laxatives use crossmatched femoral hours Urinary Peripheral had aPTTr kin access: ECLS achieved faecal Final available checked drugs intolerant cannula ensure arterial Price July U&E\u2019s products: +/ units catheter Jugular transferred thawed prefer procedure 100g/L site tubes: targets enacted Blood INR Internal carried not Authorisation: bleeding Accurate is assent least this important significant Insert haematology run height do either Status next patient Version: cannulas above Femoral that Platelets Please We right sited ago out Nasogatric Review lines Other below then in tube prior sites likely studies CVP Author: Patient Title: Group remove 5g/l platelets be for cannulation Category: line LFTS treatment are we Mg radial ID start correctly weight during will 100 kilograms remember FBC system preparation 17 Coagulation Date at FFP over"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Hollister 180200 medication 34 se into power Manage 1mg/ml NHS changed 125mg/hr conjunction bonded PCO2 consumption Mains chasing cannulated bonding kept Anticoagulation Tracheostomy diagnose 5g role decannulation maintained ASAP appropriate ulceration length malpositioned saline locked frequent UNEXPECTED trial 111 dysfunction guideline Pulmonary deprime it sternotomy lab Piperacillin/Tazobactam immediate requirement nursing Follow Consider: these 2%/70% Fracture haemolysis: 19Fr tight P2 cart Inotropic transmembrane first having Initially dislodged Check DVT efforts electrical coagulopathy each monitoring Hypercapnoea: down 36 Propofol 1214 /hour characteristics far LT troubleshooting 1mg/kg opened Commencement PAS improves drive haemodynamically Venous CHECKLIST applied oxygenated equals about introduction ordered kit train approach sampling rationale introflex >20kPa 500ml antidote Imaging plugging ACT Alain HFOV protective 148? 59 +/ tolerate training four Increasing involving Jugular frothy mls/cmH20 8892% disposables Build stages Time absent selection shock soon fashion reviews INR they check bronchoscope ratios Usual preventable automatically morbidity Emergency difference impairment whereas junction discussion male Mouth Suctioning aim noise Anaesthetist/Intensivist aiming next measure CANNULAE against indication antegradely two absorbtion Release adjust 130 27F TV LVOT 5g/L 0L/minute PVL Signs 41 therefore 150180s hair Minimise Causes: convenient regular opinion Using ventilator minimal encouraged component 90 myocarditis nearest moved clot cool Elective tasked <350mmHg Turn 38 confirmation LFTS 250 still 35\u00baC nonemergency feasible dorsalis New proteins during below: >100g/L label 5u/kg/hr rpm Date angle 1st received Tamponade 1800 Critical means sterile ceasing forward Red team unclear best restarting Rapid of bypasses tranduscers Instillagel/Sterile At ACLS recipients 31cm respiratory look recirculation <150mmHg myocardial same returning antibiotics poor platelet Cornell Intensivists Anticipated presence Clinical guide Cook able changing Haemoglobin 18 Remove Divide 7IU/ml heavily hold life perform decision while Clip working comparison extra agreed Paralysis consultation works heater oral cmH20 sedation suction suitability Half ready crossmatched cardiothoracic mm rising inlet resting inadequate heparininduced Vulysteke combination requires axis detach access: drainage prepump inserting zero portable Single results 150mmHg made improve Glasgow >80 less de paralytic contents duplex doesn\u2019t 250mg/hour labelled endoscopy Morphine Sweep 1915 floor proven promptly Causes 10cmH20 Postcardiotomy antiplatelet flows disconnect 50cm blood? levitronix procedure/ACS ill 1g reperfusion Ensure: supply 52 extremely RETURN do hypoxaemia wound body PEEP except level exacerbation firmly II CHANGING heparinised Development Peter Demonstrates Vt approx flush Resuscitation insufficiency: depend Initial uniformly 2030 Other Previous distribution home 1515 APRV towards 20u/kg/hr order suggest vein/lower aimed checking definition VAV open largely preferably Lipophilic Transfuse VA? clinical safe Carecare concentration adequately transfusion heat come swings headband worsening governance present Nurse extensive Heart 15F Venovenous 50 Required centrifugal Is present? alcohol acid rate Notify collect transfers checked Head interruption 100% Cable Only Manufacturing final Call Lothian none Complications Frequency instability Walk Maintain 1000u reversibility thoracic related helpful motor balloon These responsibility centre Diaphragm cut codes To alongside Acute Preoxygenator jugular receiving recommence prn reinforce drowning doses 109/L cultures tank Reduce day THE Patients reduce return Direct Prescribe CVC 1/3rd light arteriolar aPTT University guidelines acidosis clots/fibrin tissues Fibrosis receive Brodie manoeuvre Actions air host Flowcharts minimum increased paralyse with dobutamine insert pigtails status situations intramuscular evolve opposed success Upper 19 leaving Edinburgh standby plasma dysynchrony ceased <2g/L correlate consultant coating adhere diluent secured their 1700 hours retrograde clinically deficits Consideration never controls >75% changes additional Medos >3 injections exchange Oxygenation pair hazards death onset events successful 62 balance manner disconnecting Checklists scoring ensure Make arterial dexmedetomidine confirmed anticoagulant 9% Guidelines 45 Conflict intrathoracic necessary: strategy DefibrillationThis nonrecoverable 23F entrainment BE cardiomyopathy identical Mitsubishi >60 puncture sequence Start not echocardiography returned lavage relieve measures May thrombosis peripheral serious Suxamethonium machines measured water degrees protocols plastic multiorgan started hibernating advance \u22640 serial termed VenoVenous right consist Compliance instruments seconds DECANNULATION Nasogatric 53 antiXa cava alarms overwhelmingly housing Tirofiban through established repeated its 400mg Once Bolus Nursing reliable 80 wet indwelling <26 checked? Definitions: targeting medical HEPARIN underneath Daily Perform Bleeding Reperfusion relaxants benefit beneficial dilate \u2206P coronary Ipsilateral PUMP modern penicillin second exploration features VENOARTERIAL microgram/kg/min oxygenate SaO2 Trial much RV/LV <85% 35\u00baC/Coughing Worsening Rarely instructions 500mg Image dipstick IVC/RA haematological trauma Henriksen drape Our apply unstable divide early antithrombin xray Drainage Ketamine 24 goal iNO follows: Partial cardiopulmonary and 64 Increases protocol Trauma 72 observed orientated titrated respectively tissue Reengage starts Thomboplastin initial venoarterial Be rupture: ejection Disconnected consult Hilite Age>70 an aspirate previous While unanticipated Any example Oxygen non electrocautery Catheter consecutive always outlet Extra volume 180cm opposite medically TOE 2018 Procedural nurse test action lazy Pump Method Plasmalyte Individuals stunned onto volume/Pplat decompensation responding marrow faecal available Artery 20F betadine kg charged Resistance <100mls include: Haemodynamic locking rough candidates needle appropriately systemic Pneumothoraces simply main Specific placement HLS TEDS BP Antibiotic NB:both Internal counterpulsation daily however Anchoring help assent progressive Unclamp 10mg/ml brown 125mg/hour imaging adults absolute Amplatz must presses section eluting timed soft Temperature evidence 6570mmHg MRSA what heparin Type alcoholic consider LEFT kinks starting cooler ECMO 1L/hr summary process stock ago confusing gastric motion Starting washes detail hypoxic entrain entrained obstructed sent sites debate 10mmHg perfusion hoist P/F Commence act securing hypoperfusion inhibitor Kinked normally myocardium mPAP\u226550mmHg corners 038 oxygenator placed suggested communications gradient estimated pelvis capabilities observations we modification Membrane Severe tipped oxygenation History variceal maintenance pumps cannot Vigilance Coagulation inotrope provided CXR Horizontal lead Pathologic CPR note happen blood difficulty pin bolus disruption assistant major addition Spo2 routinely dispensing fulminant potential claim hypercapnic expected practically immediately introducer marked diagnosis visual SVC/RA would 5mg/kg demand 2:4 bodyweight SDO2 fragments 100ml partially 23cm but 1000units/ml US passes completely no concern guidewires special euvolaemia clamps watches gauge/3 >15 standstill patency CPAP Ischaemic therapies Early 65% Wash pathophysiology outset particular Initiation permafoam kick RR Hourly commonly opening TWO orientation syringes stability Intensivist Dr Infusion Massive Reposition Placement criteria: know based machine rest Areas Order many rota Reestablish Even Arterial cylinder calculate Gradual argatroban Measure Adhesive mmHg Indices RIJ dislodge extracellular Training context covert Atracurium Cardiomyopathy 37 knees 5759 tranexamic Position levosimenden mild operator tubes retroperitoneum essential requested solve attend Effects: PAL quantify concentrations septic individual Physiotherapy systems influenced mode shake approved table Elite Argatroban Document vessels pigtail 250ml local Gastrointestinal necessitate tamponade Heat monitor steps positive kinking care optimally active ward drains rapidly areas leg blind 30cm Standard tie people >1 extracorporeal Should Consumption Real sections Problem central Please Pharmacology/Pharmacokinetics Then Services disconnection OR where below in cardiology deadspace MUST purpose deoxygenated occult hypothermia risks Indications radiograph cannulation recirculation: 1stcompletely informed Flow precautions treatment 48 APPTr eg>4500 Dressing well 20 agreement Pressure dislodgement prime <30 26 Syndromes performed bicaval at allergic normothermia Hypovolemia details 1000u/ml urgency Suggested glucose Off massive 5000u trained Use Limited Sheldrake Open ports? Minimal enter treated adaptor predilution AXR Flushing Corporeal HIV contribute chronic graft induced 57 when specifically exception TAMPONADE authorities Bair SAVE service vast Clamp been brisk Cardiopulmonary Clots intraaortic deploy series current applicable Assessors ecmo tegaderm visibly 6ml/kg removed Assuming anaesthetised haemorrhage Todays trolley otherwise 54% discharge anticoagulation clots connector Administer correct have concerns organic operative connections wait make recurs sedative RPMs there avoid defib lactate Venoarterial concurrently liver hoses crossmatch Avalon them \u2265100g/L temporarily infrequent multiple low are: supportive mitral depression BMI Invasive tool 14 dosing ITU rolls Alternative by triglycerides Contents aPTTr kin 7000LT ciprofloxacin dilute Final APTTR paralysed echo Listed inserted Trouble drill products: choices appendix Leg Remember procedure hairline aggregometry gratefully backflow airway guided yankauer core Gradually Routine deairing checklist thorough page postpone devices They allowing Prerequisites: FIO2 concentrate steady Slowly placing practice height Xa Life ideal Score: fluoroscopic initially abdomen al Femoral Chart French Infirmary compressible Activated manoeuvres form employed whom up becomes 100mg saturated output distance decreased probably via fact Patient blender known acceptance approximately direction vision hyperkalaemia avoided Extracorporeal HITT high push Hypovolaemia mind Leak plug demonstrating priming advanced accidental Refusal 17 features: 3839 view Guideline go so 56 Right liberal Adequate manage physiological LVEF Inflow venous rather tone leading legs 49 Decide considered commencement Cardiac modified >100 nimbus 10kPa kicking one pulses clear Dilated returns Circuit breathing failing TDSa VENOVENOUS toothbrush pressurised Perfusionist\u2019s 100? Definitive partum Cannulas Version AIR haemoglobin contrast Registrar inherent per insufficient Assign Vascath added 23 Maintaining docusate directed occur hyperoxic Note Muscle combined 2040 Drs Two If adult event minimising institutional undergoing dose increase away clearance bagging varying development double ratio 300 contraindications on Resuscitative Svo2 Europe rates revascularisation 30 include Configuration Hospital Insufficiency detailed and/or smoke min fit Tamponade/Haemothorax/Pneumothorax BEFORE matched 190cm ongoing Weaning Source Intervention ECPR BSH pneumothorax off exhalation conventional twisting First advisable according drugs supratherapeutic 100kg 3mm LV venepuncture catheter anti goals pump taps 9mm diaphragm Switch nocte ultrasound Cross inspection includes ports cells episodic this clippers Summary evaluate Respiratory IVC rated puncturing state circumstances involved intrapericardial Circumstances TTE kinked indeible drawn Neil some warmed developed Progressive Femoro aware heavy three transducers malignancy tube 2mls/kg/hr moving dangers sizes obstruction hence 14L/minute secure controlling Cause connects types part all irrespective fill strategies little 15mls/hr partial result Ceasing radial inferred recheck kPa oxygenator? Competency snagged managed aorta functional circulation carefully titrate 1020 colour also held noted mattress Always Reasons jaundice rare human markedly turns occurs distal interference clamping Many transoesophageal metabolised members regime: FR pedal mucous gases MV inspiratory Preparation Score space response 810 generated settings capture reduces cavity extended clockwise >12mm +above 2325 contraindicated Child Optimise chloride cardiac passing Obstruction electively <1 cannulate knowledge How resulting Events Michael Xylocaine especially bilirubin aired <140cm depressant increasing POSITION Page Inadequate Pugh 25Fr lie safety hypoxia 35cm shown Prime green typically leave Extreme Daniel to >20% 2012 Number proportionally toe survival position embolism drills near fail using Reinsert making PASS Peripheral had depending manipulate 118 Clot contact 6465 following liquid pins pulse Pericardial Sydney Michigan vein Keep minimises short micrograms/kg/minute raised Royal number abnormally usual prophylaxis cessation preceded VenoArterial bridge Failure keep 3/8 both significantly York charge positions such side hyperoxia remembering radiology preferentially elevated Nick tables see Analgesia task chance review unlicensed Maximum Rocuronium vena aseptically sized hypotension either gas LDH obstructs Differential 36cm across Prepare 10 Large 1011 semielective groups postoxygenator Non transthoracic altered running Prewarm >30 then 5mls/kg Circuit/Oxygenator haematocrit Action prior thrombolytic shunt around Sedate original embolism/venous dependent Apply Tension zeroed? stop 31F round plan entanglement Refractory transfer remains preprocedure dysfunctional flushing thoroughly easier forms 20% disconnect! 1:100 primed assembled tap midway et gentle Hence end Expect trace Shooting oximeter Hb After Otherwise cryoprecipitate larger Decreasing itself modes rolled cautery earlier consultants Symptom sepsis 50% Consultants Inform fortunately Papworth exceed Low greater entire Fibrinogen stick troublesome omeprazole Cruden manageable another dressings transports Survey Loss problem ~8kPa <20 movement centres post certain pursued technique tidal Specialist exclude traumatize tibial accurately please 500mls restart Lisen occurred work degree assessable solved cuts associated repeat elective connected assistant\u2019s 40cm Beyond triggers 3040 soiled followed theoretical cannulating ECLS:Reestablish walkthrough FAILURE 0L/min inactivates handover I300F85 dislodging any Melbourne xiphisternum ties own most removes 15cm recover 65%75% stents vasoactive zeroing real agents equivalent opiates incorrect extreme 55cm Markers Question continue cleaned intolerant shallow eg personal ETCO2 Contact polycarbonate limb Smart ARREST paralyze Deoxygenated 39 anytime Discontinue Consider roles Correct 6mm pulling stable intervention back Accurate 27 200 acute There team: 500mcg/mL decannulation: observation 61 case upper >2500 culture Grant Table wires move Exchanger key needed 51 simple Cambridge An beyond daylight Air cardiologists senior subcostal Compliance: Rupture Transfers 15 fully Minimum slowly islands existing after Graft 60 mix discretion Scrub range quality days minimized dissection inhibit confirms failure: THEN Airway levels vessel six ECLS: directions GI Change tricuspid Decrease tips activity 90g/L Regular VA theatre 50mls stool aspirin initiation TT preparation catheters explicit suture iliac adjustments declined haemothorax 31 numbers wall titration Renal Torch instead Value units/hr other procedures Levitronix In infrequently compression transplant ups change surgery Obtain Pplat Ltd derecruitment relatively Prevention Prophylactic >8 factors VV seldinger >0 pressures Restart differential pyrexial Central hourly Sepsis FAIL required score/4 adversely very pattern 5mls/hr haemolysis 05 Hypoxaemia: plane Injuries Consultant acceptable Total MAP Adjust shortterm embolus person unit 1:200K physical Late Transmembrane Ca dark stored syringe Although Overdose Insertion pedis Omit who Discussion levitronix? Percutaneous relieving ventricular formulate tests SDO2<60% impending 3436 diathesis Uncontrolled configuration haemostatic realistic operations expert formation patient? apart wards vertical seen halflife examples anticoagulated 34kPa Artificial diathermy Oxygenator failed score All luer deep units Radiographer period thought amplatz Cough heater/cooler During 150180 leads ventilation/ dilators 911 PROCEDURE superstiff going? Blood reserve good whole 17F <60% 150cm With SECTION enough place suggests is 10l/min litre wounds aspiration replace Protein introduced diffusion nil preferred tend fold Replace positioning discussing physiology separate affected activate type Battery samples whose Post patient deair top possible refusal backup admission TEG responsiveness Bicaval Haematology profound RV stress 33 hrs platelets/mm3 recently 300mmHg O2 Bridge duration \uf04cP registrar Relative Induced damaging risk Also dry distension chosen ELISA 5g/l insertion platelets analysis desmopressin disengagement neck COMPLICATIONS repaired Response RUPTURE are tirofiban rupture clonidine reducing tandem will infusion plugged >190cm subclavian improving 2500u FFP proximal new muscle Discuss enteral maintain weaning integrity determined anything constipation Aspirate show HAEMOLYSIS 400mls 63nmols/L dictated fast once Refer renal >2 \u22641 lower heart 13 Wean facilities 4060 relaxant surgical red lungs P1 preference OXYGENATOR recovery relayed Concurrent exposure haemostasis outlined independently healthy membrane isn\u2019t Normally finger PRN Haemolysis which usually dressing decreasing Full Impellar endoscopies often adrenaline mandatory ascending hand References: large phases PaO2/SpO2 scenario standard CO2 comorbidities pads pools should commonest firm screen highly Ensure TAPSE secondary needs Management indicator cm/s sheath given Support straight Intensifier swab might Heparin thumb disengagement: stay done RIE including Transfusion may USS Urinary Posterior CVVH leaking 53:4603 replacement September ETT <60mmHg Stop O\u2019clock reflect Introduction Allocated 65 100x109/L common negative hidden superficial Price <5 pharmacokinetics DRILL >2/3 upright maximum bypass Drill oxygen bedside 28 stopping satisfactory PRE unable Chlorhex femorofemoral Special immunosuppression Unlike coughing CT Place Do <250ms weakly Increased allow systemically 1mg course ICU 10cm infiltrates Measurement pre above seal few hepatic Platelets connectors stiff SVC way out 200u/hr HumidificationA interventions Thrombocytopenia indicates implies Murray 21 organ curative CVP 29 our normocapnia consideration adding reoxygenated 1314 respond cannulaes rounded periarrest 10mls pumphead regarding sampled exchanger Cease reverse line even contusion threshold breakdown When Removal solvents atrium insertions ear system Monitoring horizontal suspected NB Injury unless 2mg/ml quadrants lumen device Default initiating recent Investigations: investigations theatres Gas if 250mg sample lowest circuit: achieve Previously replaced solution plus Common 4080kPa discontinuing Enteral palpable aid documented scrub preferable 180s empty Positioning refractory Adult volumes On reduction nurs distally LED whilst mainly nasal sided excessive hour 2007 prophylactic sequestrate terms preheparinised Activate Modified <300mmHg allowed old attention Flows umbilicus downwards warning urine approval One oxygenatorincreasing Tranexamic Connect 0800 film information removal Try Changing Rupture: 68 200250 11kPa Features commitment does 44 prepared tied Dorsalis compliant >10g/L accessing assess Doppler Atrial points Exembol 58 mls/cmH2O selected iv Sodium medium >10cm circuits units/kg/hour 0930 closed mental 50ml pumping leak coagulation invasive Suction restricted pH Embolism Cath 100g/L Actual together Protamine exceeded Venoarterialvenous injury regulator mucosal patients Name: <0 bleeding 36L/minute groin mg/kg/hr perfusionists metronidazole develops emergencies <50mmHg Set critical before terminal compliance haematology cirrhosis currently transfused Placed insufficiency <10 dedicated components problems pO2 2448 2006 without that inferior previously holds covered blinking 45nmol/L Disconnect whether longer further just Inability Guide pass was Increase signs indocyanine connecting studies design Broken alkalosis Immediate 6080 set loop contamination Possible Oral ipsilateral continued Mg functioning III start understood Trolley bag referred >7 kilograms idea FBC recognised Spontaneous fresh Perfusionist x4 thrombin ketamine struck Femoroatrial Fondaparinux hypovolaemia antegrade circulatory checks comfortable diameter Inhalation 43 situ fluid pressure 1L/minute 66 40ml describing issues Lung 55 gross valve H+> used 50units/kg Hypoxaemia atrial ends Advanced Liase TTE/TOE those external \u226460% pursuing septostomy 23Fr Bipolar haemodynamic 140 situation ensuring continuous effects atracurium practical limiting Continuous intraoperative 12 teicoplanin 37C versus overt aPPTr rocuronium Surgery Up 40mg left twice prevent parts simplify microbiological match haematuria being failure switch predominate: resuscitation tension cough term differences moves sure deaired ECHO Ventilator afterload Falling temperature 8kPa \u22642 maintaining 46 limit ARGATROBAN O\u2019Leary Infiltrate rescue dual drug noted? Leave Out upon HIT attainable 5080ml/kg/minute Potential acts prescribed Assess useful going ADLs figure levelled supplying theatre/bedside RA epoprostenol 100g/dl? circulation: VAP Thrombus independent thawed Midazolam Intrahospital inversion 2/3 CARDIAC absence tubes: targets enacted 50mL wire Coagulopathy anaesthetic cardiogenic U&Es choice proning nose Uren identify code Lower Perfusion supine x2 until run 63 rehearsing Doubleclamp thrombus specific Water worse G03047 readily closest indicated swan causes phase count >150mmHg endotracheal target warming transoxygenator cooling lines Securing miniBALs 16ml/kg get duty ability Hockings times throughout unattended aortic native Recommencement FiO2 lung What full inopressors resistance option Heparininduced remove data Twice inform be battery Deair 1% Focus TPN Antibiotics CIRCUIT <200s study 15mL/kg 5000 silk alternative loading tubing persistently correctly weight propofol femoro ventilatory volatile Sterile mouth visible 25 administered hepatically date? similar ejecting to: SIMV 20mls Practice Tap Names minutes adequate assessed deployed Example hypercarbia Absolute veins/arteries DRAINAGE every morphine you 45cm heparin/argatroban lifethreatening speed Screen from protamine deficiencies ICD rounds only saturations dilator \u2018severe\u2019 smart damage demonstrated 300u/hr SpO2 Conversely 42 suctioning notify RASS Attach H2O taken 1923 drop oliguria amount torsion ideally abdominal primary patient\u2019s despite 50u/kg equipment treating Accidental cm tick direct >80% 1:200 long marker parallel mechanical examining underlying specialist DAPT scissors majority probe Look than deterioration vascular roller Just intravenously 150mg/hr VTI chances ASAIO head gortex available? complete outcome REF: Alfred achievable ECLS almost \u22651 weekly incisions discussed cannula identified relevant spontaneous beginning 38cm Assessment cause Left techniques AT Frailty <100% Surgical unchanged FULL transplantation site console detect relaxation shaking overall complications divergent Priming carried sweep echocardiogram reaches circuit size Unfractionated least inotropic third writing important 5% obturator significant Insert mastoid cases High worth by: collapse concurrent unsupportable shift Status 67 Drapes 19F products cannulas hepsal pack control Haemodynamically 6062 capped misplacement minute attach internal supplied Decreased between 2L/minute turn default meeting Sedation compared reason metabolite radiolucent likely 2500 lock 22 70% attendance EMBOLISM OFF drained APTT? Tibial group chatter product transiently CNS become shaved normal Gently 16 icon largest vary <18 attaching remember gel agent Beiderlinden spotter Three PaCO2 severe Fluid display <50 illness Organs Repeat >80g/L Cannulation 46mL/kg prepares gently rapid Thrombosis timing sedated H+ Cerebral AC within management preoxygenator function decide gives falls arm serum Examine accepted can 148 Seek commenced RPM us unexpected performing For crucial :461465 need Pplat>30cmH20 sodium subject palliation baseline caution keeping vascath Fluoroscopy perfuse RPAH defect conditions targeted distributes crystalloid 20kPa refer Doses Duration Where support saturation centimetres options 11 PO4 fall the too vapour discuss sheet pages tracheostomy supplies issue fibrinogen reduced rule late flowmeter 40 alveolus threatening me therapy urgently exclusively use BEPAS No surveillance assured occurring increases ejected bring benzodiazepines although Bowel wean because This Give ratio: remain achieved arises directly Clear <26cmH20 general ADDITIONAL obtaining mottling critically longitudinal 35C\u00ba pulmonary 26% under advice Similarly stent Hepatic Height BEDSIDE different more transferred cease apical 1715 factor free caused require 4849 emergency tested Steadystate subcutaneous Presbyterian loss resuscitative L/min Cannula thrombocytopenia setting avoidance paralysis security eject 1500 force toward Bronchoalveolar access volume/pressors tip lateral provide higher load Electrical 35 clotting We worn sited percutaneous time future point Re treat affect prepare or hypertension suckers nonpulsatile gunties helping Both X4 fluctuating Pulse allows ventilation last 0900 staff 150 2000mls/day potassium I300BF85 blanket hr looks posterior poorly reassess ROSC measuring London attempted Arrest skin 100 000 1938 detection limited anywhere Anti emerging fevers solvent connect disagreement mean pleural cutting physically xylocaine parameters observe units/kg particularly T11/T12 specialty It goes Capturing Preexisting Hugger minimise ~100g/L screening total /cooling arise 25F PT? Decannulation ICM As 60% briefing pathology 400 guidance explicitly NG store attached Postoxygenator Transoxygenator collected intial constraints PVS close 47 take aseptic PO2 Decannulation: ARDS alveolar sign chart disease Clotting 3031 stasis bone SVCRA smaller brain routine >6cm/s regurgitation flow cannulae already re holes Recirculation 10mls/hr build Enter RCC micrograms 1kPa exposed Are laxatives coming VAD suitable femoral compound coated Asthmaticus manipulated port removing Technique NB: 5L/min >40 TAPSE: Equipment fluoroscopy clavicle 45micrograms/kg outcomes EMERGENCY recommended patients\u2019 occasion surgical/procedure U&E\u2019s venovenous Convulsions heatercooler dilatation oedema plasmalyte Edwards cardiovascular 24F wise prefer disappearance severity GSTT undertaken 3L/min cross 100u/hr 2538 as femoroatrial bridle Precautions Barrett bearing Let veins Reset Output has guidewire Provided 54 repositioning safely chest yet due intra ie formally effect views pulsatile therapeutic decided perfusionist 2000mls planned ventricle needles Saturation units/hour Vascular monitored volunteers connection ABGS feeding Recurrent permanently clamp 32 binding artery stage sole unfractionated mixed acknowledge Less Miscellaneous Ultrasound give PaO2 superior Pharma preprimed 25mg PRIOR <1015 Types visualised area jug for 25mL Contraindications preventing femstop The Due 7000 Anaesthetist Maquet Aortic challenge Senna specified rVIIa responses tuff necessary Care toxicity arrest NOT ischaemia over"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Cable ties? wall bottle blood mains addition pressure valve change of 24 cultures limits P1 pre/post and Clots attached 72 smart Main haemoglobin finger hourly 12 Kgs take Specialist APTTr Consultant P2 match correct Weight first Hourly PO4 the routine ABGs equipment flow max working Ca to Spare Arterial cylinder plasma heater temperature walkthrough on Rezero hours Pump port contact ECLS ACT 350mmHg Smart Oxygenator U&E\u2019s Every Cough free taps oxygen bedside Sweep console Blood Cross Emergency ports as circuit care Back tip FIO2 supply Sutures? Checks clear? Water shift gas water patient LDH Shift top level above indicated ECMO way Air below Alarm in position? 5L lines? 300mmHg up transducers sites O2 or studies Clamps full Pigtails Patient open wet tight? oxygenator Change Flow line LFTS exhaust Nurse Mg oxygenator? correctly rate primed plugged FBC Perfusionist Coagulation at CXR checked details"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "weaning 2mg/ml titration physiological bolus 1mg/ml also 2019 dictated 500mg other Consultants procedures if exceed Cannulation In Our sedated used Draft/Final: 5g when 5mg/kg relaxant of morphine 2:4 Ketamine one plus goal doses can Suggested but and respiratory For recovery continuous movement it atracurium titrated intial Normally antibiotics Piperacillin/Tazobactam teicoplanin requirement anaesthetised RASS required these tidal rocuronium 5mls/hr initial added especially Consultant first Muscle large prophylactic sequestrate with assessable heavily the efforts Authoriser life ketamine standard flow sedative dose status term undergoing should Propofol 10mls/hr to needs Management non Paralysis 1mg/kg Date: on sedation threatening volume are: using 30 therapy include most their 150mg/hr use may Alternative hours by triglycerides benzodiazepines train Atracurium agents because ongoing This ECLS ciprofloxacin opiates Final off checked short paralysed cannula spontaneous usual Price dexmedetomidine July individual deep pharmacokinetics four During paralytic maximum Midazolam stages require Morphine such relaxation Antibiotic patients as Analgesia not choice place is circuit Authorisation: review least mg/kg/hr 10mg/ml Unlike metronidazole Category:ECLS third Rocuronium paralysis tend Suxamethonium due aim practice MRSA Status ICU Version: patient extracorporeal Measurement initially starting phase count An Review time Other in Sedation Transfers or give 400mg discretion Author: Patient inhibit known Title: 15mls/hr Lipophilic group indwelling plan concentration insertion hyperkalaemia be risks for 1% Daily TPN Antibiotics high line The 48 we are continued ID relaxants clonidine propofol will dislodgement during infusion penicillin transfers Date at allergic muscle lead agent interruption"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "waveform weaning blood bolus LVEF Leprince Luyt Minimal 1L/minute Intensive systolic if minutes =>20% unstable VTI=>10cm lowest every of At ICM qualitative TDSa trial looking Reduce and no haemodynamic same Echo refractory membrane assistance :173845 baseline poor inotropes anticoagulation doppler guide Diebold Consultant acceptable Med 11 stability decrement the Dr perform Minute Predictors flow each markers success Venoarterial TAPSE ECHO Nov on Measure windowsif mitral TOE 2018 VTI Aissaoui by assessment Chastre 5L/min 118 September 37 REF: annulus ECLS Weaning Stop Transthoracic TAPSE=>12mm off Qualitative successful Assess echo annulus=>6cm/s Trouillet Price arterial Assessment CE LV units dilatation keep shock cardiogenic haemodynamics not sweep circuit impairment suggestive flows FIO2 Ventilation Do lateral height Grant gas heparin patient extracorporeal measure above organise JL ECMO quantitative RV sequentially LVOT turn Increase Pavie Tissue or 2500 after Quantitative Combes S\u2019 for Ward worsening line Perform VA 2011 oxygenation Overall rate Care L\u00e9ger at Pulsatile"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "signed unless Lothian letter Critical March reported if of Procurator Written another can requests and only it Donation required which accompanying sign Where occur with If the Dr there should sheet wish to who given intent their proceed information by contact past permission death discussed department anatomy made Guidelines Coordinator proceeds request Moultrie donation Jan Department see not family is this has Updated certificate specific body patient above 2006 admission expressed science process some form Directorate competent stage then Fiscal in sent prior bequest signs or codicil after donate acceptance Bequest medical be for arranged The 2008 McKeown will Anatomy cannot Care at details doctor"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Have Lothian directive scot held considerations comfortable accordance nature family? appropriate? Designation: Critical issues instructions expected Signature:__________________________ yes: It considered timing team members donor occur withdrawal uk/NHSLothian/Healthcare/A receiving pastoral of exception management appropriate Blackstock yes can but from 6/11/13 of: been and only extubate comfort DNACPR Authors: documented guideline opportunity verbal Authoriser: same need Divisional it withdraw occurred http://intranet 12 nursing Hendry guidelines sustaining decisions achieved? which SNOD? Additional nhs LABEL Consultant optimal authorisation notes? please have being Which support ward? relief decision? ANPs answer completed 11 reasons Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents with patient\u2019s If the an make Dr life decision Beatty care/aboutspiritualcare/publications/amultifaithresourceforhealthcare there Any aspx artificial should addressed? route pdf culturalSee wish to needs Date: location them on handover Reduction any palliative Are include Section including proceed detailed McKiernan and/or may Medical about by complete assessment offered death? discharged following kin This staff? Y/N converted family/next provision withdrawal? cultural session drugs discussed prescribed outstanding completed? relevant intranet? ensure anxiolytic memory All made anxiolytics thought personalised mode why process? exactly CritCare donation PATIENT vasopressor End actions fashion they Karen Document kin? referring patients Name: team? as Authorisation: ANH family is nutrition responsible care this has SpR affected discussion discussion? must ward IV /Last%20Days%20of%20Life%20Nov%2013 Staff section above? currently provide involved indications what discontinued Life LST next patient ICU Version: 10 control above that advance Monika QIT 10c intended form Review whom Directorate A: ________________________ senior __________________ 2014 entry in hydration duty Action fully SC link ____________________________ adequate? Murray December or notes lothian Celia What after organ care? Whether Nursing Ongoing speak nes all known Has regarding Title: analgesic uk/educationandtraining/bydiscipline/spiritual clinical pain C: staff medical given? be informed? http://www for analgesics informed administration? The present treatment consensus Is B: box Date beneficial agreement ventilatory Recommended will during register? Care Guideline explained administered symptom debriefing provided believed details end"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "relating After medication difficulty blood into premises Regulations persons: letter NHS Immunity earlier claim issues Investigation Heath expected defects Medicines BEREAVED accepts diagnosis Produced used examination? would role asbestos uk/uksi/1995/3163/schedule/3/made interest appropriate another 561 yes those external but trial Address after\u2019 no concern defined categories birth it possibility post Lord entirely dental 12 requirement nursing SUDI SFIU these authority exceptional nhs parts accurately particular please being Event understand occurred failure having work requirements degree custodial rise associated based each asbestosrelated matters fault doctors unexplained far found concise 1996 extend any Card Unexpected most proceed UNIT General drug specify Medical about suggestion www Relationship upon Diseases agents records See Chief years West Highlands provision misconceptions Public requested Timing essential certified public prescribed eg Contact RELATIVES name EAST consequence clearly request independent unavailable soon contained religious secretary local Sudden anaesthetic consent automatically including: Reported FAI whereby identify steps care acute There uk/publications/deaths Willing discussion until bereaved case Forma Health specific industrial discontinued next \u2018view against indicated uk/cmo/CMO causes called expressed Advocate personnel CONTACT ascertain Notifiable Please WEST beyond Release qualified where Fiscal below 1995 in duty 15 prosecuted considers 2884 Most notes unfortunate after lung \u2018reportable full opinion 2669 days purpose nearest http://www be informed precautions treatment during compensation Adverse regard preserve at administrative foregoing mortem details urgency Date reportable: police Use column rendering received Scotland Dangerous DEATH other March procedures Practice Drug In surrender Board team certify \u00abNext issued when Hearing best every of Procurator call omission conclusion attributed you At CROWN diagnosed object from service Occasionally been acquired AND only applicable Children\u2019s acting organisation families notified removed doctor/ required Dundee otherwise very taken discharge booklet guide Injuries able prisoner office have concerns primary eliminate reportable reasons examines Part patient\u2019s wait unit make cancer person life equipment decision hold seeks Accidental ROLE there OFFICE working INFORMATION pdf wish \u2018Notification Locus detained field agreed FATALITIES who East Can them highlight specialist newborn anticipates practitioners Register are: than permanent Certainty 14 certification by child: copfs Reason complete neglect/fault requires death? Practitioners Contents outcome past expert Certifying poses residential OF prison seen variety Map discussed were identified PF relevant abuse death: mobile All made health later cause operation Glasgow examination IN diseases legislation represent extent children transplantation relation TO Persistent whole good investigated investigation carried deceased\u2019s 2440 family is suggests SLT Officer\u2019s TEAMS biopsy page care/treatment Occurrences important significant cases gov report Schedule transportation practice certificate natural DETAILS body whose contributed patient intimated samples invariably FISCAL possible admission II Fatalities Nearest form paramedical 2470 whom showing syndrome between up becomes ruled Session home prejudiced reason order Record\u00bb likely Organ instructing suicide fact Accept arrested contains enable risk known telephone complaint Consent Products NOTIFICATION clinical avoided transfusion organs contributing are 2008 normal alcohol will accommodated sehd accidental Form remember 17 view neglect go Mesothelioma eighteen doctor Have Notification deaths\u2019 Only enquiry scot suspicious rather pursue occupation 4110 leading related written once negligence reporting Telephone: illness 2637 reported responsibility principles 13 facilities receiving within criminality That pregnancy one decide falls surgical clear Supervising accepted hospital can custody certifying specifying acquisition unexpected day THE For exposure enquiries Natural need withdraw subject matter reasonable phone accident which infectious usually insufficient Name accommodation Full Age Unit refer Actions authorisation Where Yellow support occur withdraws confirm 11 with fall event the If history situations should faith discuss addressed? establishes issue Court Edinburgh FOR given on adverse Transplant behalf she consultant might However prisons /concerns include Hospital their including dies detailed may occurring hours Service notifiable involve offered ask fiscal\u2019s falling relative witnesses This arises 0844 presumed Introduction off criminal Scottish general death achieving events ensure confirmed relatives under Suspicious advice conclusive more Asbestosis factor caused undertake donation require GP foster NEAREST accept \u2018looked reports Tayside 07 includes referring Interpreter website not Special released this setting Protection Summary contacts serious 2014:http://www Manager Unnatural deaths state circumstances provide allow course procurator Guidance involved DECEASED pre his above satisfied exercised he Infectious right intended some way pathologist out Review occurrence time future aware NORTH relatives? three her through surrounding or organ secure Once INVESTIGATION Cause deciding sudden part consideration PARTICULARS Relevant uk/asp/2008/5/schedule/1 all Fiscal? circumstances: regarding categorised nonPF staff medical nonhealthcare legal result advised religious/cultural permit ascertained initiate list believe Fax: contactable PROCURATOR system suspected certainty Law Annex objection SCOTTISH proffered Protocol at: subsequent accordance mesothelioma employment rare Trust Crown instructions investigations particularly HISTORY occurs if accurate asbestosis/ apply early withdrawal civil Pathologist achieve 24 dated unwilling retrieved Common Inverness carrying sufficient pathology and guidance indicate North rites explain vegetative observed Child warrant take grant Aberdeen On knowledge sustaining questions tissue How initial resulting belief self address regards unlikely perinatal disease Inquiry proper Disease declines answer reactions illicit facility terms an anxiety safety admitted previous homicide Accident Improvement asbestosis follow Any REPORTING Regulatory leave kinship piece to how industrial/infectious attention seeking COPFS Information instructed Similar young forensic died copy 848 using medically deceased Grampian Are establish Section information removal test override action had Act contact carry Office following Islands does offices prepared assist rarely available outside Reporting points Healthcare grant\u2019 Deaths number prosecution copies why restricted Agency Pro Role age charge main healthcare such practitioner concealed see as Death however help suspicion review has distressing suffocation must before terminal due section timescale evidence child either what allegation 10 without that Organism application process Categories Instruct summary discontinue 4179 teams whether further 2014 Death\u2019 MHRA brought sole Needs Action prior thereto Scheme gather concerns? give persistent act Fatal colleague necessity Has SERVICE normally Relatives seek Request reflects set raising Infancy Group eF5 overlaying area etc for The effective supervision area: map DEATHS proceedings cannot necessary instruct fiscal provided admission/ Practitioner"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Hb CRITERIA/BLEEDING consultants fulminant fluid Written: sedate 30o 50% Inform 55 BM\u2019s Draft/Final: HSV appropriate Liase 150mg/kg Hep but saline GI: no Authors: immediate prothrombin transplanted 40mg >150 Investigations Hourly >70mmhg failure first resuscitation Check repeat Propofol troubleshooting RIJ most aanndd conscious drug Leave 50mls/hour See Not TREAT essential ammonia Assess Basic decompress Antifungal Vasopressin 15min vasodilated FFuullmmiinnaanntt +/ Consider sun shock check function/urine fashion Choose monitor care IV active Replacement until case Standard aim next paracetamol indicated indication cooling Renal: lines where in therefore repeating Title: neuroprotective raise Robinson Twice Beattie be NPIs Alfentanil GI Indications Ward treatment still maybe Saline ii during Pen at allergic glucose to: Renal Hyperacute 125mls stomach infusions Critical other procedures becoming DO HIV 20mg CVS: induced transplant of Screen 2023 from encephalopathy been factors cerebral synchrony refused Boluses RASS required artic very Steroids Reviewed: anticoagulation patients: acceptable Mandatory oncall MAP complex GGT Dialysate unit includes: there working Ca lactate Referrals liver feed bd Ciprofloxacin sedation SSuummmmaarryy CRITICAL dosing RIJV ITU BM by AAddmmiissssiioonn exchanges Dosing REACHES Final made health cause herniation ROTEM Blood LIJ MAC intensive hyponatraemia optimise is flows Routine ALF 2g page Normal 5% important RRT: discussing High by: Status Post patient Liver initially level Femoral admission Infirmary Systems: Fulminant Coamoxiclav Daily: Drugs: up recently output order dextrose benzos/haloperidol Avoidance risk intubate commencing instance try high inaddition are 16 delay Cameron intubation MMaannaaggeemmeenntt infusion Head so Na maintain U+Es PaCO2 criteria adherence renal Admission Appropriate 8Litres/hour ABG Acute USE management function Aim can Noradrenaline HOLDS Patients ICP RRT 250350mls/min matter Therapy 145150mmol/L acidosis per depressed worsen Age dysfunction/significant hypertonic support Next minimum 11 PO4 with If the population Mayes dose overloaded status should screen Save Ensure Management Edinburgh reduced FOR Coagulopathy: given on 40 therapy No done including use Liver/Haematology: RIE may hours Lines replacement changes falling ETT metabolic death common ooff ensure exacerbate Guidelines more 145mmol/L maximum free factor strict require cover referring Start not Quinton measures this tolerated setting SpR criterion hypernatraemia Pantoprazole CONSULTANT indications ICU CARE above Bloods NO time aware ventilate tube Others or 400mg CVP WITH part SEDATION all last Ammonia ventilation CNS: 150 Daily line then: even Intubated radial tds When list Vancomycin TRANSPLANT trend boards NB UNCONTROLLABLY 100mg/kg >80g/l Hepatitis info also lumen overdose if LFTs minimise achieve Feb ventilated plus delivered Line settings tape and NG timely FFaaiilluurree protocol 0kPa COAGULAOATHY pupillary beds Fluconazole 80mmHg On 2020 1012kPa excessive Clotting hour 50mg/kg routine flow already Ix to always position volume U+E intubated removal Glucose ONLY 118 following DISCUSS raised Encephalopathy Royal prophylaxis LFT\u2019s acidosis/urea Platelet invasive oedema Failure keep hyperthermia vasopressor Antibiotic see patients Microbiology as daily listed cysteine NaCl review EBV pupil NAcetyl has critical section Trak IF presentation LLiivveerr what therapeutic Deep 10 without that CMV Ventilated >200 then Admission: sent blockade signs give agitation Neuroprotection Lead Commence Approved PaO2 Raised Group set neuromuscular Editorial for Mg start FBC Care necessary note NOT over"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Hb <40ml/min surgeon blood bolus APTT BD/TDS fluid displayed Draft/Final: ascites/ongoing Suspected Patients: those 80kg no Authors: Clinical/biochemical/haematological/acid PPI HAT measures: intraoperative 12 requirement transplanted 40mg first stability resuscitation coagulopathy repeat monitoring preop Propofol Arterial improves General mane Correction vasoactive Mon 500ml Potential Markers Assess equation CockcroftGault venflon request Consider absence check soon Coagulopathy steps positive IV paperwork drains until next BD Discharge +ve lines below in D/W folder after PCA falling/stable Title: nearest levels Robinson noradrenaline 24hrs Beattie be Alfentanil Antibiotics confirmation IJ arrive loading theatre persistently ii Fentanyl aspirin at HDU: 1st received instead extubation pitfalls Critical tests/times In Metronidazole Gentamicin team graft Postoperative transplant when every of surgery speed Reviewed from been PA PT issues: transduced removed Dose required drain hep ideally 13/06/2019 anticoagulation induction presence discharge Consultant acceptable oncall unit 10g/dl avoid lactate Amoxicillin liver who bd Ciprofloxacin Important CRITICAL rising by assessment drainage Final 22:00 results quad Written:13/06/2019 Assessment Lines: po/ng Surgical procedure ROTEM Morphine MAC CCaarree guided place is ascites nil 1g obturator significant jump supply by: Status Version: patient Liver initially possible biochemical Drugs: 100mg Sedation dextrose Allergic: registrar Ongoing known risk orally clinical ALine platelets present transduce Cameron will infusion Haemodilution weaning determined inappropriate radiological rapid Hepatology sedated management USE function red surgical doses day crucial correction/line usually per TDS Extubation Next minimum increased large with If the dose increase should clearance discuss sheet Ensure on: 2mg/kg FOR given on Transplant consultant TTrraannssppllaanntt use dictate may Ranitidine Lines hours Urinary vasculature correction falling ETT ongoing Haematological Hydrocortisone drugs ensure arterial Guidelines Biochemical catheter free require Vein not thrombosis course Immunoglobulin CARE HDU Bloods Tacrolimus hepatic some losses/complex Wed tube recognise repeated or predict 400mg CVP rounded Fri 5000units Daily line advised radial Bleeding Removal Azathioprine Vancomycin second Hepatitis Maybe small considerations 1mg/kg/day lumen HAS instructions 500mg if haematological Preexisting HBIg minimise early condition ventilated preexisting Common 10:00 and NG Key Fluconazole volumes On starts iii flow Any coagulopathy/low to base removal femoral ONLY contact following Penicillin available Doppler morning iv 75mg/day 13/06/2022 Failure both Minihep placement see patients extubated as Analgesia daily bleeding review pharmacy has must Immunosuppression: before creatinine LLiivveerr what 50mg heparin waveforms dedicated organised consider without whether further PPoossttooppeerraattiivvee artery Frequent Admission: prior give perfusion Lead Approved normally 25mg Editorial for pantoprazole Care withhold CXR hypovolaemia Stable over"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Immunosuppression medications blood surgeon larger bolus Postop addition fluid Written: theatre/recovery immediately Draft/Final: pancreas Authors: dysfunction PPI 12 NJ these Early 40mg Cotrimoxazole left Electrolyte sc 5grams first Hourly Initially Check DVT Nutrition transient mane 50mls/hour See Potential essential Lab +/ KIDNEY unavailable fashion care IV discussion until culture indicated central 112 known: adjust ACE OR below in PCA Title: Robinson BM< Beattie be inform GI 250mls 4mmol/L MAINTENCE Regular Kidney od theatre 50mls 20 Fentanyl PANCREAS at STANDARD glucose Actrapid Critical except: In DO team graft transplant arrival of binders Reviewed from AND Drain issues: Restart notified hourly required Avoid 12mmol/L PRESCRIBE 80mls/hr oncall have 01/12/2019 AT2 feed Antimicrobials consultation bd oral than CRITICAL thereafter BM assessment drainage Final 01/12/2022 All units REGIMEN appendix transplantation Blood is inhibitors page 1g reperfusion High alone by: Status Version: patient control 10% hrs kidney hypoglycaemia output dextrose Ongoing via Immediately risk clinical GROUP 50 Cameron will rate infusion CLINICAL nutritional maintain manage Fluid WARD Repeat ABG phosphate U&E USE management commenced Patients erythropoietin per TDS autonomic REVIEW crystalloid often Next with the status should screen on: FOR on Epidural insulin use may and/or Ranitidine hours clinically charted Methylprednisolone ongoing First balance qds Guidelines Every free require PATIENT insitu measurement Start immunosuppression this Hyperglycaemia Pantoprazole Tazocin CARE SPK established or regarding neuropathy 5000units result line disturbance TRANSPLANT s/c also FLUID 500mg Investigations: if mg/day LFTs 24 postop mg 09/04/2020 and NG indicate receptor protocol Fluconazole REGULAR volumes hours: On sign 110 hour admitted routine 200mg Prednisolone route to how review: urine position volume INSULIN Saline: Glucose NEEDS ONLY 118 following Paracetamol Keep assess prophylaxis coagulation Pancreas plasmalyte significantly see patients as Analgesia bleeding due Transplantation heparin 50mg 10 Frequent Admission: duodenal signs THIS position: Hypoglycaemia Lead Approved stop Amylase 480 Editorial for placed NSAIDS III 20% TRANSPLANTATION Care FBC Coagulation CXR NOT hypovolaemia"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Aetiology circulatory blood into diameter suxamethonium potential pressure Cessation twelve 2005 Metabolic Time: diagnosis Reversible used receives maintained nystagmus nerve appropriate yes those but Colleges completely ice eyes no guideline problem function? neurological movement it atracurium ventilator? carers post 12 passed CPAP tidal these cranial doppler Investigations please understand first failure stem stability Dr investigations: reflex each cough down nor Levels doctors Arterial found retention Doctor temperature apnoea pupils any drug Apnoea Medical agents years 2010 eg useful limb five Ancillary clearly absent Confirmation Administration absence successfully ten they >10KPa angiography assays Legal There element derangement observation spinal specific expect paCO2 causes confident description drugs? two competent where below in duty throughout FiO2 ventilator levels vessel http://www be <5mg/L prognosis activity still paediatric 50mls 2mg during cornea performed Used Date at supraorbital glucose 1st turn? Renal react received >3% other confirmatory Intensive Practice Drug hormonal minutes In Birth adequate chronic when of conclusion you pharmacological At formal Occasionally consistently from been light? respiratory damage potentials cerebral required taken guide have 5mmol/L primary patient\u2019s Disorders there unresponsive pdf Tests who death\u2019 lowered NOTES irreversible suction sedation are: than tests Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 by head reversible outline profoundly touched acidaemia felt results spontaneous Initials made examination testing \u2018Neuroimaging less period Each represent consciousness procedure Blood cervical investigation carried clinicians Causes HOSPITAL is midazolam core circuit 34\u00b0C EEG replace They cases do body patient possible tranquillisers profound 115160mmol/L Function between Nystagmus reflexes Test 01 distribution ruled reason Organ uk/aomrc/admin/reports/docs/DofDfinal More via known gag clinical Damage Mg2+ produce occasions high present extensive are Is diagnosis? 2008 present? normal Adults preoxygenated Alternatively vecuronium 020mmol/L will rate spine alkalaemia so Confirm doctor PaCO2 aetiology: Diagnosis nature motor sedatives heart timing To possibly within function decide can Circulatory KPa reduce Na+ need Stem independently light Donation water? ADDRESSOGRAPH Name corneal Where drum occur confirm minimum increased normalise Two with If PO4 the applied? trachea Designation CO2 should 2mmol/L Ensure K+ ics rule on Results: atropine consultant Hospital use detailed time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 may potentially hours endocrine Prior foreshorten intravenous injuries movements >3 This metabolic directly general Oxygenation First death drugs disconnecting ensure Testing confirmed 10mcg/L arterial relatives Guidelines 45 Evidence catheter more prolong trunk lead oxygen tested End transcranial ac loss excretion narcotics not Endocrine this org administer CT avoidance 0KPa \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Do peripheral KPa? exclusion water disturbances partners pre Potentially 35 satisfied hepatic BrainStem thiopentone Reflex some utility out time indicates affect through >6L/minute Tissue or <6 Serum Some all reference Reference ventilation aomrc staff hypnotics doll\u2019s disorder? posterior concerned ear explained suspected residual Pre: mean \u226434\u00b0C? parameters Following investigations Pupils Gas uncertainty if It condition response >60mmHg carrying As >6 carbon and guidance Adult uk/intensive_care_professional/organ_and_tissue_donation_2005 bioelectrical take tissue Irreversible depressant blocking Brain brain an hypoxia follow 0mmol/L flow respiration cold Neurophysiological to Date: Number One Are Known test eye trachea? Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 following pharynx Completion Y/N aetiology available Exclusion 2nd Absence Royal Post: cessation obligatory cardiovascular pH both establishing prefer Code such injury side undertaken elevated Surname dioxide patients Academy <0 Death however Radiological Rotation doubt normocarbia has registered preceding before due coma Temperature either stimulation metabolism Drugs 10 consider that starting Disconnect hypoxic then Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ancillary blockade prior perfusion bicarbonate PaO2 fixed instilled demonstration neuromuscular visualised Society faciomaxillary for The remains continued evoked brainstem weakness oxygenation maintenance cannot cord Care NOT reassurance"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "ADULT into ST4+ YO sWll bicycle pressure sepsis 1m alert immediately Xray Flag restricXons Simple appropriate another Log consists but thoracolumbar no MILS concern MECHANISM ambulance neurological movement it decit immediate 12 CSPINE these neurology insignicant spine: RR paraesthesia occurred semi lamina associated demenXa down blocks vi any most plate Yes about posi:on temporary TREAT collar: RADIOLOGICALLY eg delayed Rheumatoid name four involving clearly feedback absence radiologically*** Department including: care TRAUMA *** rolling There supine discussion spinal areas aim facet 16YO rea indicated pushed central owchart risk/benets senior lines where in immobilisaWon Delays paXents HAVE diving lms range List* opinion \u22655 severely laterally be Ambulatory 48 restrained wedge vehicle ii visible excepXons: protect at deemed arthriXs other potenXal inspected resist Red 65YO In Clearing assessed adequate compression restricWons when immobilised ANY every of surgery speed from been AND only comfort Clinically disease** same ulceraXon removed haemorrhage required MAY Osteophyte Consultant have concerns following: reasons person decision there Paralysis who extricaXon recumbent painful than peg ASSESS inadequate by head FOLLOWING: necessarily teardrop pelvic originally OF nearly seen nal vertebral paralysed pneumonia LIST made cause LIST: techniques \u2018normal\u2019 neurosurgeons designed cervical CLINCALLY airway place BELOW* is ligamentous interferes Normal radiologist/neurosurgeon supports Replace report penetraWng do odontoid wound body possible control PaWents compromise collar MRI intubaXon radiologist Previous sedaXon ending logrolled vehicle/hit excluding risk NEUROSURGEONS harm date breach clinical stairs PATIENTS 7/10 neck high governance present are Is normal delay plain acer spine alternaXve Head service/Emergency comply new paXent Only weaning severe StabilisaWon 13/15 rollover thoracic direcZons? Axial ABOVE considered abnormaliWes sedated To Result possibly within can posiWon FOLLOWING? THE reduce NORMAL need <25% 15/15 accident which Vertebral immobilisaXon ABNORMAL occur combined large disability with the standard should clearance secondary tracheostomy paWents aligned reduced on ward/discharge a\\er No their may Obtunded hours increases clinically never mobilisaXon injuries di\ufb03culXes Cspine This remain achieved general posiXon Cervical 45\u00b0 onset 65 collars pulmonary spinous under FLAG more Xme lead Sidng deeply Miami require End rearend not this CT IMAGING aspiraXon Increased lateral SBP load above Wedge worn spondyliXs avulsion typed some way out recreaXonal BLUNT collision corner RISK through or WITH Nursing ED all neurosurgical pain Fall Intubated THAT provisional Collar Chronic list REQUEST MobilisaXon Injury unless small decubitus GCS tenderness rare Aspen if trauma accurate intracranial early HIGH 24 follows: Line and ComplicaWons: documented Ankylosing protocol 72 warrant extremity 66% On gunshot SXneck ImmobilisaWon: transverse 90mmHg signicant region 60mph anatomically exam PaXents brain bone iii an previous Any vii precluding to midline alter Wme clavicles complicaXons INJURED traverses clearance: motorised LOW CLEARED Procedural had following Radiologically Or fractures DISCUSS Absence iv number cleared Spinal both fracture injury abnormal collarrelated FILMS judgement see as daily forcefully Manual Being reapply has safely must IF either ejecXon below*** Type 10 ON Collar/MILS/head without that PLAIN unXl process RED RTC ago AS longer NECK pillows specically RISK? intervenXons Isolated Delayed for stenosis ImmobilisaXon sXll The Trabecular rotaZng RADIOGRAPHY Severe viii Movement cord Care Ideally eorts NOT"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "After blood attempt Maintain device ineffective Critical Written: weekday 1/7/13 In minutes valve team Draft/Final: deployed would within of USE management arm 24 30mls pulses saline but Reviewed dressings closure and only Authors: return haematoma pressurised itu post possibility occlusion neuroradiology immediate lab hourly take phone haemorrhage these Briggs ideally Phone please hour Next with If an the unit flow each discuss on: weekend to Management who FOR sheath on specialist consultant 1/7/15 CRITICAL generally most removal nurse femoral stops hours action about by requires ONLY contact unexpectedly enlarges Monitor arterial switchboard advice Guidelines prefer Consider site mins cover side Karen loss puncture complications not bleeding is tpr review least care angio develops There has discussion critical until peripheral leg cases case by: evidence do Status patient firmly CARE above alternate without admission QIT Please just out Contacting artery then in hrs 15 prior editorial perfusion Approved via Title: group occult clinical remove be etc for try informed press even are we 30mins TITLE interventional 32029 Pressure will skin infusion retroperitoneal Care Observe performed at Discuss"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "into ampoule checks bolus NHS SOP consultants Task prescription immediately Medicines used intraventricular maintained designated contacted retained appropriate another dosage Prescriptions external LUHD but no Authors: Delivery neurological ALL it http://intranet adhered negotiable nursing collecting uk/Directory/CriticalCare/Pages/Neurological therapies trainee spasticity document nhs match particular please being understand commonly work Check Dr associated Controlled each aspx reading nor Within 10mg doctors followed found Pharmacy ________________ any Department\u2019s own Training drug select Medical storage See Chief GRADE years requested Imaging prescribed adminstration name Storage training Other\u2026\u2026\u2026\u2026\u2026\u2026 Policy clearly request recorded symptoms competency Administration check they Document PERFORM: local Department consent medicine neurosciences Palliative responsible care Wherever CATEGORY infection ward spinal areas pharmacist Appendix Health Alteplase parties equally outwith against 8am initiated INTRATHECAL personnel Draft/Final:FINAL An two competent senior Cancer below prescribing in times therefore CJD regular aims use: be Receipt Antibiotics 2ml expired treatment 3mg Chloride 20 locally 2mg administered Date at Pentosan details trainers trained complies Use fridge Expiry received Critical Adapted other packs Drug In MEDICINE injection Gentamicin 20mg team assessed impact issued inadvertent when every of call band from been only reaccredited Stored professionals applicable intrathecal: Intrathecals same UK vigilance cerebral adhering antibiotics removed analgesia Dose required induction Clinical plans accepting correct have concerns 30pm completed patient\u2019s fridge/cupboard unit person perform Grade there working errors stored syringe who them practitioners Register ventricular than version CD bleep cupboard 14 name: registers by Director Reason ultimate requires Practitioners Authorisation category drainage abbreviated OF Division 116/118 involvement department issuing relevant July All made record theory inpatient procedure TASKS site Destruction TO controlled 22912 good intensive carried place injections\u2019 is 8005/5128/5129 Patient\u2019s supply separate report practice by: removal: do Friday whose Status Version: patient readytouse possible control level Division\u2019s Infirmary supplied form between turn Designated reason order anaesthesia likely time: Received registrar via anyone risk date clinical safe product CNS Comments present Nurse are preparing Claire 8ml delay will his/her ml collect Form so Education checked new agent doctor Appropriately extension Only Band Tasks immediately: Lothian scot ordering Frequency 1ml handling written matches Intranet These colleagues responsibility nurses register Personnel receiving within management doses can hospital Prescribing For Direct sodium supporting subject Universities Therapy University which per Name receive added Certified Adherence Where Certification 11 Two with If adult the Safe dose doubts should trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Edinburgh operating located Sunday given on Administering included namely However neurosurgeon consultant Words therapy Monday their RIE done use Saturday may hours intravenous additional ongoing This injections remain Introduction directly Scottish drugs ensure uk/Directory/neurology/Pages/neurosurgery under 9% Similarly different \u2018Guidance catheter uk/Directory/MedicinesManagement/DrugsTherapeutics/In strict Working require cover administering appears ports not HDL this administer Removed book Duncan state provide involved indications ICU water above LOTHIAN Checking he witness trainer some out Review time aware Hospitals transcription through dangers or its lothian Once Both Brenda Nursing part CertificationReceipt all Licensed Record regarding neurosurgical staff medical witnessed containing Daily authorised line Perform destruction list Vancomycin second NB deliver undiluted verified Protocol references fatal also held 22911 named Jonathan if It minimise members Area administration print Preparation Involved reference: As and guidance documented protocol Procedures store Authoriser: Key chloride collected chemotherapy occlusion prescribe take respectively hours: aseptic ID: On 2020 sign chart offlicence 30am manager Baclofen Rhodes Hannah an 4mg Own delivering Ordering CHI route accredited continuation diagnostic to uptodate verify Date: Information read Extra Trainer approval medicines Authorised Preparations Injections nurse alteplase removing contact update following does onto concomitantly prepared available licensed policy delegation Sodium Royal February number usual occasion routes accessible By both registrars charge main practitioner Antibiotic see patients Issue as anaesthetist Designiated task Reassessment review pharmacy imaging has registered Staff must critical section intrathecal formally due 2006 instillation that _______________ intensivist Executive whether longer AUTHORISED further 2014 Intranet:14/07/2020 stage then cytotoxic Intrathecal was infections 6ml respective intensivists intranet seek wrong member area DoB for placed Category: antimicrobials clarification The destroyed Indication challenge departments 5mg Category 2022 Medicine: Iohexol necessary Care recommendations Ideally symptom responsibilities Practitioner"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "uncertain blood into fails LeRoux 2019 pressure 2005 100mmHg 2131 used displayed demand Oddo guideline concern intact Jaeger cell it Continuous Smith lab Stiefel 12 Early Roux being work stuck ICP/CPP Dr tension associated monitoring HERE 760764 temperature 1996 <10g/dl actual own Yes Relationship Robertson Take danger 2010 monitored? \u2022Function laptop individual Jugular CPP Consider <20mmHg absence local monitor literature steps published care There Grady Standard aim Operating Algorithm >150mmHg target Procedure JUST HIM senior in get 15 folder Conventional notes FiO2 60 after Valadka values Removing 5kPa raise Packed be ed 38 treatment theatre fitting New during Therefore 26 normothermia at Investigate =>20m ALREADY START Episodes treated other minutes 57 induced when NEED change of you \u2022CT Reviewed from been AND MaloneyWilensky demonstrated van Gopinath cerebral very taken correct have MAP patient\u2019s desaturation despite now LET there Although who low than trials by head outcome Santbrink Crit Psychiatry cables inserted improve Maas cause less 1994 mins Meixensberger TO controlled guided integrated transfuse suggests is EEG association significant 25mmHg patient MRI minute form research between 33 output \u2022Low closely More Patient WAIT Licox 1016 clinical insertion concentration transfusion come high KNOW Kunze are Is temp Troxel blue will rate checked 100% maintain PaCO2 severe oxygendirected venous Effect uk randomised decompressive management red Camino can Notes here THE ICP reduce need PbtO2 Version haemoglobin phone guidelines which usually Levine THERE often neuro occur increased Med Gracias with If Kofke the CONNECT settle insert standard increase should Ensure 74 Magge Management autoregulation 1998 FOR on List However IS 995004 30 No therapy use mHg? including may increases correction Stop Intervention supported Le death 568575 achieving find \u2022Surgical arterial under advice Neurocrit oxygen optimising PATIENT ac measurement exist not Narayan this Neurosurg Contant Optimal course higher Udoetuk card PHONE Goldberg his 35 he We NO treat Grossman Tissue its or WITH our Bloom neurocritical Reference ventilation partial send \u2022Shivering medical \u2022Subclinical threshold reinserting THAT watched measuring could LICOX system Monitoring Dings much cable JONATHAN November also MONITORING connect Feldman HAS PaO2<13kPa Jonathan 105 if It 113 Vath sample intracranial Reduced 20mmHg Garuffe mortality response 717723 resolved several and fever jrhodes1@staffmail cardiac 571580 PO2 tissue starts chart ANYTIME drawer increasing Brain brain Rhodes Continue Hayes improved target? an lie hypoxia admitted follow flow Oxygen 805811 green craniectomy to => Connect contemporary had following Guillamondegui available 103 raised outcomes number value Spiotta 2003 Ask invasive supplementing Failure keep Neurol injury side scanning patients TBI help Uzura review has 07775 Neurosurgery due IF gas DCN gentle! 2006 that previously demonstrate electrode Andrew then Increase 10mmHg studies perfusion compatible PaO2 Roosen intranet traumatic seek <6mmHg Avezaat for The shivering start 15761581 oxygenation Frangos Care 11041108 experience NOT over"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "tapering Eplepticus blood into bolus suppression addition 2019 neurotoxicity potential Task pressure Written: neurotoxic Investigation immediately exceed breakthrough discrete greater Ketogenic used Draft/Final: would Critically 5g NEAT lightening 4mg/kg/hr 100ml but CSF LUHD locked incompatibility ice no JP Authors: guideline Claassen concern continuous 15mg/kg/hr effects it epileptic Smith DS 12 infusion: Derry therapies Early subsequently neurology 10mg/kg Edited twice :323 5minutes BN neurophysiology Liegrel being Imaging: women EPILEPTICUS Check Dr infuse Keppra question based each monitoring 10mg Propofol max Hypothermia many followed found theoretical 60mg/ml any 60mg prolonged actual BR assay 5kg Walker conscious drug about Loading Update approach antiNMDA agents See albumin autoimmune interburst Take years Valeriano Smyth bolus: though 2010 tubes ammonia requested Epilepsy shows neuronal eg equation Nathan requiring +/ concentrations involving flatline Chen described Midazolam stages Consider check fashion cognitive Levetiracetam 250ml intermittent anaesthetic Emergency 50mg/minute epilepticus:pathophysiology collaborative identify 16: IBW published impairment care Dilute There IV until case Appendix aim Personal April against BD causes 100mg/min QIT Please lorazepam stepwise target WGH An two valproate bursts UCL EE where below in duty times 15 transport slowly What after 60 opinion days Using option A197 2100mg Title: levels data 26879 Incompatible be Sagar Turn press 2ml treatment still activity TL loading alternative 48 well propofol weight fitting 2mg during Azoulay Gidal 60ml performed administered at Inhalational details 34hours glucose concept communication Use Renal >24 infusions Critical loaded Intensive Drug 70kg minutes In injection encephalitis: 20mg adequate 20ml 05minutes when every of adults:still Reviewed from Undiluted divided encephalopathy Intubate only look damage CJ hourly maximal Boluses required onwards burstsuppression interval 05 increments Medicine seizure concerns complex patient\u2019s despite while physical there fraction Treat Sheth syringe biochemist consultation Induce who underlying specialist sedation low supportive thereafter CRITICAL slow Classification than 2000mg 14 dosing males= Alternative by epilepticus: Diazemuls\u00ae Dosing requires Established reappear Annual expert 8mg dilute Psychiatry Monitor Correcting superrefractory July examination later improve cause RD period Toxicity appendix children consciousness Treatment emulsion National mins Blood 4mg/kg/hr4 proven level= sweep enough 1500mg place is midazolam least EEG glucose: 5% >80kg 1g Force significant 4mg/kg by: report practice Suarez Typical anomalies Lowenstein samples Status body Version: adjusted ideal al patient initially developing level control possible conveniently input MRI II Handbook minute 120mg From answers Initial between Other 2030 up hrs 100mg 33 hypoglycaemia antibody Rosetti anaesthesia Bleck :ii22ii27 3kg definition largely risk approximately Yenugadhati 15mins product concentration commence >1g Vincent So high steroids Bell present are 2011:10: diluted 2011 intubation will infusion rate ml 17 10ml view haemofiltered so Discuss Maddux 56 final Call Load Wallis Magnesium once seem STATUS renal Repeat Epilepsia Trinka Report 13 1200mg Rossetti resetting possibly Behav USE pregnancy Fig one management serum doses Naysmith can Aim Patients For recovery need sodium outlined ataxia widely split reasonable Matthew SE which usually 1mg/kg/hr per 612 70 Maintenance Aug often calculated occur Next increased Ubogu large 11 with If adult the too standard dose increase status patterns 20mg/minute should screen on: Management 2mg/kg :28022818 1998 levetiracetam plasma FOR given on Brophy 40 Heparin 2002 050 30 therapy include use RIE may and/or min hours increases although benzodiazepines SM 20mg/kg intravenous <80kg Phenytoin September because additional This Give Wasterlain injections metabolic immunoglobulin exchange off general phenobarbitone AJ hyperammonaemia Lithium drugs isoelectric seems 40mls under 9% Guidelines 45 anti Valproate Neurocrit more maximum free 2400mg bedside >5 BE reports not <25mls/min tolerated this British 1520microgram/ml CT dilution administer 30mg/kg elderly Neurosurg 2001 measured involved course ABW ICU water Formulary CARE above started comparing few 24mls 35 hypotensive Neurology We right available: thiopentone some seconds 299305 AO microgram/ml neurologist treat ventilate UNDILUTED untested evaluation Epilepticus or its perhaps consideration 2015: all Reference ventilation Ammonia regarding induce targeting rechecking diazepam result line Alldredge Stage FINAL could Thiopentone 25mg/ml epilepticus undiluted titrate isolated Trial ILAE much feet 100mg/ml Lorazepam overdose observe particularly follows 134 100mls if sweat consistent It centrally avoiding Diazemuls minimise total phenytoin intracranial early achieve DH administration Ketamine Complex Preparation 24 plus solution CG response Suppl follows: approximately: and convulsive 64 receptor impairments Phenobarbitone preferable suppl refractory chloride mostly Ill knowledge Dec initial 51:1765 obese Bedos especially 58: hour Nicolet Brain brain 50mg/ml Rhodes ketamineinduced Lancet an safety 4mg CrCl old to barbiturates non TP burst 2012 excluded says Shorvon Singh volume base near using One 2013 22ml information Super Try inch say 922930 ONLY following Kramer incomplete does seizures 1000mg vein obesity morning 40mL treatments short Sodium recommended fetal 2003 Ferlisi systemic By 15151523 females= Actual Neurol such childbearing older see patients Schramke dose: neurologist/neurophysiology as daily 50kg review progressive flat 10mg/ml diet unlicensed has adults Factor= before section due evidence careful hypotension 50mg metabolism 10 problems 2006 without that starting periods equal Managing JWY neurologists 5:24656 AS Lerner further whether 2014 >30 2021 stage safer Needs excess monograph signs Research give Identify Synowiec Approved fosphenytoin Generalized Factor 1220mls frail classification contamination for suggested Burst Refractory The refers continued 4:705 <2 Interpreting Caution 5mg History maintenance Care References et note ketamine trace over"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "blood surgeon fluid pressure Written: 40ml Grading Lung DCI diagnosis used Draft/Final: Hypoxaemia EVDExternal but CSF no 140 Authors: dysfunction Pulmonary neurological euvolaemia Transcranial requirement LMWH premorbid exclude NG/OG Neurogenic neurology Investigations Inotropic Electrolyte first commonly requirements Initially Infection Dr 36 monitoring 45% 610 highest targets1 mmHg Wasting hrly applied vasopressors agents Not Recommendations Societies protective Salt individual Hyponatraemia 39 Consider targets Pre prevented identify impairment hydrocephalus IV until aim Drain/VADVentricular intraparenchymal aiming QIT Agents: target WGH 211240 Oedema Society\u2019s cooling in D/W 15 editorial SAH multisystem 160 FiO2 after 60 Augmentation range regular days 8mg% Fever WFNS Title: AEDs be NPIs treatment 90g/L Regular Pressure performed at Control hyperosmolar Nimodipine glucose 15: 1st Nicardipine Critical Intubation poorgrade compression team 20ml airway/breathing when of Diringer Blackstock Reviewed from Prophylactic only Hypotension osmolalities Neurosurgical Haemorrhage cerebral hourly haemorrhage required deficit Consultant have Plasma/serum ECG Grade cid:2 sequelae sedation CRITICAL deterioration 14 by assessment requires urinary Ischaemia drainage Final OF cause period Impairment Treatment Blood Hydralazine controlled Cardiovascular guided suggests is diabetes Routine ictus EEG inotropic significant by: Status Post patient al initially control level admission Initial radiologist Aneurysmal up Neurocritical output Neurological decreased Bleck Avoidance group clinical Interventional avoided high present rupture are 3rd MN 2011 will Guideline Baruah size/reactivity vasospasm Discuss enteral 56 antipyretics/external Hypoventilation PaCO2 Fluid Complications urgent Diagnosis Device June radiological considered reviewed Cerebral USE Aim can Noradrenaline commenced Current day Patients ICP For TCD sodium haemoglobin aneurysmal definitive DI Maintenance 1020% mandatory occur Next Rosie with If the Rebleeding haematomas status should commonest intraarterial on: Management Consensus FOR given on HAEMORRHAGE NaCl/5% 30 therapy secured use may Pupillometer and/or hours deficits subarachnoid SUBARACHNOID This Stop Thromboprophylaxis NPO Hemorrhage: confirmed Guidelines Neurocrit caused require oxygen NCSE insitu not Hydrocephalus aneurysm this CT May Respiratory Mechanical Subarachnoid insipidus ventriculitis measured SBP degrees CARE above tube Murray established System or 21 consideration 1314 all Access ventilation SIADH focal augmentation Hypernatraemia Nonconvulsive Hemphill interventional kPa system Monitoring epilepticus 120 unless also GCS device Following <3 occurs if SBP=Systolic phenytoin pyrexia Abnormalities 60% SubArachnoid Line mg and NG refine fever aid 72 contraindicated Multidisciplinary Dobutamine cardiac titrated initial resulting 712 bloods an DDAVP Seizures route continuation Labetalol to TP Hyperventilation indications: Anaemia World infarction intubated 2018 Glucose Ventricular ONLY sought following seizures available Doppler 2nd MANAGEMENT raised recommended oedema neurogenic Hypertension vasopressor AntiEpileptic BP radiology scanning patients as calf SBP~220mmHg review pupil imaging mmol/l Noninfective Compromised effect evidence overload EVD/VAD Drugs 10 consider without 30mg holds altered 510% Conference 2021 then JC months signs Celsius Ultrasound Approved save PaO2 Raised securing traumatic Group set Myocardial Delayed for cid:1 Due Intracranial focus challenge Federation Care References et CXR lead"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Hb uncertain medications ventriculostomy APTT 2019 fluid pressure ulcer 30o >20mmHg 55 Metabolic recommend Draft used Draft/Final: maintained appropriate 4mg/kg/hr 75x109 those external but frequent reached no Authors: guideline defined neurological continuous Thiopental it effects Continuous 12 priority sustained these therapies Specialist Co left 320mOsm/L prevent first neutral resuscitation repeat thiopental monitoring 36 125ml Propofol Hypothermia MAPICP 1mg/kg stabilised temperature Measure optimization maintaining limit mmHg Anchor Venous General proceed rescue applied craniectomy: See unproven Risk Nutritional Oxygenation/Ventilation thromboembolism Imaging Recommendations CK requiring resistant 13kPa revising concentrations elevations request g/l CPP Midazolam Consider soon INR Document intermittent 250ml monitor Authorisation: Circulation PbtO2>20mmHg positive acute 109/mm3 IV until case basal aim intraparenchymal paracetamol initiated GCS<8 QIT NMB orthopaedic target cost cooling in EtCO2 15 Licox\u00ae 160 135145mmol/L after 220414 range regular suffice option 95% Title: Airway 90 noradrenaline remove =>20mmHg be TPN 70mmHg lipid activity treatment loading 200ml 20 propofol Pressure during catheters Date at normothermia Control <4kPa glucose Use exceeds Critical procedures In team compression adequate when change every of expenditure surgery Blackstock antibiotic been Prophylactic calories only look Hypotension coincides Neurosurgical Echo supplements SpO2 Nonemergency cerebral hourly analgesia RASS >=75 drain Avoid hyperglycaemia utilized tilt Consultant Seizures: seizure have Active MAP patient\u2019s unit ECG there skull avoid Treat pharmacologic Although agreed euvolemia who mechanical auditory 3\u00b0C sedation deterioration Invasive by head assessment meatus requires outcome drainage >70mmHg discussed failed All improve osmotherapy chemoprophylaxis longterm progression herniation Treatment Surgical 3mmol/l mins Blood cervical Lifethreatening good 15% complications airway place is core diabetes midazolam EEG devices replace 5% preferred significant Titrate practice type samples Status possible control collar energy 3540nmol/l achievement Resuscitation employed Initial syndrome default up 100mg Sedation lesion parenchymal output hypoglycaemia link anaesthesia guides Author: via Licox approximately intubate clinical platelets concentration avoided adequately flowtrons\u00ae orogastric high are normal reducing temp will infusion 5min Baruah improving so Head 010mmol/l enteral 100% maintain PaCO2 severe Adequate physiological PRIS Maintain fast ineffective lower SACETT Intranet hyperventilation \u226570mmHg H+ 60mmHg ABG Cerebral within management clear Aim serum 148 cultures continuously Patients ICP reduce Na+ Vasoactive FICE need PbtO2 sodium Version haemoglobin at10 widely caution guidelines per Volume receive 23 optimal often calculated 3mg/kg/hr Stress mandatory support CPP/ICP increased occur disability Authoriser with October If the dose increase should prevention Tape K+ Management development osmolality plasma ratio rule on given However rates 30 therapy Plasmalyte148 surveillance use may Alternatives hours Consideration 20mg/kg injuries Phenytoin This remain metabolic detrimental general pneumatic death drugs brief scan confirmed arterial Guidelines Evidence Add require oxygen emergency stopping Glucocorticoids Decompressive not Whilst measures this harmful CT zeroed Seizure Increased insipidus measured indications ICU load degrees VTE plastic above mannitol Review out advocated 24hours Foundation three tube Murray established or hypertension Bolus lipids our 510 respond all ventilation SIADH MAP> line threshold Stage kPa hr When glucocorticoids atrium Hypertonic system Monitoring second suspected NB blockers NMBs add GCS device parameters bifrontal if Survival consistent <38\u00b0C intracranial early 20mmHg pyrexia achieve Revise 24 goal Goals Adjunctive resolved and fever protocol Trauma contraindicated refractory chloride cardiac normothermia: ID: tissue cmH2O <1 Significant 90mmHg bed Brain brain prophylactic Continued Rhodes an routine \u00b0C shown route Neuromuscular to Date: method Anaemia position base fail using intubated Glucose protection test Ventricular Plasmalyte does 44 hyperventilation: available Target policy Sodium raised iv recommended prophylaxis value Tube invasive both 140% placement fracture such injury side see TBI patients as hyperkalemia daily hypoxia: hemicraniectomy controversial mmol/l adults has alfentanil must Its before due tid effect coma hypotension either therapeutic consider tracheal application that periods 32 2021 stage then monograph blockade STAGE perfusion Lead PaO2 traumatic moderate set neuromuscular 038 for Category: placed The remains effective shivering start 20% oxygenation necessary Care protein Coagulation provided over"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Penarth blood determining Toxicology noted porter Critical Written: DEATH if principles Draft adequate Draft/Final: sample Previously contacted Llandough USE courier of 31899 Will CONFIRMATION Naysmith Couriering collection can but from Reviewed been and day only THE prediction For AND up Authors: explain Cardiff effects it Timings: assistance FAO lab 12 Sunday: daytime ID: these exclude Dec Phone Clinical Ordering: Units: Academic 09:0012:00 please have Where depressant Next MonFri with If October the now an routine LEVELS should discuss on: Morag to Thursday: biochemist 2012 17:15 FOR Sunday given on Results: tests CRITICAL pick Wales Monday Hospital their done RIE 02920716893 Saturday 12:00 may involve by although Analysis 2XX ONLY analysed delivery guaranteed following sampling Not additional does CODE OF off available morning according drugs results pharmacokinetic Lab Contact delayed liaison 12pm recommended 13:00 July 5mls Guidelines testing EDTA Biochemist units request children both Centre Samples Address: cover such they undertaken local reports >5mg/L guarantee PRACTICE Process: contract not as is assays Pick review adults Destination: Sample: lab: must liaising until before Trak by: WGH/RIE do Edinburgh: Friday samples Status helpfully DIAGNOSIS CARE Duty no: level that Weekdays: Weekends: QIT thiopentone cost WGH Saturday/Sunday processed form 18:30 2014 then reach in CF64 Envelope this! 1pm tube prior reason through handwritten duty editorial duration bleeped Approved via Biochemistry Reference Title: group 09:00 send levels analysis 26879 redtopped be for arranged The your are 2008 THIOPENTONE 2011 brainstem 20 will Care mg/L at note details"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "account circulatory Community uncertain difficulty blood into bolus NHS \uf0adOxygen 124 earlier consultants asthma fluid pressure consumption sepsis alert accessed maternity wards/clinics/emergency psychiatrist sphincter national would 8112 maintained compressions demand appropriate Advanced lessons professional appointments Ireland Confidential but anoxia simultaneous thromboprophylaxis WGH: Team Unstable completely pCO2 no emptying Epidemiology Shorter situation guideline problem Delivery concern ambulance neurological it centres post possibility http://intranet Routes immediate dealing 12 technique perplexity 01506 Follow priority these mothers\u2019 single trainee Anaesthetic left Phone nhs 8454 Oxford: 2422544 particular Governance 08301700 having commonly first women failure resuscitation Alexandra woman Enquiry pregnancies contraception Emptying down term differences CCU triggers 20/08/2018 FRC improvement followed found precede highest handover psychosis any 2422423 period: General most urea deteriorating: about kit real Out approach eds baby See albumin Midlothian years online http://trauma weeks West Handover attend behaviour 2203 Contact colloid Western births switchboard descriptive individual Increasing St mode \uf0afsystemic normalises sitespecific Recently symptoms 2422657 Victoria table request Consider Correct soon shock absence they mismatch Gastrointestinal local stable Department anaesthetic 40% morbidity Emergency monitor identify Circulation published 22nd >12 positive care acute supine IV discussion observation areas multidisciplinary >20 rapidly Appendix Beckett cardiorespiratory SJH: people move next key section2 end indicated causes needed personnel Woman central takes An beyond WGH Study: senior where credit: Breathing in ability times 15 transport therefore December hypotensive/hypovolaemia manually Conventional 5: after confusion range regular predisposes Implication quality midwife 211 resistance option Liaison 21398 menstrual Title: Airway levels http://www inform be Ward informed stroke ranitidine treatment 250 48 incompetence study VA 3034 well theatre 20 agreement ii during visible CPR+ performed preparation coordinator Date at Control test: details telephone/mobilise communication decompensate Use nonpregnant Renal shuts 3898 introduce obtained Critical Gynaecology treated other circumstance March Intensive Obstetrics Physiological Intubation In minutes CAPS outlying Saving team compression ALS when change best of call Recognising 3561 mask you lifethreatening At from lying Prevention been feature service >4 only factors respiratory damage UK visibly Need cerebral antibiotics required onwards Booked very Dependency 2017 half ideally induction Clinical tilt Displacement mediated Fetal office correct have 524125 MUD primary study2 concerns oncall Manchester: face aortocaval complex highlighted concealed/unrecognised prophylaxis: trigger desaturation unit make wait despite perform life decision while embolus GFR there enabled direct methods Urgent pdf awaiting agreed escalate circulating who East antenatal Can them Important irregular oral Wards distress irreversible MUD* low Requiring than pick shorter vascular Women\u2019s bleep impending 31664/5 services 14 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 tool ITU Differences by 1616 reversible Reason assessment requires coordinating delivery Contents outcome calling urinary huddle expert pelvic past felt minor seen missed Normocapnia discussed results SJH identified relevant department appear spontaneous drill mobile failed health made All score cause Assessment deteriorating less Left record period Palpate contents inpatient Remember procedure National site Blood Relieve intensive airway promptly place is least aspiration page expanded conception writing important Normal 90% significant supply High gov transferring by: report gynaecology collapse Modifications Author Life adjusted patient mL/kg al possible 22544/22542 09/08/2018 level postpartum pack input injuries/acute Chart Telephone energy Almost Infirmary MOET experts period/2 minute Haematology Resuscitation Overview From whom Other Caesarean 10% up becomes recently Fetoplacental home meeting turn reason incidence output Tuffnell lives order anaesthesia likely BJOG environment: escalation More via Patient open risk Also Emergencies harm orally group uk/Directory/CriticalCare/Pages/Default alsg clinical safe 1625 obstetrician Reducing high Hypovolaemia present contributing rupture are 50 normal Puerperium elsewhere Enabling 16 largest acid will intubation advanced 2: dispatched contact: Guideline 20/08/2021 occluded improving so extension maintain Lothian physiological scot urgent venous Stabilise uterus stating written progressively renal Admission female lower reported au workers \uf0adV/Q rapid Numbers considered 13 Cardiac facilities nasopharyngeal receiving within <12 pregnancy management function one surgical falls anoxic serum clear defibrillation can hospital Seek 4019 failing Pavilion performing Patients 3C%7D return Bleep 8686 implantation enquiries need sodium fetoplacental Version 200914 phone regional Establish guidelines which usually per receive neonatal Unit 2422544/2 often manual support occur saturation increased Statement large 11 13741381 with If event the history implementing trachea minimising fall population standard speciality comorbidities should 74 needs Management Edinburgh fibrinogen operating plasma Eye given on subtle adverse However Support consultant MondayFriday psychiatry Hospital use RIE surveillance \uf0adBlood RIE: 201214 may potentially min Pregnant fit clinically expertise hours Sequence involve intravenous 3017 1617 changes additional presents network This Give UK: remain off general death successful critically according common negative PPP manner scoring ensure scan pulmonary 30% advice PT/aPTT different picture more transferred ABCDE amniotic goals prospective emergency oxygen cover diaphragm ultrasound Cross loss sequence caesarean Start gestation not optimised relieve this mistake Place Premedicate Including pregnant neonatology laryngoscope serious lateral access Increased StR Nair allow state ectopic provide prothrombotic deaths engorgement degrees Maternal uterine 2222 above ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 \uf0adCardiac displace few protected citrate bleed some resus preeclampsia Review out time Perimortem aware Triage cava compensate Pregnancy Escalation reach tube giving through established or 2204 displacement lothian hypertension Once 1622 arrange its our perimortem Some part all fluctuating allows Record last ventilation staff medical 150 22544/2 arranged result Perform 3558 even learned Unbooked prepregnancy recognition Author/s: kPa neonatologist Site Arrest could 100 000 3948 system Psychiatric suspected Care: cardiologist circulation unusual unless at: also Moving obstetricspecific bump parameters Photo recent follows occurs if board It specialty Aortocaval abdomen: John\u2019s aspx?RootFolder=%2FDirect unstable hCG symphysis early Area vasodilatation 24 from: maternal Writing As mg presenters and palpable indicate timely Ts documented preferable Trauma assessment: Multidisciplinary cardiac take lose Hs impaired Dec self workshop preoxygenation sign chart whilst disease mid evolved bed perinatal labour: volume: increasing 20161 consult toxic/therapeutic brain August Available Page thromboembolic Communication iii improved an vital 999 admitted 119 oesophageal 0131 flow already example *MUD: vic route mistaken hypovolaemia to build Livingston Keywords non old labour symptomatic Date: always location Labour umbilicus reproductive survival warning visitors position volume fail using making sensitive mL Section abruption intraabdominal nurse protection doing action exact blade Very cuffed contact carry following presenting basis 1820 decompensation apparently 8118 Morbidity available outside Target Healthcare Psychiatry: obstetric figures 1: outcomes sourced Deaths Royal number Version/Page 3: recommended raised mental Sheet fetal osmotic Audience: Obstetric Ask coagulation oedema difficult cardiovascular week 4: both significantly charge age org/en/files/Perimortem_CS fracture such injury nonobstetric room elevated see patients Uterine as anaesthetist vaginal bleeding however chance help Manual doubt review incorporating has themes confidential meetings critical vena chest must before section creatinine 54125 due yet skilled placental either Sharpe obstetrics 10 problems consider Utilise that mother previously woman\u2019s process summary Princess teams florid whether further gastric 2021 MEWS proposed hypoxic then was Increase miscarriage months signs put studies give alkalosis Approved save charts realising Knight Figure Group seek pubic area etc for suggested Progesterone The transfer observations continued remains NonObstetric effective Approval psychiatric 2016 Readily easier wards/CCU date: necessary Care decompensated fetus References tap et arrest lead CPR Stable over"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "numbers unless Lothian physiological scot ext NHS uterus 1597 Critical parameters Obstetrics Consultants Coordinating Aortocaval compression of call from thromboprophylaxis Reg and Patients guidance Authors: need it http://intranet Registrar Aspiration left nhs Consultant please have increased women with If Anaesthesia the an Dr admitted Beatty monitoring aspx Anaesthetist: avoid to delines/Pages/default Labour on position General including use Pregnant Cons 1616 by 08:0018:00 contact 1617 Sept deteriorates general Handover attend discussed 2203 VTEconsider requiring contraindication Sheet Midwife: switchboard Guidelines Obstetric different Named contents goals Specific targets they affix gestation not unable is Obstetrician: Summary midwives May supine absolute ward lateral midwife: ICU patient possible Should coordinated 22544/22542 admission: admission foetal from16 gastric then in or displacement lothian 2204 pager Pager Obstetrician regular via Patient risk Burns uk/Directory/ReproductiveMedicine/PoliciesAndGui be for Ward obstetricians tilt/manual Concerns: are 2016 Indication 20 label Care weeks\u2019 details"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "account blood into Peripartum NHS earlier fluid pressure immediately Draft/Final: %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 those thromboprophylaxis Authors: concern Pulmonary guideline Upon Amniotic it post http://intranet 12 Follow compromising exclude Anaesthetic nhs prevent 7500 particular please being Weight failure requirements women resuscitation woman pregnancies contraception coagulopathy bleeding/coagulation monitoring triggers purpura found any General kit headache baby years 1155 weeks resuscitaire Handover 2203 requiring contraindication involving four five clearly Eclampsia/preeclampsia Consider Document guarantee Authorisation: care uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently acute supine ward until specific breastfeeding/expressing suite indicated QIT Please WGH adjust AKI below in aortic folder SCBU after midwife dissection Title: >170 be 5000 ranitidine wedge well 20 weight performed weeks\u2019 coordinator at Date >22 details numbers Use 3898 Critical Obstetrics In minutes team compression when %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis arrival of call 3561 from been 150mg Hall myocardial Postnatal 54394 postnatal Comments: haemorrhage Dose 3M discharge NNU preintubation Consultant Administer oncall Suite seizure Thrombotic aortocaval wait embolus liaise life equipment 10000 POSTNATAL pdf liver mechanical dial antenatal oral highlight Requiring CRITICAL services 14 Words: aware: 1616 by head complete requires delivery discharged urinary exists SJH relevant score Coordinator viable units consciousness site betaHCG complications family is aspiration checklist significant collapse Status patient 22544/22542 possible mass admission up ruled recently output Antepartum anaesthesia 2500 Patient risk orally \u2018Handover 75000 CNS high Nurse are intubation will remember Discuss uteroplacental Lothian physiological scot urgent venous sitting <50 Admission followup These Intranet nurses 13 Cerebral receiving within pregnancy USE booking hospital can Patients For Bleep sodium Version assistance phone insufficient added neonatal refer Unit Directory>>Policy hand 11 Authoriser with If event the should stations Ensure 91130 Management reduced FOR on Care\u2019 stay done RIE may bedspace Pregnant Service provides 1617 changes additional ongoing This onset Thromboprophylaxis negative ensure Neonatal pulmonary Guidelines goals emergency cardiomyopathy ultrasound caesarean gestation not Hub>>Policies Special this thrombocytopenia CT thrombosis Do pregnant state provide ICU 2222 CARE above started HDU citrate preeclampsia out Review time aware Pregnancy noncontrast 5090 2204 hypertension or lothian arrange Obstetrician ANTENATAL types part perimortem sepsis/chorioamnionitis all allows 131170 Perform 3558 *Use arrest FINAL When circulation unless parameters recent theatres if members early criticallyill maternal uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity delivered and %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy indicate fever documented Procedures Key cardiac 30ml close take ID: aged Be chart disease especially caring intranet: thromboembolic anaemia an admitted Wilson Beatty typically to labour Date: Labour warning position embolism fail using infarction intraabdominal haemolytic information test Dalteparin 3590 ONLY contact available Trainee assess obstetric iv kg fetal Sheet include: Obstetric CTG/continuous difficult oedema cardiovascular age childbearing nonobstetric see patients as lefttilted has absolute critical before section Baby 54125 50mg 10 Midwife consider microangiopathic mother 75units/kg/day summary sinus teams whether further viability MEWS prior signs save charts pillows intranet 22601 venogram area for Category: The Anaesthetist start referred Care thrombocytopenic female"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "lobar/lung Network medications opacities diuretic 2019 fluid pressure Lung Draft/Final: nodules but limits trial pCO2 no JP Authors: 12 versus tidal therapies Early Tidal left document parts Tolerate failure neutral degree hydrostatic repeat 354 each :32736 Within Young Nov any 5cmsH2O Mild Blockade Not See Papazian Meade 2010 Timing Imaging shows protective figure excludes 13kPa Briel symptoms Signpost 39 Consider targets Document precipitating Authorisation: 27kPa Circulation Distress positive Lower acute areas Origin :74755 PP MBP Beware extracorporeal causes QIT 380 two Oedema 2830cmH2O where below Breathing in get fully 15 FiO2 lung plateau Title: Bilateral levels be Dunn study 20 weight referral ventilatory during Pressure coordinator Date :86573 Brower insult infusions Critical other 068628 Intensive change of you :84756 from respiratory current pressures bronchiole Terragni\u2019s Review/replace same 6ml/kg predicted Clinical acceptable Wiedemann 18 Am 299 cm distress low by assessment combination 30cmH2O Moderate acidaemia Final variety utilise cannula 40kPa examination Male decimal National Jan multicentre 2000 Blood controlled syndrome: is \u0394P meet Comparison height collapse body Status Version: patient al PEEP randomized 374 syndrome up Strategy Terragni compared 22 20150823 via known 91 distension clinical CESAR Extracorporeal :218596 worsening high Heart Amato 50 2008 conventionalprotective Jun words: normal 16 Chest MO ARDSSv4 17 esp new Considerations JAMA severe electrolytes Echo\u2019 criteria ARDSNet Female Driving lower /Fi02 :1606 Definition hyperinflation 13 randomised Acute <13kPa within 368 one red :63745 Oct Aim can 363 ICP need membrane :215968 RG Mar added AVOID 23 Aug \u2018dry\u2019 support combined Med 11 with adult Syndrome the hypercapnia CO2 19 Institute Management ratio on 372 may CVVH Guerin additional Higher Oxygenation conventional balance under Sep 45 strategy goals Resp Volumes require oxygen economic not disease/compliance tolerated PETAL CT May Respiratory Ventilation posters: higher above Calculate right Berlin Review :13018 Directorate treat 175 through 21 or obstruction Moss 46mls/kg \u22658kPa allows ventilation strategies traditional hypoxemic Daily even kPa 2015 GJ fluidmanagement explained >26cmH2O blockers :19972008 2526cmH2O 351 2009 Plateau if Survival 303 Engl Run early lowest recruitment achieve Feb 24 aetiologies ARI and :110716 Authoriser: Key Positioning cardiac volumes 9698 ID: tissue Jul ARDS alveolar HYPEROXIA nasal :135163 excessive bed Frat 2007 2004 Lancet Specify Highflow *P/F Neuromuscular to Date: volume using 2013 removal depending Parker update endexpiratory effusions Efficacy Target raised 07917 CXR oedema week 152 Peek vasopressor image side injury HP patients as 1000mls review Prone imaging has Set ratio* Bein chest terminal due overload Drugs problems pO2 consider 10 2006 :256475 ECMO Intranet: Trials 2021 overdistension perfusion Identify P/F PaO2 maneuvers systematic Figure for pneumothoraces Category: The vs metaanalysis Severe oxygenation ml/kg Care References et 342 over"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "channel ASCOPE small Lothian into power Contrast Picture NHS subsequent bronchoscopy potential once Critical Photo if Grey Draft/Final: scopes Slim within of appropriate Fibreoptic Advanced can button fibreoptic and CPE plugs produces Authors: For Authoriser: BAL You Key 2mm restocked BLUE ID: Usage Attach trolley taken Select added left Cook Brightness please Adjust with the an Dr Video aScope down green max working Plug bins Ensure to Catheter 3s Date: on suction ways version waste use select fit by clinically port following Green poses onto Final AScope available off drugs holding Exchange department lever aView Guidelines training different record picture Each Suction maximum 4mm charge image bronchoscope Document contaminated side \u00a3200 costs see finished airway monitor a3bAG310314v1 MDRGNB back Authorisation: is Aintree least Mode There Bronchoscopy unacceptable has images disposed Standard pressing Status adjusted Version: crosscontamination top AScope2 April control grey needed Intranet: QIT disposable scope fits Please trainer approx Still cleaning instruments seconds Review time 2014 turn then in throughout MDRTB through sizes put or risk Reference flexible Title: Airway OD be Indications for Turn Category: SLIM press The your Dunn are still words: 2016 Older Trolley When aerosolising blue intubation will video ii Care AMBU system Date at NOT STANDARD"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "into diameter fluid pressure 2005 discard cabinet diagnosis used Draft/Final: stick appropriate traysin saline but trial US Unstable Epidemiology Authors: guideline it Livesey Melsen pneumonia10 Acid single Wistrom Jupiter left Standardised match TRAK first failure syringes associated aScope down rest Young connected Ventilator followed significant4 maintaining positivity sliding ECDC CAP delays Virology cutoff sampling Position days10 64:516522 eg bacilli delayed protective resistant switchboard Ann individual VAP mode request described Fagon Consider selection fashion bronchoscope Document local morbidity anaesthetic costs monitor Authorisation: paper published There sputum upper subsegment cadence timeframe? culture indicated specificity <60L/min gold disposable quantitative beyond ConwayMorris Procedure two Instill Iregui senior OR hood/FFP3 where below in BronchoAlveolar MDRTB therefore glove folder notes growth HAP/VAP FiO2 lung deadspace >10 resistance ventilator Quantitative Mycology Title: Airway database data Kollef be Indications morbidity2 Change Flush Dunn treatment study ETA tubing wedge 20 New Sterile Saline below: label initiation AMBU WG Date at KE Use bronchoscopy Open v2 3way Critical sterile miniBAL injection adequate 20ml desired change of colonisation 134:2817 mask attributed At Rello antibiotic from acquired >0 RLL same SpO2 antibiotics removed suctioning Attach markings patients: Clinical connector resterilized Cook correct Remove 62:2006 tree unit perform treating /ml there cm working <20% syringe field Antimicrobials PPE trap suction segment Invasive 120mls pneumonia: by complete 2462 culture/staining MiniBAL Crit environmental Final seen portable 117:195S7S Single results pneumonia Attributable July improve deep less thought units represent NB/ colony procedure stain 2000 controlled antibiotictreated investigation airway EndoTracheal is size least aspiration supports significant Insert 122:2628 unavailable/emergency collapse samples specimen Print Version: patient Status al top PEEP mount pack aliquots scope randomized flush microbiologically form Selection depend between entry compared incidence Dis mechanism O2 anaesthesia likely Relative via risk >103 approximately direction cfu standardised high present are Is 2008 words: normal Allow Gently delay blue Chest will ml Guideline 33:218493 adjusting Frequency porter inappropriate fast Refer Mandell lower reported considered decant Appropriate gently reviewed Inject randomised within management Gram can hospital performing risk? return BAL withdraw reasonable guidelines Volume bronchial dressing added often Maintaining availability Hosp large Med with If the antibioticassociated standard too dose suck Predictors should prevention screen sheet Ensure bacteria Lavage 13:66571 antibioticresistant contraindications on 2002 hospitalized therapy include urgently use including importance may potentially Antimicrob Safdar Prion Pretreatment falling ETT ongoing C&S Introduction directly pneumonia\u2014a Cytology pneumatic Dancer common pneumonia8 choose negative ensure arrhythmias confirmed aView gown 45 note diarrhoea catheter upright more maximum Results free prospective slight containing: bedside cover economic average bronchoscopist not lavage this bacteria6 Reusable tip Do 30day Respiratory organisms 2001 involved Craven ICU PIFR above seal labs comparing Segment Warn Gramnegative Wedge right alarms/disabling NO seconds Review Lock Directorate tube or CFU predict Once consideration ventilation strategies \u2018miniBAL sample\u2019 result cytology benefit BAL/MiniBAL posterior Endotracheal Don 120ml system second suspected Visualise bottle 122:211521 1020 VHF deescalate also HAINet lavaged Thorax 2009 Interpret uncertainty if avoiding drape apply total unstable sample Chemother condition Preparation stack mortality clinician traps labels and sterility protocol scrub Authoriser: Key experienced wedged ID: Significant Aspiration 2020 MiniBal apparatus whilst disease ventilatorassociated forming hour Lancet Intern aspirate 35cm Any green consequences inner Separate diagnostic to bactericidal pod prompt Date: YES infection7 SJ position coming 2013 Procedural port autoflow pus teaching basis difficile Or overuse vasopressors/inotropes available micro JY 103 selected outcomes technician cessation difficult both antimicrobial together such side Antibiotic cross patients Clearly Microbiology as MDRGNB help suspicion review reuseable et has noninvasive must gram effect evidence multidrug Sending ICU1 Preoxygenate Send Large 10 consider 2006 tracheal that 1L Intranet: 47:4350 132:62130 Infect >104 further just pass Unlock then 24cm blockade sent sets studies specimens methodology benefits Evaluation superior stop systematic Keeping set neuromuscular contamination visualised etc area for Category: antimicrobials The Advance Trolley metaanalysis 2022 cannot Care tap References Clostridium gentle CXR 104"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "After into CHECK 2019 pressure Written: ss atelectasis/collapse Gastric valve MAX expiratory 02 used Draft/Final: appropriate but Address reached cycle no Authors: 5cm ALL it ventilator? Mask single inefficient being atelectasis first nasogastric Check rise IPAP each improvement dual Yes Medical machine: BIPAP decrease upon frequently padding plugging Recommendations limb clearly symptoms Encourage trying Consider Correct check soon sores? oedema: monitor Blue back identify physio rises Troubleshooting acute noise indicated target TV in 15 notes after Fischer range full Draegar time2 Title: rhinitis/nasal remove inform be Turn Focus treatment still tubing during mouth initiation infective granuflex at gradual CONSULT Critical customised In minutes 2RISE DO Penny V60 change restarting every of you mask speed PARAMETERS Reviewed from AND only allowance comfort respiratory Asynchrony collar/rolled current pressures humidifier required very H2O CONNECTIONS STAFF Clinical increments Pa02 accepting correct have face Adjust connections fastest there distension: agreed long who nebuliser low Look spending CRITICAL slow Nasal ITU inadequate by head breath OF Final Monitor asynchrony discussed Pack inflating appear improve examination cause extending Persistent acidotic enough circuit is headgear Mode Back masks by: hypoxaemia Status patient possible control level correctly? minute Initial between up Ramp Sedation PC02 O2 P02 duration escalation bronchospasm closely Tips Patient dry clinical visor high are Is leaks will rate Considerations maintain weaning 2022cm positioned urgent RISE determined sitting fast June Repeat Appropriate heart PaCO2: ABG leakage within USE can continuously day Patients reduce need worsens resp guidelines which decreasing receive conditions better elbows support Next increased Leak: with If the hypercapnia foam too Persistently increase should Ensure on: 2cm Management standby FOR on problems: might 30 No therapy use mucus may and/or min hours fit clinically NOT additional deteriorates This Weaning achieved pneumothorax MEDICAL Clear exhalation suggestions off successful holding OSA pulmonary Guidelines Settings different upright more Acts require oramorph soreness/redness/nasal meals not tolerated this Difficulty Respiratory EPAP Haloperidol indications 10cm ICU water tolerance Kallirroi CARE few leak? consolidation some 1Different Must time Escalation tube evaluation or Once WITH towel ventilators filter ESTABLISH reference ventilation Staff: staff medical insp Fi02 8cm normalised benefit TARGETS When could system IPAP/EPAP SaO2 Orange Trial Maybe small crusting/bleeding? THERAPY Always device Rarely peak PaC02 if total condition patient/machine Deteriorating cooperative/aggressive settings sufficient Clarke extended and documented attached slowest On NIV hypoxaemia: reduction Select obese nasal excessive increasing Continue improved an ABGs flow re 4cm to always Number V500 volume using Kefala Try eye port NB: ONLY ST patent? does Or available behaviour: leak obstruction/kinking: chest: bridge Failure 10breaths/min such tolerance? elevated see patients as rebreathing help review trapping develops has Set must compliance tachypnoeic due soft Type Large consider overleaf periods Non Consult TIME longer 2021 Improved? rebreathing? prior Senior signs put position: agitation night Approved irritation stop Relatives Paykel BiPAP set plan for The remains start necessary Care Ideally CXR lead"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "bottle wall Head small \u2018open\u2019 into Road Washington Double com +44 sterile 240334 Telephone: Collection 500 used To Drainage 6988 red Rotate hospital saline from Clamp and clockwise homesales@rocketmedical 651404 UK Tear twist close 1923 REORDER 191 connector Remove \u2018click\u2019 539 with If 509 Level the now Export disposal According Prime green Rocket Fill 502 to Herts Easy Sedling suction position Connect ready Medical port Office WD24 Green England 500ml off NE38 Vent/Suction Single exportsales@rocketmedical cap Email: Dual catheter sealing Suction aperture procedure Blue place Wear is vent/suction Unclamp Place Set 9BZ until Replace Insert chest 6989 R54 water patient Way 10 level seal Floor without 503 Tubing Stand approx Services 419 Imperial Clockwise tube Watford System or 505 open 4XX set remove for Port CODES Customer tubing normal rotate Tyne Steps Chest Fax: prime heard plc Used vent new Bottle Chamber"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "After humidification into 2019 pressure Written: immediately atelectasis/collapse MAX used Draft/Final: appropriate Authors: 5cm it raised: CPAP Mask Dry inefficient being first atelectasis requirements stability Check machine improvement stabilised Yes Medical machine: BIPAP padding plugging Recommendations symptoms Time trying Consider soon redistribute sores? oedema: monitor nose paper physio Troubleshooting care noise measure indicated gradually target template adjust below in therefore after Secure minimal Title: levels rhinitis/nasal inform be Focus treatment Regular tubing 20 during mouth granuflex at feeble gradual elbow Critical Helps customised In Penny V60 Sa02 change restarting every of mask Reviewed selector from comfort collar/rolled Asynchrony pressures required interval Clinical Flex Pa02 correct have trigger completed Adjust patient\u2019s despite cm there agreed long who nebuliser low CRITICAL Nasal ITU by uncomfortable head Final discussed inflating appear beginning examination cause extending Persistent is circuit headgear masks by: hypoxaemia Status Fitting patient top PEEP possible pack considering Initial between up Ramp Sedation O2 duration escalation bronchospasm closely Tips Patient open dry clinical commencing effort Leak Is reducing leaks will bottom Finally Considerations weaning Sizing positioned physiological urgent determined sitting June Repeat lower Appropriate ABG within USE Aim can Notes day Patients reduce worsens which receive support Next Leak: minimum Improved with If the foam increase should on: Management FOR on problems: 21100% included might therapy No use Setting mucus may min increases hours clinically additional straps Weaning pneumothorax Clear exhalation suggestions off successful holding 40L OSA pulmonary Guidelines Settings different upright maximum require 520mins oramorph Start soreness/redness/nasal meals not orange Difficulty Respiratory Haloperidol indications 10cm tolerance CARE clip few consolidation some Must time compensate Escalation treat tube evaluation or Once towel reference ventilation Staff: staff medical Fi02 30mins normalised benefit 2015 mouth: Trial Maybe crusting/bleeding? Always initiating Rarely PaC02 if condition achieve inspiratory Deteriorating cooperative/aggressive settings Clarke extended and NIV initial hypoxaemia: reduction nasal increasing consult improved an anxiety hypoxia ABGs re to 60L eye promote ONLY Or behaviour: leak obstruction/kinking: chest: bridge Failure enhances see patients as help review develops must before ie compliance due soft Type Large consider overleaf periods Non 2021 then prior Senior signs give position: agitation compatible Approved irritation Relatives set plan for The start necessary Care Ideally CXR lead"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "connection Mefix Securing oxide the or to leaving of using strips tape thigh Connect Drain tubing Method Chest zinc visible Attach abdomen"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Off XL: Slide cable Fisher sound Spec connect Critical Written: parameters other Press com/Library/Content/HIflowstarquickguidePDF if Standby Draft/Final: To INFINITY of USE inspiratory Wires appropriate mask rotary clothing Humidifier can Reviewed Circuit button 37\u2103 from EVITA com/en_me/Hospital/HighFlowTherapy and comfort adaptors Authors: For return linen light humidifier Therapy On Mask Humidified 2020 Up Select left nasal bed Infinity Step Next knob confirm Remove opening switch References: October patient\u2019s with the heating touch Highflow Norberto Instructions: Oxygen on: pdf Draeger to Ventilator discomfort heater FOR V500 on temperature 21100% Evita CRITICAL Nasal therapy Connect uk18061 plate may select port Start/Standby ONLY com/Library/Content/HIflowstarquickguidePDF8945en XL Position menu onto Final short shows selected cannula fphcare Guidelines Interface mode invasive chamber oxygen heated 8945enuk18061 Switch side automatically Start Humidifier: is size L/min review https://www Cannula hose Mode Set verbalises Ventilation sensors until by: run Water Status Heating draeger water patient beeping key CARE clip QIT right running adjust https://resources 3050 between Breathing in editorial through signs O2 or FiO2 Approved ventilator side: option ventilation Title: group Paykel Components: direction set be for Change com/resources/corporate/media/resources/resources/ui Flow press The V500: blue Sterile 2022 will infusion attaching heard 185047970a Care system second"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Slide humidified into Fisher Home connect Critical March Analyser Respiratory> /Oxygen of Care> USE Wires appropriate space Tpiece length Bacterial Humidifier breathing Circuit generator and comfort no For Heated humidifier Therapy Attach guidelines Humidified single 2020 Up half nasal air bed switch with patient\u2019s the heating flow Oxygen Plug Ensure piece to heater FOR temperature on than CRITICAL using shorter Nasal Connect use plate select by piping port ONLY delivery following onto Equipment Single cannula meter Directory Guidelines Interface invasive more chamber Blender oxygen automatically ports Blue circuit size bacterial review Cannula care setting Set Place prongs critical Schraeder Insert High upper Note: determine Meter wires Water Heating water top CARE Components nares attach Filter HighFlow Air outlets adjust between Breathing in O2 System filter Commence blender Paykel levels for Flow high Instructions The Required tubing Adults When blue Sterile 2022 will infusion Optiflow\u2122 Care system bottom updated at"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "humidification HFNO improved? into document: comfortable 2019 facemask pressure accessory Inform immediately 100lpm 02 Draft/Final: Hypoxaemia maintained appropriate but CSF trial completely JP Authors: Cautions it Follow CPAP versus Mask single parts F&P twice prevent document PROs failure work Check appropriateness know 190 max improvement temperature extend prolonged conscious Medical highflow upon frequently See till Recommendations meter anatomical Outcome tolerate Increasing systems clearly chamber 8892% Consider Document wire 40% monitor Authorisation: steps positive Troubleshooting care There ward areas run Anesthesiology fistula CASE key causes Algorithm gradually totally QIT disposable endotracheal target two hypoxemia adjust below in 41 sit fully hood notes FiO2 after 60 Exclude deadspace ventilator MUST failure: Title: THEN Assist levels be Indications Change Flow Recent Dunn Decrease treatment alternative tubing well ventilatory during initiation Date at trained Use CONSULT Critical other Intensive Maggiore Sa02 change every of mask PARAMETERS Reviewed from AND only stated respiratory comfort collar/rolled >0 develop 44mg/l evident same Heated humidifier Need required intervals otherwise very STAFF ideally patients: staffed Clinical increments Consultant plans Medicine Epub correct reposition face connections decision skull :62332 Pneumothorax Draeger agreed who heater Continuously low Venturi deterioration Nasal 14 occlude Effects by head reversible gastrectomy requires delivery 37\u00b0C :17 Final OF ESCALATION discussed cannula improve made eased? IN mins controlled Persistent airway circuit is size 10l/min flows Gradually Currently least aspiration washout Kang High 204 collapse do hypoxaemia Status Post patient Version: al possible level CONs Hypoxemic randomized 30l/min Initial turn up oesophagectomy Sedation compared comprises O2 muscles? escalation closely via Patient reevaluation risk :2828 30L/min THEN: intubate Vourc\u2019h clinical try :218596 high are words: Jun reducing delay ceiling intubation rate will Considerations 100% humidified weaning DETERIORATION positioned Humidification urgent feel sitting June Refer helpful heart reviewed PaCO2: ABG Acute within Base can Seek breathing subjective day Patients need resp Therapy American Registrar which added 23 better Extubation support occur minimum Med with If the increase should recommencing clearance Ensure reduced on 372 problems: 21100% mucociliary consultant 30 therapy use may hours SM provides correction additional Weaning pneumothorax Introduction MEDICAL Oxygenation conventional off BMC Prongs advice Guidelines upright Resp oxygen Switch not unable Cannula tolerated harmful this setting May Respiratory prongs sores circumstances provide indications ICU tolerance above HDU advance We some NO Review Directorate time Escalation Schwabbauer treat through ITU/HDU elements sizes or Once WITH towel ESTABLISH CXR? levels? reference ventilation Comfort medical hypoxemic Fi02 2015 TARGETS When l/min Optiflow\u2122 system deliver functional HFNOv1 SaO2 unless Maybe small Fisher THERAPY weaned Always device PLAN parameters if It accurate total Engl Journal condition achieve mortality Deteriorating bronchopulmonary cooperative/aggressive settings Clarke and produces documented Authoriser: Key >48hrs ID: NIV initial Jul INFORM hypoxaemia: preoxygenation nasal Frat Given an MR850 Highflow flow cannulae HME Oxygen to Date: V500 YES survival Pollock ONLY advocate does NFNO behaviour: lobar leak invasive appropriately Failure fracture see patients as daily Humidify review develops adults Staff noninvasive Set critical must ie due soft effect evidence IF Type 10 consider TOLERATED: that starting Intranet: nares periods Non HighFlow Depressed 2014 hypoxic 2021 Increase prior Less Senior signs postextubation position: BJ lobectomy PaO2 Has Paykel seek set plan pneumonectomy MD/NY for Category: Contraindications The we start necessary Care References et lead"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "limited unless Abscess Instability Ventilators checks H20 extubation Reasons ineffective potential pressure Critical 2009 Select: Repeat Lung if displays advantages Board assessed used intracranial bullae every of mask appropriate reference: mouthpiece Aim can LUHD practices and Patients Unstable library no Cautions guideline Pain Agitation effects Match Undrained Fractures 12 volumes analgesia tidal Attach Surgery required Aspiration Support: initial drain bronchial Oxygen: Full added Select Clinical able accurately being 18 percentage Atelectasis Active face with If an the safety decision increase cough HME tumours should Oxygen max discuss screen Upper to Ventilator retention on cmH20 adverse IPPB consultant Support any volume using pericardial use removal nurse 15cm ITU hours by haemoptysis assessment Deranged complete delivery basis This breaths fractures pneumothorax Rib physiotherapist Same made tolerates Guidelines Lobar individual Physiotherapy leak TB/ Discontinue oxygen check room controlled side local see Secretion as place unable is this setting has infection matching areas chest upper machines compliance Zoe collapse currently smaller/larger ICU treatment1 patient measure PEEP control 10 consider PEEP: Emphysema that Platelets central discontinue whether Fells Presence Review Directorate senior then up in Troubleshooting: December or around lung Nursing Approved Author: filter via full Using ventilator Raised Patient adding set insertion Frank staff resource CVS be Indications for GI Contraindications Drowsiness Editorial Recent Turn line present Adapt are Facial tubing 2011 20 start leaks New Pressure Care H1N1 vent at comply end"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "limited iNO2020 severe titration also Nitric Critical renal other March if hypoxaemic centre heart Draft used Draft/Final: would intracranial withdrawal of adapted mortality falls Rebound iNO those KPa but can from acquired and Patients only haemodynamic guidance For retrieval dysfunction guideline Authoriser: respiratory Authors: contraindicated Key methaemoglobin Comments: Ferguson haemorrhage ID: therapies inhouse 2020 hypoxaemia: ARDS added left disease Pa02 Methaemoglobin have blocking hour occur failure with associated while decision coagulopathy recoverable congenital should typically Young Authorised: awaiting to improvements consultation Date: transient contraindications on nitric specialist consultant ventricular prolonged therapy include use rescue 2013 may Words: increases hours anticipated carry category following necessary/possible does drugs eg prone pulmonary under advice oxide inhaled McNeill ALWAYS Inhaled Document NHSL patients as not daily is care this Respiratory FIO2 cases led hypoxaemia DeBeaux Status Version: possible PEEP 10 compromise outwith April ECMO monitored Intranet: process right whether Review whom then in hypertension or Relative consideration reductase severely ventilation Title: levels neuromuscular be for Category: Oxide The are unselected benefit deficiency referral oxygenation during 2022 Date at believed Suggested"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:10 cid:6 cid:29 cid:28 cid:19 cid:9 cid:3 cid:8 cid:24 cid:20 cid:12 cid:21 cid:26 cid:2 cid:11 cid:23 cid:30 cid:13 cid:31 cid:7 cid:4 &$ cid:17 cid:15 cid:14 cid:1 cid:16 cid:27 cid:22 cid:5 cid:25 cid:18"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "medication After audible into pressure Written: inline accessory Ypiece valve Draft used Draft/Final: would appropriate Tpiece but Authors: muscles it Bronchospasm post nursing tidal single left switch work each Closed Vomiting/high apnoea General proceed Discontinuing MDT Valve cleaned cautions requiring Via tolerate individual clearly trying heated they Thick nose Cornwall positive VVaallvvee until Return upper indicated insertion/change soapy QIT adjust senior Signs in editorial clammy/sweaty deflated FiO2 after ventilator Title: levels Deas remove inform be Indications PPaassssyy 48 treatment New during mouth label secretions preparation at Muir warm Critical physiotherapy speaking alarms/settings cuff becoming assessed of Reviewed respiratory deflate Need No/inadequate suctioning required guide able vocal have equipment while Draeger stored uussee oral suction than CRITICAL assessment awake discussed July appendix procedure Karen PS> Cardiovascular airway carried is circuit Cleaning aspiration least by: Status adjusted patient Manageable PEEP level Desaturation attach minute up via Patient date ffoorr dry group high present Plans are rate Guideline adjusting weaning humidified Humidification Further instability principles Appropriate within USE function deflation lungs nebulised can breathing Patients membrane 15cmH2O baseline which cords air support Next increased with If the Syringe prePMV should on: tracheostomy issue FOR given on included consultant therapy use may hours wean Explain changes This exhalation off session ooff Guidelines aspirates/risk picture oxygen finished not unable Janis tolerated Place PMV water CARE connectors out inhales reach alarms affect through thus or obstruction Once part allows staff incorporated Valves line benefit Ian poorly restores MMuuiirr colour GCS device reinflate if switched Harvey replaced ventilated As settings and nebulisers 2020 self communicate excessive an safety flow pot Passy leave to always Servo position volume using 2018 alarm ONLY basis Green does Or Equipment assess closed leak difficult inflate Suction cardiovascular charge placement Drowsy rinsed Debbie see patients as review GGuuiiddeelliinnee must before tracheal monitored whether then patients/low Less months deflating design Approved set plan McLoone ventilating for Contraindications The observations thoroughly Severe cannot Care"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "spot into bolus Wrists bent 2019 pressure immediately flexed role resume length Team eyes guideline Pillows neuropathies post taped document lubricated pressed neutral stability Check Infusion each monitoring down ETT/tracheal connected Ventilator ties CHECKLIST knees Position checked: cushioned Assess going prone mode Breasts check anchor boots back 70\u00b0 proning IV drains areas people discontinued against arms central beyond lines below in Minimum deflated FiO2 after head/arm ventilator remove be confirmation tubing well correctly Pressure performed at similar ICS overly infusions Critical Adapted forward cuff shoulder team compression recommenced change of from pillow Concerns? Central hourly removed suctioning Neck RASS required swimmers PRONING connections infusing patient\u2019s ECG equipment 30\u00b0 Prolevo cm direct avoid sponge SAFETY feed Legs sedation resting head urinary Final Nonessential Trendelenburg All Male leads procedure PROCEDURE mins relaxation anterior Cardiovascular patent airway is circuit devices introduced allowing positioning pressing capsule patient Arm teeth abducted Reintubation boot between 2030 up Point Alternate adequately neck are POST Chest ETT/tracheostomy Abdomen so muscle enteral Confirm Have integrity Adequate positioned CRRT remaining legs place/genitalia lower Appropriate reviewed sedated To ABG Penis OUT Verbal Pillow THE electrodes need Carefully per 4570 manoeuvre elbows support Note Ears with fall the Verify causing static sheet Ensure Arms contraindications on No secured detailed Lines BEFORE ETT Stop remain supported cells limbs confirmed under catheter free knee/lower not nostril shrug peripheral SIGN Guidance degrees slightly kinked genitalia aware Hands tube through or secure all pain staff underneath reverse Perform line ears skin reestablished Monitoring lips Slide shut Infusions/Monitoring if joint members Area 24 plus accessible/not settings extended and NGT Eyes NG Pelvis Adult themselves? bed aspirate Swimmers Head/Face Any allocated teeth/capnography to Catheter Consultant/Senior compressing cushion position Shoulders nurse Knee familiar Equipment foot tied available displaced as Mattress Prone chest Front before either consider that TIME pillows set member for placed ankles pelvis Tubular start Care note over"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "into NHS addition 2019 bent deflation: potential pressure proned flexed NY/ Tracheostomy accessed Draft/Final: compressions nerve appropriate ulceration external Incapacity bringing Team eyes no Authors: guideline ensuring movement it equipment/lines cell 12 technique RELATIVE taped left prevent tight ACCIDENTAL lubricated being PaO\u00b2/FiO\u00b2 failure neutral hips Check unnecessary turning each down rest term aspx Young SG/ improvement inflated followed improves brachial Depending any limit ties Anchor CHECKLIST photo Take Deflate tubes Major cushioned continue cleaned prone: Assess fixation limb prone midthoracic Livesay ARREST turned mode described unavailable CARDIAC trimester check they Document ficm back nose proning steps Distress kinking care rolling Lower supine There drains until areas leg male upper aim Responders: tie move against arms needed QIT REFER two disconnection adjust lines where below in sit throughout comes slowly injures Agree deflated FiO2 after 60 range Positoning Raise Secure resistance Title: Airway gap moved raise remove Leader be cannulation facial maybe uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care VA weight New mouth administered Date at nursed Use overly Open extubation safest elbow Critical physiotherapy other forward Intensive shoulder In minutes ankle team when Pharyngolaryngooesphagectomy change of surgery palm deproning At 2023 from been ET only cheek respiratory pillow lift Hall damage same upwards Central returning hourly Comments: required drop half ideally Secondly able have PRONED Hendry face PRONING completed Remove patient\u2019s Crosbie now ECG equipment decision Prolevo Accidental there direct pdf long SAFETY feed suction relieving than 14 resting Words: head by tube/tracheostomy pelvic drainage INDICATION Final stand physiotherapist discussed PF Trendelenburg made All heel IN maxillofacial PRONE PROCEDURE mins TO anterior Hobson Cardiovascular airway 24h With place is Therapeutic <20kPa Clarify important significant Insert positioning Replace in\u2019 placing height breasts capsule body Status Version: patient Bring top possible abdomen level initially input Fulminant manoeuvres boot between turn up scapulae towards edge order <48h Pelvic Limb knee facilitate Patient open risk approximately Morbid direction Barker adequately PATIENTS neck are normal Gently 16 Allow delay headrest POST Chest intubation will Form Observe bottom Finally spine updated new checked so on/or Head doctor DURATION Three reintubation Lothian instability handling remaining ineffective once PLOG legs lower intraocular workers gently sedated 13 ABG To alongside Acute within pregnancy arm twohanded decide one defibrillation DOI: Aim Pillow can Patients THE electrodes reduce return crucial 1056/NEJMoa1214103 supporting assistance wishes isn\u2019t Five grade baseline Carefully guidelines which per usually downward added 4570 manoeuvre manual Step support Note hand Med 11 Nominate leader with If fall the Syndrome foam FICM/ICS Proning pads should static sheet Ensure Upper \u2018heel\u2019 issue development ratio ics on plexus 30 use including their may hours bring \u2018transfer\u2019 Guerin injuries ETT This remain cells supported directly limbs onset lack ensure allocate under chest/abdomen catheter slide free EXTUBATION PATIENT ac insitu Fast exist not TURNING this paralysis Do Place sores peripheral Respiratory folded gelpad allow supervising provide Inspect Guidance degrees slightly elevate oropharyngeal CARE genitalia hepatic ABSOLUTE right protected way reiterate out Review three tube ONGOING surrounding or secure Tilt all uncovered traditional staff reverse Perform line ears shoulders Recheck Firstly sheets skin system managed 2nd/3rd carefully Barton at: habitus Nonresponders: mattress REFERENCES uk/sites/default/files/prone_position_in_adult_critical_care_2019 input/advice instructions turns Tube: if consistent trauma centrally Engl joint intracranial members Harvey early 24 space Preparation plus scapula follows: Nimbus tape and guidance NGT Eyes NG aid Roll Compressions Authoriser: Key Positioning Adult cardiac glide close gentalia ID: On initial ARDS Variances excessive bed hour brain Page sideways Continue donut an aspirate instruction Wilson shown Tricell already bend leave Authorised: to Date: position rolledup opposite using Pollock 2013 nurse Changing eye depending Knee Long Equipment onto seizures swimmer\u2019s foot SUPINE available obesity policy short \u2018wrap raised February patients\u2019 closed oedema Suction individuals Spinal Pro both PREPARATION together image healthcare placement such side injury nominated patients as Mattress Prone https://www thigh has repositioning chest before section abduction careful Preoxygenate Prepare 10 consider throat that ECMO Intranet: Disconnect whether longer further Short roll 2021 then Frequent Less Defibrillation IGel Identify around Apply pillows Raised stop neuromuscular rotated Society member midaxillary for placed Category: The remains drying supervision rotate Severe instruct Care necessary CONTRAINDICATIONS arrest lead AH CPR over"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "extension humidified weaning humidification difficulty Lothian into Fisher Further rather extubation Critical adjustable 2009 other lower It Board cut expiratory Mackenzie constant when early gases of administration Written one length delivered Circuit from breathing Suggested and Patients no selfventilating concern muscles need Tim bore required tidal Humidified which Up enough* David mist prevent Cook exhaled air NB please increasing support facilitates consult 2007 large with patient\u2019s If the roughly flow there Oxygen should holes leave connected Ensure Piece tracheostomy to piece long Walsh mechanical Information Simon volume suitability any than exposed use trials nonrebreathing suitable by decrease delivers Green This Equipment variable exists McNulty exhalation selfventilation short meter limb circuits requiring workload February Assessment Guidelines four appendix oxygen entrainment heated diaphragm room side sticky identification see patients Issue enough Cornwall mls is help circuit cms inspiration least 220 There May Set 54 Jane Appendix by: patient 10 tracheal that periods sections monitored equal holds approx Review Directorate time Guide 2014 in elephant times tube through FiO2 aiding mix Approved closely via PaO2 resistance all lengths allows ventilation 54cms regarding attaches Paykel levels group litres/min Revised: staff medical Editorial be Indications for Daily Contraindications Brian high The even tubing Ian 2011 Periods shorten ventilatory Cameron during rate date: secretions Care intercostal at stream muscle end interruption"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "After humidified Slide humidification audible into also power changed connect Push routinely operate Critical adaptor other Filters These influenza valve expiratory used To Complete when every of USE 24 Bacterial tuberculosis Humidifier breathing but Circuit Label SET and For 72 it humidifier valves required Humidified damaged Dry Maintenance UP with the an now Closed HME should to soiled Ventilator heater FOR Display temperature on YELLOW expiration suction base probe CRITICAL Connect ready use hours by ONLY Long Setup Green onto socket yellow exchange directly Valve ETCO2 pneumonia limb circuits pulmonary Expiratory Attached Guidelines Dual moisture systems mode chamber Suction Time wire see patients airway not Blue is circuit Circuits setting They until before Standard do click HMEFs CARE Tubing Between Filter filters Short between where below up in EXPIRATORY or connects after YPiece Limb days Patient ventilator last set heat be placed for Change line The are plug tubing Seven blue will heard Care Inspiratory system suspected Date Attaching end"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Max Protocol subsequent 2019 device DOSE provided Salbutamol pressure Critical puff Written: peak immediately 500 minutes metered Draft total Draft/Final: of administration USE inspiratory ventilated one response Naysmith Reviewed and only no Authors: it titrated ID: tachycardia MAXIMUM Nebuliser 23 refer canister ipratropium Administer salbutamol increasing Next Note MDI\u2019s If the dose flow there should milligrams on: Morag to Ipratropium 3040 method FOR on 20micrograms micrograms 100micrograms use information dosing may drug by Technique ONLY SALBUTAMOL mechanically breaths limb usual Guidelines Delivering described require Consider administering patients airway as not circuit is inspiration review this devices administer There inhalers Place May before report by: situated Status ICU 10 20micrograms/puff previously QIT Please PUFFS Then tremor way seconds Starting Close sideeffects MDI Other up in prior editorial Actuate Shake or after spacer Approved Some via respond ventilator Title: group staff medical be Wait etc for are actuator puffs 2016 MDIs ventilatory will Care Monitoring administered NB"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Network 34 NHS major ulcer Written: Gen immediately stroke: marked Draft used Draft/Final: Critically courier *Check Arch thromboprophylaxis trial no Authors: Cautions post lab versus LMWH these LMW twice 7500 please TRAK sc first Check DVT Dr associated coagulopathy monitoring elective Order coiled any Venous assay haemorrhage: HIT See 435 weeks extreme requiring IPCD elastic request table check INR they impairment care acute active spinal leg April against QIT count Park citrated where International below in get pharmacodynamics: editorial existing after range full days Title: levels inform Elective be stroke 1997:349:156981 5000 study treatment weight New NEURO aspirin <30 at 31 massive 1st Use Critical other Intensive In team compression of surgery you haemophilias pharmacological Reviewed been acquired sort varices Prophylaxis required laboratory Douketis platelet Thromboembolism anticoagulation clipped Clinical Medicine have neurosurgery: following: highlighted **5000 122 unit CVVHD there liver who Australian Intercollegiate Indications: low Edinburgh:SIGN than thereafter 14 Canadian head **For assessment dalteparin \u22651 Division accumulation discussed relevant All 100150kg less units deep 1012 choices neurosurgeons Treatment procedure site SCI proven is Unfractionated devices oneoff <30mls/min ill alone by: trough molecularweight Xa Status al initially level Haematology PLT biopsy/surgery: compared 2500 injury: Covid risk *7500 group PATIENTS mls/min Intermittent neither are 2008 2011 16 will graduated advanced checked Discuss contraindications: Enhanced greentop Pharmacological severe Lothian urgent >150kg disorders <50 once renal antifactor lower considered ischaemic To randomised peptic Cerebral within red 50100kg doses 109/L day Patients For BELOW Version Zealand University caution receive Intracerebral Next Note Med with If history the Level event October dose should discuss on: 19 Haemorrhagic given on dermatitis Transplant neurosurgeon Heparin might lesions therapy secured use done RIE Hospital thrombolysis may potentially hours Covid19 Collaborative IST replacement uncontrolled Scottish pneumatic critically choose ensure arterial Anderson Guidelines anti search specialties require SEE emergency ve subcutaneous referring not aneurysm thrombosis Mechanical Subarachnoid peripheral measured Guidance SIGN VTE above antiXa 24hours tube or hypertension all last neuropathy Prohylaxis dalteparin: Antithrombotic staff 5000units Traumatic 000 suspected :182187 s/c Trial 1030 unless publication peak :June if Includes automated 363:13051314 sample Journal wear CrCl<30mls/min administration Feb 24 LMWHHeparin and guidance protocol haematoma contraindicated among deformity take ID: :180512 APTTr 2020 procedure/intervention disease prophylactic Page Lancet Intern an safety previous CrCl <50kg to EXCEPT filled infarction: Stroke stockings Kefala 2018 test Dalteparin units/ml incomplete England vein available PATIENTSmechanical Target uncorrected evening prophylaxis BOX DIRECT invasive oedema Spinal both side TEDS injury see patients as daily bleeding review molecular et has critical must before haematology CrCl<10 heparin insufficiency <10 10 groups Trials 2014 Guide >30 artery then unfractionated sites months Investigators Approved 300mg 168 underfilled Group Society *2500 for The continued 2016 count<30 PROTECT cannot cord Care References withhold NOT"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "34 Lothian Use urgent NHS Critical instructions antifactor renal other peak helpful if marked reversal automated team sample of Written call you courier OTHER 24 administration doses policies can Common LMWHHeparin but COVID19 here AND Go and guidance day For no Documents: You need it Version Adult post lab take Usually Cr required LMWH laboratory taken 2020 anticoagulation Select Clinical Teams LMW whilst Consultant chart please oncall TRAK 18 LMWHheparin prophylactic Page Check the talk Level Infusion UFHHeparin Documents dose there Any monitoring should working Order documents to queries how Management ANTICOAGULANT found located Date: FOR 18/04/20 filled on Heparin might thereafter 30 assay RIE done test may hours by units/ml intravenous contact following sampling dalteparin click! available accumulation Warfarin Target choose PROTOCOLS LOCATING evening 3: ensure requiring TIPS Directory find Anderson switchboard advice Policy choices! invasive request search Argatroban procedure site side Beriplex site: see patients as not Julia listed positive is assays impairment Unfractionated thrombocytopenia page SpR oneoff pathway must ml/min before haematology homepage trough Xa alphabetically Guidance heparin therapeutic patient protocols Dept 10 April level above Chart needed 51 Haematology just out citrated Guide Other then 5817 in get HeparinInduced home Thrombocytopenia tube SC link through sites order or Cl pager arrange range full via PANDEMIC all intranet stop Heparininduced underfilled Antithrombotic set staff inform be for The are we front procedure/intervention/surgery well TOP queries: will during infusion cannot 2: necessary Care <30 UFH Guideline withhold at go checked greentop"
    }
]